Third Coast Bancshares, Inc 8-K, filed Sep 9, 2022
Third Coast Bancshares, Inc. (TCBX)
About this 8-K
Third Coast Bancshares, Inc filed this 8-K on September 9, 2022, reporting on events of September 8, 2022.
Items reported
- Item 1.01: Entered into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to shareholders' rights
- Item 5.03: Charter or bylaw amendment, or fiscal year change
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
| |
||||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code:
Former name or former address, if changed since last report: Not Applicable
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01 | Entry into a Material Definitive Agreement. |
Investment Agreement
On September 8, 2022, Third Coast Bancshares, Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Castle Creek Capital Partners VIII, L.P. (“Castle Creek”) and certain other accredited investors party thereto (together with Castle Creek, collectively, the “Purchasers”), pursuant to which the Company has agreed to issue and sell (i) 69,400 shares of a new series of preferred stock to be designated Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share, with a liquidation preference of $1,000 per share (the “Series A Preferred Stock”); and (ii) warrants to purchase an aggregate of 175,000 shares of the Company’s common stock, par value $1.00 per share (“Common Stock”) (or, at the election of the warrant holder in accordance with the terms of the warrant agreement (the “Warrant Agreement”), described below, Series B Convertible Perpetual Preferred Stock, par value $1.00 per share (“Series B Preferred Stock”), or Non-Voting Common Stock (as defined below)) at an exercise price equal to $22.50 per share, in a private placement (the “Private Placement”) for gross proceeds of $69,400,000. The Company intends to use the net proceeds of the Private Placement for general corporate purposes.
Subject to the terms and conditions set forth in the Investment Agreement and the certificate of designation for the Series A Preferred Stock (the “Series A Certificate of Designation”), the Series A Preferred Stock will be convertible into, (i) shares of Common Stock, subject to a cap with respect to each Purchaser equal to 9.9% of the total outstanding shares of Common Stock (the “Regulatory Cap”), and thereafter, subject to such Regulatory Cap, (ii) shares of Series B Preferred Stock, and (iii) following the requisite shareholder approval and subject to the terms and conditions of the Certificate of Amendment to the Company’s First Amended and Restated Certificate of Formation (the “Non-Voting Common Stock Certificate of Amendment”), non-voting common stock, par value $1.00 per share, of the Company (the “Non-Voting Common Stock,” together with the Common Stock, Series A Preferred Stock, Series B Preferred Stock, and the Warrant, the “Securities”). Pursuant to the rules of The Nasdaq Stock Market LLC (“Nasdaq”), no Purchaser may convert or exercise its Securities if doing so would cause the Purchaser, when combined with the other Purchasers in the Private Placement, to own more than 19.9% of the Common Stock outstanding immediately prior to the execution of the Investment Agreement (the “Exchange Cap”).
The closing of the Private Placement is subject to customary conditions to closing and is anticipated to occur on September 22, 2022.
The foregoing description of the Investment Agreement does not purport to be complete and is qualified in its entirety by reference to the Investment Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Series A Preferred Stock and Series B Preferred Stock
On September 9, 2022, the Company filed the Series A Certificate of Designation with the Texas Secretary of State and the certificate of designation for the Series B Preferred Stock with the Texas Secretary of State (the “Series B Certificate of Designation”, and together with the Series A Certificate of Designation, the “Certificates of Designation”). The preferences, limitations, powers and relative rights of the Series A Preferred Stock and the Series B Preferred Stock are set forth in the respective Certificates of Designation, and are described below.
Series A Preferred Stock
The Series A Preferred Stock will, with respect to dividend rights and rights on liquidation, winding-up and dissolution of the Company, rank (i) on a parity with each other class or series of preferred stock established after the issuance date of the Series A Preferred Stock by the Company, the terms of which expressly provide that such class or series will rank on a parity with the Series A Preferred Stock as to dividend rights and rights on liquidation, winding-up and dissolution of the Company, and (ii) senior to the Common Stock and each other class or series of capital stock outstanding or established after the issuance date of the Series A Preferred Stock by the Company, the terms of which do not expressly provide that it ranks on a parity with or senior to the Series A Preferred Stock as to dividend rights and rights on liquidation, winding-up and dissolution of the Company. Holders of the Series A Preferred Stock shall be entitled to receive with respect to each share of Series A Preferred Stock, when, as and if declared by the board of directors of the Company, but only out of funds legally available therefor, non-cumulative dividends on each January 15, April 15, July 15 and October 15, beginning on the first such date following the issuance date of the Series A Preferred Stock by the Company, at a rate per annum equal to 6.75% of the $1,000 liquidation preference of each such share. The Company’s ability to pay dividends on the Common Stock or any securities ranking junior to the Series A Preferred Stock is limited by the Series A Certificate of Designation for any dividend period if dividends are not declared and paid in full on the Series A Preferred Stock.
Subject to the terms and conditions set forth in the Series A Certificate of Designation, the Regulatory Cap and the Exchange Cap, the Series A Preferred Stock is convertible into Common Stock and Non-Voting Common Stock at a rate equal to its liquidation preference of $1,000 per share divided by the conversion price of $22.50 (the “Conversion Price”). The Series A Preferred Stock that is converted into Series B Preferred Stock shall convert at a rate of one share of Series B Preferred Stock for one share of Series A Preferred Stock.
The Conversion Price is subject to adjustment in accordance with the terms of the Series A Certificate of Designation in connection with certain customary events, including, without limitation, certain dividends, distributions, subdivisions, splits, combinations, tender or exchange offers, and share issuances.
Holders of Series A Preferred Stock will have no voting rights except as may be required by law; provided, however that the Series A Preferred Stock, voting as a single class, must approve by a majority of the shares of Series A Preferred Stock at the time outstanding, (i) any amendment, alteration or repeal of any provision of the certificate of formation of the Company, including the Series A Certificate of Designation, that would alter or change the preferences, limitations, voting powers, or relative rights of the holders of the Series A Preferred Stock so as to affect them significantly and adversely; (ii) any amendment or alteration of the certificate of formation of the Company, including the Series A Certificate of Designation, to authorize, create or increase, or to obligate the Company to authorize, issue or increase, the authorized amount of any securities ranking senior to the Series A Preferred Stock; or (iii) prior to the first anniversary of the issuance date of the Series A Preferred Stock by the Company, any amendment or alteration of the certificate of formation of the Company, including the Series A Certificate of Designation, to authorize, create or increase, or to obligate the Company to authorize, issue or increase, the authorized amount of any securities that rank on a parity with the Series A Preferred Stock, provided, however, that such vote or consent in favor of the creation of parity securities shall not be unreasonably withheld, conditioned or delayed.
The Company may redeem, in whole or in part, the shares of Series A Preferred Stock at the time outstanding at any time, subject to regulatory approval, following the fifth anniversary of the issuance date of the Series A Preferred Stock (the “Optional Redemption Date”); provided, however, that the Company shall not be permitted to redeem unless the closing price of the Common Stock is greater than one hundred twenty percent (120%) of the Conversion Price (without taking into account any downward adjustment thereto in accordance with the terms of the Series A Certificate of Designation) for any twenty (20) trading days within a period of thirty (30) consecutive trading days. The redemption price for shares of Series A Preferred Stock redeemed pursuant to the preceding sentence shall be equal to $1,000 per share, plus any declared and unpaid dividends thereon, without regard to, or accumulation of, any undeclared dividends, to but excluding the date of redemption. In addition and notwithstanding the above, the Company may redeem in whole but not in part, the shares of Series A Preferred Stock at the time outstanding at any time if the Series A Preferred Stock ceases to constitute Additional Tier 1 capital.
Upon the consummation of certain mergers, consolidations, sales or reorganizations, each share of Series A Preferred Stock outstanding immediately prior to such event shall become at the effective time of such event the right to receive, at the election of the holder of Series A Preferred Stock, (A) the kind of securities, cash and other property receivable in such event by the holder of the Series A Preferred Stock with respect to that number of shares of Common Stock into which the shares of Series A Preferred Stock would then be convertible assuming that on the date such option is exercised the applicable regulatory approval has been obtained and remains in effect, or (B) cash payable by the Company or such other person in an amount equal to the liquidation preference of the Series A Preferred Stock, in each case plus, if the such event is consummated prior to the Optional Redemption Date, an amount equal to the cumulative cash dividends that would be payable by the Company from the date of the consummation of such event through the Optional Redemption Date as if the dividends on the Series A Preferred Stock were cumulative.
Series B Preferred Stock
The Series B Preferred Stock will rank pari passu with the Common Stock with respect to the payment of dividends or distributions, whether payable in cash, securities, options or other property, and with respect to issuance, grant or sale of any rights to purchase stock, warrants, securities or other property on a pro rata basis with the Common Stock determined on an as-converted basis assuming all shares of Series B Preferred Stock had been converted pursuant to the terms of the Series B Certificate of Designation as of immediately prior to the record date of the applicable dividend or distribution. The Series B Preferred Stock will, with respect to rights upon liquidation, winding up and dissolution, rank (i) subordinate and junior in right of payment to all other securities of the Company which, by their respective terms, are senior to the Series B Preferred Stock or the Common Stock, and (ii) pari passu with the Common Stock pro rata on an as-converted basis.
Each share of Series B Preferred Stock will automatically convert into 44.44 shares of Non-Voting Common Stock effective as of the close of business on the date that the Company obtains shareholder approval for and files the Non-Voting Common Stock Certificate of Amendment to authorize the class of Non-Voting Common Stock. The Company must request shareholder approval of the amendment to the Company’s certificate of formation to authorize the class of Non-Voting Common Stock no later than its the 2023 annual meeting of Company shareholders. Unless the shares of Series B Preferred Stock have previously been converted into shares of Non-Voting Common Stock as described above, each share of Series B Preferred Stock will automatically convert into one share of Common Stock upon a permissible transfer (as defined in the Series B Certificate of Designation) of such shares of Series B Preferred Stock to a non-affiliate of such holder or may be converted into one share of Common Stock at any time, provided that, upon such conversion, the holder and its affiliates will not own or control in the aggregate more than 9.9% of the Company’s voting securities or violate the Exchange Cap.
Holders of Series B Preferred Stock will have no voting rights except as may be required by law.
Except to the extent a liquidation may be deemed to be a redemption, the Series B Preferred Stock will not be redeemable by either the Company or by the holder.
The foregoing description of the Certificates of Designation does not purport to be complete and is qualified in its entirety by the full text of the Series A Certificate of Designation, attached at Exhibit 3.1 hereto, and the Series B Certificate of Designation, attached Exhibit 3.2 hereto.
Warrant Agreement
In connection with the Private Placement, the Company agreed to issue an aggregate of 175,000 Warrants to certain investors in the Private Placement. The Warrants have an exercise price of $22.50 per share pursuant to the terms of the Warrant Agreement. The Warrant is exercisable at any time after closing date of the Private Placement and expire at 11:59 p.m., New York City time, on the seventh anniversary of the date of issuance of the Warrant. Exercise of the Warrants for Common Stock is subject to the Exchange Cap and Regulatory Cap.
The exercise price and the number of shares of Common Stock for which the Warrant is exercisable are subject to adjustment from time to time upon the occurrence of certain customary events, including, without limitation, certain share issuances, dividends, distributions, stock splits, subdivisions, reclassifications, combinations and repurchases in accordance with the terms of the Warrant Agreement.
The foregoing description of the Warrant and the Warrant Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Warrant Agreement, which is filed as Exhibit 4.1 to this Current Report on Form 8-K and incorporated herein by reference.
Registration Rights Agreement
In connection with the closing of the transactions contemplated by the Investment Agreement, the Company will enter into a registration rights agreement with the Purchasers (the “Registration Rights Agreement”). Pursuant to the terms of the Registration Rights Agreement, the Company will file a resale registration statement no later than the second anniversary of the Closing Date of the Investment Agreement to register the resale of the Securities.
Pursuant to the Registration Rights Agreement, if the Company intends to file a registration statement covering a primary or secondary offering of any of its Common Stock, Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock, Warrants or other securities, other than a registration pursuant to a registration statement on Form S-8 or a registration statement on Form S-4 or in connection with any dividend or distribution reinvestment or similar plan, the Company will promptly give notice to the holders of the Securities of its intention to effect such a registration and the Company will effect the registration under the Securities Act of 1933, as amended (the “Securities Act”), of all registrable securities that the holders request to be included in such registration.
The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights Agreement, attached as Exhibit 10.2 hereto.
Voting Agreement
The Investment Agreement obligates the Company to submit proposals to the Company’s shareholders no later than the 2023 annual meeting of shareholders for (i) approval of the issuances of shares of Common Stock in excess of the Exchange Cap in accordance with Nasdaq rules, and (ii) approval of the Non-Voting Common Stock Certificate of Amendment to authorize the class of Non-Voting Common Stock (collectively, the “Proposals”). The directors and certain executive officers of the Company entered into a voting agreement, dated September 8, 2022 (the “Voting Agreement”), in connection with the Private Placement pursuant to which they agreed to vote in favor of the Proposals.
The foregoing description of the Voting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Voting Agreement, attached as Exhibit 10.3 hereto.
Letter Agreement
In connection with the closing of the transactions contemplated by the Investment Agreement, the Company will enter into a letter agreement with Castle Creek (the “Letter Agreement”), which provides Castle Creek with certain board representative, board observer, preemptive, information and other rights. Pursuant to the Letter Agreement, Castle Creek will be entitled to have one representative appointed to the Company’s board of directors and the Third Coast Bank, SSB’s (the “Bank”) board of directors for so long a Castle Creek, together with its respective affiliates, owns, in the aggregate, 4.9% or more of all of the outstanding shares of the Company’s Common Stock on an as converted
basis. If Castle Creek, together with its respective affiliates, owns, in the aggregate, 4.9% or more of all of the outstanding shares of the Company’s Common Stock on an as converted basis and does not have a board representative on the Company’s board of directors or the Bank’s board of directors, respectively, the Company or the Bank, as applicable, will invite a person designated by Castle Creek to attend meetings of the Company’s and the Bank’s board of directors as an observer.
So long as Castle Creek, together with its respective affiliates, owns, in the aggregate, 4.9% or more of all of the outstanding shares of the Company’s Common Stock on an as converted basis, if the Company makes any public or nonpublic offering or sale of any equity (including Common Stock, preferred stock or restricted stock), or any securities, options or debt that is convertible or exchangeable into equity or that includes an equity component, then, subject to certain customary exceptions, Castle Creek will be afforded the opportunity to acquire from the Company for the same price (net of any underwriting discounts or sales commissions) and on the same terms as such securities are proposed to be offered to others, up to the amount of new securities in the aggregate required to enable it to maintain its proportionate Common Stock equivalent interest in the Company immediately prior to any such issuance of new securities.
Pursuant to the Letter Agreement, the Company also agreed to reimburse Castle Creek for up to $100,000 of transaction expenses in connection with the Private Placement.
The foregoing description of the Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter Agreement, attached as Exhibit 10.4 hereto.
| Item 3.02 | Unregistered Sales of Equity Securities. |
The information set forth under Item 1.01 of this Current Report on Form 8-K with respect to the Private Placement is incorporated by reference into this Item 3.02. Piper Sandler & Co. (the “Placement Agent”) served as the placement agent for the Private Placement. The Company will pay a fee to the Placement Agent in connection with the Private Placement. The Company has also agreed to reimburse the Placement Agent and Castle Creek for certain expenses incurred in connection with the Private Placement.
The securities to be sold in the Private Placement will be issued without registration under the Securities Act in reliance upon the exemption provided under Section 4(a)(2) of the Securities Act and Regulation D promulgated under thereunder as securities offered and sold only to accredited investors (as defined in Rule 501(a) of Regulation D under the Securities Act) in a transaction not involving any public offering.
| Item 3.03. | Material Modifications to Rights of Security Holders. |
The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.
| Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03. The Certificates of Designation were effective upon filing with the Texas Secretary of State on September 9, 2022.
| Item 7.01 | Regulation FD Disclosure |
Independent Outside Loan Review
In connection with the offering, the Company retained an independent third party loan review firm to conduct an evaluation of the Bank’s loan portfolio and to estimate future cumulative losses within the Bank’s commercial loan portfolio under certain economic stress scenarios and confidentially shared the evaluation with investors. The loan review firm selected a representative sample of 551 loans representing $2.94 billion, or approximately 80% of the Bank’s commercial loan portfolio, across all asset classes and risk grades and performed individual loan reviews.
The evaluation was based on the loan review firm’s proprietary analysis and was not prepared in accordance with generally accepted accounting principles. The evaluation also included a review of, among other things, the Bank’s policies and practices regarding credit policy and administration, product mix, asset concentrations, file accuracy and completeness, loan review, risk management and assessment, and appraisal practices. Based on the loan review firm’s analysis using its (i) baseline economic outlook and (ii) most pessimistic economic outlook, it forecast that the Bank’s 30-month expected future cumulative losses on its loan portfolio would be $16.9 million and $44.1 million, respectively, through December 31, 2024, which compares to the Company’s current allowance for loan losses of $26.7 million as of June 30, 2022. The loan review firm’s baseline economic outlook and most pessimistic economic outlook are based on numerous assumptions, including change in U.S. real GDP on an annual average basis of (i) 2.7%, 2.6%, and 2.8% for 2022, 2023 and 2024, respectively, in the baseline economic outlook, and (ii) 1.3%, -2.9%, and 1.2% for 2022, 2023 and 2024, respectively, in the most pessimistic economic outlook.
Management closely monitors the loan portfolio and the value of the collateral in the loan portfolio. After considering the hypothetical cumulative loss scenario set forth in the loan review and other information, including information regarding the Bank’s borrowers, guarantors, and loan collateral, management believes that the Bank’s loans are appropriately risk rated and that the allowance for loan losses is appropriately determined in accordance with GAAP. However, if management’s assumptions and judgments about the collectability of the loan portfolio are incorrect, the Bank may experience additional losses beyond its current reserves. Such losses could materially affect the Company’s financial condition and ability to execute our business and financial plans.
Press Release
On September 8, 2022, the Company issued a press release announcing the Private Placement, which is furnished as Exhibit 99.1 and is incorporated herein by reference.
In connection with the Private Placement, the Company delivered an investor presentation to potential investors on a confidential basis, a copy of which is furnished herewith as Exhibit 99.2.
The information in this Item 7.01 is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, unless specifically identified therein as being incorporated therein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit Number |
Description | |
| 3.1 | Series A Certificate of Designation | |
| 3.2 | Series B Certificate of Designation | |
| 4.1 | Form of Warrant Agreement | |
| 10.1* | Form of Investment Agreement, dated September 8, 2022, by and among Third Coast Bancshares, Inc. and the several purchasers thereto | |
| 10.2 | Form of Registration Rights Agreement | |
| 10.3 | Form of Voting Agreement | |
| 10.4 | Form of Letter Agreement | |
| 99.1 | Press Release, dated September 8, 2022 | |
| 99.2 | Investor Presentation | |
| 104 | Cover Page Interactive Data File | |
| * | Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished to the Securities and Exchange Commission upon request; provided, however, that the parties may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any document so furnished. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THIRD COAST BANCSHARES, INC. | ||||||
| Date: September 9, 2022 | By: | /s/ R. John McWhorter | ||||
| R. John McWhorter | ||||||
| Chief Financial Officer | ||||||
Exhibit 3.1
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS
OF
SERIES A CONVERTIBLE NON-CUMULATIVE PREFERRED STOCK
OF THIRD COAST BANCSHARES, INC.
Pursuant to Sections 21.155 and 21.156 of the
Business Organizations Code
of the State of Texas
Third Coast Bancshares, Inc. (the “Corporation”), a corporation organized and existing under the Texas Business Organizations Code (the “TBOC”), in accordance with Section 21.155 of the TBOC, does hereby certify:
That pursuant to the authority conferred upon the Board of Directors by the Certificate of Formation of the Corporation, the Board of Directors on September 1, 2022 adopted the following resolution creating a series of 69,400 shares of preferred stock designated as “Series A Convertible Non-Cumulative Preferred Stock,” par value $1.00 per share (“Series A Preferred Stock”):
RESOLVED, that pursuant to the authority conferred upon the Board of Directors in accordance with the provisions of the Certificate of Formation, a series of preferred stock, par value $1.00 per share, of the Corporation be and hereby is created, and that the designation and number of shares thereof and the voting and other powers, preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and restrictions thereof are as follows:
Section 1. Definitions. The following terms have the meanings set forth below or in the section cross-referenced below, as applicable, whether used in the singular or the plural:
“Additional Shares of Common Stock” means all shares of Common Stock issued by the Corporation after the date hereof, other than Excluded Stock.
“Additional Tier 1 Capital” means Additional Tier 1 capital for purposes of capital adequacy regulations of the Federal Reserve Board (or any successor regulatory authority with jurisdiction over bank holding companies), as then in effect and applicable to the Corporation.
“Affiliate” means, with respect to any Person, any Person directly or indirectly controlling, controlled by or under common control with such other Person.
“Applicable Regulatory Approval” means, with respect to a particular Holder, all governmental, quasi-governmental, court or regulatory approvals, consents or statements of non-objection necessary to allow such Holder to acquire the shares of Common Stock issuable upon conversion of the Series A Preferred Stock held by it or to own or control such shares of Common Stock (taking into account Section 8(f), 8(g) and 8(h)) and the expiration or earlier termination of any required waiting period, including any approvals, consents or statements of non-objection required by any state or federal banking regulatory authority.
1
“Board of Directors” means the board of directors of the Corporation or, with respect to any action to be taken by such board of directors, any committee of the board of directors duly authorized to take such action.
“Business Day” means any day other than a Saturday, a Sunday or a day on which banks are required or permitted by law or executive order to be closed in the State of Texas.
“Capital Event” means the receipt by the Corporation of a legal opinion from counsel experienced in such matters to the effect that, as a result of any change, event, occurrence, circumstance or effect occurring on or after the Issue Date, the Series A Preferred Stock does not constitute, or within 90 days of the date of such legal opinion will not constitute, Additional Tier 1 Capital (or its then equivalent if the Corporation were subject to such capital requirement).
“Certificate of Designation” means this Certificate of Designation to the Certificate of Formation.
“Certificate of Formation” means the First Amended and Restated Certificate of Formation of the Corporation, as amended prior to the Issue Date and as amended by this Certificate of Designation and as may be further amended in accordance with the terms of this Certificate of Designation.
“Closing Price” of the Common Stock (or any other securities, cash or other property into which the Series A Preferred Stock becomes convertible in connection with any Reorganization Event) on any Trading Day means the reported last sale price per share (or, if no last sale price is reported, the average of the bid and ask prices per share or, if more than one in either case, the average of the average bid and the average ask prices per share) on such date as reported by the principal national securities exchange on which the Common Stock (or such other property) is listed, or if the Common Stock (or such other property) is not so listed or quoted on a U.S. national securities exchange, or, if no closing price for the Common Stock (or such property) is so reported, the last quoted bid price for the Common Stock (or such property) in the over-the-counter market as reported by Pink Sheets LLC or similar organization, or, if that bid price is not available, the market price of the Common Stock (or such property) on that date as determined by a nationally recognized independent investment banking firm retained for this purpose by the Corporation.
“Common Stock” means the Corporation’s common stock, par value $1.00 per share.
“Common Cap” has the meaning set forth in Section 8(g).
“Corporation” has the meaning set forth in the preamble.
“Corporation Redemption” has the meaning set forth in Section 7(c).
“Corporation Redemption Notice” has the meaning set forth in Section 7(c).
“Conversion Date” has the meaning set forth in Section 8(e).
2
“Conversion Notice” has the meaning set forth in Section 8(b).
“Conversion Price” means, for each share of Series A Preferred Stock, $22.50; provided, however, that in the event an adjustment in the Conversion Price occurs pursuant to Section 12, contemporaneously with such adjustment a corresponding adjustment shall be made in the $22.50 amount used in this definition, including such amount as it may previously have been adjusted pursuant to Section 12 (each a “Reference Amount”) so that, after giving effect to such adjustment, each reference to the applicable Reference Amount shall be to an adjusted amount that bears the same ratio to the respective Reference Amount that the Conversion Price as adjusted pursuant to Section 12 bears to $22.50 (or the then applicable Conversion Price).
“Conversion Rate” means that number of Conversion Securities into which one share of Series A Preferred Stock shall be convertible pursuant to Section 8(a), determined by dividing the Liquidation Preference by the Conversion Price; provided, that Series A Preferred Stock that is converted into Series B Preferred Stock shall convert at a rate of one share of Series B Preferred Stock for one share of Series A Preferred Stock.
“Conversion Securities” means shares of Common Stock, Series B Preferred Stock or Non-Voting Common Stock, as the case may be, as determined pursuant to Section 8(h).
“Current Market Price” means, on any date, the average of the daily Closing Price per share of the Common Stock or other securities on each of the twenty (20) consecutive Trading Days preceding the earlier of the day before the date in question and the day before the Ex-Date with respect to the issuance or distribution giving rise to an adjustment to the Conversion Price pursuant to Section 12.
“Dividend Payment Date” has the meaning set forth in Section 3(a)(i).
“Dividend Period” has the meaning set forth in Section 3(a).
“Exchange Cap” has the meaning set forth in Section 8(i).
“Exchange Cap Allocation Amount” has the meaning set forth in Section 8(i).
“Exchange Property” has the meaning set forth in Section 15(a).
“Excluded Stock” means (1) issuances of any securities issued as a result of a stock split, stock dividend, reclassification or reorganization or similar event that is covered by Section 12(a)(i) or (ii), but solely to the extent such issuance is made to all holders of Common Stock; (2) shares of Common Stock issued pursuant to the granting or exercise of employee stock options, restricted stock or other stock incentives or awards pursuant to the Corporation’s stock incentive plans approved by the Board of Directors or the issuance of stock pursuant to the Corporation’s employee stock purchase plan approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise, for the benefit of any employees, officers or directors of the Corporation, in each case in the ordinary course of providing incentive compensation; (3) shares of Common Stock, Series B Preferred Stock or Non-Voting Common Stock, as applicable, issued upon the conversion of shares of Series A Preferred Stock, Series B Preferred Stock, or Non-Voting Common Stock or upon the exercise of any Warrants; (4) shares
3
of Common Stock issued upon exercise of warrants outstanding as of the date of the Investment Agreement; (5) shares of Common Stock, Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or other securities that are convertible into or exchangeable or exercisable for Common Stock, Series A Preferred Stock, Series B Preferred Stock, or Non-Voting Common Stock, issued as full or partial consideration for a merger, acquisition, joint venture, strategic alliance, license agreement or other similar nonfinancing transaction; or (6) the Warrants issued pursuant to the Warrant Agreements and the shares of Series A Preferred Stock issued pursuant to the Investment Agreement.
“Ex-Date”, when used with respect to any issuance or distribution, means the first date on which the Common Stock or other securities trade without the right to receive the issuance or distribution giving rise to an adjustment to the Conversion Price pursuant to Section 12.
“Existing Buyer” has the meaning set forth in Section 8(i).
“Holder” means a Person in whose name the shares of the Series A Preferred Stock are registered, which may be treated by the Corporation and the Transfer Agent as the absolute owner of the shares of Series A Preferred Stock for the purpose of making payment and settling conversions and for all other purposes.
“Investment Agreement” means the Investment Agreement, dated as of September 8, 2022, by and among the Corporation and the investors named therein, as it may be amended from time to time.
“Issue Date” means the original date of issuance of the Series A Preferred Stock.
“Junior Securities” has the meaning set forth in Section 2.
“Liquidation Preference” means, as to the Series A Preferred Stock, $1,000 per share, plus all declared but unpaid dividends thereon, without regard to, or accumulation of, any undeclared dividends.
“Non-Voting Common Stock” means, if authorized by all necessary action on the part of the Corporation, the Corporation’s non-voting common stock, par value $1.00 per share.
“Non-Voting Common Stock Certificate of Amendment” means an amendment to the Certificate of Formation to be filed with the Secretary of State of the State of Texas to authorize the Non-Voting Common Stock in an amount of shares sufficient to permit the full conversion of the Series B Preferred Stock into shares of Non-Voting Common Stock.
“Optional Redemption Date” has the meaning set forth in Section 9(a).
“Parity Securities” has the meaning set forth in Section 2.
“Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, governmental entity, unincorporated organization or other legal entity.
4
“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading.
“Reorganization Event” has the meaning set forth in Section 15(a)(iv).
“Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the primary U.S. national securities exchange or market on which the Common Stock is listed or, if the Common Stock is not listed on a U.S. national securities exchange, on the principal other market on which the Common Stock is then traded.
“Senior Securities” means any shares or equity securities that rank, with respect to dividend rights and rights on liquidation, winding up and dissolution of the Corporation, senior to the Series A Preferred Stock.
“Series A Preferred Stock” has the meaning set forth in the preamble.
“Series B Preferred Stock” means the Corporation’s Series B Convertible Perpetual Preferred Stock, par value $1.00 per share.
“Shareholder Approval” has the meaning set forth in the Investment Agreement.
“TBOC” has the meaning set forth in the preamble.
“Trading Day” means any day on which the principal national securities exchange on which the Common Stock (or such other property) is listed is open for trading, or, if the Common Stock (or such other property) is not listed on a national securities exchange, any Business Day. A “Trading Day” only includes those days that have a scheduled closing time of 4:00 p.m. (New York City time) or the then standard closing time for regular trading on the relevant exchange or trading system.
“Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
“Transfer Agent” means Continental Stock Transfer & Trust Company, the Corporation’s duly appointed transfer agent, registrar, conversion and dividend disbursing agent for the Series A Preferred Stock, or such other successor entity as the Corporation may, in its reasonable discretion, appoint from time to time.
“Warrant Agreement” means each Warrant Agreement, dated as of the Issue Date, by and between the Corporation and the investor named therein, as each may be amended from time to time.
“Warrants” has the meaning set forth in the Investment Agreement.
5
Section 2. Ranking. The Series A Preferred Stock will, with respect to dividend rights and rights on liquidation, winding-up and dissolution of the Corporation, rank (i) on a parity with each other class or series of preferred stock established after the Issue Date by the Corporation, the terms of which expressly provide that such class or series will rank on a parity with the Series A Preferred Stock as to dividend rights and rights on liquidation, winding-up and dissolution of the Corporation (collectively referred to as “Parity Securities”); and (ii) senior to the Common Stock and each other class or series of capital stock outstanding or established after the Issue Date by the Corporation, the terms of which do not expressly provide that it ranks on a parity with or senior to the Series A Preferred Stock as to dividend rights and rights on liquidation, winding-up and dissolution of the Corporation (collectively referred to as “Junior Securities”). The Company has the right to authorize or issue additional shares or classes or series of Junior Securities without the consent of the Holders.
Section 3. Dividends.
(a) From and after the Issue Date, the Holders shall be entitled to receive with respect to each share of Series A Preferred Stock, when, as and if declared by the Board of Directors, but only out of funds legally available therefor, non-cumulative dividends (subject to Section 3(b) below) on each January 15, April 15, July 15 and October 15, beginning on the first such date following the Issue Date (each, a “Dividend Payment Date”), at a rate per annum equal to 6.75% of the Liquidation Preference of each such share. If any Dividend Payment Date is not a Business Day, then dividends will be payable on the first (1st) Business Day following such date and dividends shall accrue to the actual payment date. The term “Dividend Period” means each period from and including a Dividend Payment Date (or the Issue Date in the case of the first Dividend Period) to but excluding the next Dividend Payment Date. The amount of dividends payable for any Dividend Period shall be computed on the basis of a 360-day year consisting of twelve 30-day months.
(b) Dividends payable on shares of Series A Preferred Stock shall be non-cumulative. To the extent that any such dividends payable on the shares of Series A Preferred Stock on any Dividend Payment Date are not declared and paid, in full or otherwise, on such Dividend Payment Date, then such unpaid dividends shall not cumulate and shall cease to accrue and be payable and the Corporation shall have no obligation to pay, and the Holders shall have no right to receive, dividends accrued for the Dividend Period ending immediately prior to such Dividend Payment Date after such Dividend Payment Date. Holders shall not be entitled to any dividends, whether payable in cash, property or stock, in excess of full dividends for each Dividend Period on the Series A Preferred Stock. No interest, or sum of money in lieu of interest, shall be payable in respect of any dividend payment or failure to make any dividend payment.
(c) Each dividend contemplated by Section 3(a) will be payable to Holders of record as they appear in the records of the Corporation at the close of business on the December 31, March 31, June 30 and September 30 immediately preceding the corresponding Dividend Payment Date.
Section 4. Payment Restrictions. During any time that any shares of Series A Preferred Stock are outstanding, the Corporation shall not (i) declare or pay dividends on, make distributions with respect to, or redeem, purchase or acquire, or make a liquidation payment with respect to, or pay or make available monies for the redemption of, any Common Stock or other Junior Securities, or (ii) redeem, purchase or acquire, or make a liquidation payment with respect to, or pay or make available monies for the redemption of, any Parity Securities (otherwise than pursuant to pro rata offers to purchase all or any pro rata portion of such Parity Securities and the Series A Preferred
6
Stock), unless in each case full dividends on all outstanding shares of the Series A Preferred Stock have been paid or (in the case of current dividends) declared and set aside for payment (except for (w) dividends or distributions paid in shares of, or options, warrants or rights to subscribe for or purchase shares of, Common Stock or other Junior Securities, (x) redemptions or purchases by conversion or exchange of Junior Securities for or into other Junior Securities, or of Parity Securities for or into other Parity Securities or Junior Securities, (y) purchases by the Corporation or its Affiliates as a broker, dealer, advisor, fiduciary, trustee or comparable capacity in connection with transactions effected by or for the account of customers of the Corporation or customers of any of its subsidiaries or in connection with the distribution or trading of such capital stock and (z) acquisitions of shares of Common Stock in respect of exercises of employee equity awards or any related tax withholding). When dividends are not paid in full (or declared and a sum sufficient for such full payment is not so set apart) for any Dividend Period on the Series A Preferred Stock and any Parity Securities, dividends declared on the Series A Preferred Stock and Parity Securities (whether cumulative or non-cumulative) shall only be declared pro rata so that the amount of dividends declared per share on the Series A Preferred Stock and such Parity Securities shall in all cases bear to each other the same ratio that accrued dividends per share on the shares of the Series A Preferred Stock (but without, in the case of any non-cumulative preferred stock, accumulation of unpaid dividends for prior Dividend Periods) and such Parity Securities bear to each other.
Section 5. Voting Rights.
(a) Except as otherwise provided herein or as otherwise required by the TBOC, the Series A Preferred Stock shall have no voting rights. However, as long as any shares of Series A Preferred Stock are outstanding, the vote or consent of the Holders of a majority of the shares of Series A Preferred Stock at the time outstanding, voting as a single class, either in writing without a meeting or by vote at any meeting called for the purpose, will be necessary to effect or validate:
(i) any amendment, alteration or repeal of any provision of the Certificate of Formation (including this Certificate of Designation) that would alter or change the preferences, limitations, voting powers, or relative rights of the holders of the Series A Preferred Stock so as to affect them significantly and adversely;
(ii) any amendment or alteration of the Certificate of Formation (including this Certificate of Designation) to authorize, create or increase, or to obligate the Corporation to authorize, issue or increase, the authorized amount of any Senior Securities; or
(iii) prior to the first (1st) anniversary of the Issue Date, any amendment or alteration of the Certificate of Formation (including this Certificate of Designation) to authorize, create or increase, or to obligate the Corporation to authorize, issue or increase, the authorized amount of any Parity Securities; provided, however, that such vote or consent in favor of the actions set forth in this Section 5(a)(iii) shall not be unreasonably withheld, conditioned or delayed.
(b) Notwithstanding anything to the contrary herein, Holders shall not have any voting rights (1) other than as set forth above in this Section 5, and (2) if, at or prior to the effective time of the act with respect to which such vote would otherwise be required, all outstanding shares of Series A Preferred Stock shall have been converted in accordance with the terms of this Certificate of Designation.
7
Section 6. Liquidation.
(a) In the event the Corporation voluntarily or involuntarily liquidates, dissolves or winds up, subject to the rights of any creditors of the Corporation or any holders of Senior Securities or Parity Securities, the Holders at the time shall be entitled to receive liquidating distributions per share of Series A Preferred Stock in an amount equal to the greater of (i) the amount of the Liquidation Preference per share of Series A Preferred Stock or (ii) the amount that the Holders would have received in respect of the Conversion Securities issuable upon conversion of such share of Series A Preferred Stock had they converted such share of Series A Preferred Stock immediately prior to such event, in each case out of assets legally available for distribution to the Corporation’s shareholders, before any distribution of assets is made to the holders of the Common Stock, any other Conversion Securities or any other Junior Securities. After payment of the full amount of such liquidating distributions, Holders of the Series A Preferred Stock shall have no right or claim to any of the remaining assets of the Corporation.
(b) In the event the assets of the Corporation available for distribution to shareholders upon any liquidation, dissolution or winding-up of the affairs of the Corporation, whether voluntary or involuntary, shall be insufficient to pay in full the amounts payable with respect to all outstanding shares of the Series A Preferred Stock and the corresponding amounts payable on any Parity Securities, Holders and the holders of such Parity Securities shall share ratably in any distribution of assets of the Corporation in proportion to the full respective liquidating distributions to which they would otherwise be respectively entitled.
(c) The Corporation’s consolidation or merger with or into any other entity, the consolidation or merger of any other entity with or into the Corporation, or the sale of all or substantially all of the Corporation’s property or business will not constitute its liquidation, dissolution or winding up.
Section 7. Optional Redemption by the Corporation.
(a) The Corporation, at the option of the Board of Directors or any duly authorized committee of the Board of Directors, may redeem out of assets legally available therefor, in whole or in part, the shares of Series A Preferred Stock at the time outstanding at any time following the fifth (5th) anniversary of the Issue Date (such anniversary, the “Optional Redemption Date”), provided, however, that the Corporation shall not be permitted to redeem unless the Closing Price of the Common Stock is greater than one hundred twenty percent (120%) of the Conversion Price (without taking into account any downward adjustment thereto in accordance with the definition thereof) for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days. The redemption price for shares of Series A Preferred Stock redeemed pursuant to the preceding sentence shall be equal to $1,000 per share, plus any declared and unpaid dividends thereon, without regard to, or accumulation of, any undeclared dividends, to but excluding the date of redemption.
(b) In addition and notwithstanding the above, the Corporation, at the option of the Board of Directors or any duly authorized committee of the Board of Directors, may redeem out of assets legally available therefor, in whole but not in part, the shares of Series A Preferred Stock at the time outstanding at any time following a Capital Event. The redemption price for shares of Series A Preferred Stock redeemed pursuant to this Section 7(b) shall be equal to $1,000 per share, plus any declared and unpaid dividends thereon, without regard to, or accumulation of, any undeclared dividends, to but excluding the date of redemption.
8
(c) Any redemption made by the Corporation pursuant to this Section 7 (the “Corporation Redemption”) shall be made by providing thirty (30) days’ advance written notice (the “Corporation Redemption Notice”) to the Holders of shares of Series A Preferred Stock.
(d) Upon receipt of a Corporation Redemption Notice, a Holder of shares of Series A Preferred Stock may elect to convert such shares into Conversion Securities in accordance with Section 8 hereof. Such Holder shall notify the Corporation within ten (10) Business Days of receipt of the Corporation Redemption Notice whether such Holder shall elect to convert its shares of Series A Preferred Stock into Conversion Securities in accordance with Section 8 hereof.
(e) The Corporation may not deliver to a Holder a Corporation Redemption Notice unless on or prior to the date of delivery of such Corporation Redemption Notice, the Corporation shall have segregated on the books and records of the Corporation an amount of cash sufficient to pay all amounts to which the Holders of shares of Series A Preferred Stock are entitled upon such redemption pursuant to this Section 7. Any Corporation Redemption Notice delivered shall be irrevocable and shall be accompanied by a statement executed by a duly authorized officer of the Corporation.
(f) The price per share of Series A Preferred Stock required to be paid by the Corporation pursuant to this Section 7 shall be paid in cash to the Holders whose Series A Preferred Stock is being redeemed within five (5) Business Days of the effective date of the Corporation Redemption.
(f) Any redemption of the Series A Preferred Stock is subject to receipt by the Corporation of any required prior approval by the Board of Governors of the Federal Reserve System and to the satisfaction of any conditions set forth in the capital guidelines or regulations of the Board of Governors of the Federal Reserve System applicable to redemption of the Series A Preferred Stock.
Section 8. Conversion at the Option of the Holder.
(a) Subject to Sections 8(f), 8(g), 8(h) and 8(i), shares of the Series A Preferred Stock are convertible, in whole or in part (unless previously converted at the option of the Holder thereof pursuant to a notice delivered in accordance with Section 8(b)), into shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) at the Conversion Rate.
(b) Any written notice of conversion (“Conversion Notice”) pursuant to this Section 8 shall be duly executed by the Holder, and specify:
(i) the number of shares of Series A Preferred Stock to be converted;
9
(ii) the name(s) in which such Holder desires the shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) issuable upon conversion to be registered and whether such shares are to be issued in book-entry or certificated form (subject to compliance with applicable legal requirements if any of such certificates are to be issued in a name other than the name of the Holder);
(iii) if certificates are to be issued, the address to which such Holder wishes delivery to be made of such new certificates to be issued upon such conversion; and
(iv) any other transfer forms, tax forms or other relevant documentation required and specified by the Transfer Agent, if necessary, to effect the conversion.
(c) If specified by the Holder in the Conversion Notice that shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) issuable upon conversion of the Series A Preferred Stock shall be issued to a Person other than the Holder surrendering the shares of Series A Preferred Stock being converted, then the Holder shall pay or cause to be paid any transfer or similar taxes payable in connection with the shares of Common Stock (or Series B Preferred Stock or Non-Voting Common Stock, as appliable) so issued.
(d) Upon receipt by the Transfer Agent of a completed and duly executed Conversion Notice, payment in compliance with Section 8(c), if applicable, and surrender of a certificate representing share(s) of Series A Preferred Stock to be converted (if held in certificated form), the Corporation shall, within three (3) Business Days or as soon as possible thereafter, issue and shall instruct the Transfer Agent to register the number of shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) to which such Holder shall be entitled upon conversion in the name(s) specified by such Holder in the Conversion Notice. If a Holder elects to hold its shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) issuable upon conversion of the Series A Preferred Stock in certificated form, the Corporation shall promptly send or cause to be sent, by hand delivery (with receipt to be acknowledged) or by first-class mail, postage prepaid, to the Holder thereof, at the address designated by such Holder in the Conversion Notice, a certificate or certificates representing the number of shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) to which such Holder shall be entitled upon conversion. In the event that there shall have been surrendered a certificate or certificates representing shares of Series A Preferred Stock, only part of which are to be converted, the Corporation shall issue and deliver to such Holder or such Holder’s designee in the manner provided in the immediately preceding sentence a new certificate or certificates representing the number of shares of Series A Preferred Stock that shall not have been converted.
(e) The issuance by the Corporation of shares of Common Stock (or, once the Common Cap has been reached, Series B Preferred Stock or, after Shareholder Approval, Non-Voting Common Stock) upon a conversion of shares of Series A Preferred Stock pursuant to this Section 8 shall be deemed effective immediately prior to the close of business on the day (the “Conversion Date”) of receipt by the Transfer Agent of the Conversion Notice and other documents, if any, set forth in Section 8(b), payment in compliance with Section 8(c), if applicable, and the surrender by such Holder or such Holder’s designee of the certificate or certificates representing the shares of Series A Preferred Stock to be converted (if held in certificated form), duly assigned or endorsed for transfer to the Corporation (or accompanied by duly executed stock powers relating thereto).
10
(f) Notwithstanding anything to the contrary in this Certificate of Designation, no conversion pursuant to this Section 8 with respect to shares of the Series A Preferred Stock of any Holder shall occur unless, with respect to such Holder, the Applicable Regulatory Approval has been obtained and remains in effect.
(g) Notwithstanding anything to the contrary in this Certificate of Designation, no conversion pursuant to this Section 8 with respect to shares of Series A Preferred Stock held by any Holder shall be permitted to the extent such conversion would result in such Holder owning, together with its Affiliates, more than 9.9% of the outstanding shares of Common Stock after giving effect to such conversion (the “Common Cap”). Those shares of Series A Preferred Stock which are not convertible pursuant to the preceding sentence shall remain outstanding or shall be converted in accordance with Section 8(h), at the election of the Holder.
(h) In the event that the shares of Series A Preferred Stock held by any Holder and its Affiliates would represent upon conversion more than 9.9% of the outstanding shares of Common Stock after giving effect to such conversion and taking into consideration any shares of Common Stock otherwise beneficially owned by such Holder or any of its Affiliates (the number of shares of Series A Preferred Stock representing shares of Common Stock upon conversion in excess of such percentage, the “Excess Shares”), then for all purposes of Section 7 and this Section 8 such Excess Shares shall be convertible into a number of shares of Series B Preferred Stock (or, after Shareholder Approval, at the election of the Holder, Non-Voting Common Stock) equivalent to the number of shares of Common Stock into which such Excess Shares would otherwise have been convertible (including, without limitation, taking into account any adjustments to such number of shares of Common Stock that would have been issuable in respect of the Excess Shares required by Section 12). In such event, (i) each reference in Section 7 or this Section 8 to shares of Common Stock issuable upon conversion of the Series A Preferred Stock shall be deemed a reference to the applicable Conversion Security and (ii) for purposes of the adjustment provisions in Section 12, the number of shares of Common Stock outstanding at any given point of time shall include the number of shares of Non-Voting Common Stock then outstanding assuming Shareholder Approval had been obtained at the time.
(i) Notwithstanding anything to the contrary, the Corporation shall not issue any shares of Common Stock upon the conversion of the Series A Preferred Stock if the issuance of such shares of Common Stock (taken together with each issuance of such shares of Common Stock (1) upon the conversion of the Series B Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series B Preferred Stock or otherwise, (2) upon the conversion of the Non-Voting Common Stock in accordance with the Certificate of Formation as amended by the Non-Voting Common Stock Certificate of Amendment or otherwise, or (3) upon the exercise of the Warrants pursuant to the Warrant Agreements) would exceed 19.9% of the total outstanding shares of Common Stock of the Corporation, or more than 19.9% of the total voting power of the Corporation’s securities, in each case immediately preceding the issuance of the Series A Preferred Stock and Warrants pursuant to the Investment Agreement and the Warrant Agreements (the number of shares which may be issued without violating such limitation, the “Exchange Cap”), except that such limitation shall not apply in the event that the Corporation
11
obtains the approval of its shareholders as required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of such amount. Until such approval is obtained, the holders of the Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants (collectively, the “Existing Buyers” and each, individually, an “Existing Buyer”) shall not be permitted to convert Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock or exercise Warrants with respect to more than such Existing Buyer’s pro rata amount of such Exchange Cap (such amount, with respect to each Existing Buyer, its “Exchange Cap Allocation Amount”) determined based upon such Existing Buyer’s percentage ownership of the sum of (1) the aggregate number of shares of Common Stock issuable upon the conversion of all shares of Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock, plus (2) the aggregate number of shares of Common Stock issuable upon exercise of the Warrants. In the event that such Existing Buyer shall sell or otherwise transfer any of such Existing Buyer’s shares of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Warrants, the transferee shall be allocated a pro rata portion of such Existing Buyer’s Exchange Cap Allocation Amount with respect to such portion of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants so transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation Amount so allocated to such transferee. Upon conversion and exercise in full of such Existing Buyer’s Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants, the difference (if any) between such Existing Buyer’s Exchange Cap Allocation Amount and the number of shares of Common Stock actually issued to such Existing Buyer upon such Existing Buyer’s conversion in full of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants shall be allocated to the respective Exchange Cap Allocation Amounts of the remaining Existing Buyers of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants on a pro rata basis in proportion to the relative Exchange Cap Allocation Amounts of such Existing Buyers.
Section 9. Conversion Procedures.
(a) On any Conversion Date, any shares of Series A Preferred Stock converted to Conversion Securities shall cease to be outstanding, in each case, subject to the right of Holders of such shares to receive Conversion Securities into which such shares of Series A Preferred Stock are convertible.
(b) The Person or Persons entitled to receive the Conversion Securities issuable upon any such conversion shall be treated for all purposes as the record holder(s) of such Conversion Securities as of the close of business on the applicable Conversion Date. No allowance or adjustment, except as set forth in Section 12, shall be made in respect of dividends payable to holders of Conversion Securities of record as of any date prior to such applicable Conversion Date. Prior to such applicable Conversion Date, Conversion Securities issuable upon conversion of any shares of Series A Preferred Stock shall not be deemed outstanding for any purpose, and Holders of shares of Series A Preferred Stock shall have no rights with respect to Conversion Securities (including voting rights as applicable, rights to respond to tender offers for the Conversion Securities and rights to receive any dividends or other distributions on the Conversion Securities) by virtue of holding shares of Series A Preferred Stock.
12
(c) Shares of Series A Preferred Stock duly converted in accordance herewith, or otherwise reacquired by the Corporation, shall resume the status of authorized and unissued preferred stock of the Corporation, undesignated as to series and available for future issuance.
(d) In the event that a Holder of shares of Series A Preferred Stock shall not by written notice designate the name in which Conversion Securities to be issued upon conversion of such Series A Preferred Stock should be registered or the address to which the certificate or certificates representing such Conversion Securities should be sent, the Corporation shall be entitled to register such shares, and make such payment, in the name of the Holder of such Series A Preferred Stock as shown on the records of the Corporation and to send the certificate or certificates representing such Conversion Securities to the address of such Holder shown on the records of the Corporation.
Section 10. Reservation of Conversion Securities.
(a) The Corporation shall at all times reserve and keep available out of its authorized and unissued Conversion Securities, solely for issuance upon the conversion of shares of Series A Preferred Stock as provided in this Certificate of Designation, free from any preemptive or other similar rights, such number of applicable Conversion Securities as shall from time to time be issuable upon the conversion of all the shares of Series A Preferred Stock then outstanding. For purposes of this Section 10(a), the number of Conversion Securities that shall be deliverable upon the conversion of all outstanding shares of Series A Preferred Stock shall be computed as if at the time of computation all such outstanding shares were held by a single Holder.
(b) All Conversion Securities delivered upon conversion of the Series A Preferred Stock shall be duly authorized, validly issued, fully paid and non-assessable, free and clear of all liens, claims, security interests and other encumbrances (other than liens, charges, security interests and other encumbrances created by the Holders).
(c) Prior to the delivery of any securities that the Corporation shall be obligated to deliver upon conversion of the Series A Preferred Stock, the Corporation shall use its reasonable best efforts to comply with all federal and state laws and regulations thereunder requiring the registration of such securities with, or any approval of or consent to the delivery thereof by, any governmental authority.
(d) The Corporation hereby covenants and agrees that, if at any time the Common Stock shall be listed on any national securities exchange or automated quotation system, the Corporation shall, if permitted by the rules of such exchange or automated quotation system, list and keep listed, so long as the Common Stock shall be so listed on such exchange or automated quotation system, all Common Stock issuable upon conversion of the Series A Preferred Stock; provided, however, that if the rules of such exchange or automated quotation system permit the Corporation to defer the listing of such Common Stock until the first conversion of Series A Preferred Stock into Common Stock in accordance with the provisions hereof, the Corporation covenants to list such Common Stock issuable upon conversion of the Series A Preferred Stock in accordance with the requirements of such exchange or automated quotation system at such time.
13
Section 11. Fractional Shares.
(a) No fractional Conversion Securities shall be issued as a result of any conversion of shares of Series A Preferred Stock.
(b) In lieu of any fractional Conversion Security otherwise issuable to a Holder in respect of any conversion pursuant to Section 8, the Corporation shall at its option either (i) issue to such Holder a whole Conversion Security, or (ii) pay an amount in cash (computed to the nearest cent) equal to such fraction times the average Closing Price of the Common Stock (as adjusted by the Conversion Rate for Series B Preferred Stock) for the twenty (20) consecutive Trading Days ending on the second Trading Day immediately preceding the applicable Conversion Date.
(c) If more than one share of the Series A Preferred Stock is surrendered for conversion at one time by or for the same Holder, the number of full Conversion Securities issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Series A Preferred Stock so surrendered.
Section 12. Anti-Dilution Adjustments.
(a) Except as provided in Section 12(c), the Conversion Price shall be subject to the following adjustments:
(i) Stock Dividends and Distributions. If the Corporation pays dividends or other distributions on the Common Stock in shares of Common Stock, then the Conversion Price in effect immediately prior to the Ex-Date for such dividend or distribution will be multiplied by the following fraction:
OS0
OS1
Where,
OS0 = the number of shares of Common Stock outstanding immediately prior to Ex-Date for such dividend or distribution.
OS1 = the sum of the number of shares of Common Stock outstanding immediately prior to the Ex-Date for such dividend or distribution plus the total number of shares of Common Stock constituting such dividend or distribution.
If any dividend or distribution described in this clause (i) is declared but not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to make such dividend or distribution, to such Conversion Price that would be in effect if such dividend or distribution had not been declared.
(ii) Subdivisions, Splits and Combination of the Common Stock. If the Corporation subdivides, splits or combines the shares of Common Stock, then the Conversion Price in effect immediately prior to the effective date of such share subdivision, split or combination will be multiplied by the following fraction:
OS0
OS1
14
Where,
OS0 = the number of shares of Common Stock outstanding immediately prior to the effective date of such share subdivision, split or combination.
OS1 = the number of shares of Common Stock outstanding immediately after the opening of business on the effective date of such share subdivision, split or combination.
If any subdivision, split or combination described in this clause (ii) is announced but the outstanding shares of Common Stock are not subdivided, split or combined, the Conversion Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to subdivide, split or combine the outstanding shares of Common Stock, to such Conversion Price that would be in effect if such subdivision, split or combination had not been announced.
(iii) Debt or Asset Distributions. If the Corporation distributes to all holders of shares of Common Stock evidences of indebtedness, shares of capital stock, securities, cash or other assets (excluding any dividend or distribution referred to in clause (i) above, any dividend or distribution paid exclusively in cash, any consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, and any dividend of shares of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit in the case of certain spin-off transactions as described below), in exchange for consideration in an amount less than the fair market value of the property so distributed then the Conversion Price in effect immediately prior to the Ex-Date for such distribution will be multiplied by the following fraction:
SP0 – FMV
SP0
Where,
SP0 = the Current Market Price per share of Common Stock on such date.
FMV = the fair market value of the portion of the distribution applicable to one share of Common Stock on such date as determined by the Board of Directors.
In a “spin-off,” where the Corporation makes a distribution to all holders of shares of Common Stock consisting of capital stock of any class or series, or similar equity interests of, or relating to, a subsidiary or other business unit, the Conversion Price will be adjusted on the 15th Trading Day after the effective date of the distribution by multiplying such Conversion Price in effect immediately prior to such 15th Trading Day by the following fraction:
MP0
MP0 + MPS
15
Where,
MP0 = the average of the Closing Prices of the Common Stock over the first ten Trading Days commencing on and including the fifth Trading Day following the effective date of such distribution.
MPS = the average of the Closing Prices of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock over the first ten Trading Days commencing on and including the fifth Trading Day following the effective date of such distribution, or, if not traded on a national or regional securities exchange or over-the-counter market, the fair market value of the capital stock or equity interests representing the portion of the distribution applicable to one share of Common Stock on such date as determined by the Board of Directors.
In the event that such distribution described in this clause (iii) is not so paid or made, the Conversion Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to pay or make such dividend or distribution, to the Conversion Price that would then be in effect if such dividend or distribution had not been declared.
(iv) Cash Distributions. If the Corporation makes a distribution consisting exclusively of cash to all holders of the Common Stock, excluding (a) any cash dividend on the Common Stock to the extent a corresponding cash dividend is paid on the Series A Preferred Stock pursuant to Section 3(a), (b) any cash that is distributed in a Reorganization Event or as part of a “spin-off” referred to in clause (iii) above, (c) any dividend or distribution in connection with the Corporation’s liquidation, dissolution or winding up, and (d) any consideration payable in connection with a tender or exchange offer made by the Corporation or any of its subsidiaries, then in each event, the Conversion Price in effect immediately prior to the Ex-Date for such distribution will be multiplied by the following fraction:
SP0 – DIV
SP0
Where,
SP0 = the Closing Price per share of Common Stock on the Trading Day immediately preceding the Ex-Date.
DIV = the amount per share of Common Stock of the dividend or distribution.
16
In the event that any distribution described in this clause (iv) is not so made, the Conversion Price shall be readjusted, effective as of the date the Board of Directors publicly announces its decision not to pay such distribution, to the Conversion Price which would then be in effect if such distribution had not been declared.
(v) Self Tender Offers and Exchange Offers. If the Corporation or any of its subsidiaries successfully completes a tender or exchange offer for the Common Stock where the cash and the value of any other consideration included in the payment per share of the Common Stock exceeds the Closing Price per share of the Common Stock on the Trading Day immediately succeeding the expiration of the tender or exchange offer, then the Conversion Price in effect at the close of business on such immediately succeeding Trading Day will be multiplied by the following fraction:
(OS0 x SP0)
AC + (SP0 x OS1)
Where,
SP0 = the Closing Price per share of Common Stock on the Trading Day immediately succeeding the expiration of the tender or exchange offer.
OS0 = the number of shares of Common Stock outstanding immediately prior to the expiration of the tender or exchange offer, including any shares validly tendered and not withdrawn.
OS1 = the number of shares of Common Stock outstanding immediately after the expiration of the tender or exchange offer.
AC = the aggregate cash and fair market value of the other consideration payable in the tender or exchange offer, as determined by the Board of Directors.
In the event that the Corporation, or one of its subsidiaries, is obligated to purchase shares of Common Stock pursuant to any such tender offer or exchange offer, but the Corporation, or such subsidiary, is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then the Conversion Price shall be readjusted to be such Conversion Price that would then be in effect if such tender offer or exchange offer had not been made.
(vi) Issuance of Additional Shares of Common Stock. In the event the Corporation issues Additional Shares of Common Stock, without consideration or for a consideration per share less than the Conversion Price in effect immediately prior to such issuance, then the Conversion Price shall be reduced, concurrently with such issue, to a price (calculated to the nearest one-hundredth of a cent) determined in accordance with the following formula:
CP2 = CP1* [(A + B) ÷ (A + C)].
17
For purposes of the foregoing formula, the following definitions shall apply:
(A) “CP2” shall mean the Conversion Price in effect immediately after such issuance or deemed issuance of Additional Shares of Common Stock;
(B) “CP1” shall mean the Conversion Price in effect immediately prior to such issuance or deemed issuance of Additional Shares of Common Stock;
(C) “A” shall mean the number of shares of Common Stock outstanding immediately prior to such issuance or deemed issuance of Additional Shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon conversion, exercise or exchange of Series A Preferred Stock, Series B Preferred Stock or Warrants, or any other securities convertible into Common Stock);
(D) “B” shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had been issued or deemed issued at a price per share equal to CP1 (determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP1); and
(E) “C” shall mean the number of such Additional Shares of Common Stock issued in such transaction.
(b) The Corporation may make such decreases in the Conversion Price, in addition to any other decreases required by this Section 12, if the Board of Directors deems it advisable to avoid or diminish any income tax to holders of the Common Stock resulting from any dividend or distribution of shares of Common Stock (or issuance of rights or warrants to acquire shares of Common Stock) or from any event treated as such for income tax purposes or for any other reason.
(c) (i) All adjustments to the Conversion Price shall be calculated to the nearest 1/10 of a cent. No adjustment in the Conversion Price shall be required if such adjustment would be less than $0.01; provided, that any adjustments which by reason of this subparagraph are not required to be made shall be carried forward and taken into account in any subsequent adjustment.
(ii) No adjustment to the Conversion Price shall be made if Holders may participate in the transaction that would otherwise give rise to an adjustment, as a result of holding the Series A Preferred Stock, without having to convert the Series A Preferred Stock, as if they held the full number of shares of Common Stock into which a share of the Series A Preferred Stock may then be converted.
(iii) The Conversion Price shall not be adjusted:
(A) for any Excluded Stock;
(C) for a change in the par value of Common Stock; or
(C) for accrued and unpaid dividends on the Series A Preferred Stock.
18
(iv) In the event that any of the circumstances contemplated in Section 12(a) take place with respect to the Non-Voting Common Stock, the Conversion Price shall be appropriately adjusted with respect to the shares of Non-Voting Common Stock to be issued following conversion of the Series A Preferred Stock.
(d) Whenever the Conversion Price is to be adjusted in accordance with Section 12(a) or Section 12(b) (or the definition of Conversion Price), the Corporation shall: (i) compute the Conversion Price in accordance with Section 12(a) or Section 12(b) (or the definition of Conversion Price), taking into account the $0.01 threshold set forth in Section 12(c); (ii) as soon as reasonably practicable following the occurrence of an event that requires an adjustment to the Conversion Price pursuant to Section 12(a) or Section 12(b) (or the definition of Conversion Price), taking into account the $0.01 threshold set forth in Section 12(c) (or if the Corporation is not aware of such occurrence, as soon as reasonably practicable after becoming so aware), provide, or cause to be provided, a written notice to the Holders of the occurrence of such event; and (iii) as soon as reasonably practicable following the determination of the revised Conversion Price in accordance with Section 12(a) or Section 12(b) (or the definition of Conversion Price), provide, or cause to be provided, a written notice to the Holders setting forth in reasonable detail the method by which the adjustment to the Conversion Price was determined and setting forth the revised Conversion Price.
(e) Notwithstanding anything to the contrary in this Section 12 or otherwise in this Certificate of Designation, the Corporation shall not take any action that would result in the Conversion Price being adjusted to below the then par value (if any) of the Conversion Securities deliverable upon conversion of the Series A Preferred Stock. Additionally, under no circumstances will the number of Conversion Securities deliverable upon conversion of the Series A Preferred Stock exceed (when taken together with all other outstanding shares of Common Stock) the applicable number of Conversion Securities that the Corporation is authorized to issue.
Section 13. Replacement Certificates. The Corporation shall replace any mutilated stock certificate at the Holder’s expense upon surrender of such stock certificate to the Corporation. The Corporation shall replace stock certificates that become destroyed, stolen or lost at the Holder’s expense upon delivery to the Corporation of satisfactory evidence that the stock certificate has been destroyed, stolen or lost, together with any indemnity that may be reasonably required by the Corporation.
Section 14. Redemptions. The Series A Preferred Stock shall not be redeemable either at the Corporation’s option or at the option of any Holder, except as set forth in Section 7 hereof.
Section 15. Reorganization Events.
(a) In the event of:
(i) any consolidation or merger of the Corporation with or into another Person, in each case pursuant to which the Common Stock will be converted into cash, securities or other property of the Corporation or another Person;
(ii) any sale, transfer, lease or conveyance to another Person of all or substantially all of the property and assets of the Corporation, in each case pursuant to which the Common Stock will be converted into cash, securities or other property of the Corporation or another Person;
19
(iii) any reclassification of the Common Stock into securities including securities other than the Common Stock; or
(iv) any statutory exchange of the outstanding shares of Common Stock for securities of another Person (other than in connection with a merger or acquisition) (any such event specified in clauses (i) through (iv), a “Reorganization Event”), each share of Series A Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of Holders, become at the effective time of such Reorganization Event the right to receive, at the election of the Holders and upon written notice to the Company of such election, (A) the kind of securities, cash and other property receivable in such Reorganization Event by the Holder with respect to that number of shares of Common Stock into which the shares of Series A Preferred Stock would then be convertible assuming that on the date such option is exercised the Applicable Regulatory Approval has been obtained and remains in effect and disregarding for these purposes Section 8(h) (such securities, cash and other property, the “Exchange Property”), or (B) cash payable by the Corporation or such other Person in an amount equal to the Liquidation Preference, in each case plus, if the Reorganization Event is consummated prior to the Optional Redemption Date, an amount equal to the cumulative cash dividends that would be payable by the Corporation from the date of the consummation of such Reorganization Event through the Optional Redemption Date as if the dividends on the Series A Preferred Stock were cumulative. Notwithstanding anything to the contrary, in no event shall a Reorganization Event trigger the requirement to pay any dividend on the Series A Preferred Stock with respect to any Dividend Period that ended prior to the consummation of a Reorganization Event and for which no dividend was declared by the Board of Directors.
(b) In the event that holders of the shares of Common Stock have the opportunity to elect the form of consideration to be received in such transaction, the Holders shall be entitled to make the same election in the event the Holders elect to receive such consideration in accordance with clause (a)(iv)(A) above.
(c) The above provisions of this 15 shall similarly apply to successive Reorganization Events and the provisions of Section 12 shall apply to any shares of capital stock of the Corporation (or any successor) received by the holders of the Common Stock in any such Reorganization Event.
(d) The Corporation (or any successor) shall, within ten (10) days of the occurrence of any Reorganization Event, provide written notice to the Holders of such occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property and the Holder shall, within twenty (20) days after receipt of such notice, provide the Corporation with written notice of its election under clause (a)(iv) above.
Section 16. No Impairment. The Corporation shall not amend its Certificate of Formation or participate in any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action for the purpose of avoiding or seeking to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but shall at all times in good faith assist in carrying out all such action as may be reasonably necessary or appropriate in order to protect the conversion rights of the holders of the Series A Preferred Stock against dilution or other impairment as provided herein.
20
Section 17. Miscellaneous.
(a) All notices referred to herein shall be in writing or electronic mail, and, unless otherwise specified herein, all notices hereunder shall be deemed to have been given upon the earlier of receipt thereof or three (3) Business Days after the mailing thereof if sent by electronic mail or registered or certified mail with postage prepaid, addressed: (i) if to the Corporation, to its office at 20202 Highway 59 North, Suite 190, Humble, Texas 77338, Attention: Chief Financial Officer, or (ii) if to any Holder, to such Holder at the address of such Holder as listed in the stock record books of the Corporation, or (iii) to such other address as the Corporation or any such Holder, as the case may be, shall have designated by notice similarly given.
(b) The Corporation shall pay any and all stock transfer and documentary stamp taxes that may be payable in respect of any issuance or delivery of shares of Series A Preferred Stock or Conversion Securities or other securities issued on account of Series A Preferred Stock pursuant hereto or certificates representing such shares or securities. The Corporation shall not, however, be required to pay any such tax that may be payable in respect of any transfer involved in the issuance or delivery of shares of Series A Preferred Stock or Conversion Securities or other securities in a name other than that in which the shares of Series A Preferred Stock with respect to which such shares or other securities are issued or delivered were registered, or in respect of any payment to any Person other than a payment to the registered holder thereof, and shall not be required to make any such issuance, delivery or payment unless and until the Person otherwise entitled to such issuance, delivery or payment has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid or is not payable.
(c) This Certificate of Designation does not provide for an exchange, reclassification or cancellation of any issued shares.
[Signature page follows]
21
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation to be signed by its duly authorized officer, on September 9, 2022.
| THIRD COAST BANCSHARES, INC. | ||
| By: | /s/ Bart O. Caraway | |
| Name: Bart O. Caraway | ||
| Title: Chairman, President and Chief Executive Officer | ||
Exhibit 3.2
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS
OF
SERIES B CONVERTIBLE PERPETUAL PREFERRED STOCK
OF THIRD COAST BANCSHARES, INC.
Pursuant to Sections 21.155 and 21.156 of the
Business Organizations Code
of the State of Texas
Third Coast Bancshares, Inc. (the “Corporation”), a corporation organized and existing under the Texas Business Organizations Code (the “TBOC”), in accordance with Section 21.155 of the TBOC, does hereby certify:
That pursuant to the authority conferred upon the Board of Directors by the Certificate of Formation, the Board of Directors on September 1, 2022 adopted the following resolution creating a series of 69,400 shares of preferred stock designated as “Series B Convertible Perpetual Preferred Stock,” par value $1.00 per share (“Series B Preferred Stock”):
RESOLVED, that pursuant to the authority conferred upon the Board of Directors in accordance with the provisions of the Certificate of Formation, a series of preferred stock, par value $1.00 per share, of the Corporation be and hereby is created, and that the designation and number of shares thereof and the voting and other powers, preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and restrictions thereof are as follows:
Section 1. Definitions. The following terms have the meanings set forth below or in the section cross-referenced below, as applicable, whether used in the singular or the plural:
(a) “Affiliate” has the meaning set forth in 12 C.F.R. Section 225.2(a) or any successor provision.
(b) “Board of Directors” means the board of directors of the Corporation or, with respect to any action to be taken by such board of directors, any committee of the board of directors duly authorized to take such action.
(c) A “business day” means any day other than a Saturday or a Sunday or a day on which banks are required or permitted by law or executive order to be closed in the State of Texas.
(d) “Certificate” means a certificate representing one (1) or more shares of Series B Preferred Stock.
(e) “Certificate of Designation” means this Certificate of Designation to the Certificate of Formation.
1
(f) “Certificate of Formation” means the First Amended and Restated Certificate of Formation of the Corporation, as amended prior to the filing of this Certificate of Designation with the Secretary of State of the State of Texas and as amended by this Certificate of Designation and as may be further amended.
(g) “Common Stock” means the Corporation’s common stock, par value $1.00 per share.
(h) “Corporation” has the meaning set forth in the preamble.
(i) “Dividends” has the meaning set forth in Section 3.
(j) “Exchange Agent” means Continental Stock Transfer & Trust Company, solely in its capacity as transfer and exchange agent for the Corporation, or any successor transfer and exchange agent for the Corporation.
(k) “Exchange Cap” has the meaning set forth in Section 5(b).
(l) “Exchange Cap Allocation Amount” has the meaning set forth in Section 5(b).
(m) “Existing Buyer” has the meaning set forth in Section 5(b).
(n) “Holder” means a Person in whose name the shares of the Series B Preferred Stock are registered, which may be treated by the Corporation and the Exchange Agent as the absolute owner of the shares of Series B Preferred Stock for the purpose of making payment and settling conversions and for all other purposes.
(o) “Investment Agreement” means the Investment Agreement, dated as of September 8, 2022, by and among the Corporation and the investors named therein, as it may be amended from time to time.
(p) “Liquidation Distribution” has the meaning set forth in Section 4.
(q) “Mandatory Conversion Date” means, with respect to shares of Series B Preferred Stock of any and all Holders, the Non-Voting Common Stock Certificate of Amendment Effective Date.
(r) “Non-Voting Common Stock” means, if authorized by all necessary action on the part of the Corporation, the Corporation’s non-voting common stock, par value $1.00 per share.
(s) “Non-Voting Common Stock Certificate of Amendment” means an amendment to the Certificate of Formation to be filed with the Secretary of State of the State of Texas to authorize the Non-Voting Common Stock in an amount of shares sufficient to permit the full conversion of the Series B Preferred Stock into shares of Non-Voting Common Stock.
(t) “Non-Voting Common Stock Certificate of Amendment Effective Date” means the date that the Corporation shall have filed the Non-Voting Common Stock Certificate of Amendment with the Secretary of State of the State of Texas as required by the TBOC.
2
(u) “Permissible Transfer” means a transfer by the Holder (i) to the Corporation; (ii) in a widely distributed public offering of Common Stock or Series B Preferred Stock; (iii) that is part of an offering that is not a widely distributed public offering of Common Stock or Series B Preferred Stock but is one in which no one transferee (or group of associated transferees) acquires the rights to receive two percent (2%) or more of any class of the Voting Securities of the Corporation then outstanding (including pursuant to a related series of transfers); or (iv) to a transferee that controls more than fifty percent (50%) of the Voting Securities of the Corporation without giving effect to such transfer.
(v) “Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, governmental entity, unincorporated organization or other legal entity.
(w) “Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading.
(x) “Series A Preferred Stock” means the Corporation’s Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share.
(y) “Series B Preferred Stock” has the meaning set forth in the recitals.
(z) “TBOC” has the meaning set forth in the preamble.
(aa) “Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
(bb) “Voting Security” has the meaning set forth in 12 C.F.R. Section 225.2(q) or any successor provision.
(cc) “Warrant Agreement” means each Warrant Agreement, dated as of the Closing Date (as defined in the Investment Agreement), by and between the Corporation and the investor named therein, as each may be amended from time to time.
(dd) “Warrants” has the meaning set forth in the Investment Agreement.
Section 2. Designation; Number of Shares. The series of shares of Preferred Stock hereby authorized shall be designated the “Series B Convertible Perpetual Preferred Stock”. The number of authorized shares of the Series B Preferred Stock shall be 69,400 shares. The Series B Preferred Stock shall have $1.00 par value per share. Each share of Series B Preferred Stock has the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications, or terms or conditions of redemption as described herein. Each share of Series B Preferred Stock is identical in all respects to every other share of Series B Preferred Stock.
3
Section 3. Dividends. The Series B Preferred Stock will rank pari passu with the Common Stock with respect to the payment of dividends or distributions, whether payable in cash, securities, options or other property, and with respect to issuance, grant or sale of any rights to purchase stock, warrants, securities or other property (collectively, the “Dividends”) on a pro rata basis with the Common Stock determined on an as-converted basis assuming all shares had been converted pursuant to Section 5 as of immediately prior to the record date of the applicable Dividend (or if no record date is fixed, the date as of which the record holders of Common Stock entitled to such Dividends are to be determined). Accordingly, the Holders of record will be entitled to receive as, when, and if declared by the Board of Directors, Dividends in the same per share amount as paid on the number of shares of Common Stock with respect to the number of shares of Common Stock into which the shares of Series B Preferred Stock would be converted, and no Dividends will be payable on the Common Stock or any other class or series of capital stock ranking with respect to Dividends pari passu with the Common Stock unless a Dividend identical to that paid on the Common Stock is payable at the same time on the Series B Preferred Stock in an amount per share of Series B Preferred Stock equal to the product of (a) the per share Dividend declared and paid in respect of each share of Common Stock and (b) the number of shares of Common Stock into which such share of Series B Preferred Stock is then convertible (without regard to any limitations on conversion of the Series B Preferred Stock); provided, however, that if a stock Dividend is declared on Common Stock payable solely in Common Stock, the Holders will be entitled to a stock Dividend payable solely in shares of Series B Preferred Stock. Dividends that are payable on Series B Preferred Stock will be payable to the Holders of record as they appear on the stock register of the Corporation on the applicable record date, as determined by the Board of Directors, which record date will be the same as the record date for the equivalent Dividend of the Common Stock. In the event that the Board of Directors does not declare or pay any Dividends with respect to shares of Common Stock, then the Holders will have no right to receive any Dividends.
Section 4. Liquidation.
(a) Rank. The Series B Preferred Stock will, with respect to rights upon liquidation, winding up and dissolution, rank (i) subordinate and junior in right of payment to all other securities of the Corporation which, by their respective terms, are senior to the Series B Preferred Stock or the Common Stock, and (ii) pari passu with the Common Stock pro rata on an as-converted basis. Not in limitation of anything contained herein, and for purposes of clarity, the Series B Preferred Stock is subordinated to the general creditors and subordinated debt holders of the Corporation, and the depositors of the Corporation’s bank subsidiaries, in any receivership, insolvency, liquidation or similar proceeding.
(b) Liquidation Distributions. In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, Holders will be entitled to receive, for each share of Series B Preferred Stock, out of the assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to shareholders of the Corporation, subject to the rights of any Persons to whom the Series B Preferred Stock is subordinate, a distribution (“Liquidation Distribution”) equal to (i) any authorized and declared, but unpaid, Dividends with respect to such share of Series B Preferred Stock at the time of such liquidation, dissolution or winding up, and (ii) the amount the Holder of such share of Series B Preferred Stock would receive in respect of such share if such share had been converted into shares of Common Stock at the then applicable conversion rate at the time of such liquidation, dissolution or winding up (assuming the conversion of all shares of Series B Preferred Stock at such time, without regard to any limitations on conversion of the Series B Preferred Stock). All Liquidation Distributions to the Holders and the holders of Common Stock set forth in clause (ii) above will be made pro rata to the Holders and the holders of Common Stock on an as-converted basis.
4
(c) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in which the Holders receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or property) of all or substantially all of the assets of the Corporation, will not constitute a liquidation, dissolution or winding up of the Corporation.
Section 5. Conversion.
(a) General.
(i) Unless the shares of Series B Preferred Stock shall have previously been converted into shares of Non-Voting Common Stock pursuant to Section 5(a)(iii), a Holder shall be permitted to convert, or upon the written request of the Corporation shall convert, shares of Series B Preferred Stock into shares of Common Stock at any time or from time to time, provided that upon such conversion the Holder, together with all Affiliates of the Holder, will not own or control in the aggregate more than nine point nine percent (9.9%) of the Common Stock (or of any class of Voting Securities issued by the Corporation), excluding for the purpose of this calculation any reduction in ownership resulting from transfers by such Holder of Voting Securities of the Corporation (which, for the avoidance of doubt, does not include Series B Preferred Stock). In any such conversion, each share of Series B Preferred Stock will convert initially into 44.44 shares of Common Stock, subject to adjustment as provided in Section 6 below.
(ii) Unless the shares of Series B Preferred Stock shall have previously been converted into shares of Non-Voting Common Stock pursuant to Section 5(a)(iii), each share of Series B Preferred Stock will automatically convert into 44.44 shares of Common Stock, without any further action on the part of any Holder, subject to adjustment as provided in Section 6, below, on the date a Holder transfers any shares of Series B Preferred Stock to a non-affiliate of the Holder in a Permissible Transfer.
(iii) Effective as of the close of business on the Mandatory Conversion Date, each share of Series B Preferred Stock will automatically convert into 44.44 shares of Non-Voting Common Stock, without any further action on the part of any Holder.
(iv) To effect any permitted conversion under Section 5(a)(i) or Section 5(a)(ii), the Holder shall surrender the certificate or certificates evidencing such shares of Series B Preferred Stock, duly endorsed, at the registered office of the Corporation, and provide written instructions to the Corporation as to the number of whole shares for which such conversion shall be effected, together with any appropriate documentation that may be reasonably required by the Corporation. Upon the surrender of such certificate(s), the Corporation will issue and deliver to such Holder (in the case of a conversion under Section 5(a)(i)) or such Holder’s transferee (in the case of a conversion under Section 5(a)(ii)) a certificate or certificates for the number of shares of Common Stock into which the Series B Preferred Stock has been converted and, in the event that such conversion is with respect to some, but not all, of the Holder’s shares of Series B Preferred Stock, the Corporation shall deliver to such Holder a certificate or certificate(s) representing the number of shares of Series B Preferred Stock that were not converted to Common Stock or Non-Voting Common Stock.
5
(v) Upon occurrence of the Mandatory Conversion Date, the Corporation shall promptly provide notice of such event and the resulting conversion of the Series B Preferred Stock to each Holder. Such notice shall provide instructions for the surrender to the Corporation of certificates for shares of Series B Preferred Stock held of record by such Holders for issuance of certificates representing shares of Non-Voting Common Stock into which the Series B Preferred Stock have been converted pursuant to Section 5(a)(iii).
(vi) All shares of Common Stock or Non-Voting Common Stock delivered upon conversion of the Series B Preferred Stock shall be duly authorized, validly issued, fully paid and non-assessable, free and clear of all liens, claims, security interests, charges and other encumbrances.
(b) Principal Market Regulation. Notwithstanding anything to the contrary, the Corporation shall not issue any shares of Common Stock upon the conversion of the Series B Preferred Stock if the issuance of such shares of Common Stock (taken together with each issuance of such shares of Common Stock (1) upon the conversion of the Series A Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series A Preferred Stock or otherwise, (2) upon the conversion of the Non-Voting Common Stock in accordance with the Certificate of Formation as amended by the Non-Voting Common Stock Certificate of Amendment or otherwise, or (3) upon the exercise of the Warrants pursuant to the Warrant Agreements) would exceed 19.9% of the total outstanding shares of Common Stock of the Corporation, or more than 19.9% of the total voting power of the Corporation’s securities, in each case immediately preceding the issuance of the Series A Preferred Stock and Warrants pursuant to the Investment Agreement and the Warrant Agreements (the number of shares which may be issued without violating such limitation, the “Exchange Cap”), except that such limitation shall not apply in the event that the Corporation obtains the approval of its shareholders as required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of such amount. Until such approval is obtained, the holders of the Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants (collectively, the “Existing Buyers” and each, individually, an “Existing Buyer”) shall not be permitted to convert Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock or exercise Warrants with respect to more than such Existing Buyer’s pro rata amount of such Exchange Cap (such amount, with respect to each Existing Buyer, its “Exchange Cap Allocation Amount”) determined based upon such Existing Buyer’s percentage ownership of the sum of (1) the aggregate number of shares of Common Stock issuable upon the conversion of all shares of Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock, plus (2) the aggregate number of shares of Common Stock issuable upon exercise of the Warrants. In the event that such Existing Buyer shall sell or otherwise transfer any of such Existing Buyer’s shares of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Warrants, the transferee shall be allocated a pro rata portion of such Existing Buyer’s Exchange Cap Allocation Amount with respect to such portion of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants so transferred, and the restrictions of the prior sentence shall apply to such transferee
6
with respect to the portion of the Exchange Cap Allocation Amount so allocated to such transferee. Upon conversion and exercise in full of such Existing Buyer’s Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants, the difference (if any) between such Existing Buyer’s Exchange Cap Allocation Amount and the number of shares of Common Stock actually issued to such Existing Buyer upon such Existing Buyer’s conversion in full of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants shall be allocated to the respective Exchange Cap Allocation Amounts of the remaining Existing Buyers of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants on a pro rata basis in proportion to the relative Exchange Cap Allocation Amounts of such Existing Buyers.
(c) Reservation of Shares Issuable Upon Conversion. The Corporation will at all times reserve and keep available out of its authorized but unissued Common Stock and, when authorized, Non-Voting Common Stock solely for the purpose of effecting the conversion of the Series B Preferred Stock such number of shares of Common Stock or Non-Voting Common Stock as will from time to time be sufficient to effect the conversion of all outstanding Series B Preferred Stock; and if at any time the number of shares of authorized but unissued Common Stock or Non-Voting Common Stock (when authorized) will not be sufficient to effect the conversion of all then outstanding Series B Preferred Stock, the Corporation will take such action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued Common Stock or Non-Voting Common Stock to such number of shares as will be sufficient for such purpose.
(d) No Impairment. The Corporation will not, by amendment of its Certificate of Formation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the carrying out of all the provisions of this Section 5 and in the taking of all such actions as may be necessary or appropriate in order to protect the conversion rights of the Holders against impairment.
(e) Compliance with Law. Prior to the delivery of any securities that the Corporation shall be obligated to deliver upon conversion of the Series B Preferred Stock, the Corporation shall use its reasonable best efforts to comply with any federal and state laws and regulations thereunder requiring the registration of such securities with, or any approval of or consent to the delivery thereof by, any governmental authority.
(f) Listing. The Corporation hereby covenants and agrees that, if at any time the Common Stock shall be traded on any national securities exchange, the Corporation will, if permitted by the rules of such exchange, list and keep listed, so long as the Common Stock shall be so listed on such exchange, all the Common Stock issuable upon conversion of the Series B Preferred Stock; provided, however, that if the rules of such exchange require the Corporation to defer the listing of such Common Stock until the first conversion of Series B Preferred Stock into Common Stock in accordance with the provisions hereof, the Corporation covenants to list such Common Stock issuable upon conversion of the Series B Preferred Stock in accordance with the requirements of such exchange at such time.
7
Section 6. Adjustments.
(a) Combinations or Divisions of Common Stock. In the event that the Corporation at any time or from time to time will effect a division of the Common Stock into a greater number of shares (by stock split, reclassification or otherwise other than by payment of a Dividend in Common Stock or in any right to acquire the Common Stock), or in the event the outstanding Common Stock will be combined or consolidated, by reclassification, reverse stock split or otherwise, into a lesser number of shares of the Common Stock, then the dividend, liquidation, and conversion rights of each share of Series B Preferred Stock in effect immediately prior to such event will, concurrently with the effectiveness of such event, be proportionately decreased or increased, as appropriate.
(b) Reclassification, Exchange or Substitution. If the Common Stock is changed into the same or a different number of shares of any other class or classes of stock, whether by capital reorganization, reclassification or otherwise (other than a division or combination of shares provided for in Section 6(a) above), (1) the conversion ratio then in effect will, concurrently with the effectiveness of such transaction, be adjusted so that each share of the Series B Preferred Stock will be convertible into, in lieu of the number of shares of Common Stock which the Holders would otherwise have been entitled to receive, a number of shares of such other class or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Series B Preferred Stock is then convertible (without regard to any limitations on conversion of the Series B Preferred Stock) immediately before that transaction and (2) the Dividend and Liquidation Distribution rights then in effect will, concurrently with the effectiveness of such transaction, be adjusted so that each share of Series B Preferred Stock will be entitled to a Dividend and Liquidation Distribution right, in lieu of with respect to the number of shares of Common Stock which the Holders would otherwise have been entitled to receive, with respect to a number of shares of such other class or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Series B Preferred Stock is then convertible (without regard to any limitations on conversion of the Series B Preferred Stock) immediately before that transaction.
(c) Certificates as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 6, the Corporation at its expense will promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each Holder a certificate executed by the Corporation’s President (or other appropriate officer) setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation will, upon the written request at any time of any Holder, but no more frequently than once per fiscal quarter, furnish or cause to be furnished to such Holder a like certificate setting forth (i) such adjustments and readjustments, and (ii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Series B Preferred Stock.
8
Section 7. Reorganization, Mergers, Consolidations or Sales of Assets. If at any time or from time to time there will be a capital reorganization of the Common Stock (other than a subdivision, combination, reclassification or exchange of shares otherwise provided for in Section 6) or a merger or consolidation of the Corporation with or into another corporation, or the sale of all or substantially all the Corporation’s properties and assets to any other Person, then, as a part of such reorganization, merger, consolidation or sale, provision will be made so that the Holders will thereafter be entitled to receive upon conversion of the Series B Preferred Stock, the number of shares of stock or other securities or property of the Corporation, or of the successor company resulting from such merger or consolidation or sale, to which a holder of that number of shares of Common Stock deliverable upon conversion of the Series B Preferred Stock would have been entitled to receive on such capital reorganization, merger, consolidation or sale (without regard to any limitations on conversion of the Series B Preferred Stock).
Section 8. Redemption. Except to the extent a liquidation under Section 4 may be deemed to be a redemption, the Series B Preferred Stock will not be redeemable at the option of the Corporation or any Holder at any time. Notwithstanding the foregoing, the Corporation will not be prohibited from repurchasing or otherwise acquiring shares of Series B Preferred Stock in voluntary transactions with the Holders, subject to compliance with any applicable legal or regulatory requirements, including applicable regulatory capital requirements. Any shares of Series B Preferred Stock repurchased or otherwise acquired may be cancelled by the Corporation and thereafter be reissued as shares of any series of preferred stock of the Corporation.
Section 9. Voting Rights. The Holders will not have any voting rights, except as may be permitted for securities that are Nonvoting Securities, as set forth in 12 C.F.R. § 225.2(q)(2), or any successor provision. If the Holders shall be entitled by law to vote as a single class with the holders of outstanding shares of Common Stock, with respect to any and all matters presented to the shareholders of the Corporation for their action or consideration (by vote or written consent), each share of Series B Preferred Stock shall be entitled to a number of votes equal to the number of shares of Common Stock into which such share of Series B Preferred Stock is convertible pursuant to Section 5.
Section 10. Protective Provisions. So long as any shares of Series B Preferred Stock are issued and outstanding, the Corporation will not, without obtaining the approval (by vote or written consent) of the Holders of a majority of the issued and outstanding shares of Series B Preferred Stock, alter or change the rights, preferences, privileges or restrictions provided for the benefit of the Holders so as to affect them adversely, or take any action that would have the effect of adversely changing any preference or any relative or other right provided for the benefit of the Holders. In the event that the Corporation offers to repurchase shares of Common Stock, the Corporation shall offer to repurchase shares of Series B Preferred Stock pro rata based upon the number of shares of Common Stock such Holders would be entitled to receive if such shares were converted into shares of Common Stock immediately prior to such repurchase.
Section 11. Notices. All notices required or permitted to be given by the Corporation with respect to the Series B Preferred Stock shall be in writing, and if delivered by first class United States mail, postage prepaid, to the Holders at their last addresses as they shall appear upon the books of the Corporation, shall be conclusively presumed to have been duly given, whether or not the Holder actually receives such notice; provided, however, that failure to duly give such notice by mail, or any defect in such notice, to the holders of any stock designated for repurchase, shall not affect the validity of the proceedings for the repurchase of any other shares of Series B Preferred Stock, or of any other matter required to be presented for the approval of the Holders.
9
Section 12. Record Holders. To the fullest extent permitted by law, the Corporation will be entitled to recognize the record Holder of any share of Series B Preferred Stock as the true and lawful owner thereof for all purposes and will not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other Person, whether or not it will have express or other notice thereof.
Section 13. Term. The Series B Preferred Stock shall have perpetual term unless converted in accordance with Section 5.
Section 14. No Preemptive Rights. The Holders are not entitled to any preemptive or preferential right to purchase or subscribe for any capital stock, obligations, warrants or other securities or rights of the Corporation, except for any such rights that may be granted by way of separate contract or agreement to one or more Holders.
Section 15. Replacement Certificates. In the event that any Certificate will have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Corporation or the Exchange Agent, the posting by such Person of a bond in such amount as the Corporation or the Exchange Agent may determine is necessary as indemnity against any claim that may be made against it with respect to such Certificate, the Corporation or the Exchange Agent, as applicable, will deliver in exchange for such lost, stolen or destroyed Certificate a replacement Certificate.
Section 16. Other Rights. The shares of Series B Preferred Stock have no preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications, or rights, other than as set forth herein or as provided by applicable law.
Section 17. General Provisions. In addition to the above provisions with respect to Series B Preferred Stock, such Series B Preferred Stock shall be subject to, and entitled to the benefits of, the provisions set forth in the Certificate of Formation with respect to preferred stock generally.
[Signature page follows]
10
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation to be signed by its duly authorized officer, on September 9, 2022.
| THIRD COAST BANCSHARES, INC. | ||
| By: | /s/ Bart O. Caraway | |
| Name: Bart O. Caraway | ||
| Title: Chairman, President and Chief Executive Officer | ||
Exhibit 4.1
FORM OF WARRANT AGREEMENT
THE ISSUANCE OF THESE SECURITIES HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION LETTER AND, IF APPLICABLE, A BROKER REPRESENTATION LETTER) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE).
WARRANT
to purchase
[________]
Shares of Common Stock of
Third Coast Bancshares, Inc.
A Texas Corporation
Issue Date: [___], 2022
1. Definitions. Unless the context otherwise requires, when used herein the following terms shall have the meanings indicated.
“Affiliate” means, with respect to any Person, any Person directly or indirectly controlling, controlled by or under common control with such other Person.
“Applicable Price” means 95% of the greater of (A) the Market Price per share of outstanding Common Stock on the date on which the Company issues or sells any Common Stock other than Excluded Stock and (B) the Market Price per share of outstanding Common Stock on the first date of the announcement of such issuance or sale.
“Appraisal Procedure” means a procedure whereby two independent appraisers, one chosen by the Company and one by the Warrantholder, shall mutually agree upon the determinations then the subject of appraisal. Each party shall deliver a notice to the other appointing its appraiser within fifteen (15) days after the Appraisal Procedure is invoked pursuant to Section 15. If within thirty (30) days after appointment of the two appraisers they are unable to agree upon the amount in question, a third independent appraiser shall be chosen within ten (10) days thereafter by the mutual consent of such first two appraisers or, if such first two appraisers fail to agree upon the appointment of a third appraiser, such appointment shall be made by the American Arbitration Association, or any organization successor thereto, from a panel of arbitrators having experience in the appraisal of the subject matter to be appraised. The decision of the third appraiser
EXHIBIT J-1
so appointed and chosen shall be given within thirty (30) days after the selection of such third appraiser. If three appraisers shall be appointed and the determination of one appraiser is disparate from the middle determination by more than twice the amount by which the other determination is disparate from the middle determination, then the determination of such appraiser shall be excluded, the remaining two determinations shall be averaged and such average shall be binding and conclusive on the Company and the Warrantholder; otherwise, the average of all three determinations shall be binding and conclusive on the Company and the Warrantholder. The costs of conducting any Appraisal Procedure shall be split equally by the Company and the Warrantholder.
“Board” means the Board of Directors of the Company.
“Business Combination” means a merger, consolidation, statutory share exchange or similar transaction that requires adoption or approval by the Company’s shareholders.
“Business Day” means any day that is not a Saturday, a Sunday or a day on which banks are required or permitted by law or executive order to be closed in the State of Texas.
“Capital Stock” means (A) with respect to any Person that is a corporation or company, any and all shares, interests, participations or other equivalents (however designated) of capital or capital stock of such Person and (B) with respect to any Person that is not a corporation or company, any and all partnership or other equity interests of such Person.
“Certificate of Formation” means the First Amended and Restated Certificate of Formation of the Company, as amended and in effect from time and time.
“Common Stock” means the Company’s common stock, par value $1.00 per share.
“Company” means Third Coast Bancshares, Inc., a Texas corporation.
“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder.
“Exchange Cap” has the meaning given to it in Section 3(c).
“Exchange Cap Allocation Amount” has the meaning given to it in Section 3(c).
“Excluded Stock” means (A) shares of Common Stock issued by the Company as a stock dividend payable in shares of Common Stock, or upon any subdivision, reclassification or split-up of the outstanding shares of Capital Stock, in each case which is subject to Section 13(B), or upon conversion of shares of Capital Stock (but not the issuance of such Capital Stock which will be subject to the provisions of Section 13(A)); (B) shares of Common Stock or other securities that are convertible into or exchangeable or exercisable for Common Stock issued pursuant to the granting or exercise of employee stock options, restricted stock or other stock incentives or awards pursuant to the Company’s stock incentive plans approved by the Board or the issuance of stock pursuant to the Company’s employee stock purchase plan approved by the Board or similar plan where stock is being issued or offered to a trust, other entity or otherwise, for the benefit of any employees, officers or directors of the Company, in each case in the ordinary course of providing incentive compensation; (C) shares of Common Stock, Series B Preferred Stock or Non-Voting Common Stock, as applicable, issued upon the conversion of shares of Series A Preferred Stock, Series B Preferred Stock, or Non-Voting Common Stock or upon the exercise of the Warrants; (D) shares of Common Stock issued upon exercise of warrants outstanding as of the date of the Investment Agreement; (E) shares of Common Stock, Series A Preferred Stock, Series B Preferred Stock,
Non-Voting Common Stock or other securities that are convertible into or exchangeable or exercisable for Common Stock, Series A Preferred Stock, Series B Preferred Stock, or Non-Voting Common Stock, issued as full or partial consideration for a merger, acquisition, joint venture, strategic alliance, license agreement or other similar nonfinancing transaction; or (F) the Warrants issued pursuant to the Warrant Agreements and the shares of Series A Preferred Stock issued pursuant to the Investment Agreement.
“Exercise Price” means $22.50 per share of Common Stock, subject to adjustment from time to time in accordance with Section 13.
“Existing Buyer” has the meaning given to it in Section 3(c).
“Fair Market Value” means, with respect to any security or other property, the fair market value of such security or other property as determined by the Board, acting in good faith, assuming a willing buyer and a willing seller, provided that no minority or illiquidity discount or control premium shall be taken into account and no consideration shall be given to any restrictions on transfer or the existence or absence of, or any limitations on, voting rights. If the Warrantholder does not accept the Board’s calculation of Fair Market Value and the Warrantholder and the Company are unable to agree on Fair Market Value, the procedures described in Section 15 shall be used to determine Fair Market Value.
“Investment Agreement” means the Investment Agreement, dated as of September 8, 2022, by and among the Company and the investors named therein, as it may be amended from time to time.
“Investor” means [______________].
“Issue Date” means [________], 2022, the original date of issuance of this Warrant.
“Market Price” means the closing sale price as reported in the composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant Capital Stock) is so listed or quoted, or, if no closing sale price is reported, the last reported sale price on the principal U.S. national or regional securities exchange on which the Common Stock (or other relevant Capital Stock) is so listed or quoted, or if the Common Stock (or other relevant Capital Stock) is not so listed or quoted on a U.S. national or regional securities exchange, the last quoted bid price for the Common Stock (or other relevant Capital Stock) in the over-the-counter market as reported on the OTC Bulletin Board or by Pink Sheets LLC or similar organization. If such security is not listed and traded in a manner that the quotations referred to above are available for the period required hereunder, the Market Price per share of the Common Stock shall be deemed to be the fair market value per share of such security as mutually determined by the Company and the Warrantholder, and if the Company and the Warrantholder cannot agree on the Market Price, the fair value will be determined using the procedures described in Section 15. The Market Price of the Series A Preferred Stock, the Series B Preferred Stock and the Non-Voting Common Stock shall be based on the Market Price of the Common Stock.
“Non-Voting Common Stock” means, if authorized by all necessary action on the part of the Company, the Company’s non-voting common stock, par value $1.00 per share.
“Non-Voting Common Stock Certificate of Amendment” means an amendment to the Certificate of Formation to be filed with the Secretary of State of the State of Texas to authorize the Non-Voting Common Stock in an amount of shares sufficient to permit the full conversion of the Series B Preferred Stock into shares of Non-Voting Common Stock.
“Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, governmental entity, unincorporated organization or other legal entity.
“Permitted Transfer” means a transfer by any Warrantholder: (i) to any existing Warrantholder, Affiliate of the Warrantholder, or any holder of Series A Preferred Stock; (ii) to a transferee (or group of associated transferees) that will acquire at least 10% of the outstanding Warrants; or (iii) with the written consent of the Company.
“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading.
“Pro Rata Repurchase” means any purchase of shares of Common Stock by the Company or any Affiliate thereof pursuant to (A) any tender offer or exchange offer subject to Section 13(e) of the Exchange Act, or (B) pursuant to any other offer available to substantially all holders of Common Stock, in each case whether for cash, shares of Capital Stock of the Company, other securities of the Company, evidences of indebtedness of the Company or any other Person or any other property (including, without limitation, shares of Capital Stock, other securities or evidences of indebtedness of a Subsidiary of the Company), or any combination thereof, effected while this Warrant is outstanding; provided, however, that “Pro Rata Repurchase” shall not include any purchase of shares by the Company or any Affiliate thereof made in accordance with the requirements of Rule 10b-18 as in effect under the Exchange Act. The “Effective Date” of a Pro Rata Repurchase shall mean the date of acceptance of shares of Common Stock for purchase or exchange under any tender or exchange offer which is a Pro Rata Repurchase or the date of purchase of shares of Common Stock with respect to any Pro Rata Repurchase that is not a tender or exchange offer.
“SEC” has the meaning given to it in Section 12.
“Securities Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder.
“Series A Preferred Stock” means the Company’s Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share.
“Series B Preferred Stock” means the Company’s Series B Convertible Perpetual Preferred Stock, par value $1.00 per share.
“Shares” has the meaning given to it in Section 2.
“Subsidiary” means, with respect to any Person, any corporation, partnership, joint venture, limited liability company, bank, savings bank, association or other entity of which such Person (i) owns or controls 50.1% or more of the outstanding equity securities either directly or indirectly through an unbroken chain of entities, as to each of which 50.1% or more of the outstanding equity securities is owned directly or indirectly by its parent or (ii) is a general partner.
“Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
“Warrantholder” has the meaning given to it in Section 2.
“Warrant” when used in the singular case, means this Warrant, and when used in the plural case, has the meaning given to it in the Investment Agreement.
“Warrant Agreement” means this Warrant Agreement and each other Warrant Agreement, dated as of [______], 2022, by and between the Company and the investor named therein, as each may be amended from time to time.
2. Number of Shares; Exercise Price. This certifies that, for value received, the Investor, its Affiliates or its registered assigns (individually and collectively, the “Warrantholder”) is entitled, upon the terms and subject to the conditions hereinafter set forth, to acquire from the Company, in whole or in part [________] fully paid and nonassessable shares of Common Stock, as the same may be adjusted from time to time pursuant to the terms of this Warrant (the “Shares”), at a purchase price per share equal to the Exercise Price. Notwithstanding any other provision of this Warrant, if the Warrantholder proposes to exercise this Warrant such that the Warrantholder, together with any other Person whose Company securities would be aggregated with such Warrantholder’s Company securities for purposes of any bank regulation or law, would collectively be deemed to own, control or have the power to vote more than 9.9% of a class of the Company’s outstanding voting securities immediately following such exercise, then the Warrantholder shall instead acquire shares of Common Stock such that the Warrantholder, together with any other Person whose Company securities would be aggregated with such Warrantholder’s Company securities for purposes of any bank regulation or law, would collectively be deemed to own, control or have the power to vote 9.9% or less of any class of the Company’s outstanding voting securities immediately following such exercise; provided, that some or all of any shares in excess of such amount, at the election of the Warrantholder, shall be (a) issued as either Series B Preferred Stock or Non-Voting Common Stock, or (b) provided for future issuance under the terms of this Warrant, as amended, with the exercise of the Warrant remaining subject to the limitation prohibiting the acquisition of more than 9.9% of any class of the Company’s outstanding voting securities set forth in the preceding clause; provided, further, that the Company shall cooperate with the Warrantholder to effectuate the issuance of such Series B Preferred Stock or Non-Voting Common Stock, or the amendment of this Warrant; and, provided, further, that all of the representations, warranties, covenants, agreements and other provisions in this Warrant shall apply, mutatis mutandis, to any such Series B Preferred Stock, Non-Voting Common Stock, or under this Warrant following amendment hereunder. The Exercise Price is subject to adjustment as provided herein, and all references to “Exercise Price” herein shall be deemed to include any such adjustment or series of adjustments.
3. Exercise of Warrant; Term. (a) To the extent permitted by applicable laws and regulations, the right to purchase the Shares pursuant to this Warrant is exercisable, in whole or in part by the Warrantholder, at any time or from time to time after the execution and delivery of this Warrant by the Company, on the date hereof, but in no event later than 11:59 p.m., New York City time, on the seventh (7th) anniversary of the date of issuance of the Warrant, by: (i) delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Warrantholder at the last address of the Warrantholder as it shall appear upon the warrant register of the Company) of a duly executed Notice of Exercise, the form of which is annexed hereto, in accordance with Section 20; and (ii) within three (3) trading days after the date said Notice of Exercise is delivered to the Company, payment to the Company of the aggregate Exercise Price in respect of the Shares thereby purchased by cash, certified or cashier’s check or wire transfer in immediately available funds to an account designated by the Company, unless the Warrantholder elects to exercise the cashless exercise procedure described in Section 3(b) below. Notwithstanding anything herein to the contrary, the Warrantholder shall not be required to physically surrender this Warrant to the Company until the Warrantholder has purchased all of the Shares available hereunder and the Warrant has been exercised in full in which case, the Warrantholder shall surrender this Warrant to the Company for cancellation within three (3) trading days after the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Shares available hereunder shall have the effect of lowering the outstanding number of Shares purchasable hereunder in an amount equal to the applicable number of Shares purchased. If the Warrantholder does not exercise this Warrant in its entirety, the Warrantholder will be entitled to receive from the Company within a reasonable time, and in any event not exceeding three (3) Business Days after the date of delivery of the applicable aggregate Exercise Price to the Company, a new warrant in substantially identical form and of the same tenor for the purchase of Shares equal to the difference between the number of Shares subject to this Warrant and the number of Shares as to which this Warrant is so exercised. The Warrantholder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Shares hereunder, the number of Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
(b) This Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Warrantholder shall be entitled to receive a certificate for the number of Shares equal to the quotient obtained by dividing [(A-B)*(X)] by (A), where:
(A) = the Market Price on the trading day immediately preceding the date on which the Warrantholder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;
(B) = the Exercise Price; and
(X) = the number of Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.
(c) Notwithstanding anything to the contrary, the Company shall not issue any shares of Common Stock upon the exercise of this Warrant if the issuance of such shares of Common Stock (taken together with each issuance of such shares of Common Stock (1) upon the conversion of the Series A Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series A Preferred Stock or otherwise, (2) upon the conversion of the Series B Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series B Preferred Stock or otherwise, (3) upon the conversion of the Non-Voting Common Stock in accordance with the Certificate of Formation as amended by the Non-Voting Common Stock Certificate of Amendment or otherwise or (4) upon the exercise of the other Warrants pursuant to the Warrant Agreements) would exceed 19.9% of the total outstanding shares of Common Stock of the Company, or more than 19.9% of the total voting power of the Company’s securities, in each case immediately preceding the issuance of the Series A Preferred Stock and the Warrants pursuant to the Investment Agreement and the Warrant Agreements (the number of shares which may be issued without violating such limitation, the “Exchange Cap”), except that such limitation shall not apply in the event that the Company obtains the approval of its shareholders as required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of such amount. Until such approval is obtained, the holders of the Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants (collectively, the “Existing Buyers” and each, individually, an “Existing Buyer”) shall not be permitted to convert Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock or exercise Warrants with respect to more than such Existing Buyer’s pro rata amount of such Exchange Cap (such amount, with respect to each Existing Buyer, its “Exchange Cap Allocation Amount”) determined based upon such Existing Buyer’s percentage ownership of the sum of (1) the aggregate number of shares of Common Stock issuable upon the conversion of all shares of Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock, plus (2) the aggregate number of shares of Common Stock issuable upon exercise of the Warrants. In the event that such Existing Buyer shall sell or otherwise transfer any of such Existing Buyer’s shares of Series A
Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Warrants, the transferee shall be allocated a pro rata portion of such Existing Buyer’s Exchange Cap Allocation Amount with respect to such portion of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants so transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation Amount so allocated to such transferee. Upon conversion and exercise in full of such Existing Buyer’s Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants, the difference (if any) between such Existing Buyer’s Exchange Cap Allocation Amount and the number of shares of Common Stock actually issued to such Existing Buyer upon such Existing Buyer’s conversion in full of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants shall be allocated to the respective Exchange Cap Allocation Amounts of the remaining Existing Buyers of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants on a pro rata basis in proportion to the relative Exchange Cap Allocation Amounts of such Existing Buyers.
4. Issuance of Shares; Authorization. Certificates for Shares issued upon exercise of this Warrant will be issued in such name or names as the Warrantholder may designate and will be delivered to such named Person or Persons within a reasonable time, not to exceed three (3) Business Days after the date of delivery of the applicable aggregate Exercise Price to the Company. In lieu of delivering certificates, the Company may issue Shares issued upon exercise of this Warrant electronically in book-entry form, in which case a statement of book-entry interests will be delivered to the Warrantholder within the aforementioned period. The Company hereby represents and warrants that any Shares issued upon the exercise of this Warrant in accordance with the provisions of Section 3 and all other provisions of this Warrant will be duly and validly authorized and issued, fully paid and nonassessable and free from all taxes, liens and charges (other than liens or charges created by the Warrantholder or taxes in respect of any transfer occurring contemporaneously therewith). The Company agrees that the Shares so issued will be deemed to have been issued to the Warrantholder as of the close of business on the date on which payment of the aggregate Exercise Price is delivered to the Company in accordance with the terms of this Warrant, notwithstanding that the stock transfer books of the Company may then be closed or certificates representing such Shares may not be actually delivered on such date. The Company will at all times hereafter reserve and keep available, out of its authorized but unissued Common Stock, solely for the purpose of providing for the exercise of this Warrant, the aggregate number of shares of Common Stock then issuable upon exercise of this Warrant. The Company will use commercially reasonable efforts to ensure that the Shares may be issued without violation of any applicable law or regulation.
5. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon any exercise of this Warrant. In lieu of any fractional share to which the Warrantholder would otherwise be entitled, the Warrantholder shall be entitled to receive a cash payment in an amount equal to such fraction multiplied by the Market Price of the Common Stock on the date of exercise.
6. No Rights as Shareholders; Transfer Books. This Warrant does not entitle the Warrantholder to any voting rights or other rights as a shareholder of the Company prior to the date of exercise hereof. The Company will at no time close its transfer books against transfer of this Warrant in any manner which interferes with the timely exercise of this Warrant.
7. Charges, Taxes and Expenses. Issuance of certificates for Shares to the Warrantholder upon the exercise of this Warrant shall be made without charge to the Warrantholder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company.
8. Transfer/Assignment. Subject to compliance with applicable securities laws, without obtaining the consent of the Company to assign or transfer this Warrant, this Warrant and all rights hereunder are not transferable or assignable, in whole or in part, by the Warrantholder, except for a Permitted Transfer. Upon a Permitted Transfer, a new warrant shall be made and delivered by the Company, as promptly as reasonably practicable, of the same tenor and date as this Warrant but registered in the name of the transferee or assignee and if the Warrantholder’s entire interest is not being transferred or assigned, in the name of the Warrantholder, upon surrender of this Warrant, duly endorsed, to the office or agency of the Company described in Section 20. All expenses (other than stock transfer taxes) and other charges payable in connection with the preparation, execution and delivery of the new warrants pursuant to this Section 8 shall be paid by the Company. The Company may not assign any of its rights, or delegate any of its obligations, under this Warrant without the prior written consent of the Warrantholder (which consent may be withheld for any reason or no reason at all). This Warrant shall be binding upon and inure to the benefit of the Company, the Warrantholder and their respective successors and permitted assigns, and shall include, with respect to the Company, any Person succeeding the Company in a Business Combination or acquisition of all or substantially all of the Company’s assets, and in such case, all of the obligations of the Company hereunder shall survive such Business Combination or acquisition.
9. Exchange and Registry of Warrant. This Warrant is exchangeable, upon the surrender hereof by the Warrantholder to the Company, for a new warrant or warrants of like tenor and representing the right to purchase the same aggregate number of Shares. The Company shall maintain a registry showing the name and address of the Warrantholder (and any transferee or assignee that becomes a Warrantholder) as the registered holder of this Warrant. This Warrant may be surrendered for exchange or exercise, in accordance with its terms, at the office of the Company, and the Company shall be entitled to rely in all respects, prior to written notice to the contrary, upon such registry.
10. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and in the case of any such loss, theft or destruction, upon receipt of a bond, indemnity or security reasonably satisfactory to the Company, or, in the case of any such mutilation, upon surrender and cancellation of this Warrant, the Company shall make and deliver, in lieu of such lost, stolen, destroyed or mutilated Warrant, a new Warrant, in identical form, of like tenor and representing the right to purchase the same aggregate number of Shares as provided for in such lost, stolen, destroyed or mutilated Warrant.
11. Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding day that is a Business Day.
12. Rule 144 Information. For so long as the Company is subject to the reporting obligations of the Securities Act and the Exchange Act, the Company covenants that it will use its reasonable best efforts to timely file all reports and other documents required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the U.S. Securities and Exchange Commission (the “SEC”) thereunder, and it will use reasonable best efforts to take such further action as the Warrantholder may reasonably request, all to the extent required from time to time to enable the Warrantholder to sell this Warrant without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or Regulation S under the Securities Act, as such rules may be amended from time to time, or (ii) any successor rule or regulation hereafter adopted by the SEC. Upon the written request of the Warrantholder, the Company will deliver to the Warrantholder a written statement that it has complied with such requirements.
13. Adjustments and Other Rights. The Exercise Price and the number of Shares issuable upon exercise of this Warrant pursuant to Section 3 shall be subject to adjustment from time to time as follows; provided, that no single event shall be subject to adjustment under more than one subsection of this Section 13 so as to result in duplication and the adjustment that has the highest value relative to the rights and interests of the Warrantholder shall be made; provided, further, that, notwithstanding any provision of this Warrant to the contrary, any adjustment shall be made to the extent (and only to the extent) that such adjustment would not cause or result in any Warrantholder and its Affiliates, collectively, being in violation of any applicable law, regulation or rule of any governmental authority or self-regulatory organization. Any adjustment (or portion thereof) prohibited pursuant to the foregoing proviso shall be postponed and implemented on the first date on which such implementation would not result in the condition described in such proviso.
(A) Common Stock Issued at Less Than the Applicable Price.
(i) If the Company issues or sells, or agrees to issue or sell, any Common Stock, Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or other securities that are convertible into or exchangeable or exercisable for Common Stock, Series A Preferred Stock, Series B Preferred Stock, or Non-Voting Common Stock, other than Excluded Stock, for consideration per share less than the Applicable Price, then the Exercise Price in effect immediately prior to each such issuance or sale will immediately (except as provided below) be reduced to the price determined by multiplying the Exercise Price in effect immediately prior to such issuance or sale by a fraction, (x) the numerator of which shall be the sum of (1) the number of shares of Common Stock outstanding on a fully-diluted basis immediately prior to such issuance or sale, plus (2) the total number of shares of Common Stock which the aggregate consideration received by the Company for the total number of such additional shares of Common Stock (or other securities that are convertible into or exchangeable or exercisable for Common Stock) so issued or sold would purchase at the Applicable Price, and (y) the denominator of which shall be the number of shares of Common Stock outstanding on a fully-diluted basis immediately after such issuance or sale (including the number of shares of Common Stock into which such other securities are convertible or for which such other securities are exchangeable or exercisable). In such event, the number of Shares issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment and (2) the Exercise Price in effect immediately prior to the issuance or sale giving rise to this adjustment, by (y) the new Exercise Price determined in accordance with the immediately preceding sentence. For the avoidance of doubt, no increase in the Exercise Price or reduction in the number of Shares issuable upon exercise of this Warrant shall be made pursuant to this sub-clause (i) of this Section 13(A).
(ii) For the purposes of any adjustment of the Exercise Price and the number of Shares issuable upon exercise of this Warrant pursuant to this Section 13(A), the following provisions shall be applicable:
(1) In the case of the issuance or sale of equity or equity-linked securities for cash, the amount of the consideration received by the Company shall be deemed to be the amount of the gross cash proceeds received by the Company for such securities before deducting therefrom any discounts or commissions allowed, paid or incurred by the Company for any underwriting or otherwise in connection with the issuance and sale thereof.
(2) In the case of the issuance or sale of equity or equity-linked securities (otherwise than upon the conversion of shares of Capital Stock or other securities of the Company) for a consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the Fair Market Value, before deducting therefrom any discounts or commissions allowed, paid or incurred by the Company for any underwriting or otherwise in connection with the issuance and sale thereof.
(3) In the case of the issuance of (i) options, warrants or other rights to purchase or acquire equity or equity-linked securities (whether or not at the time exercisable) or (ii) securities by their terms convertible into or exchangeable for equity or equity-linked securities (whether or not at the time so convertible or exchangeable) or options, warrants or rights to purchase such convertible or exchangeable securities (whether or not at the time exercisable):
(a) The aggregate maximum number of securities deliverable upon exercise of such options, warrants or other rights to purchase or acquire equity or equity-linked securities shall be deemed to have been issued at the time such options, warrants or rights are issued and for a consideration equal to the consideration (determined in the manner provided in Section 13(A)(i) and (ii)), if any, received by the Company upon the issuance or sale of such options, warrants or rights plus the minimum purchase price provided in such options, warrants or rights for the equity or equity-linked securities covered thereby.
(b) The aggregate maximum number of shares of equity or equity-linked securities deliverable upon conversion of or in exchange for any such convertible or exchangeable securities, or upon the exercise of options, warrants or other rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof, shall be deemed to have been issued at the time such securities were issued or such options, warrants or rights were issued and for a consideration equal to the consideration, if any, received by the Company for any such securities and related options, warrants or rights (excluding any cash received on account of accrued interest or accrued dividends), plus the additional consideration (in each case, determined in the manner provided in Section 13(A)(i) and (ii)), if any, to be received by the Company upon the conversion or exchange of such securities, or upon the exercise of any related options, warrants or rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof.
(c) On any change in the number of shares of equity or equity-linked securities deliverable upon exercise of any such options, warrants or rights or conversion or exchange of such convertible or exchangeable securities or any change in the consideration to be received by the Company upon such exercise, conversion or exchange, but excluding changes resulting from the anti-dilution provisions thereof (to the extent comparable to the anti-dilution provisions contained herein), the Exercise Price and the number of Shares issuable upon exercise of this Warrant shall forthwith be readjusted to such Exercise Price and number of Shares as would have been obtained had an adjustment been made upon the issuance or sale of such options, warrants or rights not exercised prior to such change, or of such convertible or exchangeable securities not converted or exchanged prior to such change, upon the basis of such change.
(d) If the Exercise Price and the number of Shares issuable upon exercise of this Warrant shall have been adjusted upon the issuance or sale of any such options, warrants, rights or convertible or exchangeable securities, no further adjustment of the Exercise Price and the number of Shares issuable upon exercise of this Warrant shall be made for the actual issuance of Common Stock upon the exercise, conversion or exchange thereof.
(iii) The Exercise Price and the number of Shares issuable upon exercise of this Warrant pursuant to Section 3 shall not be adjusted:
(A) for any Excluded Stock; or
(B) for a change in the par value of Common Stock.
(B) Dividends, Distributions, Stock Splits, Subdivisions, Reclassifications or Combinations. If the Company shall (i) declare a dividend or make a distribution on its Common Stock in shares of Common Stock, (ii) split, subdivide or reclassify the outstanding shares of Common Stock into a greater number of shares, or (iii) combine or reclassify the outstanding Common Stock into a smaller number of shares, the number of Shares issuable upon exercise of this Warrant at the time of the record date for such dividend or distribution or the effective date of such split, subdivision, combination or reclassification shall be proportionately adjusted so that the Warrantholder after such date shall be entitled to purchase the number of shares of Common Stock which such Warrantholder would have owned or been entitled to receive on such date had this Warrant been exercised immediately prior to such date. In such event, the Exercise Price in effect at the time of the record date for such dividend or distribution or the effective date of such split, subdivision, combination or reclassification shall be adjusted to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment and (2) the Exercise Price in effect immediately prior to the record or effective date, as the case may be, for such dividend, distribution, split, subdivision, combination or reclassification giving rise to this adjustment by (y) the new number of Shares issuable upon exercise of this Warrant determined pursuant to the immediately preceding sentence. Notwithstanding anything to the contrary herein, if the Company declares a dividend or makes a distribution on its Common Stock in shares of Common Stock, the Warrantholder may elect, in its sole and absolute discretion, to participate in such dividend or distribution in lieu of receiving the adjustment to the Exercise Price as described in this Section 13(B). In the event of such an election, the dividend or distribution that the Warrantholder is entitled to receive shall be based on the amount of the dividend or distribution that the Warrantholder would have received if it had exercised this Warrant in its entirety immediately prior to the record date of such dividend or distribution, as applicable. For the avoidance of doubt, the election under this Section 13(B) shall have no effect on any provisions of this Warrant other than as expressly set forth in this Section 13(B).
(C) Other Distributions. In case the Company shall fix a record date for the making of a distribution to all holders of shares of its Common Stock (i) of shares of any class other than its Common Stock other than shares referred to in Section 13(A)(i), (ii) of evidence of indebtedness of the Company or any Subsidiary of the Company, (iii) of other securities, assets or cash (excluding dividends or distributions referred to in Section 13(B)), or (iv) of rights or warrants (other than in connection with the adoption of a shareholder rights plan), in each such case, the Exercise Price in effect prior thereto shall be reduced immediately thereafter to the price determined by dividing (x) an amount equal to the difference resulting from (1) the number of shares of Common Stock outstanding on such record date multiplied by the Exercise Price per Share on such record date, less (2) the amount of cash and/or the Fair Market Value of said shares or evidences of indebtedness or securities or assets or rights or warrants to be so distributed, by (y) the number of shares of Common Stock outstanding on such record date; such adjustment shall be made successively whenever such a record date is fixed. In such event, the number of Shares issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment, and (2) the Exercise Price in effect immediately prior to the issuance giving rise to this adjustment by (y) the new Exercise Price determined in accordance with the immediately preceding sentence. In the event that such distribution is not so made, the Exercise Price and the number of Shares issuable upon exercise of this Warrant then in effect shall be readjusted, effective as of the date when the Board determines not to distribute such shares, evidences of indebtedness, securities, assets, cash, rights or warrants, as the case may be, to the Exercise Price that would then be in effect and the number of Shares that would then be issuable upon exercise of this Warrant if such record date had not been fixed.
(D) Certain Repurchases of Common Stock. In case the Company effects a Pro Rata Repurchase of Common Stock, then the Exercise Price shall be reduced to the price determined by multiplying the Exercise Price in effect immediately prior to the Effective Date of such Pro Rata Repurchase by a fraction of which the numerator shall be (i) the product of (x) the number of shares of Common Stock outstanding immediately before such Pro Rata Repurchase and (y) the Market Price of a share of Common Stock on the trading day immediately preceding the first public announcement by the Company or any of its Affiliates of the intent to effect such Pro Rata Repurchase, minus (ii) the aggregate purchase price of the Pro Rata Repurchase, and of which the denominator shall be the product of (i) (x) the number of shares of Common Stock outstanding immediately prior to such Pro Rata Repurchase minus (y) the number of shares of Common Stock so repurchased and (ii) the Market Price per share of Common Stock on the trading day immediately preceding the first public announcement by the Company or any of its Affiliates of the intent to effect such Pro Rata Repurchase. In such event, the number of Shares issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (i) the product of (x) the number of Shares issuable upon the exercise of this Warrant before such adjustment, and (y) the Exercise Price in effect immediately prior to the Pro Rata Repurchase giving rise to this adjustment by (ii) the new Exercise Price determined in accordance with the immediately preceding sentence.
(E) Business Combinations. In case of any Business Combination, reorganization or reclassification of Common Stock (other than a reclassification of Common Stock referred to in Section 13(B)), or the sale, transfer or other disposal of all or substantially all of the Company’s property, assets or business to another Person, in each case which entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or property (including cash) with respect to or in exchange for Common Stock, any Shares issued or issuable upon exercise of this Warrant after the date of such Business Combination or other event shall be exchangeable for the number of shares of stock or other securities or property (including cash) to which the Shares issuable (at the time of such Business Combination or other event) upon exercise of this Warrant immediately prior to the consummation of such Business Combination or other event would have been entitled to receive upon consummation of such Business Combination or other event; and in any such case, if necessary, the provisions set forth herein with respect to the rights and interests thereafter of the Warrantholder shall be appropriately adjusted so as to be applicable, as nearly as may reasonably be, to any shares of stock or other securities or property thereafter deliverable on the exercise of this Warrant. In determining the kind and amount of stock, securities or the property receivable upon consummation of such Business Combination or other event, if the holders of Common Stock have the right to elect the kind or amount of consideration receivable upon consummation of such Business Combination or other event, then the Warrantholder shall have the right to make a similar election upon exercise of this Warrant with respect to the number of shares of stock or other securities or property which the Warrantholder will receive upon exercise of this Warrant. In case of any such Business Combination or other event, the successor or acquiring Person (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and liabilities hereunder.
(F) Dissolution, Total Liquidation or Winding Up. If at any time there is a voluntary or involuntary dissolution, total liquidation or winding-up of the Company, then the Company shall provide the Warrantholder with written notice of the date on which such dissolution, liquidation or winding-up shall take place (and, in any event, not less than thirty (30) days before any date set for definitive action). Such notice shall also specify the date as of which the record holders of shares of Common Stock shall be entitled to exchange their shares for securities, money or other property deliverable upon such dissolution, liquidation or winding-up, as the case may be. On such date, the Warrantholder shall be entitled to receive upon surrender of this Warrant the cash, securities or other property, less the aggregate Exercise Price for this Warrant then in effect, that the Warrantholder would have been entitled to receive had this Warrant been exercised immediately prior to such dissolution, liquidation or winding-up. Upon receipt of the cash, securities or other property, any and all rights of the Warrantholder to exercise this Warrant shall terminate in their entirety. If the cash, securities or other property distributable in the dissolution, liquidation or winding-up has a Fair Market Value which is less than the aggregate Exercise Price for this Warrant then in effect, this Warrant shall terminate and be of no further force or effect upon the dissolution, liquidation or winding-up.
(G) Rounding of Calculations; Minimum Adjustments. All calculations under this Section 13 shall be made to the nearest one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a share, as the case may be. Any provision of this Section 13 to the contrary notwithstanding, no adjustment in the Exercise Price or the number of Shares issuable upon the exercise of this Warrant shall be made if the amount of such adjustment would be less than $0.01 or one-tenth (1/10th) of a share of Common Stock, respectively, but any such amount shall be carried forward and an adjustment with respect thereto shall be made at the time of and together with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, shall aggregate $0.01 or one-tenth (1/10th) of a share of Common Stock, respectively, or more.
(H) Timing of Issuance of Additional Common Stock Upon Certain Adjustments. In any case in which the provisions of this Section 13 shall require that an adjustment shall become effective immediately after a record date for an event, the Company may defer until the occurrence of such event (i) issuing to the Warrantholder of this Warrant exercised after such record date and before the occurrence of such event the additional Shares issuable upon such exercise by reason of the adjustment required by such event over and above the Shares issuable upon such exercise before giving effect to such adjustment and (ii) paying to such Warrantholder any amount of cash in lieu of a fractional Share; provided, however, that the Company upon request shall deliver to such Warrantholder a due bill or other appropriate instrument evidencing such Warrantholder’s right to receive such additional Shares, and such cash, upon the occurrence of the event requiring such adjustment.
(I) Statement Regarding Adjustments. Whenever the Exercise Price or the number of Shares issuable upon exercise of this Warrant shall be adjusted as provided in this Section 13, the Company shall forthwith file at the principal office of the Company a statement showing in reasonable detail the facts requiring such adjustment and the Exercise Price that shall be in effect and the number of Shares issuable upon exercise of this Warrant after such adjustment, and the Company shall also cause a copy of such statement to be sent by mail, first class postage prepaid, to the Warrantholder at the address appearing in the Company’s records.
(J) Notice of Adjustment Event. In the event that the Company shall propose to take any action of the type described in this Section 13 (but only if the action of the type described in this Section 13 would result in an adjustment in the Exercise Price or the number of Shares issuable upon exercise of this Warrant or a change in the type of securities or property to be delivered upon exercise of this Warrant), the Company shall give notice to the Warrantholder, in the manner set forth in Section 13(I), which notice shall specify the record date, if any, with respect to any such action and the approximate date on which such action is to take place. Such notice shall also set forth the facts with respect thereto as shall be reasonably necessary to indicate the effect on the Exercise Price and the number, kind or class of shares or other securities or property which shall be deliverable upon exercise of this Warrant. In the case of any action which would require the fixing of a record date, such notice shall be given at least five (5) days prior to the date so fixed, and in case of all other action, such notice shall be given at least ten (10) days prior to the taking of such proposed action. Failure to give such notice, or any defect therein, shall not affect the legality or validity of any such action.
(K) No Impairment. The Company will not, by amendment of its certificate of formation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company.
(L) Proceedings Prior to Any Action Requiring Adjustment. As a condition precedent to the taking of any action which would require an adjustment pursuant to this Section 13, the Company shall take any action which may be necessary, including obtaining regulatory, stock exchange (if applicable) or shareholder approvals or exemptions, in order that the Company may thereafter validly and legally issue as fully paid and nonassessable all shares of Common Stock that the Warrantholder is entitled to receive upon exercise of this Warrant pursuant to this Section 13.
(M) Adjustment Rules. Any adjustments pursuant to this Section 13 shall be made successively whenever an event referred to herein shall occur. If an adjustment in the Exercise Price made hereunder would reduce the Exercise Price to an amount below zero, then such adjustment in Exercise Price made hereunder shall reduce the Exercise Price to zero.
14. Reserved.
15. Contest and Appraisal Rights. Upon each determination of Market Price or Fair Market Value, as the case may be, hereunder, the Company shall promptly give notice thereof to the Warrantholder, setting forth in reasonable detail the calculation of such Market Price or Fair Market Value, and the method and basis of determination thereof, as the case may be. If the Warrantholder shall disagree with such determination and shall, by notice to the Company given within fifteen (15) days after the Warrantholder’s receipt of the Company’s notice of such determination, elect to dispute such determination, such dispute shall be resolved through the Appraisal Procedure.
16. Representations and Warranties of the Company. The Company hereby represents and warrants to the Warrantholder that (A) it has the corporate power and authority to execute this Warrant and consummate the transactions contemplated by this Warrant, (B) there are no statutory or contractual stockholders preemptive rights or rights of refusal with respect to the issuance of this Warrant and (C) the execution and delivery by the Company of this Warrant and the issuance of the Common Stock upon exercise of this Warrant do not and shall not (i) conflict with or result in a breach of the terms, conditions or provisions of, (ii) constitute a default under, (iii) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s Capital Stock or assets pursuant to, (iv) result in a violation of, or (v) require any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to, the Company’s certificate of formation or bylaws or any law in effect as of the date hereof to which the Company is subject, or any agreement, instrument, order, judgment or decree to which the Company is subject as of the date hereof, except for any such authorization, consent, approval or exemption that has been obtained.
17. Governing Law. This Warrant shall be binding upon any successors or assigns of the Company. This Warrant shall constitute a contract under the laws of the State of Delaware and for all purposes shall be construed in accordance with and governed by the laws of the State of Delaware applicable to agreements made and to be performed entirely within such state.
18. Attorneys’ Fees. In any litigation, arbitration or court proceeding between the Company and the Warrantholder as the holder of this Warrant relating hereto, the prevailing party shall be entitled to reasonable attorneys’ fees and expenses incurred in enforcing this Warrant.
19. Amendments. This Warrant may be amended and the observance of any term of this Warrant may be waived only, in the case of an amendment, with the written consent of the Company and the Warrantholder, or in the case of a waiver, by the party against whom the waiver is to be effective.
20. Notices. All notices hereunder shall be in writing and shall be effective (A) on the day on which delivered if delivered personally or transmitted by e-mail upon confirmation of receipt, (B) one Business Day after the date of dispatch if delivered by a nationally recognized overnight courier service, or (C) three Business Days after the date on which the same is deposited, postage prepaid, in the U.S. mail, sent by certified or registered mail, return receipt requested, and addressed to the party to be notified at the address indicated below for the Company, or at the address for the Warrantholder set forth in the registry maintained by the Company pursuant to Section 9, or at such other address and/or telecopy and/or email address and/or to the attention of such other person as the Company or the Warrantholder may designate from time to time by written notice to the other party given in accordance with this Section 20.
If to the Company, to:
Third Coast Bancshares, Inc.
20202 Highway 59 North, Suite 190
Humble, Texas 77338
Attn: R. John McWhorter, Chief Financial Officer
Email: jmcwhorter@tcbssb.com
with copies to (which copy alone shall not constitute notice):
Norton Rose Fulbright US LLP
2200 Ross Avenue, Suite 3600
Dallas, Texas 75201-7932
Attn: Michael G. Keeley, Esq.
Email: mike.keeley@nortonrosefulbright.com
If to the Warrantholder, to the address set forth under the Warrantholder’s name on the signature page hereof.
21. Remedies. If the Company fails to perform, comply with or observe any covenant or agreement to be performed, complied with or observed by it under this Warrant, the Warrantholder may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Warrant or for an injunction against the breach of any such term or in aid of the exercise of any power granted in this Warrant or to enforce any other legal or equitable right, or to take any one or more of such actions. The Company hereby agrees that the Warrantholder shall not be required or otherwise obligated to, and hereby waives any right to demand that the Warrantholder, post any performance or other bond in connection with the enforcement of its rights and remedies hereunder. None of the rights, powers or remedies conferred under this Warrant shall be mutually exclusive, and each right, power or remedy shall be cumulative and in addition to any other right, power or remedy whether conferred by this Warrant or now or hereafter available at law, in equity, by statute or otherwise.
22. Severability. Any provision of this Warrant that is prohibited or unenforceable shall be ineffective solely to the extent of such prohibition or unenforceability without invalidating the remaining provision of this Warrant.
23. Waiver. Failure of any party to exercise any right or remedy under this Warrant, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.
24. Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Warrant and the consummation of the transactions contemplated hereby.
25. Captions; Construction; Interpretation. The captions in this Warrant are for convenience of reference only, do not constitute a part of this Warrant and are not to be considered in construing or interpreting this Warrant. No party, nor its counsel, shall be deemed the drafter of this Warrant for purposes of construing the provisions of this Warrant, and all provisions of this Warrant shall be construed in accordance with their fair meaning, and not strictly for or against any party.
26. Entire Agreement. This Warrant and the forms attached hereto, and the Investment Agreement (and the other Transaction Documents as defined in the Investment Agreement), contain the entire agreement between the parties with respect to the subject matter hereof and supersede all prior and contemporaneous arrangements or undertakings with respect thereto.
[Remainder of page intentionally left blank]
IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by a duly authorized officer as of the date first herein above written.
| THIRD COAST BANCSHARES, INC. | ||
| By: |
| |
| Name: | ||
| Title: | ||
| Acknowledged and Agreed: | ||
| [Investor Name] | ||
| By: |
| |
| Name: | ||
| Title: | ||
| Address for Notice: | ||
|
| ||
| Telephone No: |
| |
| Facsimile No: |
| |
[Form of Notice of Exercise]
Date:
TO: Third Coast Bancshares, Inc.
RE: Election to Subscribe for and Purchase [Common Stock]
The undersigned, pursuant to the provisions set forth in the attached Warrant, hereby agrees to subscribe for and purchase the number of shares of [Common Stock] set forth below covered by such Warrant. The undersigned hereby agrees to pay the aggregate Exercise Price for such shares of [Common Stock] in accordance with Section 3 of the Warrant.
Payment shall take the form of (check applicable box):
| [ ] | in lawful money of the United States; or |
| [ ] | the cancellation of such number of Shares as is necessary, in accordance with the formula set forth in subsection 3(b), to exercise this Warrant with respect to the number of Shares indicated. |
A new warrant evidencing the remaining shares of [Common Stock] covered by such Warrant, but not yet subscribed for and purchased, should be issued in the name set forth below. If the new warrant is being transferred, an opinion of counsel to the effect that such transfer will not require registration of the Warrant or the Shares pursuant to any applicable securities laws is attached hereto with respect to the transfer of such warrant.
| Number of Shares of [Common Stock]: |
| |
| Name and Address of Person to be Issued New Warrant: |
| |
|
| ||
| Holder: |
| |
| By: |
| |
| Name: |
| |
| Title: |
| |
[Form of Notice of Exercise]
Exhibit 10.1
INVESTMENT AGREEMENT
BY AND AMONG
THIRD COAST BANCSHARES, INC.
AND
THE INVESTORS
DATED AS OF SEPTEMBER 8, 2022
TABLE OF CONTENTS
| Page(s) | ||||||
| Section 1. |
Certain Definitions | 1 | ||||
| Section 2. |
Purchase; Closings | 9 | ||||
| (a) |
Purchase and Sale | 9 | ||||
| (b) |
Closing | 9 | ||||
| Section 3. | Representations and Warranties of the Company | 10 | ||||
| (a) |
Organization and Authority | 10 | ||||
| (b) |
Authorization | 10 | ||||
| (c) |
Capitalization; Subsidiaries | 11 | ||||
| (d) |
No Conflicts | 12 | ||||
| (e) |
Governmental Approvals | 13 | ||||
| (f) |
Financial Statements | 13 | ||||
| (g) |
No Undisclosed Liabilities | 13 | ||||
| (h) |
Company Significant Agreements; Affiliate Transactions | 13 | ||||
| (i) |
Controls and Procedures | 14 | ||||
| (j) |
Properties | 15 | ||||
| (k) |
Taxes | 15 | ||||
| (l) |
Litigation and Other Proceedings | 16 | ||||
| (m) |
Compliance with Laws | 16 | ||||
| (n) |
Absence of Certain Changes | 17 | ||||
| (o) |
Company Benefit Plans | 17 | ||||
| (p) |
Regulatory Matters | 18 | ||||
| (q) |
Environmental Matters | 19 | ||||
| (r) |
Labor | 19 | ||||
| (s) |
Insurance | 20 | ||||
| (t) |
No Integration | 20 | ||||
| (u) |
Loan Portfolio | 20 | ||||
| (v) |
Brokers and Finders | 21 | ||||
| (w) |
Absence of Manipulation | 21 | ||||
| (x) |
Well Capitalized | 22 | ||||
| (y) |
Acknowledgment Regarding Purchase of Purchased Shares | 22 | ||||
| (z) |
Shell Company Status | 22 | ||||
| (aa) |
Investment Company | 22 | ||||
| (bb) |
Risk Management; Derivatives | 22 | ||||
| (cc) |
Foreign Corrupt Practices and International Trade Sanctions | 23 | ||||
| (dd) |
Anti-Takeover Provisions | 23 | ||||
| (ee) |
Intellectual Property | 23 | ||||
| (ff) |
Fiduciary Accounts | 23 | ||||
| (gg) |
Common Control | 24 | ||||
| (hh) |
Knowledge as to Conditions | 24 | ||||
| (ii) |
No Other Representations and Warranties | 24 | ||||
i
| Section 4. | Representations and Warranties of Investor | 24 | ||||
| (a) |
Organization | 24 | ||||
| (b) |
Authorization | 25 | ||||
| (c) |
Purchase for Investment | 25 | ||||
| (d) |
Sufficient Funds | 25 | ||||
| (e) |
No Conflicts | 25 | ||||
| (f) |
Access to Information | 26 | ||||
| (g) |
Independent Investment Decision | 26 | ||||
| (h) |
Reliance on Exemptions | 26 | ||||
| (i) |
No Governmental Review | 26 | ||||
| (j) |
Residency | 27 | ||||
| (k) |
Ownership | 27 | ||||
| (l) |
Brokers and Finders | 27 | ||||
| (m) |
Non-Reliance | 27 | ||||
| Section 5. | Deliveries at Closing | 27 | ||||
| (a) |
Company Deliverables | 27 | ||||
| (b) |
Investor Deliverables | 28 | ||||
| (c) |
Castle Creek Deliverables | 28 | ||||
| Section 6. | Covenants | 29 | ||||
| (a) |
Public Statements | 29 | ||||
| (b) |
Regulatory Approvals | 29 | ||||
| (c) |
Cooperation | 29 | ||||
| (d) |
Transfer Restrictions; Legends | 31 | ||||
| (e) |
Transfer | 32 | ||||
| (f) |
No Change of Control | 33 | ||||
| (g) |
Shareholder Approval | 33 | ||||
| (h) |
Additional Regulatory Matters | 33 | ||||
| (i) |
Merger or Sale | 35 | ||||
| (j) |
Shareholder Litigation | 35 | ||||
| (k) |
Notice of Certain Events | 35 | ||||
| (l) |
Conduct of the Business | 35 | ||||
| (m) |
Certain Transactions | 36 | ||||
| (n) |
Anti-Takeover Matters | 37 | ||||
| (o) |
Form D and Blue Sky | 37 | ||||
| (p) |
No Additional Issuances | 37 | ||||
| (q) |
Acknowledgment of Dilution | 37 | ||||
| (r) |
Use of Proceeds | 37 | ||||
| Section 7. | Conditions to Closing | 38 | ||||
| Section 8. | Termination | 41 | ||||
| Section 9. | Additional Covenants | 42 | ||||
| (a) |
Reservation for Issuance | 42 | ||||
| (b) |
Indemnification | 43 | ||||
| (c) |
Corporate Opportunities | 45 | ||||
ii
| Section 10. |
Survival | 45 | ||||
| Section 11. |
Notices | 45 | ||||
| Section 12. |
Assignment | 46 | ||||
| Section 13. |
Entire Agreement | 46 | ||||
| Section 14. |
Governing Law | 46 | ||||
| Section 15. |
Severability | 46 | ||||
| Section 16. |
Expenses | 47 | ||||
| Section 17. |
Reserved. | 47 | ||||
| Section 18. |
Construction | 47 | ||||
| Section 19. |
Counterparts and Facsimiles | 47 | ||||
| Section 20. |
Specific Performance | 48 | ||||
| Section 21. |
Amendment; Waiver | 48 | ||||
| Section 22. |
No Recourse | 48 | ||||
| Section 23. |
No Third Party Beneficiaries | 48 | ||||
LIST OF EXHIBITS AND SCHEDULES
| Exhibit A: | Form of Certificate of Designations for Series A Preferred Stock | |
| Exhibit B: | Form of Certificate of Designations for Series B Preferred Stock | |
| Exhibit C: | Form of Certificate of Amendment (Authorizing Non-Voting Common Stock) | |
| Exhibit D: | Form of Voting Agreement | |
| Exhibit E: | Form of Officer’s Certificate of the Company | |
| Exhibit F: | Form of Secretary’s Certificate of the Company | |
| Exhibit G: | Form of Officer’s Certificate of the Investor | |
| Exhibit H: | Form of VCOC Letter Agreement | |
| Exhibit I: | Form of Opinion of Company Counsel | |
| Exhibit J: | Form of Warrant Agreement | |
| Exhibit K: | Registration Rights Agreement | |
| Exhibit L: | Form of Letter Agreement | |
| Schedule 3(d): | No Conflicts | |
| Schedule 3(i): | Controls and Procedures | |
| Schedule 3(j): | Properties | |
| Schedule 3(m): | Compliance with Laws | |
| Schedule 3(n): | Absence of Certain Changes | |
| Schedule 3(p): | Regulatory Agreements | |
| Schedule 3(v): | Brokers and Finders | |
| Schedule 3(gg): | Common Control | |
| Schedule 6(l): | Conduct of Business | |
iii
This INVESTMENT AGREEMENT (this “Agreement”), dated as of September 8, 2022, is by and among Third Coast Bancshares, a Texas corporation (the “Company”), and the several purchasers of the Series A Preferred Stock (as defined herein) identified on the signature pages hereto (each an “Investor and collectively, the “Investors”).
RECITALS
The Company intends to sell to the Investors, and the Investors intend to purchase from the Company, on the terms and subject to the conditions set forth herein, an aggregate number of 69,400 shares of Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share and a liquidation value of $1,000 per share (the “Series A Preferred Stock”), which shall, subject to Section 6(s) and the terms and conditions set forth in the Series A Certificate of Designation, be convertible into (A) with respect to each Investor, a number of shares of Common Stock up to 9.9% of the total outstanding shares of Common Stock, and thereafter, subject to such ownership limitation, (B) shares of Series B Convertible Perpetual Preferred Stock, par value $1.00 per share (the “Series B Preferred Stock”), (C) following the Shareholder Approval and subject to the terms and conditions of the Certificate of Amendment to the Company’s Certificate of Formation attached as Exhibit C hereto (the “Non-Voting Common Stock Certificate of Amendment”), non-voting common stock, par value $1.00 per share, of the Company (the “Non-Voting Common Stock”) to be designated with the terms, privileges and preferences set forth in the form of the Non-Voting Common Stock Certificate of Amendment, and (D) to Warrant Eligible Investors, Warrants to be issued by the Company pursuant to the Warrant Agreement in the form attached hereto as Exhibit J (each, a “Warrant Agreement” and collectively, the “Warrant Agreements”);
Castle Creek Capital Partners VIII, LP (“CCCP VIII”) intends to purchase up to $30 million of the Series A Preferred Stock from the Company pursuant hereto and in recognition of its role in the offer and sale of the Series A Preferred Stock, the Company intends to (A) issue Warrants to CCCP VIII and (B) enter into the Letter Agreement between the Company and CCCP VIII in the form attached hereto as Exhibit L. In addition, the Company will enter into the VCOC Letter Agreement between the Company and CCCP VIII in the form attached hereto as Exhibit H;
On or prior to the date hereof, certain shareholders of the Company have entered into a voting agreement, the form of which is attached hereto as Exhibit D, pursuant to which such persons have agreed to vote shares of Common Stock which they beneficially own and over which they exercise voting control in favor of the approval of any matters necessary to effect the transactions contemplated herein, including those proposals to be submitted to shareholders pursuant to Section 6(g).
NOW THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:
Section 1. Certain Definitions. The following terms used herein shall have the meanings set forth below:
1
“Affiliate” means, with respect to any Person, any Person directly or indirectly controlling, controlled by or under common control with such other Person.
“Agency” has the meaning set forth in Section 3(u) hereof.
“Agreement” has the meaning set forth in the preamble hereof.
“Bank” has the meaning set forth in Section 3(p)(i) hereof.
“Benefit Plan” means all “employee welfare benefit plans” within the meaning of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), all employee pension benefit plans within the meaning of Section 3(2) of ERISA, including, but not limited to, plans that provide retirement income or result in a deferral of income by employees for periods extending to termination of employment or beyond, and plans that provide medical, surgical, or hospital care benefits or benefits in the event of sickness, accident, disability, death or unemployment, and all other employee benefit agreements or arrangements, including, but not limited to, all bonus, incentive, deferred compensation, vacation, stock purchase, stock option, stock award, severance, employment, change of control, golden-parachute, consulting, dependent care, cafeteria, employee assistance, scholarship, or fringe benefit or similar plans, programs, agreements or policies, in all cases whether written, unwritten or otherwise, funded or unfunded, and whether or not ERISA is applicable to such plan, program, agreement or policy.
“BHCA Control” has the meaning set forth in Section 3(gg) hereof.
“BHC Act” has the meaning set forth in Section 3(p)(iv) hereof.
“Board of Directors” means the Board of Directors of the Company.
“Board Representative” has the meaning set forth in the Letter Agreement.
“Business Day” means any day that is not a Saturday, a Sunday or a day on which banks are required or permitted by law or executive order to be closed in the State of Texas.
“Buy-In” has the meaning set forth in Section 6(d)(iv) hereof.
“Buy-In Broker” has the meaning set forth in Section 6(d)(iv) hereof.
“CBCA” has the meaning set forth in Section 6(h)(i) hereof.
“Certificate of Formation” means the First Amended and Restated Certificate of Formation of the Company, as amended prior to the date hereof and as may be further amended as contemplated by the terms hereof.
2
“Change in Control” means, with respect to the Company, the occurrence of any one of the following events:
(1) any person is or becomes a beneficial owner (other than the Investors and their Affiliates), directly or indirectly, of 50% or more of the aggregate number of the Company’s voting securities provided, however, that the event described in this clause (1) will not be deemed a Change in Control by virtue of any holdings or acquisitions: (i) by the Company or any of its subsidiaries, (ii) by any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its subsidiaries; provided that such holdings or acquisitions by any such plan (other than any plan maintained under Section 401(k) of the Code) do not exceed 50% of the then outstanding Voting Securities, (iii) by any underwriter temporarily holding securities pursuant to an offering of such securities, or (iv) pursuant to a Non-Qualifying Transaction;
(2) the event described in clause (1) above in this definition of “Change in Control” (substituting all references to “50%” in such clause with “24.9%”), and in connection with such event, individuals who, on the date of this Agreement, constitute the Board of Directors (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board of Directors, provided, that any person becoming a director subsequent to the date of this Agreement whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board of Directors (either by a specific vote or by approval of the proxy statement of the relevant party in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director (except that no individuals who were not directors at the time any agreement or understanding with respect to any Business Combination or contested election is reached shall be treated as Incumbent Directors for the purposes of clause (3) below with respect to such Business Combination or this paragraph in the case of a contested election); provided, further, that each Board Representative appointed under the Letter Agreement will be treated as an Incumbent Director even if the person designated to be such Board Representative should change;
(3) the consummation of a merger, consolidation, statutory share exchange or similar transaction that requires adoption by the Company’s shareholders (a “Business Combination”), unless immediately following such Business Combination: (x) more than 50% of the total voting power of the corporation resulting from such Business Combination (the “Surviving Corporation”), or, if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by voting securities that were outstanding immediately before such Business Combination (or, if applicable, is represented by shares into which such voting securities were converted pursuant to such Business Combination), and (y) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors at the time the Company’s Board of Directors approved the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (x) and (y) above will be deemed a “Non-Qualifying Transaction”);
(4) the shareholders of the Company approve a plan of liquidation or dissolution of the Company or a sale of all or substantially all of the Company’s assets; or
3
(5) the Company has entered into a definitive agreement, the consummation of which would result in the occurrence of any of the events described in clauses (1) through (4) of this definition above.
“Closing” has the meaning set forth in Section 2(b) hereof.
“Closing Date” has the meaning set forth in Section 2(b) hereof.
“Code” means Internal Revenue Code of 1986, as amended as of the date hereof.
“Commission” means the Securities and Exchange Commission, or any successor agency thereto.
“Common Stock” means the Company’s common stock, par value $1.00 per share.
“Company” has the meaning set forth in the preamble hereof.
“Company Financial Statements” has the meaning set forth in Section 3(f).
“Company Recommendation” has the meaning set forth in Section 6(g) hereof.
“Company Reports” has the meaning set forth in Section 3(p)(vi) hereof.
“Company Restricted Stock” has the meaning set forth in Section 3(c)(i) hereof.
“Company Significant Agreement” means any contract or agreement that is a “material contract” within the meaning of Item 601(b)(10) of Regulation S-K to be performed in whole or in part after the date of this Agreement.
“Company Stock Options” has the meaning set forth in Section 3(c)(i) hereof.
“Company Subsidiary” means any subsidiary of the Company.
“Confidential Information” has the meaning set forth in Section 6(c)(ii) hereof.
“Conversion Price” has the meaning set forth in the Series A Certificate of Designation.
“Conversion Securities” means the shares of Common Stock, Series B Preferred Stock or Non-Voting Common Stock into which the Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock is convertible (as applicable) or into which the Warrants are exercisable.
“Deductible” has the meaning set forth in Section 9(c)(iv) hereof.
“Disclosure Schedule” has the meaning set forth in Section 3 hereof.
4
“Environmental Law” means any federal, state, local or foreign statute, law, regulation, order, decree, permit, authorization, opinion, common law or agency requirement relating to: (A) the protection, investigation or restoration of the environment, health, safety, or natural resources, (B) the handling, use, presence, disposal, release or threatened release of any Hazardous Substance or (C) noise, odor, indoor air, employee exposure, wetlands, pollution, contamination or any injury or threat of injury to Persons or property relating to any Hazardous Substance.
“ERISA” has the meaning set forth in Section 1 hereof under the term “Benefit Plan.”
“ERISA Affiliate” means any Person which, together with the Company, would be treated as a single employer under Section 414 of the Code.
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission thereunder.
“Exchange Cap” has the meaning set forth in Section 6(s) hereof.
“Exchange Cap Allocation Amount” has the meaning set forth in Section 6(s) hereof.
“Existing Buyer” has the meaning set forth in Section 6(s) hereof.
“FDIC” has the meaning set forth in Section 3(p)(ii) hereof.
“Federal Reserve Board” means the Board of Governors of the Federal Reserve System.
“GAAP” has the meaning set forth in Section 3(f) hereof.
“Governmental Entity” means any court, administrative agency or commission or other governmental authority or instrumentality, whether federal, state, local or foreign, and any applicable industry self-regulatory organization.
“Hazardous Substance” means any substance that is: (A) listed, classified or regulated pursuant to any Environmental Law; (B) any petroleum product or by-product, asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls, radioactive material or radon; and (C) any other substance which may be the subject of regulatory action by any Governmental Entity in connection with any Environmental Law.
“Indemnified Party” has the meaning set forth in Section 9(c)(ii) hereof.
“Indemnifying Party” has the meaning set forth in Section 9(c)(ii) hereof.
“Insurer” has the meaning set forth in Section 3(u) hereof.
“Intellectual Property” shall mean trademarks, service marks, brand names, domain names, certification marks, trade dress and other indications of origin, the goodwill associated with the foregoing and registrations in any jurisdiction of, and applications in any jurisdiction to register, the foregoing, including any extension, modification or renewal of any such registration
5
or application; inventions, discoveries and ideas, whether patentable or not, in any jurisdiction; patents, applications for patents (including divisions, continuations, continuations in part and renewal applications), and any renewals, extensions or reissues thereof, in any jurisdiction; trade secrets and rights in any jurisdiction to limit the use or disclosure thereof by any person; writings and other works, whether copyrightable or not, in any jurisdiction; and registrations or applications for registration of copyrights in any jurisdiction, and any renewals or extensions thereof; and any similar intellectual property or proprietary rights.
“Investor” has the meaning set forth in the preamble hereof.
“Investor Related Party” has the meaning set forth in Section 22 hereof.
“IRS” has the meaning set forth in Section 3(k) hereof.
“knowledge of the Company” or “Company’s knowledge” means the actual knowledge of (i) the Chief Executive Officer of the Company, (ii) the Chief Financial Officer of the Company, (iii) the Chief Credit Officer of the Company, and (v) the executive officers of the Company having responsibility for the matter or matters that are the subject of the statement, in each case, after reasonable investigation.
“Letter Agreement” has the meaning set forth in Section 5(c)(i)(B) hereof.
“Legend Removal Date” has the meaning set forth in Section 6(d)(iii) hereof.
“Loan Investor” has the meaning set forth in Section 3(u) hereof.
“Losses” has the meaning set forth in Section 9(c)(i) hereof.
“Material Adverse Effect” means any circumstance, event, change, development or effect that (1) is material and adverse to the assets, liabilities, business, operations, results of operations or condition (financial or otherwise) of the Company and the Company Subsidiaries taken as a whole or (2) could materially impair the ability of the Company to perform its obligations under this Agreement or to consummate the Closing; provided, however, that in determining whether a Material Adverse Effect has occurred with respect to clause (1) above, there shall be excluded any effect to the extent resulting from the following: (A) changes or proposed changes in GAAP or regulatory accounting principles generally applicable to banks, savings associations or their holding companies (or authoritative interpretations thereof), (B) changes or proposed changes in laws, rules and regulations of general applicability or interpretations thereof by Governmental Entities, (C) actions or omissions of the Company expressly required by the terms of this Agreement or taken with the prior written consent of the Investors, (D) changes in general economic, monetary or financial conditions or markets generally or that are the result of factors generally affecting the banking industry, (E) changes in the market price or trading volumes of the Common Stock or the Company’s other securities in and of themselves (but not the underlying causes of such changes), (F) the failure of the Company to meet any internal or public projections, forecasts, estimates or guidance in and of themselves for any period ending on or after December 31, 2021 (but not the underlying causes of such failure), (G) changes in global or national political conditions or developments, including the outbreak or escalation of war or acts
6
of terrorism, or pandemics or disease outbreaks (including SARS-COV-2 or COVID-19, or any evolutions thereof) and (H) the public disclosure of this Agreement or the transactions contemplated hereby; except, with respect to clauses (A), (B), (D) and (G), to the extent that the effects of such changes have a disproportionate effect on the Company and the Company Subsidiaries, taken as a whole, relative to other banks, savings associations and their holding companies generally.
“Non-Voting Common Stock” has the meaning set forth in recitals hereof.
“Non-Voting Common Stock Certificate of Amendment” has the meaning set forth in recitals hereof.
“Observer” has the meaning set forth in the Letter Agreement.
“OFAC” has the meaning set forth in Section 3(m) hereof.
“Organizer Warrants” has the meaning set forth in Section 3(c)(i) hereof.
“Legend Removal Date” has the meaning set forth in Section 6(d)(iii).
“Liens” has the meaning set forth in Section 3(d) hereof.
“Permitted Liens” has the meaning set forth in Section 3(j) hereof.
“Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, unincorporated organization or other legal entity.
“Preferred Stock” has the meaning set forth in Section 3(c)(i) hereof.
“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading.
“Purchase Price” has the meaning set forth in Section 2(a) hereof.
“Purchased Shares” has the meaning set forth in Section 2(a) hereof.
“Registration Rights Agreement” has the meaning set forth in Section 5(a)(ix) hereof.
“Regulatory Agreement” has the meaning set forth in Section 3(p)(iii) hereof.
“Representatives” has the meaning set forth in Section 6(c)(ii) hereof.
“Rights” has the meaning set forth in Section 3(c)(ii) hereof.
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder.
7
“Series A Certificate of Designation” means the Certificate of Designation relating to the Series A Preferred Stock filed with the Texas Secretary of State in the form attached hereto as Exhibit A.
“Series A Preferred Stock” has the meaning set forth in the recitals.
“Series B Certificate of Designation” means the Certificate of Designation relating to the Series B Preferred Stock filed with the Texas Secretary of State in the form attached hereto as Exhibit B.
“Series B Preferred Stock” has the meaning set forth in the recitals.
“Shareholder Approval” has the meaning set forth in Section 6(g) hereof.
“Shareholder Litigation” has the meaning set forth in Section 6(j) hereof.
“Shareholders’ Meeting” has the meaning set forth in Section 6(g) hereof.
“Takeover Law” has the meaning set forth in Section 6(n) hereof.
“Taxes” means all taxes, charges, levies, penalties or other assessments that are in the nature of a tax imposed by any United States federal, state, local or foreign taxing authority, including any income, excise, property, sales, transfer, franchise, payroll, withholding, social security or other taxes, together with any interest or penalties attributable thereto, and any payments made or owing to any other Person measured by such taxes, charges, levies, penalties or other assessments (other than pursuant to commercial agreements or Benefit Plans).
“Tax Return” means any return, report, information return or other document (including any related or supporting information) required to be filed with any taxing authority with respect to Taxes, any claims for refunds of Taxes and any amendments or supplements to any of the foregoing.
“TDSML” has the meaning set forth in Section 3(p)(i) hereof.
“TCBCA” has the meaning set forth in Section 6(h)(i) hereof.
“Trading Day” means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Trading Market, or (ii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by OTC Markets Group, Inc. (including the OTC Pink); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day.
“Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
8
“Transaction Documents” means this Agreement, the schedules and exhibits attached hereto, including the VCOC Letter Agreement, the Registration Rights Agreement, the Series A Certificate of Designation, the Series B Certificate of Designation, the Non-Voting Common Stock Certificate of Amendment, the Warrant Agreements, the Letter Agreement and any other documents or agreements executed by the Company or any Investor in connection with the transactions contemplated hereunder.
“Transfer Agent” means Continental Stock Transfer and Trust Company or any successor transfer agent for the Company.
“Unlawful Gains” has the meaning set forth in Section 3(m) hereof.
“VCOC Letter Agreement” has the meaning set forth in Section 5(c)(i)(A) hereof.
“Voting Debt” has the meaning set forth in Section 3(c)(iii) hereof.
“Voting Securities” shall mean at any time shares of any class of capital stock of the Company that are then entitled to vote generally in the election of directors.
“Warrant Agreement” has the meaning set forth in the recitals.
“Warrant Eligible Investor” means an Investor who pursuant to this Agreement purchases at least $4,000,000 in aggregate liquidation amount of the Series A Preferred Stock.
“Warrantholder” means a Warrant Eligible Investor or its permitted successors and assigns.
“Warrants” means warrants to purchase shares of Common Stock (or, at the election of such Warrantholder in accordance with the terms of such agreement, Series B Preferred Stock or Non-Voting Common Stock) at an exercise price equal to $22.50 per share pursuant to the Warrant Agreement in such amounts as set forth on Warrant Eligible Investors’ signature pages hereto.
Section 2. Purchase; Closings.
(a) Purchase and Sale. On the terms and subject to the conditions set forth herein, the Investors, severally and not jointly, each hereby agree, at the Closing, to purchase from the Company, and the Company hereby agrees to sell to each Investor, severally and not jointly, the number of shares of Series A Preferred Stock and, in the case of Warrant Eligible Investors, the number of Warrants, as applicable, set forth below such Investor’s name on the signature page hereto (the “Purchased Shares”) for a purchase price of $1,000 per share of Series A Preferred Stock (the “Purchase Price”).
(b) Closing. Subject to the satisfaction or waiver of the conditions set forth in Section 7 hereof, the closing of the purchase of the shares of Series A Preferred Stock hereunder (the “Closing”) shall occur by electronic transmission or other means as the parties may mutually agree at 9:00 a.m., Central time, on the third Business Day following the day on which the conditions to Closing set forth in Section 7 hereof (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions) shall be satisfied or waived in accordance with this Agreement (the “Closing Date”), or as otherwise agreed by the Company and the Investors.
9
Section 3. Representations and Warranties of the Company. Except as set forth in the corresponding sections or subsections of the disclosure schedule delivered to the Investors by the Company prior to entering into this Agreement (the “Disclosure Schedule”), provided, that (a) no item is required to be set forth as an exception to a representation or warranty if its absence would not result in the related representation or warranty being deemed untrue or incorrect, (b) the mere inclusion of an item in the Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by the Company that such item represents a material exception or fact, event or circumstance or that such item is reasonably likely to result in a Material Adverse Effect, and (c) any disclosures made with respect to a subsection of Section 3 shall be deemed to qualify (1) any other subsection of Section 3 hereof specifically referenced or cross-referenced, and (2) other subsections of Section 3 to the extent it is reasonably apparent on its face (notwithstanding the absence of a specific cross reference) from a reading of the disclosure that such disclosure applies to such other subsections, the Company represents and warrants to each Investor as of the date hereof as follows:
(a) Organization and Authority. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Texas, and each of the Company Subsidiaries is duly organized, validly existing and is in good standing in all jurisdictions where its ownership or leasing of property or the conduct of its business requires it to be so qualified except when the failure to be so qualified would not reasonably be expected to have a Material Adverse Effect. The Company has all requisite corporate or similar power and authority to carry on its business as currently conducted. The Company has furnished or made available to the Investors true, correct and complete copies of the Certificate of Formation and the Company’s bylaws as amended through the date of this Agreement. The Company is not in violation of any of the provisions of the Certificate of Formation or its bylaws.
(b) Authorization. This Agreement has been duly and validly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery by each Investor, constitutes a binding obligation of the Company enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally, or the rights of creditors of financial institutions, the accounts of whose subsidiaries are insured by the FDIC, and subject, as to enforceability, to general principles of equity, including principles of good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity). Subject to the receipt of Shareholder Approval contemplated by Section 6(g) hereof, all of the shares of Series A Preferred Stock to be issued to the Investors and Warrants to be issued to the Warrant Eligible Investors under this Agreement and the Warrant Agreements, as applicable, and the Conversion Securities to be issued to the Investors upon conversion of the Series A Preferred Stock (or Series B Preferred Stock or Non-Voting Common Stock, as applicable) and exercise of the Warrants have been duly authorized for issuance and, when issued, paid for and delivered as set forth herein, or in the Non-Voting Common Stock Certificate of Amendment, as applicable, the shares of Series A Preferred Stock, the Warrants and the Conversion Securities will be validly issued, fully paid and non-assessable. Except for the Shareholder Approval
10
contemplated by Section 6(g) hereof, no other corporate proceedings or shareholder actions are necessary for the execution and delivery by the Company of this Agreement, the performance by the Company of its obligations hereunder, or the consummation by the Company of the transactions contemplated hereby.
(c) Capitalization; Subsidiaries.
(i) As of the date hereof, the authorized capital stock of the Company consists of (A) 50,000,000 shares of Common Stock, of which 13,501,461 shares are issued and outstanding as of August 4, 2022, and (B) 1,000,000 shares of preferred stock, par value $1.00 per share (“Preferred Stock”), of which no shares are issued and outstanding as of the date hereof. All of the outstanding shares of Common Stock have been duly authorized, are validly issued, fully paid and nonassessable and were offered, sold and issued in material compliance with all applicable federal and state securities laws and without violating any contractual obligation or any preemptive or similar rights. As of June 30, 2022, there were 153,891 shares of Common Stock authorized and reserved for issuance remaining available under the Company’s 2019 Omnibus Incentive Plan, 8,000 shares of Common Stock authorized and reserved for issuance remaining available under the Company’s 2017 Non-Employee Director Stock Option Plan, 1,228,978 outstanding options to purchase shares of Common Stock (collectively, the “Company Stock Options”), 80,382 outstanding shares of restricted stock of the Company (the “Company Restricted Stock”), and outstanding warrants to purchase 4,285 shares of Common Stock (the “Organizer Warrants”). Each Company Stock Option (i) was granted in compliance with all applicable laws and all of the terms and conditions of the plans pursuant to which it was issued, (ii) has an exercise price per share of Common Stock equal to or greater than the fair market value of a share of Common Stock on the date of such grant and (iii) has a grant date identical to the date on which the Board of Directors or compensation committee of the Board of Directors actually awarded such Company Stock Option.
(ii) The shares of Series A Preferred Stock (upon filing of the Series A Certificate of Designation with the Secretary of State of the State of Texas) will be duly authorized by all necessary corporate action, and when issued and sold against receipt of the consideration therefor as provided in this Agreement, such shares of Series A Preferred Stock will be validly issued, fully paid and non-assessable and free of preemptive rights except for those stated in the Letter Agreement. The shares of Series B Preferred Stock (upon filing of the Series B Certificate of Designation with the Secretary of State of the State of Texas) will be duly authorized by all necessary corporate action, and when issued and sold against receipt of the consideration therefor as provided in this Agreement, the Series A Certificate of Designation and/or the Warrant Agreements, such shares of Series B Preferred Stock will be validly issued, fully paid and non-assessable and free of preemptive rights except for those stated in the Letter Agreement. The shares of Common Stock (and, upon filing of the Non-Voting Common Stock Certificate of Amendment, the Non-Voting Common Stock) issuable upon the conversion of the Series A Preferred Stock and/or the Series B Preferred Stock and/or exercise of the Warrants will have been duly authorized by all necessary corporate action and when so issued upon such conversion or exercise will be validly issued, fully paid and non-assessable, and free of preemptive rights except for those stated in the Letter Agreement. The Company will reserve, free of any preemptive or similar rights of shareholders of the Company except for those stated in the Letter Agreement, a number of unissued shares of Common Stock, Non-Voting Common Stock, and Series B Preferred
11
Stock, sufficient to issue and deliver the Conversion Securities into which the Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock, as applicable, is convertible under the Series A Certificate of Designation, the Series B Certificate of Designation and/or the Non-Voting Common Stock Certificate of Amendment, and/or subject to exercise under the Warrants.
(iii) As of the date of this Agreement, no bonds, debentures, notes or other indebtedness having the right to vote on any matters on which shareholders of the Company may vote (“Voting Debt”) are issued or outstanding. Except as contemplated by the Transaction Documents or related to the Company Stock Options, the Company Restricted Stock and the Organizer Warrants, the Company does not have and is not bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements (“Rights”) calling for the purchase or issuance of, or the payment of any amount based on, any shares of Common Stock or any other equity securities of the Company or any securities representing the right to purchase or otherwise receive any shares of the Common Stock, Preferred Stock, Voting Debt or other equity securities of the Company. Except as disclosed in the Company’s documents filed with or furnished to the Commission, there are no contractual obligations of the Company or any Company Subsidiary (x) to repurchase, redeem or otherwise acquire any shares of its capital stock or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of the Company or the Company Subsidiaries, or (y) pursuant to which the Company or any Company Subsidiary is or could be required to register shares of the Company’s capital stock or other securities under the Securities Act.
(iv) Except for the Lien on the capital stock of the Bank under that certain Loan Agreement, dated March 10, 2021, by and between the Company and American National Bank & Trust, all of the outstanding shares of capital stock or other securities of each of the Company Subsidiaries, have been duly authorized and are validly issued, fully paid and non-assessable and directly or indirectly owned by the Company, free and clear of any Lien.
(d) No Conflicts. Except as set forth in Schedule 3(d) of the Disclosure Schedule, the issuance and sale of the Series A Preferred Stock, the Warrants and the Conversion Securities, the execution, delivery and performance by the Company of this Agreement, the compliance by the Company with all of the provisions of this Agreement and the consummation of the transactions herein contemplated will not (i) violate, conflict with, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration of, or result in the creation of, any lien, security interest, charge or encumbrance (“Liens”) upon any of the properties or assets of the Company or any of the Company Subsidiaries under any of the terms, conditions or provisions of (A) its certificate of formation or by-laws or other organizational documents, as applicable, or (B) any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other agreement to which the Company or any Company Subsidiary is a party or by which it or any Company Subsidiary may be bound, or any of the properties or assets of the Company or any Company Subsidiary may be subject, or (ii) subject to the Shareholder Approval, violate any statute, rule or regulation or any judgment, ruling, order, writ, injunction or decree applicable to the Company or any Company Subsidiary or any of their respective properties or assets except, in the case of clauses (i)(B) and (ii), for those occurrences that individually or in the aggregate have not had and would not be reasonably expected to have Material Adverse Effect.
12
(e) Governmental Approvals. Assuming the accuracy of the representations and warranties made by the Investors in Section 4(e), no notice to, registration, declaration or filing with, exemption or review by, or authorization, order, consent or approval of, any Governmental Entity, nor expiration or termination of any statutory waiting periods, is necessary for the consummation by the Company of the transactions contemplated by this Agreement, other than (i) as may be required by the securities or blue sky laws of the various states, (ii) any approval required pursuant to Section 7(a)(iv), (iii) the filing of the Series A Certificate of Designation, the Series B Certificate of Designation and the Non-Voting Common Stock Certificate of Amendment, and (iv) as otherwise required by this Agreement.
(f) Financial Statements. The consolidated balance sheets of the Company as of December 31, 2021 and 2020 and related consolidated statements of operations, changes in shareholders’ equity and cash flows for each year in the three year-period ended December 31, 2021, together with the notes thereto, audited by Whitley Penn LLP, and the consolidated balance sheet of the Company as of June 30, 2022 and related consolidated statements of operations and consolidated statements of comprehensive income for the six-month period ended June 30, 2022, together with the notes thereto (collectively, the “Company Financial Statements”), (1) have been prepared from, and are in accordance with, the books and records of the Company, (2) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) applied (except as may be indicated in the notes and schedules thereto) on a consistent basis during the periods involved, and (3) present fairly in all material respects the consolidated financial position of the Company at the dates set forth therein and the consolidated results of operations, changes in shareholders’ equity and cash flows of the Company for the periods stated therein (subject to the absence of notes and normal year-end audit adjustments in the case of interim unaudited statements).
(g) No Undisclosed Liabilities(i) . Neither the Company nor any Company Subsidiary has any liabilities or obligations of any nature (absolute, accrued, contingent or otherwise) that are not properly reflected or reserved against in the Company Financial Statements to the extent required to be so reflected or reserved against in accordance with GAAP, (1) except for liabilities that have arisen since June 30, 2022 in the ordinary course of business, (2) contractual liabilities under agreements entered into in the ordinary course of business or that are disclosed in the Company’s documents filed with or furnished to the Commission, and (3) liabilities that have not had and would not reasonably be expected to have a Material Adverse Effect.
(h) Company Significant Agreements; Affiliate Transactions.
(i) The Company has made available to the Investors true, correct and complete copies of all Company Significant Agreements to which the Company or any Company Subsidiary is a party or subject. Assuming the due authorization, execution and delivery by the other party to each Company Significant Agreement, each of the Company Significant Agreements is valid and binding on the Company and the Company Subsidiaries, as applicable, and in full force and effect. The Company and each of the Company Subsidiaries, as applicable, are in compliance in all material respects with and have performed in all material respects all obligations required to be performed by them to date under each Company Significant Agreement. Neither the Company nor any of the Company Subsidiaries has received written notice of, or to the Company’s knowledge is aware of, any material violation or default (or any condition which with
13
the passage of time or the giving of notice would cause such a material violation of or a default) by any party under any Company Significant Agreement. No party to a Company Significant Agreement has provided written notice to the Company or any Company Subsidiary that it intends to terminate a Company Significant Agreement or not renew such agreement at the expiration of the current term.
(ii) There are no transactions or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions, or series of related transactions between the Company or any Company Subsidiaries, on the one hand, and the Company, any current or former director or executive officer of the Company or any Company Subsidiaries or any person who beneficially owns five percent (5%) or more of the Common Stock (or any of such person’s immediate family members or Affiliates) (other than Company Subsidiaries), on the other hand, except (A) for deposit relationships or loan transactions arising in the ordinary course of business and (B) as disclosed in the Company’s documents filed with or furnished to the Commission.
(i) Controls and Procedures. Except as disclosed in Schedule 3(i) of the Disclosure Schedule:
(i) The Company has implemented and maintains disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) to ensure that material information relating to the Company, including the Company Subsidiaries, is made known to the chief executive officer and the chief financial officer of the Company by others within those entities. The Company maintains internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that is effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that (A) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (B) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company, and (C) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on its financial statements. The Company has disclosed, based on its most recent evaluation prior to the date hereof, to the Company’s outside auditors and the audit committee of the Board of Directors (x) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably expected to adversely affect the Company’s ability to record, process, summarize and report financial information, and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.
(ii) Since December 31, 2020, neither the Company nor any Company Subsidiary nor, to the knowledge of the Company, any director or officer of the Company or any Company Subsidiary has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or a Company
14
Subsidiary or their respective internal control over financial reporting, including any material complaint, allegation, assertion or claim that the Company or any Company Subsidiary has engaged in questionable accounting or auditing practices. The records, systems, controls, data and information of the Company and the Company Subsidiaries are recorded, stored, maintained and operated under means (including any electronic, mechanical or photographic process, whether computerized or not) that are under the exclusive ownership and direct control of the Company or the Company Subsidiaries or their accountants (including all means of access thereto and therefrom), except for any non-exclusive ownership and non-direct control that would not, individually or in the aggregate, reasonably be expected to adversely affect in any material respect the system of internal control over financial reporting described in this Section 3(i).
(j) Properties. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect and for any Permitted Liens and as set forth in Schedule 3(j) of the Disclosure Schedule, the Company and each Company Subsidiary have good and marketable title to all real properties and personal property owned by them and reflected on the Company Financial Statements, in each case free from liens, encumbrances, claims and defects that would materially adversely affect the value thereof or interfere with the use made or to be made thereof by them. “Permitted Liens” means (i) Liens for taxes and other governmental charges and assessments arising in the ordinary course which are not yet due and payable, (ii) Liens of landlords and Liens of carriers, warehousemen, mechanics and materialmen and other like Liens arising in the ordinary course of business for sums not yet due and payable, and (iii) other Liens or imperfections on property which are not material in amount or do not materially detract from the value of or materially impair the existing use of the property affected by such Lien or imperfection.
(k) Taxes. (i) Each of the Company and the Company Subsidiaries has (x) duly and timely filed (including pursuant to applicable extensions) all material Tax Returns required to be filed by it and (y) paid in full all material Taxes due or made adequate provision in the financial statements of the Company (in accordance with GAAP) for any such Taxes, whether or not shown as due on such Tax Returns, other than any such amounts (x) currently payable without penalty or interest, or (y) being contested in good faith by appropriate proceedings and for which reserves adequate in accordance with GAAP have been provided; (ii) no material deficiencies for any Taxes have been proposed, asserted or assessed in writing against the Company or a Company Subsidiary, which deficiencies have not since been resolved, except for Taxes proposed, asserted or assessed that are being contested in good faith by appropriate proceedings and for which reserves adequate in accordance with GAAP have been provided; and (iii) there are no material Liens for Taxes upon the assets of either the Company or a Company Subsidiary except for Permitted Liens. Neither the Company nor any Company Subsidiary has waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a material Tax assessment or deficiency, in each case that is still in effect, or has pending a request for any such extension or waiver (excluding extensions as a result of extensions of time to file Tax Returns obtained in the ordinary course of business). Each of the Company and the Company Subsidiaries has withheld and paid all material Taxes that it is required to withhold from amounts owing to employees, creditors or other third parties. Neither the Company nor any Company Subsidiary is a party to, is bound by or has any material obligation under, any Tax sharing or Tax indemnity agreement or similar contract or arrangement (other than any contract or agreement between or among the Company and any Company Subsidiary). Neither the Company nor any Company
15
Subsidiary has participated in any “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4, or any comparable transaction requiring disclosure under analogous provisions of state, local or foreign law. Neither the Company nor any Company Subsidiary has a material liability for the Taxes of any person other than the Company or any Company Subsidiary under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or foreign law) as a transferee or successor . Neither the Company nor any Company Subsidiary has been a “distributing corporation” or a “controlled corporation” in any distribution in which the parties to such distribution treated the distribution as one to which Section 355 of the Code, is applicable.
(l) Litigation and Other Proceedings. There is, and since January 1, 2019 has been, no pending or, to the knowledge of the Company, threatened, claim, action, suit, investigation or proceeding against the Company or any Company Subsidiary or to which any of their assets are subject, nor is the Company or Company Subsidiary subject to any order, judgment or decree, in each case except as, individually or in the aggregate, have not had or would not reasonably be expected to have a Material Adverse Effect. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, there is no unresolved violation, criticism or exception by any Governmental Entity with respect to any report or relating to any examinations or inspections of the Company or any Company Subsidiary.
(m) Compliance with Laws. The Company and each Company Subsidiary has all material permits, licenses, franchises, authorizations, orders and approvals of all Governmental Entities that are required in order to permit them to own or lease their properties and assets and to carry on their business as presently conducted (other than with respect to tax and environmental matters which are covered in separate representations). Since January 1, 2019, the Company and the Company Subsidiaries have complied with and are not in default or violation of, and none of them is, to the knowledge of the Company, under investigation, except for routine examinations by applicable Governmental Entities, with respect to or, to the knowledge of the Company, has been threatened to be charged with or given written notice of any violation of, any applicable domestic (federal, state or local) or foreign law, statute, ordinance, license, rule, regulation, policy or guideline, order, demand, writ, injunction, decree or judgment of any Governmental Entity, other than such noncompliance, defaults or violations that, individually or in the aggregate, have not had or would not reasonably be expected to have a Material Adverse Effect. Except for statutory or regulatory restrictions of general application and as set forth on Schedule 3(m) of the Disclosure Schedule, no Governmental Entity has placed any restriction on the business or properties of the Company or any of the Company Subsidiaries that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and each Company Subsidiary has not, nor has any other person on behalf of the Company or any Company Subsidiary that qualifies as a “financial institution” under United States anti-money laundering laws, in each case since January 1, 2019, knowingly acted, by itself or in conjunction with another, in any act in connection with the concealment of any currency, securities or other proprietary interest that is the result of a felony as defined in United States anti-money laundering laws (“Unlawful Gains”), nor knowingly accepted, transported, stored, dealt in or brokered any sale, purchase or any transaction of other nature for Unlawful Gains. The Company and each Company Subsidiary (A) does not know of any facts or circumstances that would cause it to believe that any non-public customer information has been disclosed to or accessed by an unauthorized third-party in a manner that would cause it to undertake any material remedial action; (B) has adopted and implemented in all material respects an anti-money laundering program that contains adequate and
16
appropriate customer identification verification procedures that comply with the PATRIOT Act and such anti-money laundering program meets the requirements in all material respects of Section 352 of the PATRIOT Act and the regulations thereunder, and it has complied in all respects with any requirements to file reports and other necessary documents as required by the PATRIOT Act and the regulations thereunder; and (C) will not knowingly directly or indirectly use the proceeds of the sale of the Purchased Shares, or lend, contribute or otherwise make available such proceeds to any Company Subsidiary, joint venture partner or other person, towards any sales or operations in any country sanctioned by the United States Office of Foreign Asset Control of the Treasury (“OFAC”) or for the purpose of financing the activities of any person currently subject to any United States sanctions administered by OFAC.
(n) Absence of Certain Changes. Except as set forth on Schedule 3(n) of the Disclosure Schedule, since December 31, 2021, (i) the Company and each of the Company Subsidiaries have conducted their respective businesses in all material respects in the ordinary course, consistent with prior practice; (ii) the Company has not made or declared any distribution in cash or in kind to its shareholders or issued or repurchased any shares of its capital stock or other equity interests; and (iii) no event or events have occurred that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.
(o) Company Benefit Plans.
(i) Except as has not had or would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (A) with respect to each Benefit Plan, the Company and each ERISA Affiliate, as well as each Benefit Plan, have complied, and are now in compliance with all provisions of ERISA, the Code and all laws and regulations applicable to such Benefit Plan; and (B) each Benefit Plan has been administered in accordance with its terms and all laws and regulations applicable to such Benefit Plan, including ERISA and the Code.
(ii) Except as has not had or would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and except for liabilities fully reserved for or identified in the Company Financial Statements filed prior to the date hereof, (A) no claim has been made, or to the knowledge of the Company, threatened, against the Company or any ERISA Affiliate related to the employment and compensation of employees or any Benefit Plan, including any claim related to the purchase of employer securities or to expenses paid under any defined contribution pension plan and (B) no event has occurred, and there exists no condition or set of circumstances, which could reasonably be expected to subject the Company or any Company Subsidiary to any liability under the terms of, or with respect to, any Benefit Plan or under ERISA, the Code or any other applicable law.
(iii) Neither the Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed to, any (A) Benefit Plan which is or was subject to Title IV of ERISA or Section 412 of the Code, (B) “multiemployer plan” (as defined in Section 4001(a)(3) of ERISA), (C) “multiple employer plan” within the meaning of Section 4001(a)(3) of ERISA or subject to Section 413(c) of the Code, or (D) “welfare benefit fund” within the meaning of Section 419 of the Code.
17
(iv) Except as has not had or would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (A) neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby will (i) result in any payment (including severance, unemployment compensation, “excess parachute payment” (within the meaning of Section 280G of the Code), forgiveness of indebtedness or otherwise) becoming due to any current or former employee, officer or director of the Company or any Company Subsidiary from the Company or any ERISA Affiliate under any Benefit Plan or otherwise, (ii) increase any benefits otherwise payable under any Benefit Plan, that would not be deductible under the Code, (iii) result in any acceleration of the time of payment or vesting of any such benefits, (iv) require the funding or increase in the funding of any such benefits or (v) result in any limitation on the right of the Company or any ERISA Affiliate to amend, merge, terminate or receive a reversion of assets from any Benefit Plan or related trust, and (B) neither the Company nor any ERISA Affiliate has taken, or permitted to be taken, any action that required, and, to the knowledge of the Company, no circumstances exist that will require the funding, or increase in the funding of any benefits or resulted, or will result, in any limitation on the right of the Company or any ERISA Affiliate to amend, merge, terminate or receive a reversion of assets from any Benefit Plan or related trust.
(p) Regulatory Matters.
(i) Third Coast Bank, SSB (the “Bank”), a wholly owned subsidiary of the Company, is duly registered and licensed with the Texas Department of Savings and Mortgage Lending (“TDSML”). The Bank is, and there has not been any event or occurrence since January 1, 2019 that would reasonably be expected to result in a determination that the Bank is not, “well-capitalized” as a matter of U.S. federal banking law. The Bank has at least a “satisfactory” rating under the U.S. Community Reinvestment Act of 1977, as amended.
(ii) The deposit accounts of the Bank are insured by the Federal Deposit Insurance Corporation (the “FDIC”) through the Deposit Insurance Fund to the fullest extent permitted by law, and all premiums and assessments required to be paid in connection therewith have been paid when due.
(iii) Except as forth on Schedule 3(p) of the Disclosure Schedule, (i) neither the Company nor any of the Company Subsidiaries is subject to (1) a written agreement or final order required to be publicly disclosed under 12 U.S.C. § 1818(u), (2) any restrictions on its ability to appoint or replace a director or executive officer (other than those arising under the federal securities laws and regulations or applicable listing standards), or (3) any restrictions on its ability to pay dividends or make other capital distributions, other than limitations imposed on the Company or the Company Subsidiaries or their respective boards of directors or similar governing bodies by applicable state corporation law (including general principles of fiduciary duties) and (ii) neither the Company nor any of the Company Subsidiaries is subject to any cease-and-desist or other order or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or is subject to any order or directive by, or has been since January 1, 2019 ordered to pay any civil money penalty by, or has been since January 1, 2019 a recipient of any supervisory letter from, or since January 1, 2019 has adopted any board resolutions at the request or suggestion of, any Governmental Entity (each item in this sentence, a “Regulatory Agreement”), nor has the Company or any of the Company Subsidiaries been advised since January 1, 2019 by any Governmental Entity that it is considering issuing in writing, initiating, ordering or requesting any such Regulatory Agreement, other than in each case Regulatory Agreements that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.
18
(iv) The Company is duly registered as a bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHC Act”).
(v) The Bank has no transactions with affiliates within the meaning of Sections 23A and 23B of the Federal Reserve Act, as amended, that are not in compliance in all material respects with such act or the rules promulgated thereunder.
(vi) Since January 1, 2019, the Company and each of the Company Subsidiaries has timely filed (or received a valid extension of such time of filing and has filed prior to the expiration of any such extension) all material reports, registrations, documents, filings, statements and submissions, together with any amendments thereto, that it was required to file with any Governmental Entity (the foregoing, collectively, the “Company Reports”). As of their respective dates of filing, the Company Reports complied in all material respects with all applicable statutes, rules and regulations of the applicable Governmental Entities.
(q) Environmental Matters. Except as would not, individually or in the aggregate, reasonably be expected to be have a Material Adverse Effect, the Company and the Company Subsidiaries are in compliance with all applicable Environmental Laws and (i) no real property currently or formerly owned or operated by the Company or any of the Company Subsidiaries is or has been contaminated with any Hazardous Substance at any time; (ii) neither the Company nor any of the Company Subsidiaries could be deemed the owner or operator under any Environmental Law of any property which is or has been contaminated with any Hazardous Substance; and (iii) no Hazardous Substance has been transported from any of the properties owned or operated by the Company or any of the Company Subsidiaries, other than as permitted under applicable Environmental Law. Since January 1, 2019, neither the Company nor any of the Company Subsidiaries has received any written notice from any Governmental Entity or any third party indicating that the Company or any Company Subsidiary is in material violation of any Environmental Law, other than with respect to any matter that has been resolved. The Company and the Company Subsidiaries are not subject to any court order, administrative order or decree or any indemnity or other agreement arising under or related to any Environmental Law.
(r) Labor. No employees of the Company or any of the Company Subsidiaries are represented by any labor union, nor are any collective bargaining agreements otherwise in effect with respect to such employees. No labor organization or group of employees of the Company or any of the Company Subsidiaries has made a pending demand for recognition or certification, and there are no representation or certification proceedings or petitions seeking a representation proceeding presently pending or, to the knowledge of the Company, threatened to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority. There are no organizing activities, strikes, work stoppages, slowdowns, lockouts, material arbitrations or material grievances, or other material labor disputes pending or, to the knowledge of the Company, threatened against or involving the Company or any of the Company Subsidiaries. Each of the Company and the Company Subsidiaries is in compliance in all material respects with all applicable laws with respect to employment and employment practices, terms and conditions of employment, and wages and hours. To the Company’s knowledge, no executive officer (as defined in Exchange Act Rule 3b-7) as of the date hereof, is, or is now expected to be,
19
in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement or any other contract or agreement or any restrictive covenant in favor of a third party, and, to the Company’s knowledge, the continued employment of each such executive officer does not subject the Company or any Company Subsidiary to any liability with respect to any of the foregoing matters.
(s) Insurance. The Company and each of the Company Subsidiaries are presently insured, and since January 1, 2019 have been insured, for reasonable amounts with financially sound and reputable insurance companies against such risks as companies engaged in a similar business would, in accordance with good business practice, customarily be insured. All such insurance policies are in full force and effect and no written notice of cancellation has been received by the Company or any Company Subsidiary. There is no existing material default by any insured thereunder. The Company (i) maintains directors’ and officers’ liability insurance and fiduciary liability insurance with, to the knowledge of the Company, financially sound and reputable insurance companies with reasonable benefits and levels of coverage, (ii) has timely paid all premiums on such policies, and (iii) there has been no lapse in coverage during the term of such policies.
(t) No Integration. Neither the Company, the Company Subsidiaries nor any of their respective Affiliates, nor any Person acting on its or their behalf, has issued any securities of the Company which would be integrated with the sale of the shares of Series A Preferred Stock or the Warrants for purposes of the Securities Act, nor will the Company, the Company Subsidiaries or any of their respective Affiliates take any action or steps (and neither have they taken any action or steps) that would require registration of any of the shares of Series A Preferred Stock or the Warrants under the Securities Act or cause the offering of the Series A Preferred Stock or the Warrants to be integrated with other offerings. Assuming the accuracy of the representations and warranties of the Investors, the offer and sale by the Company of the shares of Series A Preferred Stock to the Investors and the Warrants to the Warrant Eligible Investors pursuant to this Agreement and the Warrant Agreements will be exempt from the registration requirements of the Securities Act.
(u) Loan Portfolio.
(i) All of the written and oral loan agreements, notes or borrowing arrangements (including all leases, credit enhancements, commitments, guarantees and interest-bearing assets) originated or purchased and held by the Company or any of the Company Subsidiaries were solicited, originated and exist in compliance in all material respects with all applicable loan policies and procedures of the Company and the Company Subsidiaries. The information (including electronic information and information contained on tapes and computer disks) with respect to all loans of the Company and the Company Subsidiaries furnished to the Investors by the Company is, as of the respective dates indicated therein, accurate in all material respects; provided, that such information excludes information as would identify the names and addresses or other similar personal information of any customer.
(ii) The Company and each of the Company Subsidiaries has complied with, and all documentation in connection with the origination, processing, underwriting and credit approval of any mortgage loan originated, purchased or serviced by the Company or any Company Subsidiary satisfied, in all material respects (A) all applicable federal, state and local laws, rules
20
and regulations with respect to the origination, insuring, purchase, sale, pooling, servicing, subservicing or filing of claims in connection with mortgage loans, including all laws relating to real estate settlement procedures, consumer credit protection, truth in lending laws, usury limitations, fair housing, transfers of servicing, collection practices, equal credit opportunity and adjustable rate mortgages; (B) the responsibilities and obligations relating to mortgage loans set forth in any agreement between the Company or any Company Subsidiary and any Agency, Loan Investor or Insurer; (C) the applicable rules, regulations, guidelines, handbooks and other requirements of any Agency, Loan Investor or Insurer; and (D) the terms and provisions of any mortgage or other collateral documents and other loan documents with respect to each mortgage loan.
For purposes of this Section 3(u):
“Agency” shall mean the Federal Housing Administration, the Federal Home Loan Mortgage Corporation, the Federal National Mortgage Association, the Government National Mortgage Association, or any other federal or state agency with authority to (i) determine any investment, origination, lending or servicing requirements with regard to mortgage loans originated, purchased or serviced by the Company or any Company Subsidiary or (ii) originate, purchase, or service mortgage loans, or otherwise promote mortgage lending, including state and local housing finance authorities.
“Insurer” means a person who insures or guarantees for the benefit of the mortgagee all or any portion of the risk of loss upon borrower default on any of the mortgage loans originated, purchased or serviced by the Company or any Company Subsidiary, including, the Federal Housing Administration, the United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of Agriculture and any private mortgage insurer, and providers of hazard, title or other insurance with respect to such mortgage loans or the related collateral.
“Loan Investor” shall mean any person (including an Agency) having a beneficial interest in any mortgage loan originated, purchased or serviced by the Company or any Company Subsidiary or a security backed by or representing an interest in any such mortgage loan.
(v) Brokers and Finders. Except for CCCP VIII and Piper Sandler & Co. (the fees of which are set forth on Schedule 3(v) of the Disclosure Schedule), none of the Company, any of Company Subsidiaries and, to the knowledge of the Company, any of the employees or agents of the Company or any Company Subsidiary, has employed any broker or finder or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, and no broker or finder has acted directly or indirectly for the Company or any Company Subsidiary in connection with this Agreement or the transactions contemplated by this Agreement.
(w) Absence of Manipulation. The Company has not, and to the knowledge of the Company no one acting on its behalf has, taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Purchased Shares or the Conversion Securities.
21
(x) Well Capitalized. As of June 30, 2022, the Bank met or exceeded the quantitative capital requirements to be considered “well capitalized” under the FDIC’s regulatory framework for prompt corrective action.
(y) Acknowledgment Regarding Purchase of Purchased Shares. The Company acknowledges and agrees that each Investor is acting solely in the capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges that each Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by any Investor or any of its representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to such Investor’s purchase of the Purchased Shares.
(z) Shell Company Status. The Company is not, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act.
(aa) Investment Company. Neither the Company nor any of the Company Subsidiaries is an “investment company” as defined under the Investment Company Act of 1940, as amended, and neither the Company nor any of the Company Subsidiaries owns capital stock of any person that is such an investment company.
(bb) Risk Management; Derivatives.
(i) The Company and the Company Subsidiaries have in place risk management policies and procedures sufficient in scope and operation to protect against risks of the type and in amounts expected to be incurred by persons of similar size and in similar lines of business as the Company and the Company Subsidiaries.
(ii) All derivative instruments, including swaps, caps, floors and option agreements, whether entered into for the Company’s own account, or for the account of one or more of the Company Subsidiaries or their customers, were entered into (A) only for purposes of mitigating identified risk and in the ordinary course of business, (B) in accordance with prudent practices and in material compliance with all applicable laws, rules, regulations and regulatory policies, and (C) with counterparties believed by the Company to be financially responsible at the time; and each of them constitutes the valid and legally binding obligation of the Company or one of the Company Subsidiaries, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally, or the rights of creditors of financial institutions, the accounts of whose subsidiaries are insured by the FDIC, and subject, as to enforceability, to general principles of equity, including principles of good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity). Neither the Company nor the Company Subsidiaries, nor, to the knowledge of the Company, any other party thereto, is in breach of any of its obligations under any such agreement or arrangement.
22
(cc) Foreign Corrupt Practices and International Trade Sanctions. Neither the Company nor any Company Subsidiary, nor to the knowledge of the Company any of their respective directors, officers, agents, employees or any other persons acting on their behalf (i) has violated the Foreign Corrupt Practices Act, 15 U.S.C. § 78dd-1 et seq., as amended, or any other similar applicable foreign, federal, or state legal requirement, (ii) has made or provided, or caused to be made or provided, directly or indirectly, any payment or thing of value to a foreign official, foreign political party, candidate for office or any other person knowing that the person will pay or offer to pay the foreign official, party or candidate, for the purpose of influencing a decision, inducing an official to violate their lawful duty, securing any improper advantage, or inducing a foreign official to use their influence to affect a governmental decision, (iii) has paid, accepted or received any unlawful contributions, payments, expenditures or gifts, (iv) to the knowledge of the Company, has violated or operated in noncompliance with any export restrictions, money laundering law, anti-terrorism law or regulation, anti-boycott regulations or embargo regulations, or (v) is currently subject to any United States sanctions administered by OFAC.
(dd) Anti-Takeover Provisions. No Takeover Law shall apply to the transactions contemplated by this Agreement.
(ee) Intellectual Property. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and the Company Subsidiaries own (free and clear of any claims, Liens, exclusive licenses or non-exclusive licenses not granted in the ordinary course of business) or have a valid license to use all Intellectual Property used in or necessary to carry on their business as currently conducted, and (ii) such Intellectual Property referenced in clause (i) above is valid, subsisting and enforceable, and is not subject to any outstanding order, judgment, decree or agreement adversely affecting the Company’s or the Company Subsidiaries’ use of, or rights to, such Intellectual Property. The Company and the Company Subsidiaries have sufficient rights to use all Intellectual Property used in their business as presently conducted, all of which rights shall survive unchanged the consummation of the transactions contemplated by this Agreement. Neither the Company nor any Company Subsidiary has received any written notice of infringement or misappropriation of, or any conflict with, the rights of others with respect to any Intellectual Property. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, to the Company’s knowledge, no third party has infringed, misappropriated or otherwise violated the Intellectual Property rights of the Company or the Company Subsidiaries. There is no litigation, opposition, cancellation, proceeding, objection or claim pending, asserted, or, to the Company’s knowledge, threatened in writing against the Company or any Company Subsidiary concerning the ownership, validity, registerability, enforceability, infringement or use of, or licensed right to use, any Intellectual Property. To the knowledge of the Company, none of the Company or any of the Company Subsidiaries is using or enforcing any Intellectual Property owned by or licensed to the Company or any of the Company Subsidiaries in a manner that would be expected to result in the abandonment, cancellation or unenforceability of such Intellectual Property.
(ff) Fiduciary Accounts. To the knowledge of the Company, the Company and the Company Subsidiaries have, in all material respects, properly administered all accounts for which it acts as a fiduciary, including accounts for which it serves as a trustee, agent, custodian, personal representative, guardian, conservator or investment advisor, in accordance with the terms of the governing documents, applicable federal and state Law and regulation and common law. To the knowledge of the Company, none of the Company, the Company Subsidiaries or any director, officer or employee of the Company or the Company Subsidiaries has, in any material respect, committed any breach of trust or fiduciary duty with respect to any such fiduciary account and the accountings for each such fiduciary account are true and correct in all material respects and accurately reflect the assets of such fiduciary account.
23
(gg) Common Control. The Company is not and, after giving effect to the offering and sale of the Purchased Shares, will not be under the control (as defined in the BHCA and the Federal Reserve’s Regulation Y (12 C.F.R. Part 225)) (“BHCA Control”) of any company (as defined in the BHCA and the Federal Reserve’s Regulation Y). The Company is not in BHCA Control of any federally insured depository institution other than the Bank. The Bank is not under the BHCA Control of any company (as defined in the BHCA and the Federal Reserve’s Regulation Y) other than the Company. Except for the Company’s ownership interest in the Bank, neither the Company nor the Bank controls, in the aggregate, five percent (5%) or more of the outstanding shares of any class of voting securities, directly or indirectly, of any federally insured depository institution; provided, further, that except as set forth in Schedule 3(gg) to the Disclosure Schedule, neither the Company nor the Bank controls the outstanding shares of any class of voting securities, directly or indirectly, of any federally insured depository institution. The Bank is not subject to the liability of any commonly controlled depository institution pursuant to Section 5(e) of the Federal Deposit Insurance Act (12 U.S.C. § 1815(e)).
(hh) Knowledge as to Conditions. In each case, if any are applicable, to the Company’s knowledge there is no reason why it would be reasonable to expect that any regulatory approvals and, to the extent necessary, any other approvals, authorizations, filings, registrations, and notices required or otherwise a condition to the consummation of the transactions contemplated by the Transaction Documents will not be obtained.
(ii) No Other Representations and Warranties. Except for the representations and warranties contained in this Section 3 (including the related portions of the Disclosure Schedules), neither the Company nor any other Person has made or makes any other express or implied representation or warranty, either written or oral, on behalf of the Company, including any representation or warranty as to the accuracy or completeness of any information regarding the Company furnished or made available to Investor and its representatives, or any representation or warranty arising from statute or otherwise in law. Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall constitute a waiver of intentional fraud by any person.
Section 4. Representations and Warranties of Investor. Each Investor severally, but not jointly, represents and warrants to the Company, as of the date hereof, as follows:
(a) Organization. To the extent the Investor is not an individual, the Investor is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and except as has not had or would not reasonably be expected to have a material adverse effect on the Investor’s ability to perform its obligations under the Agreement or to consummate the transactions contemplated hereby on a timely basis, the Investor is duly qualified to do business and is in good standing in all jurisdictions where its ownership or leasing of property or the conduct of its business requires it to be so qualified.
24
(b) Authorization. The Investor has the requisite corporate, partnership, limited liability company or other power and authority (and in the case of an individual, the capacity) to enter into this Agreement and to carry out its obligations hereunder. The execution, delivery and performance of this Agreement by the Investor and the consummation of the transactions contemplated hereby have been duly authorized by the Investor’s board of directors, general partner, managing members, investment committee or other authorized persons, as the case may be (if such authorization is required), and no further approval or authorization by any of such persons, as the case may be, is required. No other corporate, partnership, limited liability company or other proceedings are necessary for the execution and delivery by the Investor of this Agreement, the performance by it of its obligations hereunder or the consummation by it of the transactions contemplated hereby. Assuming the due authorization, execution and delivery by the Company, this Agreement constitutes a valid and binding obligation of the Investor enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to general principles of equity, including principles of good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).
(c) Purchase for Investment. The Investor acknowledges that none of the Purchased Shares, nor the Conversion Securities have been registered under the Securities Act or under any state securities laws. The Investor (i) is acquiring the Purchased Shares, and will acquire the Conversion Securities, if any, pursuant to an exemption from registration under the Securities Act solely for investment with no present intention to distribute any of the Purchased Shares or the Conversion Securities to any Person, (ii) will not sell or otherwise dispose of any of the Purchased Shares or the Conversion Securities, except in compliance with the registration requirements or exemption provisions of the Securities Act and any other applicable securities laws, (iii) has such knowledge and experience in financial and business matters and in investments of this type that it is capable of evaluating the merits and risks of its investment in the Purchased Shares and the Conversion Securities, and of making an informed investment decision, (iv) is an “accredited investor” (as that term is defined by Rule 501 of the Securities Act), and (v) is able to bear the economic risk of an investment in the Purchased Shares and, at the present time, is able to afford a complete loss of such investment. The Investor acknowledges and agrees that none of the Series A Preferred Stock, Warrants, Series B Preferred Stock, or Non-Voting Common Stock are registered with the Commission, or traded or quoted on any national securities exchange or other inter-dealer quotation system and that the issuance of such securities pursuant to this Agreement involves securities for which a limited trading market exists, thereby requiring any investment to be maintained for an indefinite period of time.
(d) Sufficient Funds. The Investor has or will have prior to the Closing Date, sufficient cash, available lines of credit or other sources of immediately available funds to enable it to timely deliver to the Company the Purchase Price payable hereunder by the Investor.
(e) No Conflicts. The execution, delivery and performance by the Investor of this Agreement, the compliance by the Investor with all of the provisions of this Agreement and the consummation of the transactions herein contemplated will not (i) violate, conflict with, or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration of, or result in the creation of, any Lien, security interest, charge or encumbrance upon any of the properties or assets of the Investor under any of the terms, conditions or provisions of (A) its applicable governing documents or by-laws or other organizational documents, as applicable, or (B) any note, bond,
25
mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which the Investor is a party or by which it may be bound, or to which the Investor or any of its properties or assets may be subject, or (ii) violate any statute, rule or regulation or any judgment, ruling, order, writ, injunction or decree applicable to the Investor or any of its properties or assets except, in the case of clauses (i)(B) and (ii), for those occurrences that, individually or in the aggregate, have not had or would not reasonably be expected to have a material adverse effect on the Investor’s ability to perform its obligations under the Agreement or to consummate the transactions contemplated hereby on a timely basis.
Assuming the accuracy of the representations and warranties of the Company in Section 3, other than the securities or blue sky laws of the various states and except as otherwise provided in this Agreement, no material notice to, registration, declaration or filing with, exemption or review by, or authorization, order, consent or approval of, any Governmental Entity, or expiration or termination of any statutory waiting period, is necessary for the consummation by the Investor of the transactions set forth in this Agreement.
(f) Access to Information. The Investor acknowledges that it has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Purchased Shares and the merits and risks of investing in the Purchased Shares; (ii) access to information about the Company and the Company Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.
(g) Independent Investment Decision. The Investor has independently evaluated the merits of its decision to purchase the Purchased Shares pursuant to this Agreement. The Investor understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Investor in connection with the purchase of the Purchased Shares constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Purchased Shares.
(h) Reliance on Exemptions. The Investor understands and acknowledges that the Purchased Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgements and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the Purchased Shares. Without limiting any of the foregoing, neither the Investor nor any of its Affiliates has taken, and the Investor will not, and will cause its Affiliates not to, take any action that would otherwise cause the Purchased Shares to be subject to the registration requirements of the Securities Act.
(i) No Governmental Review. The Investor understands that no U.S. federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Purchased Shares or the fairness or suitability of the investment in the Purchased Shares nor have such authorities passed upon or endorsed the merits of the offering of the Purchased Shares.
26
(j) Residency. The Investor’s office (or in the case of an individual, the Investor’s residence) in which its investment decision with respect to the Purchased Shares was made is located at the address set forth for the Investor on the signature page hereto.
(k) Ownership. Except as disclosed to the Company in writing, as of the date of this Agreement, the Investor is not the owner of record or the beneficial owner of any shares of Common Stock, securities convertible into or exchangeable for Common Stock, or any other equity or equity-linked security of the Company or any Company Subsidiary.
(l) Brokers and Finders. Except for CCCP VIII and Piper Sandler & Co., no Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or the Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Investor.
(m) Non-Reliance. The Investor is not relying upon, and has not relied upon, any statement, representation or warranty made by any Person, except for the representations and warranties by the Company contained in this Agreement.
Section 5. Deliveries at Closing.
(a) Company Deliverables. At the Closing, the Company shall deliver to the Investors the following:
(i) Evidence reasonably satisfactory to the Investors of the book-entry issuance of the number of shares of Series A Preferred Stock to be purchased at the Closing by the Investors as specified herein;
(ii) the Series A Certificate of Designation in the form attached hereto as Exhibit A, and the Series B Certificate of Designation in the form attached as Exhibit B, in each case duly certified by the Secretary of State of the State of Texas;
(iii) a certificate of a senior executive officer of the Company, on its behalf, in the form attached hereto as Exhibit E, dated as of the Closing Date;
(iv) a certificate of the Secretary of the Company, in the form attached hereto as Exhibit F, dated as of the Closing Date;
(v) Norton Rose Fulbright US LLP, counsel for the Company, shall have delivered to the Investors its written opinion, dated as of the Closing Date, in the form attached hereto as Exhibit I, as to the matters set forth in Exhibit I;
(vi) a certificate from the TDSML to the effect that the Bank is existing and in good standing under the laws of the State of Texas;
27
(vii) a certificate of the Federal Reserve Bank of Dallas to the effect that the Company is a registered bank holding company under the BHC Act;
(viii) a certificate of the FDIC to the effect that the deposit accounts of the Bank are insured by the FDIC under the provisions of the Federal Deposit Insurance Act;
(ix) a duly executed copy of the Registration Rights Agreement in the form attached hereto as Exhibit K, dated as of the Closing Date (the “Registration Rights Agreement”); and
(x) if such Investor is a Warrant Eligible Investor, a duly executed copy of the Warrant Agreement, dated as of the Closing Date.
(b) Investor Deliverables. At the Closing, each Investor shall deliver to the Company the following:
(i) payment of the Purchase Price in United States dollars by wire transfer of immediately available funds to an account specified in writing by the Company;
(ii) a certificate of a senior executive officer of such Investor on its behalf (or in the case of an individual, a certificate of such Investor in an individual capacity) to the effect that the closing conditions in Sections 7(b)(i) and (ii) are met as of the Closing in the form attached as Exhibit G;
(iii) a duly executed copy of the Registration Rights Agreement; and
(iv) if such Investor is a Warrant Eligible Investor, a duly executed copy of the Warrant Agreement, dated as of the Closing Date.
(c) Castle Creek Deliverables.
(i) At the Closing and in addition to the deliverables set forth in Section 5(a), the Company shall deliver to CCCP VIII the following:
(A) a duly executed copy of a letter agreement in the form attached hereto as Exhibit H, dated as of the Closing Date (the “VCOC Letter Agreement”); and
(B) a duly executed copy of the letter agreement in the form attached hereto as Exhibit L, dated as of the Closing Date (the “Letter Agreement”).
(ii) At the Closing and in addition to the deliverables set forth in Section 5(b), CCCP VIII shall deliver to the Company a duly executed copy of the Letter Agreement and the VCOC Letter Agreement.
28
Section 6. Covenants.
(a) Public Statements. Neither the Company nor any Investor shall issue or cause the publication of any press release or other public announcement with respect to, or otherwise make any public statement concerning, the transactions contemplated by this Agreement without the prior consent (which shall not be unreasonably conditioned, withheld or delayed) of the other; provided, however, that any party may, without the prior consent of the other parties issue or cause the publication of any press release or other public announcement to the extent required by law or rule or regulation of a Trading Market.
(b) Regulatory Approvals. Each Investor and the Company shall use reasonable best efforts to obtain, as promptly as practicable, all governmental, quasi-governmental, court or regulatory approvals, consents or statements of non-objection necessary to allow it to acquire or issue, as applicable, the Purchased Shares and Conversion Securities it will or may acquire or issue, as applicable, following the date hereof, pursuant to this Agreement, the Warrant Agreements and the Non-Voting Common Stock Certificate of Amendment, and to otherwise consummate the transactions contemplated by this Agreement, including any approvals, consents or statements of non-objection required by any state or federal banking regulatory authority to the extent that any are applicable or are otherwise reasonably sought by the Investor or the Company. In performing its obligations under this Section 6(b), each Investor and the Company shall cooperate with the other party, shall reasonably consult with the other party concerning all regulatory filings, applications and support materials to the extent not filed prior to the date hereof and shall keep the other party promptly apprised of the status of matters referred to in this Section 6(b).
(c) Cooperation.
(i) Each Investor and the Company will, and will cause its Affiliates to, cooperate with the other and use reasonable best efforts to take, or cause to be taken, all actions in order to facilitate the successful consummation of the transactions contemplated hereby. Each Investor and the Company shall execute and deliver both before and after the Closing such further certificates, agreements and other documents and take such other actions as the other may reasonably request to consummate or implement such transactions or to evidence such events or matters. In particular, each Investor will use its reasonable best efforts to promptly obtain or submit, and the Company will cooperate as may reasonably be requested by each Investor to assist the Investor to promptly obtain or submit, as the case may be, as promptly as practicable, all notices to and, to the extent required by applicable law or regulation, consents, approvals or exemptions from, and assist in any appearances and proceedings before, bank regulatory authorities in connection with the transactions contemplated by this Agreement. Each Investor and the Company will have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, all the information relating to such other party, and any of their respective Affiliates, which appears in any filing made with, or written materials submitted to, any third party in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each agrees to act reasonably and as promptly as practicable. Each such party agrees to keep the other party apprised of the status of matters referred to in this Section 6(c). To the extent permitted by applicable law and to the extent such communications do not contain confidential information, each Investor shall promptly furnish the Company, and the Company shall promptly furnish each Investor, with copies of material written communications received by it or its subsidiaries from, or delivered by any of the foregoing to, any Governmental Entity in respect of the transactions contemplated by this Agreement.
29
(ii) Each party agrees to keep all information furnished by another party pursuant to this Agreement confidential (“Confidential Information”) except such information that (i) is or becomes generally available to the public (other than as a result of a disclosure by the receiving party in violation of this Agreement), (ii) was available to the receiving party on a non-confidential basis prior to its disclosure by the disclosing party, (iii) becomes available to the receiving party on a non-confidential basis from a person other than the disclosing party who is not known by the receiving party to be otherwise bound by a confidentiality agreement with the disclosing party, or is not known by the receiving party to be otherwise prohibited from transmitting the information to the receiving party, (iv) the disclosing party agrees may be disclosed, or (v) the receiving party is requested pursuant to, or required by, law, regulation, legal process or regulatory authority to disclose, and neither party hereto shall release or disclose such information to any other person, except its auditors, attorneys, financial advisors, or other consultants and advisors (collectively, “Representatives”). Each party shall be liable for any breaches of this Agreement by its Representatives. In the event that any party is requested pursuant to, or required by, law, regulation, legal process or regulatory authority to disclose any Confidential Information, such party agrees that it will provide the other party with prompt notice of such request(s) or requirement(s) (to the extent legally permitted) to enable the non-disclosing party to seek an appropriate protective order (at the non-disclosing party’s sole cost and expense), waive compliance with the provisions of this Agreement or take other appropriate action; provided that no such notice shall be required in connection with a routine examination by a regulatory authority or auditor that does not reference the Company or this Agreement. Each party agrees to use its good faith efforts to assist the other party in obtaining such a protective order. If, in the absence of a protective order or the receipt of a waiver hereunder, the disclosing party is nonetheless, based on the written advice of its counsel, compelled to disclose the Confidential Information or else stand liable for contempt or suffer other censure or significant penalty, such party, after notice to the non-disclosing party (to the extent legally permitted), may disclose such Confidential Information that the disclosing party is compelled to disclose. Notwithstanding anything in this Section 6 or elsewhere in this Agreement to the contrary, if approval or non-objection of any federal or state banking regulator is required for any Investor’s purchase under this Agreement, such Investor will not be required to deliver to the Company a copy of its Federal Interagency Biographical and Financial Report submitted to bank regulatory agencies in connection with applications. Subject to Section 16 hereof, each Investor also agrees to bear all of such Investor’s own expenses in connection with such applications, including without limitation: (i) fees and disbursements of such Investor’s own legal counsel (such Investor hereby acknowledging that neither the Company nor its legal counsel is acting as any Investor’s legal counsel in connection with any matters relating to this Agreement or the applications for regulatory approvals); (ii) filing fees; (iii) expenses, if any, of newspaper publication of notices of the filing of the applications; and (iv) any other expenses that may be required of such Investor in connection therewith. Notwithstanding anything in this Section 6 or elsewhere in this Agreement to the contrary, no Investor shall be required to provide to the Company any of its, its Affiliates’, its investment advisor’s or its or their control persons’ or equity holders’ nonpublic, proprietary, personal or otherwise confidential information including the identities of limited partners, shareholders or members of the Investor or its Affiliates or their investment advisors.
30
(d) Transfer Restrictions; Legends.
(i) Each Investor covenants that the Purchased Shares and the Conversion Securities may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with any applicable state, federal or foreign securities laws. In connection with any transfer of the Purchased Shares or Conversion Securities other than (i) pursuant to an effective registration statement, (ii) to the Company, or (iii) pursuant to Rule 144 (provided that the transferor provides the Company with reasonable assurances (in the form of a seller representation letter and, if applicable, a broker representation letter) that such securities may be sold pursuant to such rule), the Company may require the transferor thereof to provide to the Company and the Transfer Agent, at the transferor’s expense, an opinion of counsel selected by the transferor and reasonably acceptable to the Company and the Transfer Agent, the form and substance of which opinion shall be reasonably satisfactory to the Company and the Transfer Agent, to the effect that such transfer does not require registration of such Purchased Shares under the Securities Act.
(ii) Each Investor agrees that all certificates or other instruments representing the Purchased Shares and the Conversion Securities subject to this Agreement will bear a legend substantially to the following effect:
THE ISSUANCE OF THESE SECURITIES HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT (PROVIDED THAT THE TRANSFEROR PROVIDES THE COMPANY WITH REASONABLE ASSURANCES (IN THE FORM OF A SELLER REPRESENTATION LETTER AND, IF APPLICABLE, A BROKER REPRESENTATION LETTER) THAT THE SECURITIES MAY BE SOLD PURSUANT TO SUCH RULE).
(iii) Upon the request of each Investor, the restrictive legend set forth in Section 6(d)(ii) above shall be removed and the Company shall issue book entry shares without such restrictive legend or any other restrictive legend to the holder of the applicable Purchased Shares upon which it is stamped, if (A) such Purchased Shares are registered for resale under the Securities Act, (B) such Purchased Shares are sold or transferred pursuant to Rule 144, or (C) such Purchased Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information requirement under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale restrictions. Following the dates that Rule 144 becomes available for the resale of Purchased
31
Shares, without the requirement for the Company to be in compliance with the current public information requirement under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to the Purchased Shares and without volume or manner-of-sale restrictions, the Company, upon the written request of the holder, shall instruct the Transfer Agent to remove the legend from the Purchased Shares and shall cause its counsel to issue any legend removal opinion required by the Transfer Agent. Any fees (with respect to the Company or the Transfer Agent, Company counsel or otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the Company. If a legend is no longer required pursuant to the foregoing, the Company will no later than five (5) Trading Days following the delivery by an Investor to the Transfer Agent (with notice to the Company) of (1) a legended instrument representing such Purchased Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer), and (2) a representation letter to the extent required by Section 6(d)(i) (such fifth Trading Date, the “Legend Removal Date”), deliver or cause to be delivered to such Investor book-entry Purchased Shares that are free from all restrictive legends. Except as required by law or industry custom related to the issuance and trading of restricted securities, the Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 6.1(d).
(iv) If the Company shall fail for any reason or for no reason to issue to such Investor unlegended Purchased Shares by the Legend Removal Date, then, in addition to all other remedies available to such Investor, if on or after the Trading Day immediately following such five (5) Trading Day period, such Investor purchases, or a broker (a “Buy-In Broker”) purchases (in an open market transaction or otherwise) Series A Preferred Stock, Warrants, as applicable, or Conversion Securities to deliver in satisfaction of such sale in lieu of Series A Preferred Stock, Warrants, as applicable, or Conversion Securities the Investor anticipated receiving from the Company without any restrictive legend (a “Buy-In”), then the Company shall, within five (5) Business Days after such Investor’s request, honor its obligation to deliver to such Investor book-entry Purchased Shares, a certificate or certificates without restrictive legends representing such Series A Preferred Stock, Warrants, as applicable, or Conversion Securities and pay cash to such Investor in an amount equal to the excess (if any) of such Investor’s or Buy-In Broker’s total purchase price (including brokerage commissions, if any) for the Series A Preferred Stock, Warrants, as applicable, or Conversion Securities so purchased over the product of (i) such number of Series A Preferred Stock, Warrants, as applicable, or Conversion Securities, times (ii) the closing bid price on the Legend Removal Date. Notwithstanding anything to the contrary, in the event that the Company has delivered all documents required by the Transfer Agent to remove the restrictive legend from the Purchased Shares prior to the Legend Removal Date, then the Company shall have no liability under this Section 6(d)(iv) or otherwise as a result of the failure to deliver unlegended Purchased Shares by the Legend Removal Date to such Investor; provided, however, that the Company shall reasonably cooperate with such Investor and the Transfer Agent to deliver unlegended Purchased Shares as soon as practicable after the Legend Removal Date.
(e) Transfer. The Company shall cooperate, in accordance with reasonable and customary business practices with any and all transfers, whether by direct or indirect sale, assignment, award, confirmation, distribution, bequest, donation, trust, pledge, encumbrance, hypothecation or other transfer or disposition, for consideration or otherwise, whether voluntarily or involuntarily, by operation of law or otherwise, by each Investor or any of its successors and assigns of the Series A Preferred Stock, Warrants, as applicable, or Conversion Securities.
32
(f) No Change of Control. The Company shall use reasonable best efforts to obtain all necessary irrevocable waivers and make all appropriate determinations so that the issuance of Purchased Shares and Conversion Securities to an Investor, collectively, will not trigger a “change of control” or other similar provision in any of the agreements to which the Company or any of the Company Subsidiaries is a party, including without limitation any employment, “change in control,” severance or other agreements and any Benefit Plan, which results in payments to the counterparty or the acceleration of vesting of benefits.
(g) Shareholder Approval. No later than May 31, 2023 after the Closing, the Company shall duly call, give notice of, establish a record date for, convene and hold its annual shareholders’ meeting (the “Shareholders’ Meeting”), for the purpose of, among other matters, voting upon such approval required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of the Exchange Cap and upon approval and adoption of the Non-Voting Common Stock Certificate of Amendment (the “Shareholder Approval”). The Company shall: (i) through its Board of Directors recommend to its shareholders the approval and adoption of the Non-Voting Common Stock Certificate of Amendment and the approval to effect issuances in excess of the Exchange Cap (the “Company Recommendation”); (ii) include such Company Recommendation in the proxy statement delivered to shareholders; and (iii) use its reasonable best efforts to obtain the Shareholder Approval. To the extent entitled to vote, the Investor shall vote to approve the Non-Voting Common Stock Certificate of Amendment at the Shareholders’ Meeting and not take any action or inaction to directly or indirectly delay or support any opposition to the Shareholder Approval. Neither the Board of Directors nor any committee thereof shall withdraw, qualify or modify, or propose publicly to withdraw, qualify or modify, in a manner adverse to Investors, the Company Recommendation or take any action, or make any public statement, filing or release inconsistent with the Company Recommendation. The Company shall adjourn or postpone the Shareholders’ Meeting, if, as of the time for which such meeting is originally scheduled there are insufficient shares of Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of such meeting. The Company shall also adjourn or postpone the Shareholders’ Meeting, if on the date of the Shareholders’ Meeting the Company has not received proxies representing a sufficient number of shares necessary to obtain the Shareholder Approval and, following such adjournment or postponement, the Company shall use its commercially reasonable efforts to solicit proxies representing a sufficient number of shares to obtain the Shareholder Approval for up to thirty (30) days following such adjournment or postponement. Following the first of either such adjournment or postponement, if requested by the Investors, the Company shall retain a proxy solicitor reasonably acceptable to, and on terms reasonably acceptable to, the Investors in connection with obtaining the Shareholder Approval.
(h) Additional Regulatory Matters.
(i) Notwithstanding anything to the contrary in this Agreement, neither the Company nor any Company Subsidiary shall take any action (including any redemption, repurchase, or recapitalization of Common Stock, or securities or rights, options or warrants to purchase Common Stock, or securities of any type whatsoever that are, or may become, convertible into or exchangeable into or exercisable for Common Stock in each case, where each Investor is not given the right to participate in such redemption, repurchase or recapitalization to the extent of the Investor’s pro rata proportion), that would reasonably be expected to pose a substantial risk
33
that an Investor’s ownership of any class of voting securities of the Company (together with the ownership by such Investor’s Affiliates (as such term is used under the BHC Act) of voting securities of the Company) would exceed 9.9% of such class after the Closing Date, without the prior written consent of such Investor or such person, or to increase to an amount that would constitute “control” under the BHC Act, the Change in Bank Control Act of 1978, as amended (the “CBCA”), Chapter 92, Subchapter L, Sections 92.551 to 92.561 of the Texas Finance Code (the “TCBCA”), or any rules or regulations promulgated thereunder (or any successor provisions) or otherwise cause such Investor to “control” the Company under and for purposes of the BHC Act, the CBCA, the TCBCA, or any rules or regulations promulgated thereunder (or any successor provisions); provided, however, that the preceding shall not apply with respect to the TCBCA to the extent that an approval or non-objection under the TCBCA has already been obtained by the Investor in connection with the execution of this Agreement, and no additional approval or non-objection of the TDSML is required under the TCBCA with respect to the Purchased Shares held by the Investor due to the occurrence of the actions contemplated by this paragraph. In the event the Company breaches its obligations under this Section 6(h) or believes that it is reasonably likely to breach such an obligation, it shall promptly notify the affected Investor hereto and shall cooperate in good faith with such parties to modify ownership or make other arrangements or take any other reasonable action, in each case, as is necessary to cure or avoid such breach.
(ii) Notwithstanding anything in this Agreement, in no event will an Investor or any of its Affiliates be obligated to:
(A) Without limiting clause (2) below, (1) propose or accept any divestiture of any of the Investor’s or any of its Affiliates’ assets, or (2) accept any operational restriction on the Investor’s or any of its Affiliates’ business, or agree to take any action that limits the Investor’s or its Affiliates’ commercial practices in any way (except as they relate to the Company and the Company Subsidiaries) including by requiring the modification of governance, fee or carried interest arrangements with respect to, or otherwise by imposing any capital or other requirements on, the Investor or any of its Affiliates, (e) agree to provide capital to, or otherwise maintain or contribute, directly or indirectly, to the capital of, the Company or any Company Subsidiary (including the Bank) other than the payment of the Purchase Price pursuant to this Agreement, or (4) register as a bank holding company, in each case in order to obtain any consent, acceptance or approval of any Governmental Entity to consummate the transactions contemplated by this Agreement; or
(B) Propose or agree to accept any term or condition or otherwise modify the terms of this Agreement, including, for the avoidance of doubt, the terms or the amount of the Purchased Shares to be delivered by the Company under this Agreement, to obtain any consent, acceptance, approval of any Governmental Entity to the consummation of the transactions contemplated by this Agreement if such term, condition, modification or confirmation would (1) materially adversely affect (with respect to the Investor or its Affiliates) any material term of the transactions contemplated by this Agreement, or (2) reasonably be expected to adversely affect (with respect to the Investor or its Affiliates) any material financial term of the transactions contemplated by this Agreement or the anticipated benefits to the Investor and its Affiliates hereunder.
34
(iii) So long as an Investor holds any Purchased Shares or Conversion Securities, the Company will not, without the consent of the Investor, take any action, directly or indirectly through any Company Subsidiary or otherwise, that the Board of Directors believes in good faith would reasonably be expected to cause the Investor to be subject to transfer restrictions or other covenants of the FDIC Statement of Policy on Qualifications for Failed Bank Acquisitions as in effect at the time of taking such action.
(i) Merger or Sale. The Company will not merge or consolidate into, or sell, transfer or lease all or substantially all of its property or assets to, any other party unless the successor, transferee or lessee party, as the case may be (if not the Company), expressly assumes the due and punctual performance and observance of each and every covenant and condition of this Agreement to be performed and observed by the Company. For the avoidance of doubt, the Company shall not be prohibited from entering into or consummating any Non-Qualifying Transaction subject to compliance with the preceding sentence.
(j) Shareholder Litigation. The Company shall promptly inform the Investors of any material claim, action, suit, arbitration, mediation, demand, hearing, investigation or proceeding (“Shareholder Litigation”) against the Company, any Company Subsidiary or any of the past or present executive officers or directors of the Company or any Company Subsidiary that is threatened in writing or initiated by or on behalf of any shareholder of the Company in connection with or relating to the transactions contemplated hereby. The Company shall consult with the Investors and keep the Investors reasonably informed of all material filings and developments relating to any such Shareholder Litigation, except to the extent that any such disclosures would violate or breach the Company’s attorney-client privilege.
(k) Notice of Certain Events. Each party hereto shall promptly notify the other party hereto of (a) any event, condition, fact, circumstance, occurrence, transaction or other item of which such party becomes aware prior to the applicable Closing that would constitute a violation or breach of this Agreement (or a breach of any representation or warranty contained herein) or, if the same were to continue to exist as of the Closing Date, would constitute the non-satisfaction of any of the conditions set forth in Section 7 hereof, and (b) any event, condition, fact, circumstance, occurrence, transaction or other item of which such party becomes aware that would have been required to have been disclosed pursuant to the terms of this Agreement had such event, condition, fact, circumstance, occurrence, transaction or other item existed as of the date hereof; provided that delivery of any notice pursuant to this Section 6(k) shall not modify the representations, warranties, covenants, agreements or obligations of the parties (or remedies with respect thereto) or the conditions to the obligations of the parties under this Agreement. Notwithstanding the foregoing, neither party shall be required to take any action that would jeopardize such party’s attorney-client privilege.
(l) Conduct of the Business. Except as forth on Schedule 6(l) of the Disclosure Schedule, prior to the earlier of the Closing Date and the termination of this Agreement pursuant to Section 8 hereof, the Company shall, and, shall cause each Company Subsidiary to: (a) use commercially reasonable efforts to carry on its business in the ordinary course of business and to maintain and preserve its and such Company Subsidiary’s business (including its organization, assets, properties, goodwill and insurance coverage) and preserve business relationships with customers, vendors, strategic partners and others having business dealings with it; (b) refrain from
35
(1) declaring, setting aside or paying any distributions or dividends on, or making any other distributions (whether in cash, securities or other property) in respect of, any of its capital stock; (2) splitting, combining or reclassifying any of its capital stock or issuing or authorizing the issuance of any other securities in respect of, in lieu of or in substitution for capital stock or any of its other securities; (3) purchasing, redeeming or otherwise acquiring any capital stock or any of its other securities or any rights, warrants or options to acquire any such capital stock or other securities; (4) issuing, delivering, selling, granting, pledging or otherwise disposing of or encumbering any capital stock, any other voting securities or any securities convertible into or exchangeable for, or any rights, warrants or options to acquire, any such capital stock, voting securities or convertible or exchangeable securities, other than any issuance of Common Stock on exercise of any compensatory stock options or vesting of any restricted stock outstanding on the date of this Agreement, the issuance of any Common Stock pursuant to the Third Coast Bank, SSB 401(k) and Employee Stock Ownership Plan, and the issuance of any equity incentives under the Third Coast Bancshares, Inc. 2019 Omnibus Incentive Plan or the Third Coast Bancshares, Inc. 2017 Director Stock Option Plan; or (5) entering into any contract with respect to, or otherwise agreeing or committing to do, any of the foregoing.
(m) Certain Transactions.
(i) Prior to the earlier of the Closing or termination of this Agreement, notwithstanding anything in this Agreement to the contrary, the Company shall not directly or indirectly effect or cause to be effected any transaction with a third party that would reasonably be expected to result in a Change in Control unless such third party shall have provided prior assurance in writing to the Company (in a form that is reasonably satisfactory to the Company) that the terms of this Agreement shall be fully performed (A) by the Company or (B) by such third party if it is the successor of the Company or if the Company is its direct or indirect subsidiary, and the Company agrees to promptly provide copies of such assurances to the Investors. For the avoidance of doubt, it is understood and agreed that, (C) in the event that a Change in Control occurs on or prior to the Closing, the Investors shall maintain the right under this Agreement to acquire, pursuant to the terms and conditions of this Agreement, the Purchased Shares and the Conversion Securities (or such other securities or property (including cash) into which the Purchased Shares or Conversion Securities may have become exchangeable as a result of such Change in Control), as if the Closing had occurred immediately prior to such Change in Control, and (D) nothing in this Section 6(m) is intended to or shall limit in any way the Investor closing conditions contained in Section 7 hereof.
(ii) In the event that, at or prior to the Closing, (1) the number of shares of Common Stock or securities convertible or exchangeable into or exercisable for shares of Common Stock issued and outstanding is changed as a result of any reclassification, stock split (including reverse split), stock dividend or distribution (including any dividend or distribution of securities convertible or exchangeable into or exercisable for shares of Common Stock), merger, tender or exchange offer or other similar transaction, or (2) the Company fixes a record date that is at or prior to the Closing Date for the payment of any non-stock dividend or distribution on the Common Stock, then the Conversion Price under each of the Series A Preferred Stock and Series B Preferred Stock (as applicable) shall be equitably substituted to provide the Investors with substantially the same economic benefit from this Agreement as the Investors had prior to the applicable transaction. Notwithstanding anything in this Agreement to the contrary, in no event shall the Purchase Price or any component thereof be changed by the foregoing. Notwithstanding anything in the foregoing, the provisions of this Section 6(m)(ii) shall not be triggered by the transactions contemplated by this Agreement.
36
(n) Anti-Takeover Matters. If any restrictions set forth in any laws, rules or regulations related to changes in control of corporations, limited liability companies or business organizations generally (each of such articles, a “Takeover Law”) may become, or may purport to be, applicable to the transactions contemplated or permitted by this Agreement, the Company and the Board of Directors, subject to the Board of Directors’ fiduciary duties, shall grant such approvals and take such actions as are necessary so that the transactions contemplated or permitted by this Agreement may be consummated, as promptly as practicable, on the terms contemplated by this Agreement, and otherwise act to eliminate or minimize the effects of any Takeover Law on any of the transactions contemplated or permitted by this Agreement.
(o) Form D and Blue Sky. The Company agrees to timely file a Form D with respect to the Purchased Shares as required under Regulation D. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the Purchased Shares for sale to the Investors pursuant to this Agreement under applicable securities or “blue sky” laws of the states of the United States (or to obtain an exemption from such qualification). The Company shall make all filings and reports relating to the offer and sale of the Purchased Shares and Conversion Securities required under applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date.
(p) No Additional Issuances. Between the date of this Agreement and the Closing Date, except for the Purchased Shares being issued pursuant to this Agreement and the Warrant Agreements, the Company shall not issue and agree to issue any additional shares of Series A Preferred Stock, Series B Preferred Stock, Common Stock or Non-Voting Common Stock or any Warrants, other than any issuance of Common Stock on exercise of any compensatory stock options or vesting of any restricted stock outstanding on the date of this Agreement and the issuance of any Common Stock pursuant to the Third Coast Bank, SSB 401(k) and Employee Stock Ownership Plan.
(q) Acknowledgment of Dilution. The Company acknowledges that the issuance of the Purchased Shares will result in dilution of the outstanding shares of Common Stock. The Company further acknowledges that its obligations under this Agreement, including its obligation to issue the Purchased Shares pursuant to this Agreement, are not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Investor and regardless of the dilutive effect that such issuance may have on the ownership of the other shareholders of the Company.
(r) Use of Proceeds. The Company will use the net proceeds from the sale of the Purchased Shares hereunder to increase the Company’s shareholders’ equity, contribute some or all of the proceeds to the Bank and for general corporate purposes.
37
(s) Principal Market Regulation. The Company shall not issue any shares of Common Stock if the issuance of such shares of Common Stock (taken together with each issuance of such shares of Common Stock (i) upon the conversion of the Series A Preferred Stock in accordance with the Series A Certificate of Designation or otherwise, (ii) upon the conversion of the Series B Preferred Stock in accordance with the Series B Certificate of Designation or otherwise, (iii) upon the conversion of the Non-Voting Common Stock in accordance with the Certificate of Formation as amended by the Non-Voting Common Stock Certificate of Amendment or otherwise, or (iv) upon the exercise of the Warrants pursuant to the Warrant Agreements) would exceed 19.9% of the total outstanding shares of Common Stock of the Company, or more than 19.9% of the total voting power of the Company’s securities, in each case immediately preceding the issuance of the Series A Preferred Stock and Warrants pursuant to this Agreement and the Warrant Agreements (the number of shares which may be issued without violating such limitation, the “Exchange Cap”), except that such limitation shall not apply in the event that the Company obtains the approval of its shareholders as required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of such amount. Until such approval is obtained, the Investors (collectively, the “Existing Buyers” and each, individually, an “Existing Buyer”) shall not be permitted to convert Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock or exercise Warrants with respect to more than such Existing Buyer’s pro rata amount of such Exchange Cap (such amount, with respect to each Existing Buyer, its “Exchange Cap Allocation Amount”) determined based upon such Existing Buyer’s percentage ownership of the sum of (1) the aggregate number of shares of Common Stock issuable upon the conversion of all shares of Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock, plus (2) the aggregate number of shares of Common Stock issuable upon exercise of the Warrants. In the event that such Existing Buyer shall sell or otherwise transfer any of such Existing Buyer’s shares of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Warrants, the transferee shall be allocated a pro rata portion of such Existing Buyer’s Exchange Cap Allocation Amount with respect to such portion of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants so transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation Amount so allocated to such transferee. Upon conversion and exercise in full of such Existing Buyer’s Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants, the difference (if any) between such Existing Buyer’s Exchange Cap Allocation Amount and the number of shares of Common Stock actually issued to such Existing Buyer upon such Existing Buyer’s conversion in full of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants shall be allocated to the respective Exchange Cap Allocation Amounts of the remaining Existing Buyers of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants on a pro rata basis in proportion to the relative Exchange Cap Allocation Amounts of such Existing Buyers.
Section 7. Conditions to Closing.
(a) The obligations of each Investor to consummate the purchase of the shares of Series A Preferred Stock at the Closing as contemplated hereunder are subject to the fulfillment (or written waiver by such Investor (as to itself only)), prior to or on the Closing Date, of the following conditions:
38
(i) the representations and warranties of the Company in Section 3 shall be true and correct in all material respects (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein) as of the date hereof and at and as of the Closing Date as if made on such date, except to the extent that such representations and warranties are made as of a specified dates, in which case such representations and warranties shall be true and correct in all material respects as of such date, provided however, that notwithstanding anything herein to the contrary, the condition set forth in this Section 7(a)(i) shall be deemed to have been satisfied even if any representations and warranties of the Company (other than the Company’s representations and warranties in Sections 3(a), (b), (c), (d)(i)(A), (v), (dd)) are not so true and correct unless the failure of such representations and warranties of the Company to be so true and correct (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein), individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect;
(ii) the Company shall have complied in all material respects with its obligations hereunder that are required to be complied with at or prior to the Closing;
(iii) (A) no provision of any applicable law or regulation and no judgment, injunction, order or decree shall prohibit the Closing or shall prohibit or restrict such Investor or its Affiliates from owning or voting any Purchased Shares or Conversion Securities of the Company in accordance with the terms thereof and (B) no lawsuit shall have been commenced by any Governmental Entity seeking to effect any of the foregoing, such Investor’s purchase, ownership or voting of the Purchased Shares or Conversion Securities or otherwise materially and adversely affecting the ability of the parties hereto to complete the transaction described herein;
(iv) with respect to the Purchased Shares to be acquired by such Investor at the Closing:
(A) such purchase shall not (1) cause such Investor or any of its Affiliates to violate any banking law or regulation, or (2) cause such Investor, together with any other person whose ownership of securities of the Company would be aggregated with such Investor’s ownership of securities of the Company for purposes of any applicable banking law or regulation, to collectively be deemed to own, control or have the power to vote Purchased Shares which (assuming, for this purpose only, full conversion and/or exercise of such Purchased Shares by such Investor and such other Persons) would represent more than 9.9% of any class of voting securities of the Company outstanding at such time.
(B) such Investor shall have received (x) feedback, satisfactory in such Investor’s reasonable good faith judgment, from the Federal Reserve Board (which may be the absence of any communication) to the effect that the purchase of the Purchased Shares and the consummation of the Closing and the transactions contemplated by this Agreement will not result in such Investor or any of its Affiliates (i) being deemed in control of the Company for purposes of the BHC Act, (ii) otherwise being regulated as a bank holding company within the meaning of the BHC Act or required to serve as a source of strength for the Company or any Bank, or (iii) being required to file a notice under the CBCA (or a notice has been submitted and such Investor has not received any objection after the expiration or earlier termination of any applicable waiting period), and (y) feedback, satisfactory in such Investor’s reasonable good faith judgment, from the TDSML (which may be the absence of any communication) to the effect that the purchase of the Purchased Shares and the consummation of the Closing and the transactions contemplated by this Agreement will not result in such Investor or any of its Affiliates (1) being deemed a bank holding company within the meaning of the Texas Banking Act (Tex. Fin. Code § 31.001 et seq.),
39
a holding company within the meaning of the Texas Savings Bank Act (Tex. Fin. Code § 91.001 et seq.), or the equivalent thereof for purposes of applicable Texas law, (2) becoming subject to regulation by the TDSML or Texas Department of Banking under applicable Texas law, or (3) being required to file a notice under the TCBCA (or a notice has been submitted and such Investor has received approval from the TDSML, or has not received any objection after the expiration or earlier termination of any applicable waiting period, as applicable); and otherwise the Company and such Investor shall have obtained all applicable governmental or regulatory approvals or authorizations of or, to the extent required by applicable law or regulation, consents, approvals or exemptions from bank regulatory authorities, required in connection with the transactions contemplated by this Agreement (or has not received any objection after the expiration or earlier termination of any applicable waiting period);
(v) since the date hereof, there shall not be any action taken, or any law enacted, entered, enforced or deemed applicable, by any Governmental Entity, which shall impose or contain any restraint or condition that would reasonably be expected to reduce in any material respect the economic benefits to such Investor of the Agreement or that would require Investor to comply with requirements that are materially restrictive or burdensome to such Investor or its Affiliates (it being understood that information commonly required or restrictions commonly imposed in transactions of this type will not be deemed materially restrictive or burdensome);
(vi) the Company shall simultaneously issue and deliver at the Closing to such Investor hereunder the number of shares of Series A Preferred Stock set forth below such Investor’s name on the signature page hereto;
(vii) since December 31, 2021, there shall not have occurred any circumstance, event, change, development or effect that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on the Company or the Bank;
(ix) the Company shall have delivered to such Investor all of the documents and certificates required under Section 5(a) hereof;
(x) the Investor shall have received such other documents and certificates as it may reasonably request or as may be required pursuant to this Agreement or under applicable law;
(xi) (A) using the Bank’s balance sheet as of the month end immediately prior to the Closing Date and (B) after the Closing and the consummation of the transactions contemplated by this Agreement, (1) the Bank shall meet or exceed the quantitative capital requirements to be “well capitalized” as defined in 12 C.F.R. § 208.43(b)(1); (2) the Company shall meet or exceed the quantitative capital requirements to be “well capitalized” as defined in 12 C.F.R. § 225.2(r)(1); and (3) both the Bank and the Company shall meet or exceed all specific quantitative capital requirements stated in any written agreement, order, understanding or undertaking with the Federal Reserve, the FDIC, or the TDSML, as applicable; and
(xii) as of the end of the month immediately prior to the Closing, the total value of nonperforming assets of the Bank shall not have increased by any amount in excess of 25% of the total value of nonperforming assets as of June 30, 2022, as disclosed in the Company Financial Statements.
40
(b) The obligations of the Company to consummate the sale of the shares of Series A Preferred Stock to the Investors at the Closing as contemplated hereunder are subject to the fulfillment (or written waiver by the Company), prior to or on the Closing Date, of the following conditions:
(i) the representations and warranties of the Investors in Section 4 shall be true and correct in all respects (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein) as of the date hereof and at and as of the Closing Date as if made as of such date, except for representations and warranties made as of a specified date, which shall be true and correct in all respects as of such specified date, in each case except as would not have a material adverse effect on the ability of the Investors to consummate the transactions contemplated by this Agreement in a timely manner;
(ii) the Investors shall have complied in all material respects with their respective obligations hereunder that are required to be complied with at or prior to the Closing;
(iii) no judgment, injunction, decree or other legal restraint shall prohibit, or have the effect of rendering unachievable, the consummation of the transactions contemplated by this Agreement;
(iv) the Investors shall have delivered to the Company all of the documents and certificates required under Section 5(b) hereof;
(v) CCCP VIII shall have delivered to the Company all of the documents and certificates required under Section 5(c)(ii) hereof; and
(vi) the Company shall have received such other documents and certificates as it may reasonably request or as may be required pursuant to this Agreement or under applicable law.
Section 8. Termination.
(a) This Agreement may be terminated at any time prior to the Closing Date by mutual agreement of the Company and any Investor.
(b) This Agreement may be terminated at any time prior to the Closing Date by the Company or an Investor by written notice to the other if there is a material breach of this Agreement by the other party such that Section 7(a) (in the case of a breach by the Company) or Section 7(b) (in the case of breach by an Investor) would not be satisfied and such breach or condition is not curable or, if curable, is not cured thirty (30) days prior to the date that would otherwise be the Closing Date in absence of such breach or condition; provided that this Section 8(b) shall only apply if the other party is not in material breach of any of the terms of this Agreement.
(c) This Agreement may be terminated at any time prior to the Closing Date by the Company or an Investor by written notice thereof to the other party at any time following the date that is forty-five (45) days from the date hereof if the Closing shall not have occurred on or prior to such date; provided, however, that the right to terminate this Agreement pursuant to this Section 8(c) shall not be available to any party whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date.
41
(d) If (i) an Investor or any of the Investor’s Affiliates receives written notice from or is otherwise advised by a Governmental Entity that it will not grant (or intends to rescind or revoke if previously approved) any regulatory approval or receives written notice from such Governmental Entity that it will not grant such regulatory approval on the terms contemplated by this Agreement or (ii) any Governmental Entity shall have issued any order, decree or injunction or taken any other action restraining, enjoining or prohibiting any of the transactions contemplated by this Agreement, then this Agreement may be terminated by the Company or the Investor by written notice to the other; provided, that the termination right provided in Section 8(d)(i) shall not be available to any party who shall have breached its obligations under this Agreement in any manner that shall have proximately contributed to such approval not to be obtained.
(e) This Agreement may be terminated by an Investor at any time prior to the Closing, upon written notice to the Company, if the Investor or any of its Affiliates receives written notice from or is otherwise advised by the Federal Reserve Board or the TDSML that the Federal Reserve Board or the TDSML, as applicable, will not grant (or intends to rescind if previously granted) any of the confirmations or determinations referred to in Section 7(a)(iv).
(f) This Agreement may be terminated by an Investor at any time prior to the Closing if the Company directly or indirectly effects or causes to be effected any transaction with a third party with respect to a transaction that would reasonably be expected to result in a Change in Control.
(g) In the event of any termination of this Agreement as provided in Sections 8(a), (b), (c), (d), (e), or (f) of this Agreement, this Agreement (other than Sections 1, 8, 11 through 19, and 21 through 23 which shall remain in full force and effect) shall forthwith become wholly void and of no further force and effect as between the Company and such Investor; provided, that nothing herein shall relieve any party from liability for a prior willful breach of this Agreement.
Section 9. Additional Covenants.
(a) Reservation for Issuance. The Company shall at all times reserve and keep available, out of its authorized but unissued Conversion Securities, solely for the purpose of effecting the conversion of shares of the Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock and/or exercise of the Warrants, the full number of Conversion Securities issuable upon the conversion of all the shares of the Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock and/or exercise of the Warrants from time to time outstanding.
42
(b) Indemnification.
(i) The Company agrees to indemnify, defend and hold harmless each Investor and its Affiliates and each of their respective officers, directors, partners, members, principals and employees, and each Person who controls such Investor within the meaning of the Exchange Act and the regulations thereunder, to the fullest extent lawful, from and against any and all actions, suits, claims, proceedings, costs, losses, liabilities, damages, expenses (including reasonable attorneys’ fees and disbursements), amounts paid in settlement and other costs (collectively, “Losses”) arising out of or resulting from (1) any inaccuracy in or breach of the Company’s representations or warranties in this Agreement, (2) any breach of agreements or covenants made by the Company in this Agreement (other than any Losses to the extent attributable to the acts, errors or omissions on the part of such Investor), and (3) any action, suit, claim, proceeding or investigation by any Governmental Entity, shareholder of the Company or any other person (other than the Investors and its Affiliates and the Company and Company Subsidiaries) relating to this Agreement or the transactions contemplated hereby (other than any Losses to the extent attributable to the acts, errors or omissions on the part of such Investor).
(ii) Each Investor severally, but not jointly, agrees to indemnify, defend and hold harmless the Company and its Affiliates and each of their respective officers, directors, partners, members and employees, and each Person who controls the Company within the meaning of the Exchange Act and the regulations thereunder, to the fullest extent lawful, from and against any and all Losses arising out of or resulting from (1) any inaccuracy in or breach of such Investor’s representations or warranties in this Agreement and (2) any breach of agreements or covenants in this Agreement (other than any Losses to the extent attributable to the acts, errors or omissions on the part of the Company).
(iii) A party entitled to indemnification hereunder (each, an “Indemnified Party”) shall give prompt written notice to the party indemnifying it (the “Indemnifying Party”) of any claim with respect to which it seeks indemnification promptly after the discovery by such Indemnified Party of any matters giving rise to a claim for indemnification; provided, however, that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 9(b) unless and to the extent that the Indemnifying Party shall have been actually prejudiced by the failure of such Indemnified Party to so notify such party. Such notice shall describe in reasonable detail such claim including each individual item of Loss included in the amount so stated, the basis for any anticipated liability and the nature of the misrepresentation, default, breach of warranty or breach of covenant or claim to which each such item is related and, to the extent computable, the computation of the amount to which such Indemnified Party claims to be entitled hereunder. In case any such action, suit, claim or proceeding is brought against an Indemnified Party, the Indemnified Party shall be entitled to hire, at its own expense, separate counsel and participate in the defense thereof; provided, however, that the Indemnifying Party shall be entitled to assume and conduct the defense thereof, unless the counsel to the Indemnified Party advises such Indemnifying Party in writing that such claim involves a conflict of interest (other than one of a monetary nature) that would reasonably be expected to make it inappropriate for the same counsel to represent both the Indemnifying Party and the Indemnified Party, in which case the Indemnified Party shall be entitled to retain its own counsel at the cost and expense of the Indemnifying Party (except that the Indemnifying Party shall only be liable for the legal fees and expenses of one law firm for all Indemnified Parties, taken together with respect to any single action or group of related actions). If the Indemnifying Party assumes the defense of any claim, all Indemnified Parties shall thereafter deliver to the Indemnifying Party copies of all notices and documents (including court papers) received by the Indemnified Party relating to the claim, and each Indemnified Party shall cooperate in the defense or prosecution of such claim. Such cooperation shall include the retention and (upon the Indemnifying Party’s request) the provision to the Indemnifying Party of records and information
43
that are reasonably relevant to such claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. The Indemnifying Party shall not be liable for any settlement of any action, suit, claim or proceeding effected without its written consent; provided, however, that the Indemnifying Party shall not unreasonably withhold or delay or condition its consent. The Indemnifying Party further agrees that it will not, without the Indemnified Party’s prior written consent (which shall not be unreasonably withheld or delayed), settle or compromise any claim or consent to entry of any judgment in respect thereof in any pending or threatened action, suit, claim or proceeding in respect of which indemnification has been sought hereunder unless such settlement or compromise includes an unconditional release of such Indemnified Party from all liability arising out of such action, suit, claim or proceeding.
(iv) The Company shall not be required to indemnify the Indemnified Parties pursuant to Section 9(b)(i)(1), unless and until the aggregate amount of all Losses incurred with respect to all claims pursuant to Section 9(b)(i)(1) exceed $250,000 in the aggregate (the “Deductible”), in which event the Company shall be responsible for only the amount of such Losses in excess of the Deductible. For purposes of the indemnity contained in Section 9(b)(i)(1), all qualifications and limitations set forth in the Company’s representations and warranties (other than Section 3(n)(iii)) as to “knowledge,” “materiality,” “Material Adverse Effect” and words of similar import, shall be disregarded in determining whether there shall have been any inaccuracy in or breach of any representations and warranties in this Agreement.
(v) Any claim for indemnification pursuant to Section 9(b)(i)(1) or Section 9(b)(ii)(1) for breach of any representation or warranty can only be brought on or prior to the date that is twelve (12) months after the Closing Date; provided that if notice of a claim for indemnification pursuant to Section 9(b)(i)(1) or Section 9(b)(ii)(1) for breach of any representation or warranty is brought prior to such date, then the obligation to indemnify in respect of such breach shall survive as to such claim, until such claim has been finally resolved; provided further that “twelve (12) months” shall be replaced with “thirty (30) days after the expiration of the applicable statute of limitations” with respect to breaches of Sections 3(k), (o), and (q); provided further that none of the foregoing limitations shall apply with respect to breaches of Sections 3(a), (b), (c), (d)(i)(A) and (v) or Sections 4(a), (b), (c) and (l) which shall survive for the maximum extent permitted under applicable law.
(vi) The indemnity provided for in this Section 9(b) shall be the sole and exclusive remedy of the Indemnified Parties after the Closing for any inaccuracy of any representation or warranty or any other breach of any covenant or agreement contained in this Agreement; provided that nothing herein shall limit in any way any such party’s remedies in respect of fraud, intentional misrepresentation or omission, or intentional misconduct by any other party in connection with the transactions contemplated hereby. No party to this Agreement (or any of its Affiliates) shall, in any event, be liable or otherwise responsible to any other party (or any of its Affiliates) for any punitive damages of such other party (or any of its Affiliates) arising out of or relating to this Agreement or the performance or breach hereof except to the extent actually awarded to a third party. Any liability for indemnification under this Agreement will be determined without duplication of recovery by reason of any state of facts giving rise to such liability constituting a breach of more than one representation, warranty, covenant or agreement.
44
(vii) Any indemnification payments pursuant to this Section 9(b) shall be treated as an adjustment to the aggregate Purchase Price for the Series A Preferred Stock and Warrants for U.S. federal income and applicable state and local Tax purposes, unless a different treatment is required by applicable law.
(c) Corporate Opportunities. Each of the parties hereto acknowledges that each Investor and its Affiliates and related investment funds may review the business plans and related proprietary information of any enterprise, including enterprises that may have products or services that compete directly or indirectly with those of the Company and Company Subsidiaries, and may trade in the securities of such enterprise. None of the Investors, any Affiliates thereof, any related investments funds or any of their respective Affiliates shall be precluded or in any way restricted from investing or participating in any particular enterprise, or trading in the securities thereof whether or not such enterprise has products or services that compete with those of the Company and Company Subsidiaries. The parties expressly acknowledge and agree that: (a) each Investor, any Affiliates thereof, any related investment funds, the Board Representative, the Observer and any of their respective Affiliates have the right to, and shall have no duty (contractual or otherwise) not to, directly or indirectly, engage in the same or similar business activities or lines of business as the Company and Company Subsidiaries; and (b) in the event that an Investor, any Affiliate of such Investor, any related investment funds or any of their respective Affiliates, other than in their capacity as the Board Representative or Observer, acquires knowledge of a potential transaction or matter that may be a corporate opportunity for the Company or any Company Subsidiary, such Investor, Affiliates of such Investor, any related investment funds or any of their respective Affiliates shall have no duty (contractual or otherwise) to communicate or present such corporate opportunity to the Company or any Company Subsidiary, and, shall not be liable to the Company or any Company Subsidiary or shareholders of the Company for breach of any duty (contractual or otherwise) by reason of the fact such Investor, any Affiliate thereof, any related investment fund thereof or any of their respective Affiliates, directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another person, or does not present such opportunity to the Company.
Section 10. Survival. The representations and warranties of the Company contained in this Agreement or in any certificate delivered hereunder shall survive the Closing only for the period set forth in Section 9(b)(iv) (or until final resolution of any claim or action arising from the breach of any such representation and warranty, if notice of such breach was provided prior to the end of such period in accordance with the terms of this Agreement), and thereafter each representation and warranty shall expire and have no further force and effect.
Section 11. Notices. All notices, communications and deliveries required or permitted by this Agreement shall be made in writing signed by the party making the same, shall specify the Section of this Agreement pursuant to which it is given or being made and shall be deemed given or made (i) on the date delivered if delivered by email or in person, (ii) on the third (3rd) Business Day after it is mailed if mailed by registered or certified mail (return receipt requested) (with postage and other fees prepaid) or (iii) on the day after it is delivered, prepaid, to an overnight express delivery service that confirms to the sender delivery on such day, as follows:
45
(a) if to the Company, at:
Third Coast Bancshares, Inc.
20202 Highway 59 North, Suite 190
Humble, Texas 77338
Attn: R. John McWhorter, Chief Financial Officer
Email: jmcwhorter@tcbssb.com
with a copy (which shall not constitute notice) to:
Norton Rose Fulbright US LLP
2200 Ross Avenue, Suite 3600
Dallas, Texas 75201
Attn: Michael G. Keeley, Esq.
Email: mike.keeley@nortonrosefulbright.com
(b) if to an Investor, the address set forth under such Investor’s name on the signature page hereof;
or such other address as may be designated in writing hereafter, in the same manner, by such Person.
Section 12. Assignment. This Agreement shall not be assigned by operation of law or otherwise, except that any Investor may assign all or any portion of its rights under this Agreement to any of its Affiliates or as expressly permitted in this Agreement; provided, that any such assignment shall not relieve such Investor of any liability or other obligation under this Agreement. This Agreement will be binding upon, and will inure to the benefit of and be enforceable by, the parties hereto and their respective successors and assigns.
Section 13. Entire Agreement. This Agreement (and the exhibits hereto) embodies the entire agreement and understanding between the parties hereto in respect of the subject matter contained herein. This Agreement supersedes all prior written and prior or contemporaneous oral agreements and understandings between the parties with respect to the subject matter of this Agreement.
Section 14. Governing Law. This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles or other principles that would require the application of any other law. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Delaware for any actions, suits or proceedings arising out of or relating to this Agreement and the transactions contemplated hereby.
Section 15. Severability. If any provision of this Agreement or the application thereof to any Person or circumstances is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid or unenforceable, shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties.
46
Section 16. Expenses. Except as set forth elsewhere in the Transaction Documents, the parties hereto shall be responsible for the payment of all expenses incurred by them in connection with the preparation and negotiation of the Transaction Documents and the consummation of the transactions contemplated hereby. The Company shall pay all transfer agent fees, stamp taxes and documentary taxes and duties levied in connection with the Company’s sale and issuance of the Purchased Shares to the Investors.
Section 17. Reserved.
Section 18. Construction. The following principles shall apply:
(a) the word “or” will not be exclusive;
(b) inclusion of items in a list will not be deemed to exclude other terms of similar import;
(c) all parties will be considered to have drafted this Agreement together, with the benefit of counsel, and no provision will be strictly construed against any Person by reason of having drafted such provision;
(d) the word “include” and its correlatives means to include without limitation;
(e) terms that imply gender will include all genders;
(f) defined terms will have their meanings in the plural and singular case;
(g) references to Sections, Schedules and Exhibits are to the Sections, Schedules, and Exhibits to this Agreement;
(h) the use of “will” as an auxiliary will not be deemed to be a mere prediction of future occurrences; and
(i) the headings in this Agreement are for purposes of reference only and shall not limit or otherwise affect the meaning of this Agreement.
Section 19. Counterparts and Facsimiles. For the convenience of the parties hereto, this Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original instrument, and all such counterparts will together constitute the same agreement. Executed signature pages to this Agreement may be delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file and such signature will have the same force and effect as if such facsimile or electronic page were an original thereof.
47
Section 20. Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity.
Section 21. Amendment; Waiver. No amendment or waiver of any provision of this Agreement will be effective with respect to any party unless made in writing and signed by a duly authorized representative of such party. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The conditions to each party’s obligation to consummate the Closing are for the sole benefit of such party and may be waived by such party in whole or in part to the extent permitted by applicable law. No waiver of any party to this Agreement, as the case may be, will be effective unless it is in a writing signed by a duly authorized representative of the waiving party that makes express reference to the provision or provisions subject to such waiver.
Section 22. No Recourse. The Company agrees and acknowledges that unless expressly assigned by an Investor to an Investor Related Party, no Investor Related Party has any obligations hereunder and that no person shall have any remedy, recourse or right of recovery against, or contribution from, any Investor Related Party, whether through an Investor or otherwise, in connection with the transactions contemplated by this Agreement. The term “Investor Related Party” means (a) any Affiliate of an Investor, (b) any former, current or future limited partners, members, managers, shareholders, holders of any equity, partnership or limited liability company interest, officers, directors, employees, agents, controlling persons, or assignees of an Investor or any of its Affiliates, or (c) any former, current or future limited partners, members, managers, shareholders, holders of any equity, partnership or limited liability company interest, officers, directors, employees, agents, controlling persons, assignees, or Affiliates of any of the foregoing.
Section 23. No Third Party Beneficiaries. Nothing contained in this Agreement, expressed or implied, is intended to confer or shall confer upon any person other than the express parties hereto and their successors and permitted assigns any benefit right or remedies, except as otherwise provided specifically herein. The representations and warranties set forth in Section 3 have been made solely for the benefit of the parties to this Agreement and (a) may be intended not as statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate, (b) have been qualified by reference to the Disclosure Schedules, each of which contains certain disclosures that are not reflected in the text of this Agreement, and (c) may apply standards of materiality in a way that is different from what may be viewed as material by shareholders of, or other investors in, the Company.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
48
IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date first above written.
| Third Coast Bancshares, Inc. | ||
| By: |
| |
| Name: |
| |
| Title: |
| |
SIGNATURE PAGE TO INVESTMENT AGREEMENT
| [Investor Name] | ||
| By: |
| |
| Name: |
| |
| Title: |
| |
| Aggregate Purchase Price: |
| Aggregate Number of Shares of Series A Preferred Stock to be Acquired at Closing: |
| Aggregate Number of Warrants to be Acquired at Closing: |
| Tax ID No.: |
| Address for Notice: |
|
|
|
|
|
|
| Telephone No: |
| |
| Facsimile No: |
| |
SIGNATURE PAGE TO INVESTMENT AGREEMENT
EXHIBIT A
Form of Certificate of Designations for Series A Preferred Stock
[Omitted]
Exhibit A
EXHIBIT B
Form of Certificate of Designations for Series B Preferred Stock
[Omitted]
Exhibit B
EXHIBIT C
FORM OF CERTIFICATE OF AMENDMENT
TO THE CERTIFICATE OF FORMATION
OF THIRD COAST BANCSHARES, INC.
This Certificate of Amendment is submitted for filing pursuant to the applicable provisions of the Texas Business Organizations Code.
Entity Information
The name of the filing entity is Third Coast Bancshares, Inc., and it is a for-profit corporation (the “Corporation”). The Corporation’s date of formation is January 16, 2013, and its assigned file number is 801718646.
Amendments
Article VI of the Certificate of Formation of the Corporation (the “Certificate of Formation”) is hereby amended and restated in its entirety to read as follows:
ARTICLE VI
| A. | General. |
The total number of shares of capital stock which the Corporation is authorized to issue is [______], consisting of fifty million (50,000,000) shares of common stock, par value $1.00 per share, [______] shares of non-voting common stock, par value $1.00 per share, and one million (1,000,000) shares of preferred stock, par value $1.00 per share (“Preferred Shares”). The shares of capital stock may be issued from time to time as authorized by the board of directors of the Corporation (the “Board”) without the approval of its shareholders, except as otherwise provided by governing law, rule or regulation or as set forth in this Certificate of Formation, as amended from time to time.
| B. | Preferred Stock. |
The Board is expressly authorized, without shareholder approval, to provide, when it deems advisable or necessary, for the issuance of all or any shares of the preferred stock in one or more classes or series, and to fix for each such class or series such voting powers, full or limited, or no voting powers, and such distinctive designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board providing for the establishment of such class or series as may be permitted by the Texas Business Organizations Code, including, without limitation, the authority to provide that any such class or series may be: subject to redemption at such time or times, on such conditions and at such price or prices; entitled to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions, and at such times, and payable in preference to, or in such relation to, the dividends payable on
EXHIBIT C-2
any other class or classes or any other series of capital stock of the Corporation; entitled to such rights upon the dissolution of, or upon any distribution of the assets of, the Corporation; or convertible into, or exchangeable for, shares of the same or any other class or classes of stock, or of the same or any other series of stock, of the Corporation at such price or prices or at such rates of exchange and with adjustments, all as may be stated in such resolution or resolutions adopted by the Board.
| C. | Common Stock. |
Each holder of common stock will be entitled to one vote for each share of common stock held of record on all matters on which shareholders generally are entitled to vote. There shall be no cumulative voting. Subject to the provisions of law and the rights of the preferred stock and any other class or series of stock having a preference as to dividends over the common stock then outstanding, and any other rights of shareholders provided herein, dividends may be paid on common stock out of assets legally available for dividends, but only at such times and in such amounts as the Board may determine and declare. Upon the dissolution, liquidation or winding up of the Corporation, after any preferential amounts to be distributed to the holders of the preferred stock and any other class or series of shares having a preference over the common stock then outstanding have been paid or declared and set apart for payment, and any other rights of shareholders provided herein, the holders of common stock will be entitled to receive all the remaining assets of the Corporation available for distribution to its shareholders ratably in proportion to the number of shares held by them, respectively.
| D. | Non-Voting Common Stock |
1. Definitions. For purposes of this Paragraph C, the following capitalized terms will have the meanings indicated in this Section 1, whether used in the singular or the plural.
(a) “Affiliate” has the meaning set forth in 12 C.F.R. Section 225.2(a) or any successor provision.
(b) “Certificate of Formation” means the Certificate of Formation of the Corporation, as amended and in effect from time and time
(c) “Board of Directors” means the board of directors of the Corporation.
(d) “Business Day” means any day other than a Saturday or a Sunday or a day on which banks are required or permitted by law or executive order to be closed in the State of Texas.
(e) “Certificate” means a certificate representing one (1) or more shares of Non-Voting Common Stock.
(f) “Common Stock” means the Corporation’s common stock, par value $1.00 per share.
EXHIBIT C-3
(g) “Conversion” has the meaning set forth in Section 5.
(h) “Corporation” means Third Coast Bancshares, Inc., a Texas corporation.
(i) “Dividends” has the meaning set forth in Section 3.
(j) “Exchange Agent” means Continental Stock Transfer & Trust Company, solely in its capacity as transfer and exchange agent for the Corporation, or any successor transfer and exchange agent for the Corporation.
(k) “Exchange Cap” has the meaning set forth in Section 5(b).
(l) “Exchange Cap Allocation Amount” has the meaning set forth in Section 5(b).
(m) “Existing Buyer” has the meaning set forth in Section 5(b).
(n) “Investment Agreement” means the Investment Agreement, dated as of September 8, 2022, by and among the Corporation and the investors named therein, as it may be amended from time to time.
(o) “Liquidation Distribution” has the meaning set forth in Section 4.
(p) “Non-Voting Common Stock” means the Corporation’s non-voting common stock, par value $1.00 per share.
(q) “Permissible Transfer” means a transfer by the holder of Non-Voting Common Stock (i) to the Corporation; (ii) in a widely distributed public offering of Common Stock or Non-Voting Common Stock; (iii) that is part of an offering that is not a widely distributed public offering of Common Stock or Non-Voting Common Stock but is one in which no one transferee (or group of associated transferees) acquires the rights to receive two percent (2%) or more of any class of the Voting Securities of the Corporation then outstanding (including pursuant to a related series of transfers); or (iv) to a transferee that controls more than fifty percent (50%) of the Voting Securities of the Corporation without giving effect to such transfer.
(r) “Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, governmental entity, unincorporated organization or other legal entity.
(s) “Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading.
EXHIBIT C-4
(t) “Series A Preferred Stock” means the Corporation’s Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share.
(u) “Series B Preferred Stock” means the Corporation’s Series B Convertible Perpetual Preferred Stock, par value $1.00 per share.
(v) “Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
(w) “Voting Security” has the meaning set forth in 12 C.F.R. §225.2(q) or any successor provision.
(x) “Warrant Agreement” means each Warrant Agreement, dated as of [______], 2022, by and between the Corporation and the investor named therein, as each may be amended from time to time.
(y) “Warrants” has the meaning set forth in the Investment Agreement.
2. Rights. Each share of Non-Voting Common Stock has the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications, or terms or conditions of redemption as described herein. Each share of Non-Voting Common Stock is identical in all respects to every other share of Non-Voting Common Stock.
3. Dividends. The Non-Voting Common Stock will rank pari passu with the Common Stock with respect to the payment of dividends or distributions, whether payable in cash, securities, options or other property, and with respect to issuance, grant or sale of any rights to purchase stock, warrants, securities or other property (collectively, the “Dividends”). Accordingly, the holders of record of Non-Voting Common Stock will be entitled to receive as, when, and if declared by the Board of Directors, Dividends in the same per share amount as paid on the Common Stock, and no Dividends will be payable on the Common Stock or any other class or series of capital stock ranking with respect to Dividends pari passu with the Common Stock unless a Dividend identical to that paid on the Common Stock is payable at the same time on the Non-Voting Common Stock in an amount per share of Non-Voting Common Stock equal to the product of (i) the per share Dividend declared and paid in respect of each share of Common Stock and (ii) the number of shares of Common Stock into which such share of Non-Voting Common Stock is then convertible (without regard to any limitations on conversion of the Non-Voting Common Stock); provided, however, that if a stock Dividend is declared on Common Stock payable solely in Common Stock, the holders of Non-Voting Common Stock will be entitled to a stock Dividend payable solely in shares of Non-Voting Common Stock. Dividends that are payable on Non-Voting Common Stock will be payable to the holders of record of Non-Voting Common Stock as they appear on the stock register of the Corporation on the applicable record date, as determined by the Board of Directors, which record date will be the same as the
EXHIBIT C-5
record date for the equivalent Dividend of the Common Stock. In the event that the Board of Directors does not declare or pay any Dividends with respect to shares of Common Stock, then the holders of Non-Voting Common Stock will have no right to receive any Dividends.
4. Liquidation.
(a) Rank. The Non-Voting Common Stock will, with respect to rights upon liquidation, winding up and dissolution, rank (i) subordinate and junior in right of payment to all other securities of the Corporation that, by their respective terms, are senior to the Non-Voting Common Stock or the Common Stock, and (ii) pari passu with the Common Stock. Not in limitation of anything contained herein, and for purposes of clarity, the Non-Voting Common Stock is subordinated to the general creditors and subordinated debt holders of the Corporation, and the depositors of the Corporation’s bank subsidiaries, in any receivership, insolvency, liquidation or similar proceeding.
(b) Liquidation Distributions. In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, holders of Non-Voting Common Stock will be entitled to receive, for each share of Non-Voting Common Stock, out of the assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation, subject to the rights of any Persons to whom the Non-Voting Common Stock is subordinate, a distribution (“Liquidation Distribution”) equal to (i) any authorized and declared, but unpaid, Dividends with respect to such share of Non-Voting Common Stock at the time of such liquidation, dissolution or winding up, and (ii) the amount the holder of such share of Non-Voting Common Stock would receive in respect of such share if such share had been converted into shares of Common Stock at the then applicable conversion rate at the time of such liquidation, dissolution or winding up (assuming the conversion of all shares of Non-Voting Common Stock at such time, without regard to any limitations on conversion of the Non-Voting Common Stock). All Liquidation Distributions to the holders of the Non-Voting Common Stock and Common Stock set forth in clause (ii) above will be made pro rata to the holders thereof.
(c) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 4, the merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in which the holders of Non-Voting Common Stock receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash, securities or property) of all or substantially all of the assets of the Corporation, will not constitute a liquidation, dissolution or winding up of the Corporation.
EXHIBIT C-6
5. Conversion.
(a) General.
(i) A holder of Non-Voting Common Stock shall be permitted to convert, or upon the written request of the Corporation shall convert, shares of Non-Voting Common Stock into shares of Common Stock at any time or from time to time, provided that upon such conversion the holder, together with all Affiliates of the holder, will not own or control in the aggregate more than nine point nine percent (9.9%) of the Common Stock (or of any class of Voting Securities issued by the Corporation), excluding for the purpose of this calculation any reduction in ownership resulting from transfers by such holder of Voting Securities of the Corporation (which, for the avoidance of doubt, does not include Non-Voting Common Stock), provided further that the right to convert under this Section 5(a)(i) shall not be available to a transferee of shares of Non-Voting Common Stock with respect to a transfer other than a Permissible Transfer. In any such conversion, each share of Non-Voting Common Stock will convert initially into one (1) share of Common Stock, subject to adjustment as provided in Section 6 below.
(ii) On the date a holder of Non-Voting Common Stock transfers any shares of Non-Voting Common Stock to a non-affiliate of the holder in a Permissible Transfer, each such share of Non-Voting Common Stock will automatically convert into one (1) share of Common Stock, without any further action on the part of any holder, subject to adjustment as provided in Section 6 below.
(iii) To effect any permitted conversion under Section 5(a)(i) or Section 5(a)(ii), the holder shall surrender the certificate or certificates evidencing such shares of Non-Voting Common Stock, duly endorsed, at the registered office of the Corporation, and provide written instructions to the Corporation as to the number of whole shares for which such conversion shall be effected, together with any appropriate documentation that may be reasonably required by the Corporation or the Exchange Agent. Upon the surrender of such certificate(s), the Corporation will, or will cause the Exchange Agent to, issue and deliver to such holder (in the case of a conversion under Section 5(a)(i)) or such holder’s transferee (in the case of a conversion under Section 5(a)(ii)) a certificate or certificates for the number of shares of Common Stock into which the Non-Voting Common Stock has been converted and, in the event that such conversion is with respect to some, but not all, of the holder’s shares of Non-Voting Common Stock, the Corporation will, or will cause the Exchange Agent to, deliver to such holder a certificate or certificate(s) representing the number of shares of Non-Voting Common Stock that were not converted to Common Stock.
EXHIBIT C-7
(iv) All shares of Common Stock delivered upon conversion of the Non-Voting Common Stock shall be duly authorized, validly issued, fully paid and non-assessable, free and clear of all liens, claims, security interests, charges and other encumbrances.
(b) Principal Market Regulation. Notwithstanding anything to the contrary, the Corporation shall not issue any shares of Common Stock upon the conversion of the Non-Voting Common Stock if the issuance of such shares of Common Stock (taken together with each issuance of such shares of Common Stock (1) upon the conversion of the Series A Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series A Preferred Stock or otherwise, (2) upon the conversion of the Series B Preferred Stock in accordance with the Certificate of Designation, Preferences and Rights of Series B Preferred Stock or otherwise, or (3) upon the exercise of the Warrants pursuant to the Warrant Agreements) would exceed 19.9% of the total outstanding shares of Common Stock of the Corporation, or more than 19.9% of the total voting power of the Corporation’s securities, in each case immediately preceding the issuance of the Series A Preferred Stock and Warrants pursuant to the Investment Agreement and the Warrant Agreements (the number of shares which may be issued without violating such limitation, the “Exchange Cap”), except that such limitation shall not apply in the event that the Corporation obtains the approval of its shareholders as required by the applicable rules of the Principal Trading Market for issuances of shares of Common Stock in excess of such amount. Until such approval is obtained, the holders of the Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants (collectively, the “Existing Buyers” and each, individually, an “Existing Buyer”) shall not be permitted to convert Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock or exercise Warrants with respect to more than such Existing Buyer’s pro rata amount of such Exchange Cap (such amount, with respect to each Existing Buyer, its “Exchange Cap Allocation Amount”) determined based upon such Existing Buyer’s percentage ownership of the sum of (1) the aggregate number of shares of Common Stock issuable upon the conversion of all shares of Series A Preferred Stock, Series B Preferred Stock and/or Non-Voting Common Stock, plus (2) the aggregate number of shares of Common Stock issuable upon exercise of the Warrants. In the event that such Existing Buyer shall sell or otherwise transfer any of such Existing Buyer’s shares of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Warrants, the transferee shall be allocated a pro rata portion of such Existing Buyer’s Exchange Cap Allocation Amount with respect to such portion of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants so transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation Amount so allocated to such transferee. Upon conversion and exercise in full of such Existing Buyer’s Series A Preferred Stock, Series B Preferred
EXHIBIT C-8
Stock, Non-Voting Common Stock and Warrants, the difference (if any) between such Existing Buyer’s Exchange Cap Allocation Amount and the number of shares of Common Stock actually issued to such Existing Buyer upon such Existing Buyer’s conversion in full of such Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants shall be allocated to the respective Exchange Cap Allocation Amounts of the remaining Existing Buyers of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock and Warrants on a pro rata basis in proportion to the relative Exchange Cap Allocation Amounts of such Existing Buyers.
(c) Reservation of Shares Issuable Upon Conversion. The Corporation will at all times reserve and keep available out of its authorized but unissued Common Stock solely for the purpose of effecting the conversion of the Non-Voting Common Stock such number of shares of Common Stock as will from time to time be sufficient to effect the conversion of all outstanding Non-Voting Common Stock; and if at any time the number of shares of authorized but unissued Common Stock will not be sufficient to effect the conversion of all then outstanding Non-Voting Common Stock, the Corporation will take such action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued Common Stock to such number of shares as will be sufficient for such purpose.
(d) No Impairment. The Corporation will not, by amendment of its Certificate of Formation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the carrying out of all the provisions of this Section 5 and in the taking of all such actions as may be necessary or appropriate in order to protect the conversion rights of the holders of the Non-Voting Common Stock against impairment.
(e) Compliance with Law. Prior to the delivery of any securities that the Corporation shall be obligated to deliver upon conversion of the Non-Voting Common Stock, the Corporation shall use its reasonable best efforts to comply with any federal and state laws and regulations thereunder requiring the registration of such securities with, or any approval of or consent to the delivery thereof by, any governmental authority.
(f) Listing. The Corporation hereby covenants and agrees that, if at any time the Common Stock shall be traded on any national securities exchange, the Corporation will, if permitted by the rules of such exchange, list and keep listed, so long as the Common Stock shall be so listed on such exchange, all the Common Stock issuable upon conversion of the Non-Voting Common Stock; provided, however, that if the rules of such exchange require the Corporation to defer the listing of such Common Stock until the first conversion of Non-Voting Common Stock into Common Stock in accordance with the provisions hereof, the Corporation covenants to list such Common Stock issuable upon conversion of the Non-Voting Common Stock in accordance with the requirements of such exchange at such time.
EXHIBIT C-9
6. Adjustments.
(a) Combinations or Divisions of Common Stock. In the event that the Corporation at any time or from time to time will effect a division of the Common Stock into a greater number of shares (by stock split, reclassification or otherwise other than by payment of a Dividend in Common Stock or in any right to acquire the Common Stock), or in the event the outstanding Common Stock will be combined or consolidated, by reclassification, reverse stock split or otherwise, into a lesser number of shares of the Common Stock, then the dividend, liquidation, and conversion rights of each share of Non-Voting Common Stock in effect immediately prior to such event will, concurrently with the effectiveness of such event, be proportionately decreased or increased, as appropriate.
(b) Reclassification, Exchange or Substitution. If the Common Stock is changed into the same or a different number of shares of any other class or classes of stock, whether by capital reorganization, reclassification or otherwise (other than a division or combination of shares provided for in Section 6(a) above), (1) the conversion ratio then in effect will, concurrently with the effectiveness of such transaction, be adjusted so that each share of the Non-Voting Common Stock will be convertible into, in lieu of the number of shares of Common Stock which the holders of the Non-Voting Common Stock would otherwise have been entitled to receive, a number of shares of such other class or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Non-Voting Common Stock is then convertible (without regard to any limitations on conversion of the Non-Voting Common Stock) immediately before that transaction and (2) the Dividend and Liquidation Distribution rights then in effect will, concurrently with the effectiveness of such transaction, be adjusted so that each share of Non-Voting Common Stock will be entitled to a Dividend and Liquidation Distribution right, in lieu of with respect to the number of shares of Common Stock which the holders of the Non-Voting Common Stock would otherwise have been entitled to receive, with respect to a number of shares of such other class or classes of stock equal to the product of (i) the number of shares of such other class or classes of stock that a holder of a share of Common Stock would be entitled to receive in such transaction and (ii) the number of shares of Common Stock into which such share of Non-Voting Common Stock is then convertible (without regard to any limitations on conversion of the Non-Voting Common Stock) immediately before that transaction.
EXHIBIT C-10
(c) Certificates as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 6, the Corporation at its expense will promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Non-Voting Common Stock a certificate executed by the Corporation’s President (or other appropriate officer) setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation will, upon the written request at any time of any holder of Non-Voting Common Stock, but no more frequently than once per fiscal quarter, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, and (ii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Non-Voting Common Stock.
7. Reorganization, Mergers, Consolidations or Sales of Assets. If at any time or from time to time there will be a capital reorganization of the Common Stock (other than a subdivision, combination, reclassification or exchange of shares otherwise provided for in Section 6) or a merger or consolidation of the Corporation with or into another corporation, or the sale of all or substantially all the Corporation’s properties and assets to any other Person, then, as a part of such reorganization, merger, consolidation or sale, provision will be made so that the holders of the Non-Voting Common Stock will thereafter be entitled to receive upon conversion of the Non-Voting Common Stock, the number of shares of stock or other securities or property of the Corporation, or of the successor company resulting from such merger or consolidation or sale, to which a holder of that number of shares of Common Stock deliverable upon conversion of the Non-Voting Common Stock would have been entitled to receive on such capital reorganization, merger, consolidation or sale (without regard to any limitations on conversion of the Non-Voting Common Stock), provided, however, that the Corporation shall exercise commercially reasonable efforts to provide that such stock, securities, or property shall be in a form and manner that satisfies the regulatory requirements of the holder of the Non-Voting Common Stock, including with respect to the voting rights thereof.
8. Redemption. Except to the extent a liquidation under Section 4 may be deemed to be a redemption, the Non-Voting Common Stock will not be redeemable at the option of the Corporation or any holder of Non-Voting Common Stock at any time. Notwithstanding the foregoing, the Corporation will not be prohibited from repurchasing or otherwise acquiring shares of Non-Voting Common Stock in voluntary transactions with the holders thereof, subject to compliance with any applicable legal or regulatory requirements, including applicable regulatory capital requirements. Any shares of Non-Voting Common Stock repurchased or otherwise acquired may be reissued as additional shares of Non-Voting Common Stock.
EXHIBIT C-11
9. Voting Rights. The holders of Non-Voting Common Stock will not have any voting rights, except as may otherwise be permitted for securities that are Nonvoting Securities, as set forth in 12 C.F.R. § 225.2(q)(2), or any successor provision.
10. Protective Provisions. So long as any shares of Non-Voting Common Stock are issued and outstanding, the Corporation will not, without obtaining the approval (by vote or written consent) of the holders of a majority of the issued and outstanding shares of Non-Voting Common Stock, alter or change the rights, preferences, privileges or restrictions provided for the benefit of the holders of the Non-Voting Common Stock so as to affect them adversely, or take any action that would have the effect of adversely changing any preference or any relative or other right provided for the benefit of the holders of the Non-Voting Common Stock. In the event that the Corporation offers to repurchase shares of Common Stock, the Corporation shall offer to repurchase shares of Non-Voting Common Stock pro rata based upon the number of shares of Common Stock such holders would be entitled to receive if such shares were converted into shares of Common Stock immediately prior to such repurchase.
11. Notices. All notices required or permitted to be given by the Corporation with respect to the Non-Voting Common Stock shall be in writing, and if delivered by first class United States mail, postage prepaid, to the holders of the Non-Voting Common Stock at their last addresses as they shall appear upon the books of the Corporation, shall be conclusively presumed to have been duly given, whether or not the holder actually receives such notice; provided, however, that failure to duly give such notice by mail, or any defect in such notice, to the holders of any stock designated for repurchase, shall not affect the validity of the proceedings for the repurchase of any other shares of Non-Voting Common Stock, or of any other matter required to be presented for the approval of the holders of the Non-Voting Common Stock.
12. Record Holders. To the fullest extent permitted by law, the Corporation will be entitled to recognize the record holder of any share of Non-Voting Common Stock as the true and lawful owner thereof for all purposes and will not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other Person, whether or not it will have express or other notice thereof.
13. Term. The Non-Voting Common Stock shall have perpetual term unless converted in accordance with Section 5.
14. Replacement Certificates. In the event that any Certificate will have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Corporation or the Exchange Agent, the posting by such Person of a bond in such amount as the Corporation or the Exchange Agent may determine is necessary as indemnity against any claim that may be made against it with respect to such Certificate, the Corporation or the Exchange Agent, as applicable, will deliver in exchange for such lost, stolen or destroyed Certificate a replacement Certificate.
EXHIBIT C-12
15. Other Rights. The shares of Non-Voting Common Stock have no preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends, qualifications, or rights, other than as set forth herein or as provided by applicable law.
16. Interpretation. All references within this Paragraph D to “Sections” are to sections of this Article VI, Paragraph D, of this Certificate of Formation, and not to other articles, paragraphs or sections of this Certificate of Formation.
Statement of Approval
The amendment to the Certificate of Formation has been approved in the manner required by the Texas Business Organizations Code and by the governing documents of the Corporation.
Effectiveness of Filing
This Certificate of Amendment becomes effective when it is filed by the Secretary of State.
[Remainder of Page Intentionally Left Blank]
EXHIBIT C-13
Execution
The undersigned signs this document subject to the penalties imposed by law for the submission of a materially false or fraudulent instrument and certifies under penalty of perjury that the undersigned is authorized under the provisions of law governing the entity to execute the filing instrument.
| Date: ________________, 202__ | THIRD COAST BANCSHARES, INC. | |||||
| By: |
| |||||
| Name: |
| |||||
| Title: |
| |||||
Exhibit C
EXHIBIT D
Form of Voting Agreement
[Omitted]
Exhibit D
EXHIBIT E
Form of Officer’s Certificate of the Company
[_______], 2022
The undersigned, the Chairman, President and Chief Executive Officer of Third Coast Bancshares, Inc., a Texas corporation (the “Corporation”), pursuant to Section 5(a)(iii) of the Investment Agreement, dated as of September 8, 2022 (the “Agreement”), by and among the Corporation and the several purchasers of the Series A Preferred Stock identified on the signature pages thereto, acting solely in his capacity as the duly elected, qualified and acting Chairman, President and Chief Executive Officer of the Corporation and not in his individual capacity, hereby certifies to the Investors that:
1. The Corporation has complied in all material respects with its obligations under the Agreement that are required to be complied with at or prior to the Closing.
2. The representations and warranties of the Corporation in Section 3 of the Agreement are or were, as applicable, true and correct in all material respects (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein) as of the date of the Agreement and at and as of the Closing Date as if made on such date, except to the extent that such representations and warranties are made as of a specified date, in which case such representations and warranties were true and correct in all material respects as of such date, provided however, that notwithstanding anything in the Agreement to the contrary, the condition set forth in Section 7(a)(i) of the Agreement is deemed to have been satisfied even if any representations and warranties of the Corporation (other than the Corporation’s representations and warranties in Sections 3(a), (b), (c), (v), (dd)) are not so true and correct unless the failure of such representations and warranties of the Corporation to be so true and correct (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein), individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.
3. Since December 31, 2021, there has not occurred any circumstance, event, change, development or effect that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.
4. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.
[Signature Page Follows]
EXHIBIT E-1
IN WITNESS WHEREOF, the undersigned has executed and delivered this certificate solely in the capacity indicated and not in an individual capacity as of the date first written above.
| By: |
| |
| Name: | Bart O. Caraway | |
| Title: | Chairman, President and Chief Executive Officer | |
Exhibit E
EXHIBIT F
Form of Secretary’s Certificate of the Company
[_______], 2022
I, Jo Ann Dean, hereby certify that I am the Secretary of Third Coast Bancshares, Inc., a Texas corporation (the “Corporation”). Acting solely in my capacity as the duly elected, qualified and acting Secretary of the Corporation and not in my individual capacity, I further certify on behalf of the Corporation that:
1. Attached hereto as Exhibit 1, is a true, correct and complete copy of resolutions duly adopted by the Board of Directors of the Corporation on September 1, 2022 and resolutions duly adopted by the pricing committee established by the Board of Directors of the Corporation on September 8, 2022. Such resolutions have not been rescinded, amended or modified, are in full force and effect in the form adopted, and are the only resolutions adopted by the Board of Directors relating to the transactions contemplated by the Investment Agreement, dated as of September 8, 2022 (the “Agreement”), by and among the Corporation and the several purchasers of the Series A Preferred Stock identified on the signature pages thereto.
2. Attached hereto as Exhibit 2 is a true, correct and complete copy of the Corporation’s First Amended and Restated Certificate of Formation, as amended, certified by the Texas Secretary of State on [_______________] (the “Certificate of Formation”), and there are no proceedings currently in process or contemplated to amend, modify or revoke the Corporation’s Certificate of Formation, except as contemplated by the Agreement, and the Certificate of Formation is in full force and effect on the date hereof.
3. Attached hereto as Exhibit 3 is a true, correct and complete copy of the First Amended and Restated Bylaws of the Corporation, and there are no proceedings currently in process or contemplated to amend, modify or revoke the Corporation’s Bylaws, and the Bylaws are in full force and effect on the date hereof.
4. Each person who, as an officer of the Corporation, signed the Agreement or any other document delivered in connection with the transactions contemplated by the Agreement was duly elected or appointed, qualified and acting as such officer at the respective times of the signing and delivery thereof and was duly authorized to sign such document on behalf of the Corporation, and the signature of each such person appearing on each such document is the genuine signature of such officer.
5. Norton Rose Fulbright US LLP, counsel to the Corporation, is entitled to rely on this certificate in connection with the opinions it is rendering pursuant to the Agreement.
All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
[Signature Page Follows]
EXHIBIT F-1
IN WITNESS WHEREOF, I have executed this certificate in my capacity as aforesaid as of the date first written above.
|
|
| Name: Jo Ann Dean |
| Title: Secretary |
I, Bart O. Caraway, Chairman, President and Chief Executive Officer of the Corporation, hereby certify that Jo Ann Dean has been duly elected or appointed, has been duly qualified, and is the Secretary of the Corporation and that the signature above is her genuine signature.
IN WITNESS WHEREOF, I have hereunto set my hand by and on behalf of the Corporation as of the date first written above.
| THIRD COAST BANCSHARES, INC. | ||
|
| ||
| Name: | Bart O. Caraway | |
| Title: | Chairman, President and Chief Executive Officer | |
[Signature Page to Third Coast Bancshares, Inc. Secretary’s Certificate]
EXHIBIT 1
RESOLUTIONS
[See attached.]
EXHIBIT 2
CERTIFICATE OF FORMATION
[See Attached.]
EXHIBIT 3
BYLAWS
[See Attached.]
Exhibit F
EXHIBIT G
Form of Officer’s Certificate of the Investor
The undersigned, the [________] of [________], a [________] (the “Investor”), pursuant to Section 5(b)(ii) of the Investment Agreement, dated as of September 8, 2022 (the “Agreement”), by and among the several purchasers of the Series A Preferred Stock identified on the signature pages thereto and Third Coast Bancshares, Inc. (the “Corporation”), hereby certifies to the Corporation that:
1. The Investor has complied in all material respects with its obligations under the Agreement that are required to be complied with at or prior to the Closing.
2. The representations and warranties of the Investor set forth in Section 4 of the Agreement are or were, as applicable, true and correct in all respects (without giving effect to any materiality or Material Adverse Effect or similar qualifier set forth therein) as of the date of the Agreement and at and as of the Closing Date as if made as of such date, except for representations and warranties made as of a specified date, which were true and correct in all respects as of such specified date, in each case except as would not have a material adverse effect on the ability of the Investor to consummate the transactions contemplated by the Agreement in a timely manner.
3. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.
[Signature Page Follows]
EXHIBIT G-1
IN WITNESS WHEREOF, the undersigned has executed and delivered this certificate solely in the capacity indicated and not in an individual capacity as of the date first written above.
| By: |
| |
| Name: | [______________] | |
| Title: | [______________] |
Exhibit G
EXHIBIT H
Form of VCOC Letter Agreement
THIRD COAST BANCSHARES, INC.
20202 HIGHWAY 59 NORTH, SUITE 190
HUMBLE, TX 77338
[•], 2022
Castle Creek Capital Partners VIII, L.P.
11682 El Camino Real, Suite 320
San Diego, CA 92130
Dear Sir/Madam:
Reference is made to the Investment Agreement by and between Third Coast Bancshares, Inc., a Texas corporation (the “Corporation”), and the Investors name therein, including, without limitation, Castle Creek Capital Partners VIII, L.P., a Delaware limited partnership (the “VCOC Investor”), dated as of September 8, 2022 (the “Agreement”), pursuant to which the VCOC Investor agreed to purchase from the Corporation shares of its Series A Preferred Stock and Warrants. Capitalized terms used herein without definition shall have the respective meanings in the Agreement.
For good and valuable consideration acknowledged to have been received, the Corporation hereby agrees that it shall:
For so long as the VCOC Investor, directly or through one or more Affiliates, continues to maintain a Qualifying Ownership Interest (as defined in the Letter Agreement), without limitation or prejudice of any of the rights provided to the VCOC Investor under the Agreement, the Letter Agreement or any other agreement or otherwise, provide the VCOC Investor or its designated representative with:
(i) true and correct copies of all documents, reports, financial data and other information as the VCOC Investor may reasonably request and the right to visit and inspect any of the offices and properties of the Corporation and its subsidiaries and inspect the books and records of the Corporation and its subsidiaries at such times as the VCOC Investor shall reasonably request upon three (3) business days’ notice but not more frequently than once per calendar year, provided, however, that such rights shall not extend to, confidential supervisory information (including confidential supervisory information as defined or identified in 12 C.F.R. § 261.2(c)(1)) of a Governmental Entity, customer financial records or other “exempt records” as defined by 12 C.F.R. Part 309, which information may only be disclosed by the Corporation or any subsidiary of the Corporation in accordance with the provisions and subject to the limitations of applicable law or regulation;
EXHIBIT H-1
(ii) consolidated balance sheets and statements of income and cash flows of the Corporation and its subsidiaries prepared in conformity with GAAP applied on a consistent basis (A) as of the end of each quarter of each fiscal year of the Corporation as soon as practicable after preparation thereof but in no event later than forty-five (45) days after the end of such quarter, and (B) with respect to each fiscal year end statement, as soon as practicable after preparation thereof but in no event later than one hundred twenty (120) days after the end of such fiscal year together with an auditor’s report thereon of a firm of established national reputation; and
(iii) to the extent the Corporation or any of its subsidiaries is required by law or pursuant to the terms of any outstanding indebtedness of the Corporation or any subsidiary to prepare such reports, any annual reports, quarterly reports and other periodic reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or otherwise, actually prepared by the Corporation or any of its subsidiaries as soon as available;
provided, that, in each case, if the Corporation makes the information described in clauses (ii) and (iii) of this bullet point available through public filings on the EDGAR system or any successor or replacement system of the United States Securities and Exchange Commission, the delivery of the information shall be deemed satisfied by such public filings.
Make appropriate officers and directors of the Corporation, and its subsidiaries, available periodically and at such times as reasonably requested by the VCOC Investor for consultation with the VCOC Investor or its designated representative, but not more frequently than once per calendar quarter, with respect to matters relating to the business and affairs of the Corporation and its subsidiaries; and
If the VCOC Investor’s regular outside counsel determines in writing that other rights of consultation are reasonably necessary under applicable legal authorities promulgated after the date of this letter agreement to preserve the qualification of VCOC Investor’s investment in the Corporation as a “venture capital investment” for purposes of the United States Department of Labor Regulation published at 29 C.F.R. Section 2510.3-101(d)(3)(i) (the “Plan Asset Regulation”), the Corporation agrees to cooperate in good faith with the VCOC Investor to amend this letter agreement to reflect such other rights that are mutually satisfactory to the Corporation and the VCOC Investor and consistent with the Federal Reserve Policy Statement on Equity Investments in Banks and Bank Holding Companies; provided that such consultation rights shall be limited to once per calendar quarter.
The Corporation agrees to consider, in good faith, the recommendations of the VCOC Investor or its designated representative in connection with the matters on which it is consulted as described above, recognizing that the ultimate discretion with respect to all such matters shall be retained by the Corporation and its Board of Directors.
The VCOC Investor agrees, and will require each designated representative of the VCOC Investor to agree, to hold in confidence and not use or disclose to any third party (other than its legal counsel and accountants) any confidential information provided to or learned by such party in connection with the VCOC Investor’s rights under this letter agreement except as may otherwise be required by law or legal, judicial or regulatory process, provided that the VCOC Investor takes reasonable steps to minimize the extent of any such required disclosure.
EXHIBIT H-2
In the event the VCOC Investor transfers all or any portion of its investment in the Corporation to an affiliated entity (or to a direct or indirect wholly-owned conduit subsidiary of any such affiliated entity) that is intended to qualify as a venture capital operating company under the Plan Asset Regulation, such affiliated entity shall be afforded the same rights that the Corporation has afforded to the VCOC Investor hereunder and shall be treated, for such purposes, as a third party beneficiary hereunder.
The rights of the VCOC Investor under this letter agreement are unique to the VCOC Investor and shall not be assignable or transferrable other than to an affiliated entity that is intended to qualify as a venture capital operating company under the Plan Asset Regulation.
The rights of the VCOC Investor under this letter agreement shall terminate on the earlier of (a) the date on which the VCOC Investor ceases to hold, directly or through one or more Affiliates, any Series A Preferred Stock, Series B Preferred Stock, Common Stock, Non-Voting Common Stock or Warrants, and (b) the date on which the VCOC Investor ceases to be, or ceases to intend to be, qualified as a venture capital operating company under the Plan Asset Regulation.
This letter agreement and the rights and the duties of the parties hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware and may be executed in counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
EXHIBIT H-3
| THIRD COAST BANCSHARES, INC. | ||
| By: |
| |
| Name: |
||
| Title: | ||
| Agreed and acknowledged as of the date first above written: | ||
| CASTLE CREEK CAPITAL PARTNERS VIII, LP | ||
| By: |
| |
| Name: | ||
| Title: | ||
Exhibit H
EXHIBIT I
Form of Opinion of Company Counsel
[Omitted]
Exhibit I
EXHIBIT J
Form of Warrant Agreement
[Omitted]
Exhibit J
EXHIBIT K
Registration Rights Agreement
[Omitted]
Exhibit K
EXHIBIT L
Letter Agreement
[Omitted]
Exhibit L
Exhibit 10.2
FORM OF
THIRD COAST BANCSHARES, INC.
REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (this “Agreement”) is made and entered into as of [•], 2022, by and among Third Coast Bancshares, Inc., a Texas corporation (the “Company”), and the purchaser(s) signatory hereto (each a “Registration Rights Purchaser” and collectively, the “Registration Rights Purchasers”).
This Agreement is made pursuant to the Investment Agreement, dated as of September 8, 2022, between the Company and each Registration Rights Purchaser (the “Investment Agreement”).
NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each of the Registration Rights Purchasers agree as follows:
1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Investment Agreement shall have the meanings given such terms in the Investment Agreement. As used in this Agreement, the following terms shall have the following meanings:
“Advice” shall have the meaning set forth in Section 8(g).
“Affiliate” means, with respect to any Person, any Person directly or indirectly controlling, controlled by or under common control with such other Person.
“Agreement” shall have the meaning set forth in the Preamble.
“Allowable Grace Period” shall have the meaning set forth in Section 5(d).
“Business Day” means a day other than a Saturday or Sunday or other day on which banks located in Texas are authorized or required by law to close.
“Capital Stock” means, with respect to any Person at any time, any and all shares, interests, participations or other equivalents (however designated, whether voting or non-voting) of capital stock, securities convertible into or exchangeable or exerciseable for any of its shares, interests, participations or other equivalents, partnership interests (whether general or limited), limited liability company interests, or equivalent ownership interests in or issued by such Person.
“Commission” means the United States Securities and Exchange Commission.
“Common Stock” means the Company’s common stock, par value $1.00 per share, and any securities into which such shares of common stock may hereinafter be reclassified.
“Company” shall have the meaning set forth in the Preamble.
“Effective Date” means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the Commission.
“Effectiveness Deadline” means, with respect to the Initial Registration Statement or the New Registration Statement, the tenth (10th) Trading Day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be “reviewed” or will not be subject to further review; provided, that if the Effectiveness Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on which the Commission is open for business.
Exhibit K | Page 1
“Effectiveness Period” shall have the meaning set forth in Section 2(b).
“Event” shall have the meaning set forth in Section 2(c).
“Event Date” shall have the meaning set forth in Section 2(c).
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Filing Deadline” means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the date that is the second (2nd) anniversary of the Closing Date, provided, that if the Filing Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Filing Deadline shall be extended to the next Business Day on which the Commission is open for business.
“FINRA” shall have the meaning set forth in Section 5(n).
“Grace Period” shall have the meaning set forth in Section 5(d).
“Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities, as reflected on the records of the Company.
“Holders Counsel” shall have the meaning set forth in Section 5(a).
“Indemnified Party” shall have the meaning set forth in Section 7(c).
“Indemnifying Party” shall have the meaning set forth in Section 7(c).
“Initial Registration Statement” shall have the meaning set forth in Section 2(a).
“Investment Agreement” shall have the meaning set forth in the Recitals.
“Liquidated Damages” shall have the meaning set forth in Section 2(c).
“Losses” shall have the meaning set forth in Section 7(a).
“New Registration Statement” shall have the meaning set forth in Section 2(a).
“Non-Responsive Holder” shall have the meaning set forth in Section 8(d).
“Non-Voting Common Stock” means the Company’s non-voting common stock, par value $1.00 per share, into which the Series A Preferred Stock or Series B Preferred Stock is convertible following approval by the Company’s shareholders of an amendment to its certificate of formation authorizing said stock.
“Other Securities” means shares of Common Stock, Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock, Warrants or shares of other Capital Stock or other securities of the Company which are contractually entitled to registration rights or Capital Stock which the Company is registering pursuant to a Registration Statement.
Exhibit K | Page 2
“Person” means an individual, corporation, partnership, association, joint stock company, limited liability company, joint venture, trust, governmental entity, unincorporated organization or other legal entity.
“Piggyback Registration” shall have the meaning set forth in Section 3(a).
“Principal Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading; provided, that the Principal Market shall be a Trading Market.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition).
“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.
“Registrable Securities” means all of the Shares, the Warrants, the Underlying Shares and any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the Shares, the Warrants or the Underlying Shares, provided that the Shares, the Warrants or the Underlying Shares shall cease to be Registrable Securities upon the earliest to occur of the following: (A) a sale pursuant to a Registration Statement or Rule 144 (in which case, only such securities sold shall cease to be Registrable Securities); (B) becoming eligible for sale without time, volume or manner of sale restrictions by the Holders under Rule 144; or (C) if such Shares, Warrants or Underlying Shares have ceased to be outstanding.
“Registration Rights Purchaser” or “Registration Rights Purchasers” shall have the meaning set forth in the Preamble.
“Registration Statements” means any one or more registration statements of the Company filed under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial Registration Statement, the New Registration Statement and any Remainder Registration Statements), amendments and supplements to such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such Registration Statements.
“Remainder Registration Statement” shall have the meaning set forth in Section 2(a).
“Requested Information” shall have the meaning set forth in Section 8(d).
“Required Registration Statement” means any Initial Registration Statement, New Registration Statement or Remainder Registration Statement.
“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule 144 may be amended from time to time, or any successor rule thereto.
“Rule 144A” means Rule 144A promulgated by the Commission pursuant to the Securities Act, as such Rule 144A may be amended from time to time, or any successor rule thereto.
Exhibit K | Page 3
“Rule 145” means Rule 145 promulgated by the Commission pursuant to the Securities Act, as such Rule 145 may be amended from time to time, or any successor rule thereto.
“Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule 415 may be amended from time to time, or any successor rule thereto.
“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule 424 may be amended from time to time, or any successor rule thereto.
“SEC Guidance” means (i) any publicly-available written guidance, comments, requirements or requests of the Commission staff and (ii) the Securities Act.
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Series A Preferred Stock” means the Company’s Series A Convertible Non-Cumulative Preferred Stock, par value $1.00 per share, and any securities into which such shares of Series A Convertible Non-Cumulative Preferred Stock may hereinafter be reclassified.
“Series B Preferred Stock” means the Company’s Series B Convertible Perpetual Preferred Stock, par value $1.00 per share, and any securities into which such shares of Series B Convertible Perpetual Preferred Stock may hereinafter be reclassified.
“Shares” means the shares of Series A Preferred Stock issued or issuable to the Registration Rights Purchaser pursuant to the Investment Agreement.
“Shelf Offering” shall have the meaning set forth in Section 4(a).
“Take-Down Notice” shall have the meaning set forth in Section 4(a).
“Trading Day” means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Market, or (ii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by OTC Markets Group, Inc. (including the OTC Pink); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day.
“Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market, or the NASDAQ Capital Market on which the Common Stock is listed or quoted for trading on the date in question.
“Underlying Shares” means the shares of Common Stock, Non-Voting Common Stock, Series A Preferred Stock or Series B Preferred Stock into which the Series A Preferred Stock, Series B Preferred Stock or Non-Voting Common Stock (as applicable) is convertible or which are issuable pursuant to exercise of the Warrants.
2. Mandatory Registration.
(a) On or prior to the Filing Deadline, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Registrable Securities,
Exhibit K | Page 4
by such other means of distribution of Registrable Securities as the Company may reasonably determine (the “Initial Registration Statement”). Notwithstanding the registration obligations set forth in this Section 2, in the event that (i) the Company’s counsel determines that all such Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement prior to filing the Initial Registration Statement, or (ii) the Commission informs the Company that all such Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, then the Company agrees to promptly (A) inform each of the Holders thereof and, as applicable, file the Initial Registration Statement, or use its commercially reasonable best efforts to file amendments to the Initial Registration Statement as required by the Commission and/or (B) withdraw the Initial Registration Statement and file a new registration statement (a “New Registration Statement”), in each case covering the maximum number of such Registrable Securities permitted to be registered thereon, on such form available to the Company to register for resale the Registrable Securities as a secondary offering; provided, that in the case of (ii) above, prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable best efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure Interpretation 612.09, or any successor thereto. Notwithstanding any other provision of this Agreement, if the opinion of the Company’s counsel or any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and, in the case of clause (ii) above, notwithstanding that the Company used commercially reasonable best efforts to advocate with the Commission for the registration of all or a greater number but less than all of Registrable Securities), the number of Registrable Securities to be registered on such Registration Statement will be reduced pro rata on the basis of the aggregate number of Registrable Securities owned by each applicable Holder, and under such circumstances, the Company will not be subject to the payment of Liquidated Damages in Section 2(c). In the event the Company amends the Initial Registration Statement or files a New Registration Statement, as the case may be, under clauses (A) or (B) above, the Company will use its commercially reasonable best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on such form available to the Company to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, or the New Registration Statement (the “Remainder Registration Statements”). No Holder shall be named as an “underwriter” in any Registration Statement without such Holder’s prior written consent, which consent shall not be unreasonably withheld, delayed or conditioned.
(b) The Company shall use its commercially reasonable best efforts to cause each Required Registration Statement to be declared effective by the Commission as soon as practicable, and, with respect to the Initial Registration Statement or the New Registration Statement, as applicable, no later than the Effectiveness Deadline, and shall use its commercially reasonable best efforts to keep each Required Registration Statement continuously effective under the Securities Act until the earlier of (i) such time as all of the Registrable Securities covered by such Required Registration Statement have been publicly sold by the Holders or (ii) the date that all Registrable Securities covered by such Required Registration Statement may be sold by the Holders without volume or manner of sale restrictions under Rule 144, as determined by counsel to the Company pursuant to a written opinion letter to such effect, addressed and reasonably acceptable to the Company’s transfer agent (the “Effectiveness Period”). The Company shall request effectiveness of a Required Registration Statement as of 5:00 p.m., New York City time, on a Trading Day. The Company shall promptly notify the Holders via electronic mail of a “.pdf” format data file of the effectiveness of a Registration Statement within one (1) Business Day of the Effective Date unless already available on the Commission’s EDGAR filing system or successor system. The Company shall file a final Prospectus for a Required Registration Statement with the Commission, as required by Rule 424(b) as promptly as reasonably practicable following the Effective Date.
Exhibit K | Page 5
(c) If: (i) the Initial Registration Statement is not filed with the Commission on or prior to the Filing Deadline, (ii) the Initial Registration Statement or the New Registration Statement, as applicable, is not declared effective by the Commission (or otherwise does not become effective) for any reason on or prior to the Effectiveness Deadline, or (iii) after its Effective Date, (A) such Registration Statement ceases for any reason (including without limitation by reason of a stop order, or the Company’s failure to update the Registration Statement), to remain continuously effective as to all Registrable Securities for which it is required to be effective, or (B) the Holders are not permitted to utilize the Prospectus therein to resell such Registrable Securities (other than during an Allowable Grace Period), (iv) a Grace Period applicable to a Required Registration Statement exceeds the length of an Allowable Grace Period, or (v) after the Filing Deadline, and only in the event a Registration Statement is not effective or available to sell all Registrable Securities, the Company fails to file with the Commission any required reports under Section 13 or 15(d) of the Exchange Act such that it is not in compliance with Rule 144(c)(1) (or Rule 144(i)(2), if applicable), as a result of which the Holders who are not affiliates are unable to sell Registrable Securities without restriction under Rule 144, (any such failure or breach in clauses (i) through (v) above being referred to as an “Event,” and, for purposes of clauses (i), (ii), (iii) or (v), the date on which such Event occurs, or for purposes of clause (iv) the date on which such Allowable Grace Period is exceeded, being referred to as an “Event Date”), then in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as liquidated damages and not as a penalty (“Liquidated Damages”), equal to 1.0% of the aggregate purchase price paid by such Holder pursuant to the Investment Agreement for any Registrable Securities held by such Holder on the Event Date. The parties agree that notwithstanding anything to the contrary herein or in the Investment Agreement, no Liquidated Damages shall be payable (i) if as of the relevant Event Date, the Registrable Securities may be sold by the Holders without volume or manner of sale restrictions under Rule 144, as determined by counsel to the Company pursuant to a written opinion letter to such effect, addressed and reasonably acceptable to the Company’s transfer agent, (ii) to a Holder causing an Event that relates to or is caused by any action or inaction taken by such Holder, (iii) to a Holder in the event it is unable to lawfully sell any of its Registrable Securities (including, without limitation, in the event a Grace Period exceeds the length of an Allowable Grace Period) because of possession of material non-public information or (iv) with respect to any period after the expiration of the Effectiveness Period (it being understood that this clause shall not relieve the Company of any Liquidated Damages accruing prior to the expiration of the Effectiveness Period). If the Company fails to pay any Liquidated Damages pursuant to this Section 2(c) in full within ten (10) Business Days after the date payable, the Company will pay interest on the amount of Liquidated Damages then owing to the Holder at a rate of 0.5% per month on an annualized basis (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such Liquidated Damages are due until such amounts, plus all such interest thereon, are paid in full. The Liquidated Damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event, except in the case of the first Event Date. With respect to a Holder, the Effectiveness Deadline for a Required Registration Statement shall be extended without default or Liquidated Damages hereunder in the event that the Company’s failure to obtain the effectiveness of the Registration Statement on a timely basis results from the failure of such Holder to timely provide the Company with information requested by the Company and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act (in which case the Effectiveness Deadline would be extended with respect to Registrable Securities held by such Holder).
3. Piggyback Registration.
(a) If the Company intends to file a Registration Statement covering a primary or secondary offering of any of its Common Stock, Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock, Warrants or Other Securities, whether or not the sale for its own account, (other
Exhibit K | Page 6
than a registration (i) pursuant to a registration statement on Form S-8 (or other registration solely relating to an offering or sale of securities pursuant to any employee stock plan or other employee benefit arrangement), (ii) pursuant to a registration statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145), or (iii) in connection with any dividend or distribution reinvestment or similar plan), the Company will promptly (and in any event at least ten (10) Business Days before the anticipated filing date) give written notice to the Holders of its intention to effect such a registration. The Company will effect the registration under the Securities Act of all Registrable Securities that the Holder(s) request(s) be included in such registration (a “Piggyback Registration”) by a written notice delivered to the Company within five (5) Business Days after the notice given by the Company in the preceding sentence. Subject to Section 3(b), securities requested to be included in a Company Registration Statement pursuant to this Section 3 shall be included by the Company on the same form of Registration Statement as has been selected by the Company for the securities the Company is registering for sale referred to above. The Holders shall be permitted to withdraw all or part of the Registrable Securities from the Piggyback Registration at any time at least two (2) Business Days prior to the effective date of the Registration Statement relating to such Piggyback Registration (the “Piggyback Registration Statement”). If the Company elects to terminate any registration filed under this Section 3 prior to the effectiveness of such registration, the Company will have no obligation to register the securities sought to be included by the Holders in such registration under this Section 3. There shall be no limit to the number of Piggyback Registrations pursuant to this Section 3(a).
(b) If a Registration Statement under this Section 3 relates to an underwritten offering and the managing underwriter(s) advise(s) the Company that in its or their reasonable opinion the number of securities requested to be included in such offering exceeds the number which can be sold without adversely affecting the marketability of such offering (including an adverse effect on the per share offering price), the Company will include in such registration or Prospectus only such number of securities that in the reasonable opinion of such underwriter(s) can be sold without adversely affecting the marketability of the offering (including an adverse effect on the per share offering price), which securities will be so included in the following order of priority: (i) first, the Common Stock and other securities the Company proposes to sell, (ii) second, the Registrable Securities of the Holders who have requested inclusion of Registrable Securities pursuant to this Section 3, pro rata on the basis of the aggregate number of such securities or shares owned by each such Person, or as such Holders may otherwise agree, and (iii) third, any other securities of the Company that have been requested to be so included, subject to the terms of this Agreement. The Company shall select the investment banking firm or firms to act as the lead underwriter or underwriters in connection with an underwritten offering made pursuant to this Section 3. No Holder may participate in any underwritten registration under this Section 3 unless such Holder (i) agrees to sell the Registrable Securities it desires to have covered by the underwritten offering on the basis provided in any underwriting arrangements in customary form and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements, lockup agreements and other documents reasonably required under the terms of such underwriting arrangements.
4. Underwritten Shelf Offerings.
(a) At any time that a shelf registration statement covering Registrable Securities pursuant to Section 2 or Section 3 is effective, if any Holder delivers a notice to the Company (a “Take-Down Notice”) stating that it intends to sell all or part of its Registrable Securities included by it on the shelf registration statement (a “Shelf Offering”), then the Company shall amend or supplement the shelf registration statement as may be necessary in order to enable such Registrable Securities to be distributed pursuant to the Shelf Offering (taking into account the inclusion of Registrable Securities by any other Holders pursuant to this Section 4(a)). In connection with any Shelf Offering, including any Shelf Offering that is an underwritten offering, such proposing Holder(s) shall also deliver the Take-Down Notice to all other Holders of Registrable Securities included on such shelf Registration Statement and permit each such Holder to include its Registrable Securities included on the shelf Registration Statement in the Shelf Offering if such Holder notifies the proposing Holder(s) and the Company within five (5) days after delivery of the Take-Down Notice to such Holder.
Exhibit K | Page 7
(b) The Company shall have no obligation to effect an underwritten offering under this Section 4 on behalf of the Holders of Registrable Securities electing to participate in such offering unless the expected gross proceeds from such offering exceed $10,000,000. Additionally, in no event shall the Company be required to engage in more than one such underwritten offering in any six (6) month period.
(c) If a Shelf Offering of Registrable Securities included in a Required Registration Statement is to be conducted as an underwritten offering, then the Holders of the majority of the Registrable Securities included in a Required Registration Statement shall select the investment banking firm or firms to act as the lead underwriter or underwriters in connection with such offering; provided, that such selection shall be reasonably acceptable to the Company. If, in connection with any such underwritten offering, the managing underwriter(s) advise(s) the Company that in its or their reasonable opinion the number of securities requested to be included in such offering exceeds the number which can be sold without adversely affecting the marketability of such offering (including an adverse effect on the per share offering price), the Company will include in such registration or Prospectus only such number of securities that in the reasonable opinion of such underwriter(s) can be sold without adversely affecting the marketability of the offering (including an adverse effect on the per share offering price), which securities will be so included in the following order of priority: (i) first, the Registrable Securities of the Holders who have requested registration of Registrable Securities pursuant to this Section 4, pro rata on the basis of the aggregate number of such securities or shares owned by each such Person, or as the Holders may otherwise agree amongst themselves, (ii) second, the Common Stock and other securities the Company proposes to sell, and (iii) third, any other securities of the Company that have been requested to be so included, subject to the terms of this Agreement. No Holder may participate in any underwritten registration under this Section 4 unless such Holder (i) agrees to sell the Registrable Securities it desires to include in the underwritten offering on the basis provided in any underwriting arrangements in customary form and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements, lockup agreements and other documents reasonably required under the terms of such underwriting arrangements.
(d) In addition to Sections (a) and (b) of this Section 4, a Shelf Offering of Registrable Securities included on a Piggyback Registration Statement initiated by Holders shall be subject to the procedures set forth in Section 3(b).
5. Registration Procedures.
In connection with the Company’s registration obligations hereunder:
(a) The Company shall, not less than three (3) Trading Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, proxy statements and Current Reports on Form 8-K and any similar or successor reports), furnish to one counsel designated by a majority of the outstanding Registrable Securities (“Holders Counsel”), copies of such Registration Statement, Prospectus or amendment or supplement thereto, as proposed to be filed, which documents will be subject to the reasonable review of Holders Counsel; provided that each Holder shall have the right to review, prior to filing, its selling shareholder information. The Company shall not file any Registration Statement or amendment or supplement thereto containing information which Holders Counsel reasonably objects in good faith, unless the Company shall have been advised by its counsel that the information objected to is required under the Securities Act.
Exhibit K | Page 8
(b) (i) The Company shall prepare and file with the Commission such amendments, including post-effective amendments and supplements, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period (except during an Allowable Grace Period); (ii) the Company shall cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424 (except during an Allowable Grace Period); (iii) the Company shall respond as promptly as reasonably practicable to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably practicable, provide the Holders Counsel true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that pertains to the Holders as “Selling Shareholders”; and (iv) the Company shall comply in all material respects with the provisions of the Securities Act with respect to the disposition of all Registrable Securities covered by a Registration Statement until such time as all of such Registrable Securities shall have been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition by the Holders thereof as set forth in such Registration Statement as so amended or in such Prospectus as so supplemented; provided, that each Holder shall be responsible for the delivery of the Prospectus to the Persons to whom such Holder sells any of the Registrable Securities (including in accordance with Rule 172 under the Securities Act), and each Holder agrees to dispose of Registrable Securities in compliance with applicable federal and state securities laws. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section 5(b)) by reason of the Company filing a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report under the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement, if applicable, or shall file such amendments or supplements with the Commission as promptly as reasonably practicable.
(c) The Company shall notify the Holders (which notice shall, pursuant to clauses (ii) through (iv) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made, if applicable) as promptly as reasonably practicable following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement has been filed with the Commission; and (B) with respect to each Registration Statement or any post-effective amendment, when the same has become effective; (ii) of the issuance by the Commission or any other federal or state Governmental Entity of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iii) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (iv) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading.
(d) Notwithstanding anything to the contrary herein, at any time after the Registration Statement has been declared effective by the Commission, the Company may delay the disclosure of material non-public information concerning the Company if the disclosure of such information at the time is not, in the good faith judgment of the Company, in the best interests of the Company (such delay, a “Grace Period”). During the Grace Period, the Company shall not be required to maintain the effectiveness of any Registration Statement filed hereunder and, in any event, Holders shall suspend sales of Registrable
Exhibit K | Page 9
Securities pursuant to such Registration Statements during the pendency of the Grace Period provided, the Company shall (i) promptly notify the Holders in writing of the existence of material non-public information giving rise to a Grace Period or the need to file a post-effective amendment, as applicable, and the date on which such Grace Period will begin, (ii) use commercially reasonable best efforts to terminate a Grace Period as promptly as practicable provided that such termination is, in the good faith judgment of the Company, in the best interest of the Company and (iii) promptly notify the Holders in writing of the date on which the Grace Period ends; provided, further, that, with respect to a Required Registration Statement only, no single Grace Period shall exceed sixty (60) consecutive days, and during any three hundred sixty-five (365) day period, the aggregate of all Grace Periods shall not exceed an aggregate of one hundred twenty (120) days (each Grace Period complying with this provision being an “Allowable Grace Period”). For purposes of determining the length of a Grace Period, the Grace Period shall be deemed to begin on and include the date the Holders receive the notice referred to in clause (i) above and shall end on and include the later of the date the Holders receive the notice referred to in clause (iii) above and the date referred to in such notice; provided, that no Grace Period shall be longer than an Allowable Grace Period. Notwithstanding anything to the contrary, the Company shall use commercially reasonable best efforts to cause the Transfer Agent to deliver unlegended Shares to a transferee of a Holder in accordance with the terms of the Investment Agreement in connection with any sale of Registrable Securities with respect to which a Holder has entered into an irrevocable contract for sale prior to the Holder’s receipt of the notice of a Grace Period and for which the Holder has not yet settled.
(e) The Company shall use commercially reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.
(f) The Company shall, if requested by a Holder, furnish to such Holder, without charge, at least one (1) conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such Holder (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that the Company shall have no obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR filing system or successor system.
(g) The Company agrees to promptly deliver to each Holder whose Registrable Securities are included in the applicable Registration Statement, without charge, as many copies of each Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as such Persons may reasonably request. The Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of Registrable Securities covered by such Prospectus and any amendment or supplement thereto in each case in accordance with the intended method or methods of disposition thereof.
(h) The Company shall, prior to any resale of Registrable Securities by a Holder, use its commercially reasonable best efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any general tax in any such jurisdiction where it is not then so subject or file a consent to service of process in any such jurisdiction.
Exhibit K | Page 10
(i) The Company shall enter into such customary agreements (including an underwriting agreement in customary form) and take all such other actions reasonably requested by the Holders of a majority of the Registrable Securities being sold in connection therewith or by the managing underwriter(s), if any, in order to expedite or facilitate the disposition of such Registrable Securities. In connection with any such permitted underwritten offering of Registrable Securities, (i) the Company shall (A) make such representations and warranties to the selling Holders and the managing underwriter(s), if any, with respect to the business of the Company and its subsidiaries, and the Registration Statement, Prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made by issuers in underwritten offerings, and, if true, confirm the same if and when requested, (B) use its commercially reasonable best efforts to furnish opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriter(s), if any, addressed to each of the managing underwriter(s), if any, covering the matters customarily covered in opinions requested in underwritten offerings, (C) use its commercially reasonable best efforts to obtain “cold comfort” letters and updates thereof from the independent certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) who have certified the financial statements included in such Registration Statement, addressed to each of the managing underwriter(s), if any, such letters to be in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with underwritten offerings, (D) use its commercially reasonable best efforts to include within the underwriting agreement indemnification provisions and procedures customary in such underwritten offerings and (E) deliver such documents and certificates as may be reasonably requested by the Holders of a majority of the Registrable Securities being sold in connection therewith, their counsel and the managing underwriter(s), if any, to evidence the continued validity of the representations and warranties made pursuant to clause (A) above and to evidence compliance with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company, (ii) each Holder shall not, during such period (which period shall in no event exceed one hundred eighty (180) days, subject to any then customary “booster shot” extension (which extension shall not exceed thirty (30) days) following the effective date of any Registration Statement to the extent requested by any managing underwriter, sell, pledge, hypothecate, transfer, make any short sale of, loan, grant any option or right to purchase of, or otherwise transfer or dispose of (other than to donees who agree to be similarly bound) any Registrable Securities owned by it at any time during such period, except Registrable Securities included in such registration; provided that any release of Registrable Securities from such agreement shall be effected among the Holders on a pro rata basis according to the Registrable Securities then owned by them, and (iii) the Company shall use its commercially reasonable best efforts to cause each of its directors and senior executive officers to execute and deliver customary lockup agreements in such form and for such time period up to one hundred eighty (180) days (subject to any then customary “booster shot” extensions) following the effective date of any Registration Statement as may be requested by any managing underwriter. The above shall be done at each closing under such underwriting or similar agreement, or as and to the extent required thereunder.
(j) The Company shall make available for inspection by any Holder of Registrable Securities included in such Registration Statement, any underwriter participating in any disposition pursuant to such Registration Statement, and any attorney, accountant or other agent retained by any such Holder of Registrable Securities included in such Registration Statement or underwriter (collectively, the “Inspectors”), at the offices where normally kept, during reasonable business hours, all financial and other records, pertinent corporate documents and properties of the Company and its Subsidiaries other than confidential supervisory information within the meaning of 12 C.F.R. Part 261 (collectively, the “Records”), as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and use commercially reasonable best efforts to cause the Company’s officers, directors and employees to
Exhibit K | Page 11
supply all information reasonably requested by any such Inspector in connection with such Registration Statement; provided, however, that any Records that are not generally publicly available at the time of delivery of such Records shall be kept confidential by such Inspectors unless (i) the disclosure of such Records is necessary in the reasonable judgment of the Inspectors to avoid or correct a misstatement or omission in the Registration Statement, or (ii) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction; provided, further, that each Holder of Registrable Securities agrees that it will, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, give notice to the Company to the extent legally permitted and allow the Company, at its expense, to undertake appropriate action and to prevent disclosure of the Records deemed confidential.
(k) The Company shall, in the case of an underwritten offering, use its commercially reasonable best efforts to cause its officers to use their commercially reasonable best efforts to support the marketing of the Registrable Securities covered by the Registration Statement (including, without limitation, by participation in “road shows”) if requested by the managing underwriter(s) and taking into account the Company’s business needs.
(l) The Company shall reasonably cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free, to the extent permitted by the Investment Agreement and under law, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably request. Certificates for Registrable Securities free from all restrictive legends may be transmitted by the transfer agent to a Holder by crediting the account of such Holder’s prime broker with The Depository Trust Company as directed by such Holder.
(m) The Company shall following the occurrence of any event contemplated by Sections 5(c)(ii)-(iv), as promptly as reasonably practicable, as applicable: (i) use its commercially reasonable best efforts to prevent the issuance of any stop order or obtain its withdrawal at the earliest possible moment if the stop order has been issued, or (ii) taking into account the Company’s good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure of such event, prepare and file a supplement or amendment, including a post-effective amendment, to the affected Registration Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading.
(n) The Company may require each selling Holder to furnish to the Company a certified statement as to (i) the number of securities of the Company beneficially owned by such Holder and any Affiliate thereof, (ii) any Financial Industry Regulatory Authority (“FINRA”) affiliations, (iii) any natural persons who have the power to vote or dispose of the Common Stock and (iv) any other information as may be requested by the Commission, FINRA, any state securities commission or any other government or regulatory body with jurisdiction over the Company or its activities. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of Registrable Securities because any Holder fails to furnish such information within five (5) Trading Days of the Company’s request, any Liquidated Damages that are accruing at such time shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended, until such information is delivered to the Company.
Exhibit K | Page 12
(o) The Company shall cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder and the Company shall pay the filing fee required for the first such filing (but not additional filings) within two (2) Business Days of the request therefore.
(p) If the Company becomes eligible to use Form S-3 during the term of this Agreement, the Company shall use its commercially reasonable best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.
(q) If requested by a Holders Counsel, the Company shall (i) promptly incorporate in a Prospectus supplement or post-effective amendment to the Registration Statement such information as the Company reasonably agrees (upon advice of counsel) is required to be included therein and (ii) make all required filings of such Prospectus supplement or such post-effective amendment as soon as reasonably practicable after the Company has received notification of the matters to be incorporated in such Prospectus supplement or post-effective amendment.
The Company may require each Holder of Registrable Securities as to which any registration is being effected to furnish to the Company in writing such information required in connection with such registration regarding such Holder and the distribution of such Registrable Securities as the Company may, from time to time, reasonably request in writing and the Company may exclude from such registration the Registrable Securities of any Holder who fails to furnish such information within a reasonable time after receiving such request without incurring any liability to pay the Liquidated Damages.
6. Registration Expenses. All fees and expenses incident to the Company’s performance of or compliance with its obligations under this Agreement (excluding any underwriting discounts and selling commissions, stock transfer taxes and fees of counsel or other advisors for the Holders) shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence that are the Company’s responsibility shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (B) with respect to compliance with applicable state securities or Blue Sky laws (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities and determination of the eligibility of the Registrable Securities for investment under the laws of such jurisdictions as requested by the Holders) and (C) if not previously paid by the Company in connection with an issuer filing, with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by the Holders of a majority of the Registrable Securities included in the Registration Statement), (iii) messenger, telephone and delivery expenses of the Company, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder.
Exhibit K | Page 13
7. Indemnification.
(a) Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless each Holder and each of their respective officers, directors, agents, general partners, managing members, managers, Affiliates and employees, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, general partners, managing members, managers, agents and employees of such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable and documented attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act, Exchange Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, (A) that such untrue statements, alleged untrue statements, omissions or alleged omissions are based primarily upon information regarding such Holder furnished in writing to the Company by such Holder or on behalf of such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved by such Holder or Holders Counsel expressly for use in the Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto, (B) arising out of or based upon Holder’s failure to deliver or cause to be delivered the Prospectus or any amendment or supplement thereto made available by the Company in compliance with Section 8(f), or (C) in the case of an occurrence of an event of the type specified in Sections 5(c)(ii)-(iv), related to the use by a Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing or electronic mail that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated and defined in Section 8(g) below, but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an Indemnified Party (as defined in Section 7(c)) and shall survive the transfer of the Registrable Securities by the Holders.
(b) Indemnification by Holders. Each Holder shall, notwithstanding any termination of this Agreement, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (A) to the extent, but only to the extent, that such untrue statements or omissions are based primarily upon information regarding such Holder furnished in writing to the Company by or on behalf of such Holder expressly for use therein, or (B) to the extent, but only to the extent, that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved by such Holder or Holders Counsel expressly for use in a Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto or (C) in the case of an occurrence of an event of the type specified in Sections 5(c)(ii)- (iv), to the extent, but only to the extent, related to the use by such Holder of an outdated or defective
Exhibit K | Page 14
Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated in Section 8(g), but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected, or (ii) Holder’s failure to deliver or cause to be delivered the Prospectus or any amendment or supplement thereto made available by the Company in compliance with Section 8(f). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.
(c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of one (1) counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable and documented fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give such written notice within a reasonable time of commencement of any such Proceeding shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall have materially and adversely prejudiced the Indemnifying Party in its ability to defend such Proceeding.
An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Indemnified Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel in writing that a conflict of interest exists if the same counsel were to represent such Indemnified Party and the Indemnifying Party; provided, that the Indemnifying Party shall not be liable for the fees and expenses of more than one separate firm of attorneys (plus local counsel, if reasonably necessary) at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.
Subject to the terms of this Agreement, all documented fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section 7(c)) shall be paid to the Indemnified Party, as incurred, within twenty (20) Trading Days of written notice thereof to the Indemnifying Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally judicially determined to not be entitled to indemnification hereunder.
(d) Contribution. If a claim for indemnification under Section 7(a) or 7(b) is unavailable to an Indemnified Party (other than in accordance with its terms) or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party, on the one hand, and Indemnified Party, on the other hand, in connection with the actions, statements or
Exhibit K | Page 15
omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party, on the one hand, and Indemnified Party, on the other hand, shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section 7(d) was available to such party in accordance with its terms. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 7(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 7(d), no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
The indemnity and contribution agreements contained in this Section 7 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation of the indemnification provisions under the Investment Agreement.
8. Miscellaneous.
(a) Remedies. In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate.
(b) Prohibition on Other Registrations. The Company agrees not to effect or initiate a registration statement for any public sale or distribution of any securities similar to those being registered pursuant to this Agreement, or any securities convertible into or exchangeable or exercisable for such securities (other than a registration (i) pursuant to a registration statement on Form S-8 (or other registration solely relating to an offering or sale of securities pursuant to any employee stock plan or other employee benefit arrangement), (ii) pursuant to a registration statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145), or (iii) in connection with any dividend or distribution reinvestment or similar plan), during the fourteen (14) calendar days prior to, and during the sixty (60) calendar-day period beginning on, the effective date of any Registration Statement in which the Holders of Registrable Securities are participating (except as part of any such registration, if permitted).
Exhibit K | Page 16
(c) Rule 144 Requirements. For so long as the Company is subject to the reporting requirements of the Exchange Act, the Company will use its commercially reasonable best efforts to timely file with the Commission such reports and information required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the Commission thereunder and as the Commission may require. The Company shall furnish to any Holder of Registrable Securities forthwith upon request a written statement as to its compliance with the reporting requirements of Rule 144 (or any successor exemptive rule), the Securities Act and the Exchange Act (at any time that it is subject to such reporting requirements); a copy of its most recent annual or quarterly report unless otherwise available through the Commission’s EDGAR filing system; and such other reports and documents as such Person may reasonably request unless otherwise available through the Commission’s EDGAR filing system in availing itself of any rule or regulation of the Commission allowing it to sell any such securities without registration.
(d) Obligations of Holders and Others in a Registration. Each Holder agrees to timely furnish in writing such information regarding such Person, the securities sought to be registered and the intended method of disposition of the Registrable Securities held by it, as shall reasonably be required to effect the registration of such Registrable Securities (the “Requested Information”) and shall take such other action as the Company may reasonably request in connection with the registration, qualification or compliance or as otherwise provided herein. At least ten (10) Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each holder of the information the Company requires from such Holder if such Holder elects to have any of such Holder’s Registrable Securities included in the Registration Statement. If at least five (5) Business Days prior to the filing date, the Company has not received the Requested Information from a Holder (a “Non-Responsive Holder”), then the Company may exclude from any Registration Statement the Registrable Securities of such Non-Responsive Holder.
(e) Rule 144A. The Company agrees that, upon the written request of any Holder of Registrable Securities or any prospective purchaser of Registrable Securities designated by a Holder, the Company shall promptly provide (but in any case within fifteen (15) calendar days of a request) to such Holder or potential purchaser, the following information:
(i) a brief statement of the nature of the business of the Company and any subsidiaries and the products and services they offer;
(ii) the most recent consolidated balance sheets and profit and losses and retained earnings statements, and similar financial statements of the Company for the two (2) most recent fiscal years (such financial information shall be audited, to the extent reasonably available); and
(iii) such other information about the Company, any subsidiaries, and their business, financial condition and results of operations as the requesting Holder or purchaser of such Registrable Securities shall reasonably request in order to comply with Rule 144A, as amended, and in connection therewith the anti-fraud provisions of the federal and state securities laws.
The Company hereby represents and warrants to any such requesting Holder and any prospective purchaser of Registrable Securities from such Holder that the information provided by the Company pursuant to this Section 8(e) will, as of their dates, not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading.
(f) Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration Statement and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration Statement.
Exhibit K | Page 17
(g) Limitations on Subsequent Registration Rights. The Company will not enter into any agreements with any holder or prospective holder of any securities of the Company which would grant such holder or prospective holder registration rights with respect to the securities of the Company which would have priority over the Registrable Securities with respect to the inclusion of such securities in any registration. If the Company enters into an agreement that contains terms more favorable, in form or substance, to any shareholders than the terms provided to the Holders under this Agreement, then the Company will modify or revise the terms of this Agreement in order to reflect any such more favorable terms for the benefit of the Holders.
(h) Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Sections 5(c)(ii)-(iv), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company may provide appropriate stop orders to enforce the provisions of this paragraph.
(i) No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date hereof, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.
(j) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders of a majority of the then outstanding Registrable Securities; provided that any such amendment, modification, supplement or waiver that materially, adversely and disproportionately effects the rights or obligations of any Holder vis-a-vis the other Holders shall require the prior written consent of such Holder.
(k) Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via e-mail (provided the sender does not receive a machine generated message that such e-mail transmission was not or could not be delivered) at the e-mail address specified in this Section prior to 5:00 p.m., New York City time, on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in this Section on a day that is not a Trading Day or later than 5:00 p.m., New York City time, on any Trading Day, (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows:
| If to the Company: | Third Coast Bancshares, Inc. | |||
| 20202 Highway 59 North, Suite 190 | ||||
| Humble, Texas 77338 | ||||
| Attention: R. John McWhorter, Chief Financial Officer | ||||
| Email: jmcwhorter@tcbssb.com |
Exhibit K | Page 18
| With a copy to (which copy alone shall not constitute notice): | ||||
|
|
Norton Rose Fulbright US LLP 2200 Ross Avenue, Suite 3600 Dallas, Texas 75201-7932 | |||
| Attention: Michael G. Keeley, Esq. Email: mike.keeley@nortonrosefulbright.com | ||||
If to a Registration Rights Purchaser:
To the address set forth under such Registration Rights Purchaser’s name on the signature page hereof or such other address as may be designated in writing hereafter, in the same manner, by such Person.
(l) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign its rights (except by merger or in connection with another entity acquiring all or substantially all of the Company’s assets) or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. The rights to have the Company register Registrable Securities pursuant to this Agreement shall be automatically assigned by any Registration Rights Purchaser to any transferee of the Shares only if: (i) the Registration Rights Purchaser agrees in writing with the transferee or assignee to assign such rights; (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (A) the name and address of such transferee or assignee and (B) the securities with respect to which such registration rights are being transferred or assigned; and (iii) at or before the time the Company received the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein with respect to a Holder or Registration Rights Purchaser. In the event of any delay in filing or effectiveness of the Registration Statement as a result of such assignment by a Registration Rights Purchaser or its transferee, the Company shall not be liable for any damages arising from such delay.
(m) Execution and Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such “.pdf” signature were the original thereof.
(n) Governing Law and Jurisdiction. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts made and to be performed entirely within such State. The parties hereby agree that all actions or proceedings arising out of or related to this Agreement shall be subject to the exclusive jurisdiction of the state and federal courts in the State of Delaware. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Investment Agreement.
Exhibit K | Page 19
(o) Cumulative Remedies. Except as provided in Section 2(c) with respect to Liquidated Damages, the remedies provided herein are cumulative and not exclusive of any other remedies provided by law.
(p) Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their good faith reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.
(q) Headings. The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning hereof.
(r) Independent Nature of Registration Rights Purchasers’ Obligations and Rights. The obligations of each Registration Rights Purchaser under this Agreement are several and not joint with the obligations of any other Registration Rights Purchaser hereunder, and no Registration Rights Purchaser shall be responsible in any way for the performance of the obligations of any other Registration Rights Purchaser hereunder. The decision of each Registration Rights Purchaser to purchase the Shares pursuant to the Investment Agreement has been made independently of any other Registration Rights Purchaser. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Registration Rights Purchaser pursuant hereto or thereto, shall be deemed to constitute the Registration Rights Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Registration Rights Purchasers are in any way acting in concert with respect to such obligations or the transactions contemplated by this Agreement. Each Registration Rights Purchaser acknowledges that no other Registration Rights Purchaser has acted as agent for such Registration Rights Purchaser in connection with making its investment hereunder and that no Registration Rights Purchaser will be acting as agent of such Registration Rights Purchaser in connection with monitoring its investment in the Shares or enforcing its rights under the Investment Agreement. Each Registration Rights Purchaser shall be entitled to protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Registration Rights Purchaser to be joined as an additional party in any Proceeding for such purpose. The Company acknowledges that each of the Registration Rights Purchasers has been provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Registration Rights Purchasers and not because it was required or requested to do so by any Registration Rights Purchaser. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Registration Rights Purchaser, solely, and not between the Company and the Registration Rights Purchasers collectively and not between and among the Registration Rights Purchasers.
(s) Entire Agreement. This Agreement and the Investment Agreement (and the other Transaction Documents) constitute the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous arrangements or undertakings with respect thereto. There are no restrictions, promises, warranties or undertakings, other than as set forth or referred to herein and in the Investment Agreement (and the other Transaction Documents).
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Exhibit K | Page 20
IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.
| THIRD COAST BANCSHARES, INC. | ||
| By: |
| |
| Name:[________] | ||
| Title: [________] | ||
IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.
| NAME OF INVESTING ENTITY | ||
|
| ||
| AUTHORIZED SIGNATORY | ||
| By: |
| |
| Name: | ||
| Title: | ||
| ADDRESS FOR NOTICE | ||
| c/o: |
| |
| Street: |
| |
| City/State/Zip: | ||
| Attention: |
| |
| Tel: |
| |
| Fax: |
| |
| E-mail: |
| |
Exhibit 10.3
EXHIBIT D
FORM OF VOTING AGREEMENT
This Voting Agreement (this “Agreement”), dated as of September 8, 2022, is by and among the shareholders listed on the signature page hereto (each, a “Shareholder” and, collectively, the “Shareholders”) and each of the purchasers listed on the signature page hereto (each, an “Investor” and, collectively, the “Investors”).
WHEREAS, simultaneously with the execution of this Agreement, Third Coast Bancshares, Inc., a Texas corporation (the “Company”), and the Investors are entering into an Investment Agreement (the “Investment Agreement”), dated as the date hereof, providing, among other things, for the purchase by the Investors from the Company of shares of Series A Preferred Stock;
WHEREAS, the Board of Directors of the Company has approved the Investment Agreement and the transactions contemplated thereby; and
WHEREAS, as a condition and inducement to the Investors’ willingness to enter into the Investment Agreement, the Investors have required that the Shareholders enter into this Agreement.
NOW THEREFORE, in consideration of the foregoing and the mutual premises, representations, warranties, covenants and agreements contained herein and in the Investment Agreement, the parties hereto, intending to be legally bound, hereby agree as follows:
1. Certain Definitions.
(a) For purposes of this Agreement, all capitalized terms used but not otherwise defined herein shall have the respective meanings given to such terms in the Investment Agreement.
(b) For purposes of this Agreement, “beneficially own” or “beneficial ownership” with respect to any securities shall mean having “beneficial ownership” of such securities (as determined pursuant to Rule 13d-3 under the Exchange Act).
(c) For purposes of this Agreement, the following terms shall have the following meanings:
“Company Common Stock” means the Company’s common stock, par value $1.00 per share.
“Shareholder’s Subject Shares” shall mean, with respect to a particular Shareholder, all shares of Company Common Stock beneficially owned by such Shareholder as of the date hereof and as set forth opposite such Shareholder’s name on the schedule attached hereto as Exhibit 1 and any and all such other shares of Company Common Stock acquired or otherwise beneficially owned from time to time by such Shareholder after the date of this Agreement.
EXHIBIT D-1
2. Representations, Warranties and Covenants of Shareholder. Each Shareholder hereby severally, but not jointly, represents and warrants to the Investors as follows:
(a) Title. Set forth opposite such Shareholder’s name on Exhibit 1 hereto is a true and complete list of all of the shares of Company Common Stock of which such Shareholder is the record or beneficial owner as of the date hereof. Except as set forth on Exhibit 1, as of the date hereof, such Shareholder is the sole record or beneficial owner of such Shareholder’s Subject Shares, and such Shareholder is the lawful owner of such Shareholder’s Subject Shares.
(b) Right to Vote. Except as set forth on Exhibit 1, such Shareholder has, with respect to all such Shareholder’s Subject Shares, sole voting power and sole power to issue instructions with respect to the matters set forth in Section 3, in each case with no limitations, qualifications or restrictions on such rights other than (i) pursuant to the terms of this Agreement and (ii) restrictions under applicable securities laws.
(c) Authority. Such Shareholder has the requisite power and authority to execute and deliver, and to perform such Shareholder’s obligations under, this Agreement. This Agreement has been duly and validly executed and delivered by such Shareholder, and, assuming due authorization, execution and delivery by each Investor, constitutes a valid and binding agreement of such Shareholder enforceable against such Shareholder in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to general principles of equity, including principles of good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).
(d) Conflicting Instruments. Neither the execution and delivery of this Agreement nor the performance by such Shareholder of such Shareholder’s agreements and obligations hereunder will result in any breach or violation of, or be in conflict with or constitute a default under, any term of any contract, agreement, voting agreement, stockholders’ agreement, trust agreement, voting trust, proxy, power of attorney, pooling arrangement, note, mortgage, indenture, instrument, arrangement or other obligation or restriction of any kind to which the Shareholder is a party or to or by which the Shareholder or the Shareholder’s Subject Shares are subject or bound.
3. Representations, Warranties and Covenants of Investor. Each Investor hereto, severally, but not jointly, represents and warrants to the Shareholders that (a) the execution, delivery and performance by Investor of this Agreement and the consummation by Investor of the transactions contemplated hereby are within the powers of the Investor and have been duly authorized by all necessary action and (b) Investor has duly executed and delivered this Agreement, and, assuming the due authorization, execution and delivery by each Shareholder, this Agreement constitutes Investor’s legal, valid and binding obligation, enforceable against it in accordance with its terms.
EXHIBIT D-2
4. Agreements.
(a) While this Agreement is in effect, the Shareholder agrees to vote (or cause to be voted) all of the Shareholder’s Subject Shares in favor of (i) any proposal to approve the issuance of Company Common Stock upon the conversion of the Series A Preferred Stock and (ii) any proposal to approve the Non-Voting Common Stock Certificate of Amendment (clause (i) and (ii) referred to as the “Shareholder Proposals”).
(b) While this Agreement is in effect, each Shareholder agrees not to sell, transfer, or otherwise dispose of any shares of Company Common Stock until after the conclusion of the shareholder vote on the matters contemplated by Section 6(g) of the Investment Agreement, exclusive of (i) pursuant to a transfer where the transferee has agreed in writing to abide by the terms of this Agreement in a form reasonably satisfactory to the Investors, (ii) dispositions of shares in connection with the exercise of stock options and warrants in order to pay the exercise price thereof or to satisfy tax withholding obligations in connection with the exercise of stock options or the vesting of equity awards, (iii) transfers for estate and tax planning purposes, including transfers to charitable organizations and transfers to any member of the Shareholder’s family, or to a trust or other entity for the benefit of one or more of the foregoing persons, provided that the transferee agrees in writing to be bound by the terms of this Agreement, (iv) pursuant to a qualified domestic order, or (v) by will or under the laws of intestacy upon the death of the Shareholder. Notwithstanding the foregoing, a Shareholder shall be permitted to transfer up to 5% of the Shareholder’s Subject Shares held by such Shareholder in the aggregate without complying with the foregoing provisions.
5. Fiduciary Duties of Directors. Each Shareholder that is a director or officer of the Company or its Affiliates is entering into this Agreement in his or her capacity as the record or beneficial owner of the Shareholder’s Subject Shares, and not in his or her capacity as a director or officer of the Company. Nothing in this Agreement shall be deemed in any manner to limit the Shareholder from complying with his or her fiduciary duties or other legal obligations while acting in such capacity as a director or officer of the Company or its Affiliates or otherwise limit the discretion of any such Shareholder to take any action, or fail to take any action, in his or her capacity as a director or officer of the Company or its Affiliates.
6. Miscellaneous.
(a) Entire Agreement. This Agreement (including Exhibit 1 hereto) embodies the entire agreement and understanding between the parties hereto in respect of the subject matter contained herein. This Agreement supersedes all prior written and prior or contemporaneous oral agreements and understandings between the parties with respect to the subject matter of this Agreement.
(b) Invalid Provisions. If any provision of this Agreement or the application thereof to any person (including the officers and directors parties hereto) or circumstances is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to persons or circumstances other than those as to which it has been held invalid or unenforceable, shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties.
EXHIBIT D-3
(c) Counterparts and Facsimiles. For the convenience of the parties hereto, this Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original instrument, and all such counterparts will together constitute the same agreement. Executed signature pages to this Agreement may be delivered by facsimile and such facsimiles will be deemed as sufficient as if actual signature pages had been delivered.
(d) Specific Performance. The Shareholder agrees that, in the event of his, her or its breach of any of the terms of this Agreement, Investors shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which Investors may be entitled at law or in equity; provided, however, that CCCP VIII and any Affiliates thereof shall have no right to enforce against any Shareholder any provision of this Agreement that would result in CCCP VIII (or its Affiliates) being deemed to control the shares of another Shareholder within the meaning of the BHC Act and the implementing regulations thereto (12 C.F.R. § 225.9(b)) (“Regulation Y”), including, but not limited to, such provisions as may require a Shareholder to vote for or against any matter, or that restrict or condition the ability of a Shareholder to transfer its shares, to the extent not excepted under the BHC Act and Regulation Y.
(e) Amendments; Termination.
(i) This Agreement may not be modified, amended, altered or supplemented, except that this Agreement may be modified, amended, altered or supplemented, as between the Investors and any particular Shareholder, upon the execution and delivery of a written agreement executed by the Investors and such Shareholder.
(ii) The provisions of this Agreement shall automatically terminate and be of no further force or effect upon the mutual agreement of the Investors and Shareholders in writing or the earliest to occur of (A) receipt of the Shareholder Approval or (B) the termination of the Investment Agreement in accordance with its terms.
(f) Governing Law. This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of Texas, without giving effect to conflicts of law principles or other principles that would require the application of any other law.
(g) Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective legal successors (including, in the case of each Shareholder, any executors, administrators, estates, legal representatives and heirs of such Shareholder) and permitted assigns; provided, that, except as otherwise provided in this Agreement, no party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement.
EXHIBIT D-4
(h) Notices. All notices, communications and deliveries required or permitted by this Agreement shall be made in writing signed by the party making the same, shall specify the Section of this Agreement pursuant to which it is given or being made and shall be deemed given or made (i) on the date delivered if delivered by telecopy, electronic mail or in person, (ii) on the third (3rd) Business Day after it is mailed if mailed by registered or certified mail (return receipt requested) (with postage and other fees prepaid) or (iii) on the day after it is delivered, prepaid, to an overnight express delivery service that confirms to the sender delivery on such day, as follows:
(i) if to a Shareholder, at the address of such Shareholder set forth on Exhibit 1 attached hereto or at such other address that such Shareholder may have provided in writing to the Investor; and
(ii) if to an Investor, to the address on the signature page to the Investment Agreement, with copies (which copy alone shall not constitute notice) as set forth therein.
(i) Individual Obligations. Each party’s obligations under this Agreement are individual and not joint or several obligations and no Shareholder shall have any liability to any Investor for the performance or non-performance by any other Shareholder under this Agreement, and no Investor shall have any liability to any Shareholder for the performance or non-performance by any other Investor under this Agreement.
(j) No Investor Rights. Nothing in this Agreement shall be construed to give any Investor any rights to exercise or direct the exercise of voting power as owner of the Shareholder’s Subject Shares or to vest in any Investor any direct or indirect ownership or incidents of ownership of or with respect to any of the Shareholder’s Subject Shares, except as otherwise expressly provided herein. All rights, ownership and economic benefits of and relating to the Shareholder’s Subject Shares shall remain vested in and belong to the Shareholder, notwithstanding the provisions of this Agreement, and no Investor shall have any authority to exercise any power or authority to direct the Shareholder in voting any of the Shareholder’s Subject Shares, except as otherwise expressly provided herein.
(k) The Shareholder hereby authorizes the Investors and the Company to publish and disclose in any announcement or disclosure required by any regulatory or governmental authority and in the proxy statement for the meeting of Shareholders of the Company called to consider and vote on the Shareholder Proposals the Shareholder’s identity and ownership of the Shareholder’s Subject Shares and the nature of the Shareholder’s obligations under this Agreement.
[Signature Pages Follow]
EXHIBIT D-5
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.
| INVESTOR: | ||
| [Name of Investor] | ||
| By: |
| |
| Name: |
| |
| Title: |
| |
[Signature Page to Voting Agreement]
| SHAREHOLDERS: | ||
| [Names of Shareholders] | ||
| By: |
| |
| Name: |
| |
| Title: |
| |
[Signature Page to Voting Agreement]
EXHIBIT 1
| Name of Shareholder |
Number of Shares of Company Common Stock |
Notice Information | ||
| Carolyn Bailey | 7,600 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Dr. Martin Basaldua | 95,090 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Dennis Bonnen | 143,503 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| W. Donald Brunson | 50,792 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Bart O. Caraway | 271,849 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Audrey Duncan | 25,869 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Norma J. Galloway | 7,000 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Troy A. Glander | 38,813 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Shelton J. McDonald | 5,000 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| R. John McWhorter | 223,275 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Joseph L. Stunja | 146,774 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
| Reagan Swinbank | 60,914 | 20202 Highway 59 North, Suite 190 Humble, Texas 77338
Phone: (281) 446-7000 | ||
Exhibit 10.4
EXHIBIT L
FORM OF LETTER AGREEMENT
THIRD COAST BANCSHARES, INC.
20202 HIGHWAY 59 NORTH, SUITE 190
HUMBLE, TX 77338
[•], 2022
Castle Creek Capital Partners VIII, L.P.
11682 El Camino Real, Suite 320
San Diego, CA 92130
Dear Sir/Madam:
Reference is made to the Investment Agreement by and among Third Coast Bancshares, Inc., a Texas corporation (the “Company”), and the investors name therein, including, without limitation, Castle Creek Capital Partners VIII, L.P., a Delaware limited partnership (the “Lead Investor”), dated as of September 8, 2022 (the “Agreement”). Capitalized terms used herein without definition shall have the respective meanings in the Agreement.
In recognition of the Lead Investor’s purchase of $30 million of the Series A Preferred Stock pursuant to the Agreement and its role in the offer and sale of the Series A Preferred Stock, the Company and the Lead Investor hereby agree to the matters set forth in this letter agreement.
1. Covenants. Without limiting the terms of Section 6 of the Agreement as applicable to the Lead Investor, the Company and the Lead Investor hereby agree, as follows:
(a) Access, Information and Confidentiality. So long as the Lead Investor, together with its Affiliates, in the aggregate owns 4.9% or more of all of the outstanding shares of Common Stock (provided that, in making such calculation, all shares of Common Stock into or for which shares of any securities owned by the Lead Investor are directly or indirectly convertible or exercisable, which, for the avoidance of doubt, shall include those shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock, Series B Preferred Stock, the Non-Voting Common Stock and/or the exercise of the Warrants, shall be included in both the numerator and denominator, and all Common Stock issued by the Company after the Closing Date shall be included in the denominator except for any shares of Common Stock issued in an offering in which the Lead Investor (or a permitted assignee under Section 4) was not offered the right to purchase its pro rata portion of such Common Stock in violation of Section 1(d)) (the “Qualifying Ownership Interest”), and subject to the confidentiality provision of Section 6(c) of the Agreement, the Company will (i) permit the Lead Investor to visit and inspect, at the Lead Investor’s expense, the properties of the Company and Company Subsidiaries, to examine the corporate books and to discuss the affairs, finances and accounts of the Company and Company Subsidiaries with personnel of the Company, all upon reasonable notice and at such reasonable times and as often as the Lead Investor may reasonably request, and (ii) make appropriate officers of the Company and Company Subsidiaries available periodically and at such times as reasonably requested by the Lead Investor for consultation with the Lead Investor or its designated
EXHIBIT L-1
representative with respect to matters relating to the business and affairs of the Company and Company Subsidiaries. Any investigation pursuant to this Section 1(a) shall be conducted during normal business hours and in such manner as not to interfere unreasonably with the conduct of the business of the Company, and nothing herein shall require the Company or any Company Subsidiary to disclose any information to the extent (x) prohibited by applicable law or regulation, (y) that the Company reasonably believes to be competitively sensitive proprietary information (except to the extent the Lead Investor provides assurances reasonably acceptable to the Company that such information shall not be used by such the Lead Investor or its Affiliates to compete with the Company and Company Subsidiaries), or (z) that such disclosure would reasonably be expected to cause a loss of attorney-client privilege to the Company or any Company Subsidiary (provided, that, the Company shall use commercially reasonable efforts to make appropriate substitute disclosure arrangements under circumstances where the restrictions in this clause (a) apply). In addition to the Lead Investor’s rights pursuant to Section 2 of this letter agreement and subject to the foregoing limitations, the Lead Investor shall have the right to receive all materials delivered to the Board of Directors and all committees thereof (other than matters pertaining to the Lead Investor or which would constitute confidential supervisory information within the meaning of 12 C.F.R. Part 261) as long as the Lead Investor is entitled to a Board Representative or Observer in accordance with Section 2 of this letter agreement.
(b) No Senior Preferred. So long as the Lead Investor continues to hold a Qualifying Ownership Interest, the Company shall not issue any shares or equity securities that rank, with respect to dividend rights and rights on liquidation, winding up and dissolution of the Company, senior to the Series A Preferred Stock or Series B Preferred Stock, as applicable, without the prior written consent of the Lead Investor, which consent shall not be unreasonably withheld, conditioned or delayed; provided, however, that no such consent shall be required to the extent that the Company or the Bank is required in its reasonable judgment to raise additional capital to maintain regulatory capital compliance.
(c) No Rights Agreement. So long as the Lead Investor continues to hold a Qualifying Ownership Interest, the Company shall not enter into any poison pill agreement, shareholders’ rights plan or similar agreement that shall limit the rights of the Lead Investor and its Affiliates and associates to hold any shares of Series A Preferred Stock, Series B Preferred Stock, Non-Voting Common Stock or Common Stock or Warrants or acquire additional securities of the Company unless such poison pill agreement, shareholders’ rights plan or similar agreement grants an exemption or waiver to the Lead Investor and its Affiliates and associates and any group in which the Lead Investor may become a member, immediately effective upon execution of such plan or agreement, that would allow the Lead Investor and its Affiliates and associates to acquire such additional securities of the Company.
(d) Gross-Up Rights.
(i) Sale of New Securities. So long as the Lead Investor maintains a Qualifying Ownership Interest, if the Company makes any public or nonpublic offering or sale of any equity (including Common Stock, Preferred Stock or restricted stock), or any securities, options or debt that is convertible or exchangeable into equity or that includes an equity component (such as an “equity kicker”) (including any hybrid security) (any such security, a “New Security”) (other than (A) any Common Stock, Non-Voting Common Stock, Series A Preferred Stock, Series B Preferred Stock or other securities issuable upon the exercise or conversion of any securities of the Company issued or agreed or contemplated (and disclosed to the Lead Investor in writing) to
EXHIBIT L-2
be issued as of the date of the Agreement; (B) pursuant to the granting or exercise of employee stock options, restricted stock or other stock incentives or awards pursuant to the Company’s stock incentive plans approved by the Board of Directors or the issuance of stock pursuant to the Company’s employee stock purchase plan approved by the Board of Directors or similar plan where stock is being issued or offered to a trust, other entity or otherwise, for the benefit of any employees, officers or directors of the Company, in each case in the ordinary course of providing incentive compensation; (C) issuances of capital stock as full or partial consideration for a merger, acquisition, joint venture, strategic alliance, license agreement or other similar nonfinancing transaction; (D) issuances of Common Stock upon exercise of warrants outstanding as of the date of the Agreement; (E) issuances of any securities issued as a result of a stock split, stock dividend, reclassification or reorganization or similar event, but solely to the extent such issuance is made to all holders of Common Stock); or (F) issuances of Series A Preferred Stock to other investors as part of the offering contemplated by the Agreement), then the Lead Investor shall be afforded the opportunity (provided, in the case of an offering that is not a registered public offering, that the Lead Investor satisfied any applicable “accredited investor” requirements applicable to such offering) to acquire from the Company for the same price (net of any underwriting discounts or sales commissions) and on the same terms as such securities are proposed to be offered to others, up to the amount of New Securities in the aggregate required to enable it to maintain its proportionate Common Stock equivalent interest in the Company immediately prior to any such issuance of New Securities. The amount of New Securities that the Lead Investor shall be entitled to purchase in the aggregate shall be determined by multiplying (x) the total number or principal amount of such offered New Securities by (y) a fraction, the numerator of which is the total number of shares of Common Stock and Non-Voting Common Stock then held by the Lead Investor (counting for such purposes all shares of Common Stock and Non-Voting Common Stock into or for which any securities owned by the Lead Investor (including the Warrants owned by the Lead Investor) are directly or indirectly convertible or exercisable, if any, and assuming full conversion of the Series A Preferred Stock and Series B Preferred Stock) and the denominator of which is the total number of shares of Common Stock then outstanding (counting for such purposes all shares of Common Stock and Non-Voting Common Stock into or for which any securities owned by the Lead Investor (including the Warrants owned by the Lead Investor) are directly or indirectly convertible or exercisable, and assuming full conversion of the Series A Preferred Stock and Series B Preferred Stock). Notwithstanding anything herein to the contrary, in no event shall the Lead Investor have the right to purchase New Securities hereunder to the extent such purchase would result in the Lead Investor, together with any other person whose Series A Preferred Stock and Warrants would be aggregated with the Lead Investor’s Series A Preferred Stock and Warrants for purposes of any bank regulation or law, to collectively be deemed to own, control or have the power to vote securities which (assuming, for this purpose only, full conversion and/or exercise of such securities by the Lead Investor) would represent more than 9.9% of a class of the Voting Securities or more than 33.3% of the Company’s total equity outstanding (as defined in 12 C.F.R. § 225.2 and 12 C.F.R. § 225.34, respectively); provided that the Company shall permit the Lead Investor to purchase Series B Preferred Stock or Non-Voting Common Stock to the extent that such limitation applies.
EXHIBIT L-3
(ii) Notice. In the event the Company proposes to offer or sell New Securities (the “Offering”), it shall give the Lead Investor written notice of its intention, describing the price (or range of prices), anticipated amount of New Securities, timing and other terms upon which the Company proposes to offer the same (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering), no later than ten (10) Business Days, as the case may be, after the initial filing of a registration statement with the Commission with respect to an underwritten public Offering or after the commencement of marketing with respect to a Rule 144A Offering or an Offering pursuant to Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder. If the information contained in the notice constitutes material non-public information (as defined under the applicable securities laws), the Company shall deliver such notice only to such individuals designated by the Lead Investor, and shall not communicate the information to anyone else acting on behalf of the Lead Investor without the consent of one of the designated individuals. The Lead Investor shall have ten (10) Business Days from the date of receipt of such a notice (the “Response Period”) to notify the Company in writing that it intends to exercise its rights provided in this Section 1(d) and as to the amount of New Securities the Lead Investor desires to purchase, up to the maximum amount calculated pursuant to this Section 1(d). Such notice shall constitute a nonbinding indication of interest of the Lead Investor to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s notice to it. The failure of the Lead Investor to respond within the Response Period shall be deemed to be a waiver of the Lead Investor’s rights under this Section 1(d) with respect to the Offering described in the applicable notice, which Offering shall, for purposes of this Section 1(d)(ii), still be deemed to be the same Offering even if, following the date of delivery of the notice to the Lead Investor required under the terms of this Section 1(d), changes are made to the terms of such Offering, so long as such changes do not (x) decrease the purchase price of any New Securities, (y) increase the amount or number of New Securities subject to the terms of the Offering other than pursuant to Rule 430A under the Securities Act, or (z) enlarge, enhance or increase the rights or privileges to be granted to the holders of the New Securities in any material or meaningful manner.
(iii) Purchase Mechanism. If the Lead Investor exercises its rights provided in this Section 1(d), the closing of the purchase of the New Securities in connection with the closing of the Offering with respect to which such right has been exercised shall take place within 90 calendar days after the giving of notice of such exercise, which period of time shall be extended for a maximum of 180 days in order to comply with applicable laws and regulations (including receipt of any applicable regulatory or shareholder approvals) and to satisfy any third party consent and approval requirements, including those of any securities exchange. Notwithstanding anything to the contrary herein, the closing of the purchase of the New Securities by the Lead Investor will occur no earlier than the closing of the Offering triggering the right being exercised by the Lead Investor. Each of the Company and the Lead Investor agrees to use its commercially reasonable efforts to secure any regulatory or shareholder approvals or other consents, and to comply with any law or regulation necessary in connection with the offer, sale and purchase of, such New Securities.
(iv) Failure of Purchase. In the event the Lead Investor fails to exercise its rights provided in this Section 1(d) within the Response Period or, if so exercised, the Lead Investor is unable to consummate such purchase within the time period specified in Section 1(d)(iii) above because of its failure to obtain any required regulatory or shareholder consent or approval, the Company shall thereafter be entitled (during the period of 90 days following the conclusion of the applicable period in Section 1(d)(iii)) to sell or enter into an agreement (pursuant to which the sale of the New Securities covered thereby shall be
EXHIBIT L-4
consummated, if at all, within 90 days from the date of said agreement) to sell the New Securities not purchased pursuant to this Section 1(d) by the Lead Investor or which the Lead Investor is unable to purchase because of such failure to obtain any such consent or approval, at a price and upon terms no more favorable in the aggregate to the purchasers of such New Securities than were specified in the Company’s notice to the Lead Investor. Notwithstanding the foregoing, if such sale is subject to the receipt of any regulatory or shareholder approval or consent or the expiration of any waiting period, the time period during which such sale may be consummated shall be extended until the expiration of five (5) Business Days after all such approvals or consents have been obtained or waiting periods expired, but in no event shall such time period exceed 180 days from the date of the applicable agreement with respect to such sale. In the event the Company has not sold the New Securities or entered into an agreement to sell the New Securities within said 90-day period (or sold and issued New Securities in accordance with the foregoing within 90 days from the date of said agreement (as such period may be extended in the manner described above for a period not to exceed 180 days from the date of said agreement)), the Company shall not thereafter offer, issue or sell such New Securities without first offering such New Securities to the Lead Investor in the manner provided above.
(v) Expedited Issuance; Regulatory Directive. Notwithstanding the foregoing provisions of this Section 1(d), if a majority of the directors of the Board of Directors determines that the Company must issue equity or debt securities on an expedited basis, then the Company may consummate the proposed issuance or sale of such securities (“Expedited Issuance”) and then comply with the provisions of this Section 1(d) provided that (A) the purchaser(s) of such New Securities has consented in writing to the issuance of additional New Securities in accordance with the provisions of this Section 1(d)(v), and (B) the sale of any such additional New Securities under this Section 1(d)(v) to the Lead Investor shall be consummated as promptly as is practicable but in any event no later than 90 days subsequent to the date on which the Company consummates the Expedited Issuance under this Section 1(d)(v). Notwithstanding anything to the contrary herein, the provisions of this Section 1(d)(v) (other than as provided in subclause (B) of this Section 1(d)(v)) shall not be applicable and the consent of the purchasers of such New Securities shall not be required in connection with any Expedited Issuance undertaken at the written direction of the applicable federal regulator of the Company or the Bank. Notwithstanding anything to the contrary in this letter agreement, no rights of the Lead Investor under this letter agreement will be adversely affected solely as the result of the temporary dilution of its percentage ownership of Common Stock due to an Expedited Issuance under this Section 1(d)(v); provided, however, that such rights may be adversely affected from and after such time, if any, that the Lead Investor declines to purchase Common Stock offered to the Lead Investor under this Section 1(d).
(vi) Non-Cash Consideration. In the case of the offering of securities for a consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as reasonably determined by the Board of Directors.
(vii) Cooperation. The Company and the Lead Investor shall cooperate in good faith to facilitate the exercise of the Lead Investor’s rights under this Section 1(d), including to secure any required approvals or consents.
EXHIBIT L-5
(viii) Assignment of Rights. The rights of the Lead Investor described in this Section 1(d) shall be subject to the transfer, assignment and/or conveyance of said rights from the Lead Investor to any other person and/or entity that acquires Series A Preferred Stock and Warrants from the Lead Investor or any of its Affiliates, but only if such transferee agrees in writing for the benefit of the Company to be bound by the terms of this letter agreement to the same extent as the Lead Investor (with a copy thereof to be furnished to the Company (any such transferee shall be included in the term “Lead Investor”)).
2. Governance Matters.
(a) So long as the Lead Investor maintains a Qualifying Ownership Interest, and only during such time as the Lead Investor reasonably determines that it would not result in the Lead Investor being deemed to control the Company or the Bank within the meaning of applicable banking laws, upon the written request of the Lead Investor, the Company will, concurrently with the Closing or thereafter in case of a later request, request the non-objection or approval of the Federal Reserve and the TDSML, to the extent required, for the appointment of the Board Representative (as defined below). The Company further covenants and agrees that within five (5) days of receipt of the non-objection or approval of the Federal Reserve and the TDSML, the Board of Directors will cause the Board Representative to be elected or appointed to the Board of Directors; provided that the Board Representative provides the Company with customary documentation required by director nominees in accordance with the Company’s practices. After such appointment or election of a Board Representative, so long as the Lead Investor beneficially owns a Qualifying Ownership Interest, the Company will be required to recommend to its shareholders the election of the Board Representative at the Company’s annual meeting. If the Lead Investor no longer beneficially owns a Qualifying Ownership Interest the Lead Investor will have no further rights under this Section 2, and, at the written request of the Board of Directors, shall cause its Board Representative to resign from the Board of Directors as promptly as reasonably practicable (and in any event within thirty (30) days) thereafter. The Lead Investor shall promptly inform the Company if and when it ceases to hold a Qualifying Ownership Interest in the Company.
(b) Any Board Representative (including any successor nominee) duly selected in accordance with Section 2(a) shall, subject to applicable law, be among the Company’s and the Company’s Corporate Governance and Nominating Committee’s nominees to serve on the Board of Directors. The Company shall use reasonable best efforts to have the Board Representative elected as a director of the Company by the shareholders of the Company and the Company shall solicit proxies for the Board Representative to the same extent as it does for any of its other nominees to the Board of Directors.
(c) For only so long as the Lead Investor has the right to nominate a Board Representative pursuant to Section 2(a), the Lead Investor shall have the power to designate the Board Representative’s replacement upon the death, resignation, retirement, disqualification or removal from office of such director. The Board of Directors will use its reasonable best efforts to take all action required to fill the vacancy resulting therefrom with such person (including such person, subject to applicable law, being the Company’s and the Company’s Corporate Governance and Nominating Committee’s nominee to serve on the Board of Directors, using reasonable best efforts to have such person elected as director of the Company by the shareholders of the Company and the Company shall solicit proxies for such person to the same extent as it does for any of its other nominees to the Board of Directors).
EXHIBIT L-6
(d) Any Board Representative shall be entitled to the same compensation and same indemnification in connection with his or her role as a director as the other members of the Board of Directors, and each Board Representative shall be entitled to reimbursement for documented, reasonable out-of-pocket expenses incurred in attending meetings of the Board of Directors or any committees thereof, to the same extent as the other members of the Board of Directors. The Company shall notify each Board Representative of all regular and special meetings of the Board of Directors and shall notify each Board Representative of all regular and special meetings of any committee of the Board of Directors of which the Board Representative is a member in accordance with the Company’s bylaws as then in effect. The Company shall provide each Board Representative with copies of all notices, minutes, consents and other materials provided to all other members of the Board of Directors concurrently as such materials are provided to the other members.
(e) At all times when the Lead Investor has the right to a Board Representative as provided in Section 2(a), upon the written request of the Lead Investor and in lieu of the Lead Investor’s nomination of a Board Representative, the Lead Investor may appoint one (1) individual to attend all meetings of the Board of Directors and all committees thereof (the “Observer”) and pursuant to clause (f) hereof the board of directors of the Bank and all committees thereof, which individual shall be reasonably acceptable to the Board of Directors (such approval not to be unreasonably withheld, conditioned or delayed); provided, the Observer executes and delivers to the Company and the Bank a customary confidentiality agreement for service as a board observer and provided, further, that the appointment by the Lead Investor of an Observer shall not prevent the Lead Investor from nominating a Board Representative in lieu of an Observer at a future time. No Observer shall have any right to vote on any matter presented to the Board of Directors or any committee thereof. The Company shall give each Observer written notice of each meeting thereof at the same time and in the same manner as the members of the Board of Directors, shall provide each Observer with all written materials and other information (other than confidential supervisory information within the meaning of 12 C.F.R. Part 261) given to members of the Board of Directors at the same time such materials and information are given to the members of the Board of Directors and shall permit each Observer to attend as an observer at all meetings thereof, and in the event the Company proposes to take any action by written consent in lieu of a meeting, the Company shall give written notice thereof to such Observer prior to the effective date of such consent describing the nature and substance of such action and including the proposed text of such written consents; provided, however, that the Company or the Board of Directors shall have the right to withhold any information and to exclude any Observer from any meeting or portion thereof (1) if doing so is, in the reasonable good faith judgment of the Company, after consultation with counsel, advisable or necessary to protect the attorney-client privilege between the Company and counsel, or (2) if the Board of Directors reasonably determines in good faith, after consultation with counsel, that attendance by such Observer would conflict with fiduciary requirements under applicable law. The Lead Investor covenants and agrees to hold all such information obtained from its Observer in confidence pursuant to the confidentiality and non-disclosure provisions of Section 6(c) of the Agreement and cause its Observer to execute a customary confidentiality agreement for board observers. If the Lead Investor and its Affiliates in the aggregate no longer have a Qualifying Ownership Interest, the Lead Investor will have no further rights under this Section 2(e).
(f) So long as the Lead Investor has the right to appoint a Board Representative pursuant to Section 2(a), the Lead Investor shall have the right to either nominate the Board Representative as the “Bank Board Representative” to be elected or appointed as director to the board of directors of the Bank (the “Bank Board”) or to appoint the Observer to attend all meetings of the Bank Board and all committees thereof as an observer (the “Bank Board Observer”); provided, that, the appointment by the Lead Investor of a Bank Board Observer shall not prevent the Lead Investor from nominating a Bank Board Representative in lieu of a Bank
EXHIBIT L-7
Board Observer at a future time; and provided, further, that the Bank Board Observer executes a customary confidentiality agreement for board observers. The obligations of the Company otherwise with respect to, and the conditions on the appointment and, if applicable, directorship of, the Bank Board Representative and the Bank Board Observer shall be substantially the same as those with respect to or applicable to the Board Representative and Observer, respectively.
(g) The Company acknowledges that the Board Representative and Bank Board Representative may have certain rights to indemnification, advancement of expenses and/or insurance provided by the Lead Investor and/or certain of Lead Investor’s Affiliates (collectively, the “Lead Investor Indemnitors”). The Company hereby agrees that with respect to a claim by the Board Representative or Bank Board Representative for indemnification arising out his or her service as a director of the Company or the Bank, as applicable, (1) the Board Representative or Bank Board Representative shall be entitled to the same indemnification with his or her role as a director as the other members of the Board of Directors and (2) that the Company (or the Bank, as applicable) is the indemnitor of first resort (i.e., the Company’s (or the Bank’s, as applicable) obligations to the Board Representative or Bank Board Representative, as applicable, are primary and any obligation of the Lead Investor Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by the Board Representative and Bank Board Representative are secondary). The Company further agrees that no advancement or payment by any Lead Investor Indemnitor on behalf of the Board Representative or the Bank Board Representative with respect to any claim for which the Board Representative or the Bank Board Representative has sought indemnification from the Company or the Bank, as applicable, shall affect the foregoing and the Lead Investor Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of the Board Representative and the Bank Board Representative against the Company and the Bank. The Company agrees that the Lead Investor Indemnitors are express third party beneficiaries of this Section 2(g).
(h) In addition to the foregoing, the Company will reimburse the Lead Investor and its Affiliates for all reasonable fees and expenses arising out of or related to the Board Representative’s or the Observer’s travel to monthly meetings of the Board and the Bank Board.
(i) Notwithstanding anything herein to the contrary, the rights provided by this Section 2 are personal to the Lead Investor and in no event shall such rights be assignable.
(j) For purposes of this letter agreement, “Board Representative” means such person designated by the Lead Investor to be elected or appointed to the Board of Directors and the Bank Board in accordance with all legal and governance requirements regarding service and election or appointment as a director of the Company, or any individual designated as a replacement Board Representative pursuant to Section 2(c) hereof.
3. Expenses. In the event (i) the Closing occurs, or (ii) the transactions contemplated by the Agreement are not consummated other than due to a breach by the Lead Investor of any of its obligations under the Agreement, the Company will reimburse the Lead Investor for its reasonable and documented out-of-pocket expenses incurred in connection with its due diligence and the preparation and negotiation of the Agreement and the transactions contemplated thereby including, but not limited to, (a) the reasonable fees and expenses of counsel incurred by the Lead Investor and its Affiliates in connection with the transactions contemplated by the Agreement and (b) travel expenses; provided, that, the Company shall not be obligated to reimburse the Lead Investor for amounts in excess of $100,000. In addition to the foregoing, (i) the Company shall
EXHIBIT L-8
pay the full cost of the independent loan review obtained by the Company from Gateway Asset Management Company, LLC with, at the Lead Investor’s request, personnel of the Lead Investor onsite during the review, and (ii) the fees and expenses referred to in the first sentence of Section 6 of the Registration Rights Agreement that are the Company’s responsibility shall include those expenses of the Lead Investor actually and reasonably incurred, including without limitation, reasonable attorneys’ fees, not to exceed $50,000 in the aggregate.
4. Assignment. This letter agreement shall not be assigned by operation of law or otherwise, except that the Lead Investor may assign all or any portion of its rights under this letter agreement to any of its Affiliates or as expressly permitted in this letter agreement; provided, that, any such assignment shall not relieve the Lead Investor of any liability or other obligation under this letter agreement. This letter agreement will be binding upon, and will inure to the benefit of and be enforceable by, the parties hereto and their respective successors and assigns.
5. Governing Law. This letter agreement shall be governed by, construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles or other principles that would require the application of any other law. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Delaware for any actions, suits or proceedings arising out of or relating to this letter agreement and the transactions contemplated hereby.
6. Severability. If any provision of this letter agreement or the application thereof to any Person or circumstances is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid or unenforceable, shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties.
7. Counterparts and Facsimiles. For the convenience of the parties hereto, this letter agreement may be executed in any number of counterparts, each of which shall be deemed to be an original instrument, and all such counterparts will together constitute the same agreement. Executed signature pages to this letter agreement may be delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file and such signature will have the same force and effect as if such facsimile or electronic page were an original thereof.
8. Amendment; Waiver. No amendment or waiver of any provision of this letter agreement will be effective with respect to any party unless made in writing and signed by a duly authorized representative of such party. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any party to this letter agreement, as the case may be, will be effective unless it is in a writing signed by a duly authorized representative of the waiving party that makes express reference to the provision or provisions subject to such waiver.
EXHIBIT L-9
9. Ratification. Except as otherwise expressly provided by this letter agreement, all of the terms and conditions of the Agreement are hereby ratified and shall remain unchanged and continue in full force and effect.
[Signature Page Follows]
EXHIBIT L-10
| THIRD COAST BANCSHARES, INC. | ||
| By: |
| |
| Name: | ||
| Title: | ||
| Agreed and acknowledged as of the date first above written: | ||
| CASTLE CREEK CAPITAL PARTNERS VIII, LP | ||
| By: |
| |
| Name: | ||
| Title: | ||
[Signature Page to Letter Agreement]
Exhibit 99.1
|
NEWS RELEASE | |||
| FOR IMMEDIATE RELEASE | Contact: Ken Dennard / Natalie Hairston Dennard Lascar Investor Relations (713) 529-6600 TCBX@dennardlascar.com | |||
Third Coast Bancshares, Inc. Announces Private Placement of $69.4 Million of Convertible Preferred Stock
HUMBLE, Texas, September 8, 2022 – Third Coast Bancshares, Inc. (NASDAQ: TCBX), (“Third Coast” or the “Company”), the holding company for Third Coast Bank, SSB (the “Bank”), today announced that it has entered into an investment agreement with Castle Creek Capital Partners VIII, LP (“Castle Creek”) and certain other accredited investors (collectively, the “Investors”), pursuant to which the Company expects to raise aggregate gross proceeds of $69.4 million through the issuance of non-cumulative convertible preferred stock. The Company expects to close the offering, subject to customary closing conditions, on September 22, 2022. A representative from Castle Creek will immediately join the Board of Directors of the Company and the Bank following the closing of the transaction.
“We are extremely pleased with the success of this transaction and appreciate the support that Castle Creek and the other accredited investors have shown for our team and business plan. We look forward to the partnership and operating expertise that comes with a Castle Creek investment,” said Bart O. Caraway, Third Coast’s Chairman, President and Chief Executive Officer. “This additional capital will position Third Coast Bank to execute on attractive growth opportunities in the future, and continue capitalizing on the talent dislocation in our markets. Further, we remain committed to driving toward industry leading profitability and expect the unlocking of latent value in the coming quarters through investments already made in people, technology, and our community.”
“These uncertain times call for extra thorough due diligence prior to investment and we couldn’t be more pleased with the results,” said Tony Scavuzzo, Managing Principal at Castle Creek. “The most important decision we can make as investors is partnering with a management team that has a shared vision of the future.”
The Series A Preferred Stock will have a non-cumulative dividend rate on the liquidation preference of the preferred stock of 6.75% and will be convertible into the Company’s common stock, par value $1.00 per share (“Common Stock”), at an initial conversion price of $22.50 per share, subject to an ownership cap with respect to each Investor of 9.9% of the total outstanding shares of Common Stock. Thereafter, the Series A Preferred Stock will be convertible into a new series of the Company’s non-voting preferred stock, to be designated as Series B Convertible Perpetual Preferred Stock, par value $1.00 per share, and, following approval by the Company’s shareholders, non-voting common stock, par value $1.00 per share, of the Company. The Company also agreed to issue to Castle Creek and certain other investors an aggregate of 175,000 warrants (“Warrants”) to purchase Common Stock in connection with the offering.
Piper Sandler & Co. is serving as the Company’s sole placement agent for the offering. Norton Rose Fulbright US LLP is serving as legal counsel for the Company, Fenimore Kay Harrison LLP is serving as legal counsel for Piper Sandler & Co., and Sidley Austin LLP is serving as legal counsel for Castle Creek.
About Third Coast Bancshares, Inc.
Third Coast Bancshares, Inc. is a commercially focused, Texas-based bank holding company operating primarily in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets through its wholly owned subsidiary, Third Coast Bank, SSB. Founded in 2008 in Humble, Texas, Third Coast Bank, SSB conducts banking operations through 14 branches and one loan production office encompassing the four largest metropolitan areas in Texas. Please visit https://www.tcbssb.com for more information.
No Offer or Solicitation
This press release shall not constitute an offer to sell, a solicitation of an offer to sell, or the solicitation or an offer to buy any securities. There will be no sale of securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Series A Preferred Stock and Warrants have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect Third Coast’s current views with respect to, among other things, future events, the offering of the Series A Preferred Stock and Warrants, Third Coast’s financial performance and the use of proceeds from the offering. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about Third Coast’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, Third Coast cautions you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although Third Coast believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. For a discussion of factors that could cause Third Coast’s actual results to differ materially from those described in the forward-looking statements, please see the risk factors discussed in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2022, and Third Coast’s other filings with the SEC. Any forward-looking statement speaks only as of the date on which it is made, and Third Coast does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
###

Exhibit 99.2 Third Coast Bancshares, Inc. Investor Presentation Subordinated Debt Placement Non-Cumulative Convertible Perpetual Preferred Stock Offering February 2022 July 2022 Confidential Investor Presentation

Disclaimer Legal Disclaimer This confidential presentation (this “presentation”) has been prepared solely for general informational purposes by or on behalf of Third Coast Bancshares, Inc. (“Third Coast,” “TCBX,” the “Company,” the “holding company,” “we” or “our”), the registered bank holding company for Third Coast Bank, SSB (the “Bank”), and is being furnished solely for use by prospective investors in considering participation in the proposed private offering (the “Offering”) of the Company’s preferred stock (the “Securities”). No representation or warranty as to the accuracy, completeness, or fairness of such information is being made by the Company or any other person, and neither the Company, any of its affiliates nor any other person shall have any liability for any information contained herein, or for any omissions from this presentation or any other written or oral communications transmitted or made available to the recipient by the Company or its affiliates or any other person in the course of the recipient’s evaluation of the Offering. The Company reserves the right to withdraw or amend this Offering for any reason and to reject any prospective investment in the Securities, in whole or in part. The Securities are not a bank deposit or bank account, and are not, and will not be, insured or guaranteed by the Federal Deposit Insurance Corporation (the “FDIC”) or any other federal or state government agency. Neither the Securities nor the investment in the Securities has been approved or disapproved by the Securities and Exchange Commission (the “SEC”), the FDIC, the Board of Governors of the Federal Reserve System, or any other federal or state regulatory authority, nor has any authority passed upon or endorsed the merits of the Offering or the accuracy or adequacy of this presentation. Any representation to the contrary is a criminal offense. The Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and may not be offered or resold absent registration or an exemption from registration under applicable law. The Securities are being offered only to individuals and entities that qualify as an “accredited investor,” as defined in Rule 501(a)(1)-(3) or (7) of Regulation D promulgated under the Securities Act, or a qualified institutional investor as defined in Rule 144A under the Securities Act. This presentation does not constitute an offer to sell, or a solicitation of an offer to buy, any securities of the Company by any person in any state or jurisdiction in which it is unlawful for such person to make such an offering or solicitation. The information contained herein is intended only as an outline that has been prepared to assist interested parties in making their own evaluations of the Company. It does not purport to be all inclusive or to contain all of the information that a prospective participant may desire. Each recipient of the information and data contained herein should perform its own independent investigation and analysis of the Offering and the Company. The information and data contained herein are not a substitute for a recipient’s independent evaluation and analysis. An investment in the Securities involves risks. In making an investment decision, prospective participants must rely on their own examination of the Company, including the merits and risks involved. Each potential investor should review the risk factors and other materials contained in the data room or attached to the definitive purchase agreement prior to making its investment decision. Except as otherwise indicated, this presentation speaks as of the date hereof. The delivery of this presentation shall not, under any circumstances, create any implication that there has been no change in the affairs of the Company after the date hereof, and the Company assumes no obligation to update such information except to the extent required by applicable law. Certain of the information contained herein is derived from information provided by industry sources. The Company believes that such information is accurate and that the sources from which it has been obtained are reliable. The Company cannot guarantee the accuracy of such information, however, and has not independently verified such information. The Company is not making any implied or express representation or warranty as to the accuracy or completeness of the information summarized herein or made available in connection with any further investigation of the Company. The Company expressly disclaims any and all liability which may be based on such information, errors therein or omissions therefrom. This presentation contains certain pro forma and projected information, including projected pro forma information that reflects the Company’s current expectations and assumptions. This pro forma information does not purport to present the results that the Company will ultimately realize. In addition to financial measures presented in accordance with U.S. generally accepted accounting principles (“GAAP”), this presentation contains certain non-GAAP financial measures, including, without limitation, tangible common equity, tangible assets, and the ratio of tangible common equity to tangible assets. The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for any measure prepared in accordance with GAAP. 2

Disclaimer The information contained in this presentation is confidential and proprietary to the Company and its subsidiaries. By accepting delivery of this information, the intended recipient is deemed to have acknowledged and agreed that (i) the information contained herein will be used by the recipient solely for the purpose of deciding whether to proceed with a further investigation of the Company and its subsidiaries in connection with a potential participation in the Offering, (ii) this information will be kept in strict confidence and will not, whether in whole or in part, be released or discussed by the recipient, nor will any reproductions of such information be made, for any other purpose other than an analysis of the merits of the potential investment in the Company by its intended recipient, and (iii) upon written request of the Company, this information, any other documents or information furnished and any and all reproductions thereof and notes relating thereto will be promptly returned to the Company or destroyed. This presentation is subject to the confidentiality agreement entered into by the Company with potential investors. Any purchase and sale of Securities will be governed solely by a definitive purchase agreement, and the information contained herein will be superseded in its entirety by such purchase agreement. In the event that any portion of this Presentation is inconsistent with or contrary to any of the terms or conditions of the purchase agreement, the purchase agreement shall control. This presentation does not contain all of the information you should consider before investing in Securities of the Company and should not be construed as investment, legal, regulatory or tax advice. Each potential investor should review the purchase agreement, make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the Securities mentioned in this presentation and should consult its own legal counsel and financial, accounting, regulatory and tax advisors to determine the consequences of such an investment prior to making an investment decision and should not rely on any information set forth in this presentation. The Securities described herein will be subject to significant limitations on their liquidity. Only potential investors who can bear the risk of an unregistered illiquid investment, should consider investment in the Securities. Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934 as amended, with respect to the financial condition, liquidity, results of operations, future performance, and business of the Company. These forward-looking statements are intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that are not historical facts. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, budgets, expectations, anticipations, estimates, and intentions that are subject to significant risks and uncertainties, and are subject to change based on various factors (some of which are beyond our control). Forward-looking statements often include the words “assumes,” “believes,” “expects,” “anticipates,” “estimates,” “forecasts,” “intends,” “plans,” “targets,” “potentially,” “probably,” “projects,” “outlook,” “positioned,” or similar expressions, or future conditional verbs such as “may,” “will,” “should,” “would,” and “could.” Such known and unknown risks, uncertainties and other factors that could cause the actual results to differ materially from the statements include, but are not limited to: (i) changes in general business, industry or economic conditions, or competition; (ii) changes in any applicable law, rule, regulation, policy, guideline, or practice governing or affecting bank holding companies and their subsidiaries or with respect to tax or accounting principles or otherwise; (iii) adverse changes or conditions in capital and financial markets; (iv) changes in interest rates; (v) the inability to realize expected cost savings or achieve other anticipated benefits in connection with business combinations and other acquisitions; (vi) the impact of the COVID-19 pandemic on our business and the businesses of our customers, including the impact of the actions taken by governmental authorities to contain the virus or address the impact of the virus on the United States economy (including, without limitation, the Coronavirus Aid, Relief and Economic Security (“CARES Act”) and the Economic Aid to Hard-Hit Small Businesses, Nonprofits and Venues Act), and the resulting effect of all of such items on our operations, liquidity and capital position, and on the financial condition of our borrowers and other customers; (vii) the costs and effects of litigation, investigations, inquiries or similar matters, or adverse facts and developments related thereto, including the costs and effects of litigation related to our participation in government stimulus programs associated with the COVID-19 pandemic; (viii) changes in the quality or composition of our loan and investment portfolios; (ix) adequacy of loan loss reserves; (x) increased competition; (xi) loss of certain key officers; (xii) continued relationships with major customers; (xiii) deposit attrition; (xiv) rapidly changing technology; (xv) unanticipated regulatory or judicial proceedings and liabilities and other costs; (xvi) changes in the cost of funds, demand for loan products, or demand for financial services; (xvii) other economic, competitive, governmental, or technological factors affecting our operations, markets, products, services, and prices including, but not limited to, the impact of the ongoing COVID-19 pandemic and actions taken in response to COVID-19 by governments and businesses; and (xviii) our success at managing the foregoing items. For a discussion of these and other risks that may cause actual results to differ from expectations, please refer to the sections titled Cautionary Note Regarding Forward-Looking Statements and Risk Factors in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission and any updates to those sections set forth in the Company's subsequent Quarterly reports on Form 10-Q or Current Reports on Form 8-K.Such developments could have an adverse impact on our financial position and our results of operations. The forward-looking statements are based upon management’s beliefs and assumptions. Any forward-looking statement made herein speaks only as of the date of this presentation. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. Potential investors should not rely on forward-looking statements as predictions of future performance. 3

Terms of the Proposed Offering Third Coast Bancshares, Inc. Issuer Name Non-Cumulative Convertible Perpetual Preferred Stock Security Type Up to $100 Million Amount Regulation D Private Placement with Registration Rights Issuance Type 6.825% Non-Cumulative Dividend Convertible at any time into up to 9.9% of voting common stock and remainder Convertibility into non-voting common stock or equivalent non-voting preferred stock Conversion Price $26.00 Offering Structure Perpetual / Non-Callable for 5 Years Use of Proceeds General corporate purposes including funding organic growth Placement Agent 4

Investment Highlights Emerging Community Bank in Key Texas Metropolitan Markets of Houston, Dallas-Fort Worth and Austin-San Antonio o Presence in Each of the Four Largest MSAs in Texas Well Capitalized Institution with Proven Ability to Attract Significant Equity Capital o $100M + Successful IPO Completed in November 2021 o Pre-IPO Common Raise of Over $70M Completed in August 2021 Significant Investment in People and Infrastructure Provides Scalability for Improving Returns o Hired 50+ new employees in 2021 o ~33% Organic Loan Growth in 1H 2022 Responsive and Disciplined Underwriting o In-Market Credit Analysts and Loan Committees Create Efficiencies in the Loan Approval Process Outstanding Improvement of Funding Base Highly Experienced Senior Management Team o CEO is also Founder 5

Third Coast Franchise Overview Commercially focused bank founded in 2008, with headquarters Third Coast Branch Footprint in Humble, Texas Fourteen branches and one LPO located throughout Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets Completed $100.6M Initial Public Offering and began trading under “TCBX” on NASDAQ in November 2021 Financial Highlights Balance Sheet ($M, Except per Share) As of June 30, 2022 Total Assets $3,358 Total Loans HFI $2,749 Total Deposits $2,898 Loans HFI / Deposits 94.9% Tangible Book Value per Share¹ $21.00 Tangible Common Equity / Tangible Assets¹ 8.99% Total Risk-Based Capital Ratio (Bank-Level) 12.40% Profitability 6/30/22 YTD Return on Average Assets 0.31% Return on Average Equity 2.91% Yield on Loans 4.81% Cost of Deposits 0.43% Net Interest Margin 3.90% Efficiency Ratio 76.87% Third Coast HQ Branch Asset Quality 6/30/22 YTD Third Coast Branch (13) NPAs Excl. TDRs / Assets 0.30% Third Coast LPO (1) NCOs to Average Loans 0.00% 1) Non-GAAP financial measure – see appendix for reconciliation of non-GAAP financial measure to most comparable GAAP measure Source: Company Documents, S&P Capital IQ Pro 6

Track Record of Strong Growth Since Formation Surpassed $3B in (Dollars in Millions) total assets Total Asset CAGR of 32% Since Inception Opened branches in Fort Worth, TX & Georgetown, TX Entity Formation Completed Initial Private Stock Offering Public Offering Branch Opening ($100.6M) Completed Growth Benchmark Formation of Closed merger sixth stock Third Coast Merger with Heritage offering Commercial ($70.5M) Completed fifth Capital Initial Public Offering $3,358 stock offering Surpassed $1B in Surpassed $2B ($8.4M) total assets $12 in total assets Opened branch in CARES¹ Plano, TX Loans Surpassed $650M in total assets Completed third $2,498 $1,864 stock offering Opened branch in $87 $396 ($3.3M) Conroe, TX CARES CARES Completed fourth Opened branch in Loans Completed Loans stock offering Beaumont, TX second stock Opened branch in ($5.7M) $316 Surpassed $800M offering ($7.8M) Dallas, TX Acquired in total assets Assets Third Coast Surpassed $500M Bank chartered Opened branch in Formation of the in total assets and opened Houston, TX Company branch in (Galleria) Humble, TX Opened branch in Surpassed $200M Port Arthur, TX Completed $926 in total assets initial stock $845 $1,155 offering $672 ($17.2M) $538 $409 $352 $286 $257 $227 $193 $153 $83 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 6/30/22 1) Includes $8.8 million of PPP loans and $3.2 million in Main Street loans for a total of $12.0 million in Cares Act loans Source: Company Documents, S&P Capital IQ Pro; Information is presented as of December 31 of the indicated years; 2022YTD as of June 30, 2022 7

Consistent Growth Trends (Dollars in millions, except per share amounts) Gross Loans HFI Total Deposits $2,898 $2,141 $2,749 $1,634 $2,069 $1,556 $807 $735 $809 $688 2018 2019 2020 2021 6/30/22 2018 2019 2020 2021 6/30/22 Net Income Tangible Book Value per Share¹ $12.1 $21.00 $20.87 $11.4 $16.29 $14.88 $14.23 $4.4 $4.0 $2.4 2018 2019 2020 2021 6/30/22 2018 2019 2020 2021 6/30/22 1) Non-GAAP financial measure – see appendix for reconciliation of non-GAAP financial measure to most comparable GAAP measure Source: Company Documents, S&P Capital IQ Pro; Financial information is presented as of and for the year ended December 31 of the indicated years and as of and for the six months ended June 30, 2022 8

Dynamic Texas Markets of Operation ▪ The Houston MSA is projected to grow approximately 6.0% over the next five years, ranking fifth among the nation’s 10 largest MSAs ▪ Houston is the nation’s fourth most populous city and fifth most populous metro area, with approximately Greater 2.3 million and 7.2 million residents, respectively Houston ▪ Houston is a center for global trade, with the Houston Port ranking first among U.S. ports in foreign Market tonnage ▪ The Houston MSA is corporate headquarters for 24 Fortune 500 companies and employs approximately 3.1 million workers ▪ The Dallas MSA is the largest in Texas and the fourth largest in the U.S., and has been growing by approximately 328 residents every day Dallas- ▪ The Dallas MSA boasts the largest gross domestic product in Texas and the sixth largest in the nation Fort Worth ▪ DFW headquarters 22 Fortune 500 companies, including AT&T, American Airlines and Charles Schwab Market ▪ The Dallas MSA hosts approximately 4.1 million working professionals and ranked first in the nation for total job growth in 2021 ▪ The population in the San Antonio – New Braunfels MSA is projected to grow by approximately 6.1% over the next five years, compared to 5.3% for the state of Texas and 3.2% for the United States Austin – ▪ The Austin – Round Rock – Georgetown MSA is projected to be the fastest growing large MSA in the country (as defined by MSAs with a population over two million), with a forecasted growth rate of 6.9% San Antonio through 2026 Market ▪ Austin has transformed itself into a hotbed for technology companies, and was recently designated as a top 10 Global Technology Innovation Hub city by KPMG Source: U.S. Bureau of Economic Analysis, Fortune, Greater Houston Partnership, Dallas Chamber of Commerce, Dallas Regional Chamber, Fortune Magazine, Forbes, and S&P Capital IQ Pro 9

Executive Management Bart Caraway - Chairman, President and Chief Executive Officer ▪ Founded Third Coast Bank in 2008; CEO, President and Chairman of Third Coast Bank since founding and of the Company since formation in 2013 ▪ Chairman and CEO of Third Coast Commercial Capital ▪ Texas licensed attorney and CPA with 29 years of banking and public accounting experience ▪ Served in executive roles at several community banks, most recently as CFO and COO for a Houston-based bank ▪ Graduated from the University of Texas with a BBA in Accounting ▪ Earned a law degree from the University of Houston Law School John McWhorter - Senior Executive Vice President and Chief Financial Officer ▪ Joined the Company as Chief Financial Officer and Third Coast Bank as Senior EVP and CFO in April 2015 ▪ Over 34 years of banking, bank auditing and public accounting experience as a CPA ▪ Most recently served as EVP and CFO at Bank of Houston, a $1 billion in asset bank ▪ Served as EVP and CFO of Cadence Bancorporation LLC ▪ Served as SVP and Controller of Amegy Bank, helped take the bank public ▪ Has helped complete nine acquisitions and several capital offerings ▪ Graduated from the University of Texas with a BBA in Accounting Audrey Duncan - Senior Executive Vice President and Chief Credit Officer ▪ Has served as Senior EVP and Chief Credit Officer since June 2015 ▪ Also serves as the Chairperson of the Officers’ Loan Committee and the Special Assets Committee ▪ Over 34 years of banking and bank regulatory experience ▪ Served as SVP, Credit Officer, and Director of Credit Risk Management at LegacyTexas Bank ▪ Served as a Senior and Commissioned Bank Examiner with The Federal Reserve Bank of Dallas ▪ Graduated from Texas Tech University with a BBA in Finance 10

Business Strategy Strategic Initiative Execution and Implementation ▪ Continue to recruit strategic hires Continue Robust ▪ Evaluate future de novo branch opportunities Organic Growth ▪ Leverage experienced management team, board and relationship managers ▪ Encourage and incentivize relationship managers to attract core deposits Emphasize Core Deposit Growth▪ Treasury management initiative enhances product and service offerings ▪ Development of supplementary, specialty lending verticals Thoughtfully Expand ▪ Investment in high-touch, state-of-the-art technology and delivery of quality Financial Products customer experience and Services ▪ Evaluation of future business opportunities to broaden the Third Coast brand ▪ Remain proactive in sourcing franchise accretive merger opportunities Continue to Capitalize on ▪ Stay disciplined in approach to evaluating potential merger partners Strategic Acquisition Opportunities▪ Focused on entities with strong deposit franchises 11

Diverse Lines of Business ▪ Community banking, the foundation on which TCBX has been built, remains a core strength with over 40 lenders across the state ▪ Experienced bankers serving Austin, Dallas, Houston, and San Antonio, along with Southeast Texas Community ▪ Loan products offered include C&I, Real Estate, Equipment, and Working Capital Banking ▪ Market Leadership includes bankers that have been with TCBX since inception, with over 100 years in combined experience ▪ Seasoned expert lenders in the residential real estate market on board since May 2021 ▪ Over 30 years of experience with a portfolio size over $2.1 billion and income contribution of over $60 million at their prior institution Builder ▪ Self contained business unit with a stellar credit record Finance ▪ Seasoned commercial, corporate and industrial banking leadership beginning Q4 2021 ▪ Over 25 years experience across corporate banking platforms Corporate ▪ Track record of successful build outs for larger banks Banking ▪ Targeted portfolio across industries including industrial manufacturing, services, and distribution, specialty chemicals, select infrastructure related industries 12

Loan Portfolio Overview Loan Portfolio by Maturities Fixed / Floating by Maturity < 1 Year < 1 Year 25.0% 75.0% 23.7% 8.2% 1 to 5 Years 31.8% 68.2% 1 to 5 Years Total Loans: 5 to 15 Years 8.8% 91.2% 20.2% $2,749M 5 to 15 Years >15 Years 27.4% 72.6% 47.9% Total 24.8% 75.2% > 15 Years Loan Maturities by Loan Type – 0.9% 0.6% 3.2% 7.3% 10.1% 8.7% 5.9% 5.2% 18.1% 28.3% 33.1% 39.2% 45.5% 49.2% 40.2% 26.5% 72.0% 22.7% 54.2% 54.0% 35.2% 45.8% 40.1% 22.5% 19.6% 6.5% 5.4% Owner-Occ CRE Nonowner-Occ CRE Residential C&D C&I Consumer Other > 15 Years 5 to 15 Years 1 to 5 Years < 1 Year Note: Financial information as of June 30, 2022; Other includes farmland loans, lease financing, bond anticipation notes (BANs), and agriculture loans made to farmers and ranchers relating to their operations 13 Source: Company Documents & S&P Capital IQ Pro

Loan Portfolio Overview (Continued) Top 20 Loan Relationships Loan Composition Committed Balance % of Total Relationship Type ($M) ($M) (%) Owner-Occ CRE Relationship 1 C&I - Financing $53.3 $47.6 1.7% 18.5% 5.3% Relationship 2 Real Estate - C&D $50.0 $17.4 0.6% Nonowner-Occ CRE Relationship 3 Real Estate - C&D $50.0 $8.7 0.3% 16.9% Relationship 4 Real Estate - C&D $45.0 $45.0 1.6% Residential Yield on Relationship 5 Real Estate - C&D $39.3 $23.1 0.8% Loans: C&D 33.3% Relationship 6 Real Estate - C&D $36.5 $24.8 0.9% 4.81% 9.9% Relationship 7 Real Estate - Multi Family $35.0 $34.8 1.3% C&I Relationship 8 Real Estate - C&D $35.0 $27.0 1.0% 16.0% Relationship 9 Real Estate - C&D $35.0 $27.6 1.0% Other Relationship 10 Real Estate - Commercial $33.2 $20.6 0.8% Relationship 11 Real Estate - C&D $31.9 $12.5 0.5% Relationship 12 Real Estate - C&D $30.0 $18.1 0.7% Relationship 13 Real Estate - C&D $30.0 $10.6 0.4% Energy Lending Exposure Relationship 14 Real Estate - C&D $30.0 $22.5 0.8% Amount % of Loans Relationship 15 Real Estate - C&D $30.0 $11.3 0.4% Loan Type ($M) (%) Relationship 16 C&I $30.0 – – Relationship 17 Energy - Midstream $30.0 $23.4 0.9% Upstream Operators $0.3 0.0% Relationship 18 Real Estate - Commercial $29.8 $29.8 1.1% Midstream Operators $118.2 4.3% Relationship 19 Energy - Midstream $29.6 $13.8 0.5% Upstream Support Services $27.8 1.0% Relationship 20 C&I $27.6 – – Midstream Support Services $47.9 1.7% Top 20 Relationships $711.2 $418.7 15.2% Total $194.2 7.1% Note: Financial information as of June 30, 2022; Other includes farmland loans, lease financing, bond anticipation notes (BANs), and agriculture loans made to farmers and ranchers relating to their operations Source: Company Documents 14

Specialty Lending Verticals (Dollars in Millions) Third Coast offers SBA, factoring, auto finance and builder finance loans in addition to conventional commercial and consumer lending products These verticals augment traditional product offerings, diversify revenue streams and in some cases provide for early stage customer acquisition opportunities o As SBA and factoring customers grow, the goal is to transition to conventional commercial banking products SBA Factoring Auto Finance Builder Finance ▪ Began in 2012 as a key element in ▪ Third Coast Commercial Capital was ▪ Formed in 2014 to provide for indirect ▪ Formed in 2021 to provide for traditional serving small- to medium-sized business formed in 2015 to provide working auto lending with local dealerships homebuilder lines secured by lots and single-family homes, and land in markets of operation capital solutions for small- to medium- ▪ Loans are approved with the same sized businesses acquisition and development ▪ Member of the SBA Preferred Lenders underwriting standards as other ▪ Focused on master planned, presold Program, which leads to an expedited ▪ Purchase and management of accounts commercial credits approval process for customers receivable helps customers grow and communities ▪ Losses related to the portfolio have been continue to be successful ▪ Maintain strict underwriting guidelines, approximately $34 thousand ▪ Also provides financing for bond acquisition notes (“BANs”) and lines of with losses to date less than $410 ▪ Losses related to the portfolio have been thousand approximately $2.5 million credit to institutional real estate funds ▪ Hired 20 builder finance lenders from a large Texas bank in mid 2021 Aggregate Aggregate Aggregate Aggregate Exposure: Exposure: Exposure: Exposure: $556.8M (20.3%) $72.4M (2.6%) $43.7M (1.6%) $38.4M (1.4%) $915 $509 $464 $441 $273 $88 $31 $24 $4 C&I¹ OO CRE Non-OO CRE C&D Residential RE Other Auto Finance Leases Farmland Consumer 1) Includes $12.0 million of Cares Act loans Note: Financial information as of June 30, 2022 Source: Company Documents 15

Commitment to Sound Underwriting Efficient and disciplined credit approval process differentiates Third Coast ‒ Credit professionals are located in-market and regularly accompany relationship managers to client meetings ‒ Independent Officers’ Loan Committees that meet separately for the loan officers under each Regional Market President’s authority for efficient and timely review of credits associated with aggregate relationships less than $10 million ‒ Experienced relationship managers serve on the Officers’ Loan Committees and meetings are open to lenders and underwriters to promote uniformity in underwriting standards ‒ Directors’ Loan Committee meets weekly, or on an as-needed basis, to review and approve credits associated with aggregate relationships greater than $10 million ‒ Acute focus on the borrower’s financial condition, relationship global cash flow, and collateral ‒ Underwriting of factored receivables focuses on the creditworthiness of account debtors, the experience of the management and principals of the business, billing and reporting processes, and an independent field exam, when appropriate ‒ No charge offs YTD 6/30/2022 with $21,000 of recoveries YTD Net-Charge Offs to Average Loans Third Coast 0.26% 0.26% (1) Texas Commercial Banks 0.18% 0.16% 0.16% 0.06% 0.06% 0.01% 0.01% – 2018 2019 2020 2021 6/30/22 1) Texas Commercial Banks industry aggregate data per S&P Capital IQ Pro Note: Reflects for the year ended December 31 of the indicated years and as of and for the six months ended June 30, 2022 for Third Coast and for Texas Commercial Banks Source: Company Documents, S&P Capital IQ Pro 16

Asset Quality Trends NPAs Excl. TDRs / Assets Reserve / Loans 1.01% 1.00% 0.97% 0.93% 0.84% 0.65% 0.61% 0.77% 0.48% 0.30% 2018 2019 2020 2021 6/30/22 2018 2019 2020 2021 6/30/22 Reserve / NPAs Excl. TDRs Noncurrent Loans¹ / Loans 261.6% 161.0% 134.5% 0.73% 105.3% 97.6% 0.53% 0.51% 0.50% 0.37% 2018 2019 2020 2021 6/30/22 2018 2019 2020 2021 6/30/22 1) Noncurrent Loans defined as 90 days past due + nonaccrual Source: Company Documents, S&P Capital IQ Pro 17

Deposit Composition Top 10 Deposit Relationships Deposit Composition Balance % of Int. Rate Depositor Type ($000s) Total (%) 0.5% Noninterest-Bearing Depositor 1 Demand $300,009 10.4% 1.66% 1.3% 7.5% Depositor 2 Demand $275,207 9.5% 0.43% 17.9% Interest-Bearing Demand Depositor 3 Demand $190,090 6.6% 1.75% Savings Depositor 4 Demand $188,074 6.5% 1.02% Total Dep: Depositor 5 Demand $149,509 5.2% 1.75% Time Deposits > $100K $2,898 Depositor 6 Demand $100,160 3.5% 1.95% Time Deposits < $100K Depositor 7 Demand $100,001 3.5% 1.60% Depositor 8 Demand / Time $53,114 1.8% 0.60% 72.8% Depositor 9 Demand $50,047 1.7% 1.65% MRQ Cost of Dep: 0.52% Depositor 10 Demand $49,498 1.7% 0.01% Top 10 Relationships 50.2% 0.65% Time Deposit Maturity Schedule Historical Deposit Transformation > $250k < $250k Total Maturity ($000s) ($000s) ($000s) $2,898 < 90 Days $ 40,453 $ 48,469 $88,922 3 to 6 Months $ 21,917 $ 27,684 $49,601 1.84% $2,141 6 to 12 Months $ 48,482 $ 35,552 $84,034 1.45% $1,634 1 to 2 Years $ 1,614 $ 3,967 $5,581 2 to 3 Years – $ 1,167 $1,167 $807 $735 3 to 4 Years $ 1,229 $ 701 $1,930 0.84% 4 to 5 Years – $ 1,164 $1,164 0.47% 0.43% > 5 Years – – – 2018 2019 2020 2021 6/30/22 Total $113,695 $118,704 $232,399 Total Deposits Cost of Deposits Note: Financial information as of June 30, 2022; Dollars in millions unless otherwise noted Source: Company Documents 18

Funding and Liquidity (Dollars in Thousands) Funding and Liquidity as of June 30, 2022 Funding Source Available Balance Total % Available Cash & Cash Equivalents $320,203 – $320,203 100.0% Securities (Available for Sale) – 157,261 157,261 - Brokered Deposits¹ 612,505 227,011 839,516 73.0% Public Funds – 159,020 159,020 - FHLB Advances 771,338 120,425 891,763 86.5% Hold Co Line of Credit – 30,875 30,875 0.00% Fed Funds Line of Credit 50,500 – 50,500 100.0% Hold Co Subordinated Notes – 82,250 82,250 - 1) Available brokered deposits internal policy limit on brokered deposits of 25% of Total Assets Source: Company Documents 19

Net Interest Income Economic Value of Equity Interest Rate Spread & Sensitivity Change Over 12-Month Horizon¹ 12.9% 9.9% 8.9% 6.5% 4.7% 3.2% –– (3.5%) (4.3%) -100 bps Base +100 bps +200 bps +300 bps The Company remains in compliance with internal policies in all stressed scenarios Holding less than 5.0% of assets in securities, the Company is at little risk of accumulating large unrealized gains or losses given changes in the interest rate environment, reducing volatility of capital Recently entered into a $200 million Float-for-Fixed swap 1) As of June 30, 2022 Source: Company Documents 20

Holding Company Bank Level Pro Forma Capital Position Third Coast has not paid and does not intend to pay a common dividend while it continues to reinvest earnings into capital to support organic growth Tang. Common Equity / Tang. Assets¹ 14.2% 11.6% 11.3% 10.9% 9.0% 8.5% 8.2% 7.0% 6.2% 5.5% 19YE 20YE 21YE 6/30/22 Pro Forma ² Total RBC Ratio Tier 1 Capital Ratio Leverage Ratio 15.1% 14.4% 12.5% 12.3% 14.4% 12.6% 13.5% 11.6% 12.5% 11.5% 12.4% 11.9% 10.8% 8.9% 7.2% 19YE 20YE 21YE 6/30/22 Pro Forma ² 19YE 20YE 21YE 6/30/22 Pro Forma ² 19YE 20YE 21YE 6/30/22 Pro Forma ² 1) Non-GAAP financial measure – see appendix for reconciliation of non-GAAP financial measure to most comparable GAAP measure 2) For illustrative purposes only, pro forma adjustments for the proposed offering assume $100.0 million of gross proceeds, $96.3 million of net proceeds after offering costs, 100% of net proceeds are downstreamed to the Bank, and 20% risk-weighting assumed Note: Bank-level Total Risk-Based Capital, Tier 1 Capital and Leverage ratios shown as the Company won’t be required to file consolidated until 2023 Source: Company Documents, S&P Capital IQ Pro 21

Appendix – Board of Directors Hold Co. Director Summary Biography Name Age Since ● Serves as Chairman, President and Chief Executive Officer of Third Coast ● Has over 29 years of banking and public accounting experience and is a Texas licensed attorney and CPA Bart O. Caraway 51 2013 ● Served as CFO and COO for a Houston, TX bank and assisted with de novo formation and integration of two acquisitions ● Created and developed the role of Director of Financial Institutions Services for Briggs & Veselka, Co. ● Partner in Tax services at Ernst & Young from 2007 until her retirement in 2019 ● Over 30 years of experience consulting large multinational companies on tax and accounting matters Carolyn Bailey 61 2019 ● Previously served as America's Digital Tax Administration Services Leader and the US Business Tax Compliance Leader ● Served as Director of Income Tax Reporting and Accounting for Continental Airlines and GE Capital prior to Ernst & Young ● Licensed medical doctor since 1981 ● Founder and president of Basaldua & Heller, P.A, a physician group in Kingwood, TX Dr. Martin Basaldua 71 2013 ● Co-founder of Kingwood Medical Center Hospital ● Organized and led the creation of Methodist Medical Group, PLLC and served as CEO of Methodist Health Services, LLC ● Over 46 years of commercial banking and asset based lending experience ● Currently serves as a Senior Relationship Manager at Fortiter Wealth Management W. Donald Brunson 77 2019 ● Co-founded and served as Chairman of the Board of Bank of Houston ● Served as the first CEO and President of Northwest Crossing National Bank, which was the predecessor to Amegy Bank ● Previously served as EVP and Houston Market President of Third Coast Bank for six years prior to retirement in 2018 ● Also served as the President of Third Coast Commercial Capital from October 2015 to July 2018 Norma J. Galloway 80 2019 ● Has nearly 50 years of banking experience, including 27 years of lending and management with First City Bank, Houston, TX ● Served as Chairman of the Board and President of First City Bank, North Belt ● 17 years of experience with Compass Bank ● President and Partner with Nava & Glander, PLLC and practices primarily in the area of business litigation ● Troy A. Glander 51 2013 Fellow of the Texas Bar Foundation ● Served on the board of directors for the Texas Association of Defense Counsel ● Attorney and currently serves as the COO and General Counsel for Joslin Construction Texas and affiliated companies Shelton J. McDonald 42 2019 ● Principal and COO for Kopis Capital Management ● Prior to Joslin, spent 11 years practicing law and has been licensed to practice by the State Bar of Texas since 2005 ● Currently serves as a Business Development Officer at Third Coast Bank ● Served as director and Treasurer of the San Jacinto Rive Authority Joseph L. Stunja 69 2013 ● Retired as President from Friendswood Development Company after 34 years with the company ● Co-owner and operator Re/MAX Associates Northeast from 1998 to 2010 ● Founded Heritage Bank in 2008 where he served as President, Chairman and Chief Executive Officer Dennis Bonnen 50 2020 ● First elected to the Texas Legislature in 1996 and served until January 2021 for a total of 12 terms ● Served as the Speaker of the Texas House of Representatives from January 2019 to January 2021 ● Previously served as a board member of Heritage Bancorp, Inc. and Heritage Bank since 2017 ● Reagan Swinbank 41 2020 Partner at Sprint Waste Services, and has actively managed Sprint Waste Services since its inception in 2006 ● Also serves as a partner at Sprint Transport and Sprint Landfills 22

Appendix – Historical Financial Highlights (Dollars in thousands, except per share amounts) As of and for the Years ended December 31, YTD 2018 2019 2020 2021 6/30/2022 Balance Sheet Total Assets $845,983 $928,337 $1,867,293 $2,499,412 $3,358,062 Gross Loans HFI $688,359 $808,606 $1,556,092 $2,068,724 $2,749,177 Deposits $734,698 $807,258 $1,633,831 $2,141,199 $2,898,264 Tangible Common Equity¹ $54,452 $57,304 $102,230 $279,681 $282,722 Tangible Book Value Per Share¹ $14.23 $14.88 $16.29 $20.87 $21.00 Tangible Common Equity / Tangible Assets¹ 6.44% 6.17% 5.53% 11.28% 8.47% Profitability Net Income $4,004 $2,381 $12,115 $11,424 $4,364 Diluted Earnings per Share $1.03 $0.60 $1.91 $1.40 $0.32 Efficiency Ratio¹ 80.47% 86.19% 67.18% 74.43% 76.87% Net Interest Margin 4.36% 4.08% 4.24% 4.65% 3.90% Return on Average Assets 0.52% 0.27% 0.73% 0.55% 0.31% Return on Average Equity 7.67% 4.22% 10.74% 6.70% 2.91% Asset Quality NPAs Excl. TDRs to Total Assets 0.84% 0.65% 0.61% 0.48% 0.30% ALLL to NPAs Excl TDRs 97.6% 134.5% 105.3% 161.0% 261.6% ALLL to Total Loans 1.01% 1.00% 0.77% 0.93% 0.97% NCOs to Average Loans 0.01% 0.06% 0.26% 0.16% – Noncurrent Loans / Loans 0.73% 0.53% 0.51% 0.50% 0.37% 1) Non-GAAP financial measure – see appendix for reconciliation of non-GAAP financial measure to most comparable GAAP measure Source: Company Documents; S&P Capital IQ Pro 23

Appendix – Non-GAAP Reconciliations (Dollars in thousands, except per share amounts) As of and for the Years ended December 31, YTD 2018 2019 2020 2021 6/30/2022 Tangible Book Value Per Share Total Shareholders Equity $54,452 $57,304 $121,718 $299,007 $301,967 (-) Goodwill – – 18,034 18,034 18,034 (-) Other Intangibles – – 1,454 1,292 1,211 Tangible Common Equity 54,452 57,304 102,230 279,681 282,722 (÷) Shares Outstanding 3,827,528 3,852,071 6,276,759 13,403,324 13,464,093 Tangible Book Value Per Share $14.23 $14.88 $16.29 $20.87 $21.00 Book Value per Share $14.23 $14.88 $19.39 $22.31 $22.43 Tangible Common Equity / Tangible Assets Total Assets 845,983 928,337 1,867,293 2,499,412 3,358,062 (-) Goodwill – – 18,034 18,034 18,034 (-) Other Intangibles – – 1,454 1,292 1,211 Tangible Assets 845,983 928,337 1,847,805 2,480,086 3,338,817 Total Shareholders Equity 54,452 57,304 121,718 299,007 301,967 (-) Goodwill – – 18,034 18,034 18,034 (-) Other Intangibles – – 1,454 1,292 1,211 Tangible Common Equity 54,452 57,304 102,230 279,681 282,722 (÷) Tangible Assets 845,983 928,337 1,847,805 2,480,086 3,338,817 Tangible Common Equity / Tangible Assets 6.44% 6.17% 5.53% 11.28% 8.47% Total Shareholders Equity / Total Assets 6.44% 6.17% 6.52% 11.96% 8.99% Efficiency Ratio Net Interest Income 30,455 33,951 67,881 90,553 53,520 (+) Noninterest Income 2,159 1,217 2,682 4,878 2,932 Operating Revenue 32,614 35,168 70,563 95,431 56,452 Noninterest Expense 26,244 30,310 47,403 71,025 43,526 (÷) Operating Revenue 32,614 35,168 70,563 95,431 56,452 Efficiency Ratio 80.47% 86.19% 67.18% 74.43% 77.10% Note: Shareholders Equity includes ESOP-owned shares Source: Company Documents; S&P Capital IQ Pro 24

Contact Information Corporate Headquarters Contact Information Bart Caraway Chairman, President & Chief Executive Officer bcaraway@tcbssb.com Third Coast Bancshares, Inc. 20202 Highway 59 North, Suite 190 John McWhorter Humble, TX 77338 Chief Financial Officer jmcwhorter@tcbssb.com 25

Building Relationships. Growing Communities. Doing Good. 26